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Abstract 
The research described in this thesis covers two fields of investigation: 
1) Biaryl and styrene Synthesis by Cross-Coupling of Fluorous-tagged Photo-activated 
Arylgermanes and Towards the Preparation of Boscalid and Analogues 
Biaryls are generally prepared by cross-coupling between aryl metals. However, even the 
most robust of these aryl metal species cannot be carried through complex synthetic 
sequences due to their reactivity particularly towards electrophiles. In this thesis, the 
development of trialkylgermanes as ‘safety-catch’ coupling precursors for biaryl and styrene 
synthesis was achieved. The safety-catch germanes are fluorous-tagged to facilitate parallel 
synthesis using fluorous SPE techniques and are activated towards Pd(0)-catalysed 
cross-coupling with aryl bromides by oxidative photolysis using a UV lamp. The stability 
profile of the fluorous-tagged arylgermanes was examined. They are stable under strong 
basic, nucleophilic and reductive conditions but labile in acidic and oxidative environments. 
This stability profile provides unique opportunities for synthetic route design in target 
orientated syntheses by allowing the germane group to be installed early in the sequence but 
only activated for cross-coupling when required. This method has been applied to the 
synthesis of the plant anti-fungal agent boscalid® and its alkynyl derivatives. 
2) Novel Protocol for Solid Phase Synthesis of Radio-iodinated Ligands for Imaging 
of Cannabinoid Receptors in the Brain 
Rimonabant® is a CB1 receptor antagonist indicated for the treatment of obesity, metabolic 
syndrome, addiction and smoking cessation. Radio-labelled analogues are potential PET 
(Positron Emission Tomography) and SPECT (Single Photon Emission Computed 
Tomography) imaging agents for visualising the distribution of cannabinoid receptors in 
the brain for medical research. Conventional methods for the preparation of radio-iodinated 
cannabinoid receptor ligands employ organostannane precursors which undergo 
electrophilic ipso-iododestannylation with concomitant formation of toxic organostannane 
by-products. Rigorous removed of organostannane residues is necessary prior to injection 
the ligand for in vivo experiments. In this thesis, a novel, non-toxic, solid-supported and 
facile approach for the parallel synthesis of iodinated cannabinoid receptor ligands based 
on the skeleton of rimonabant has been demonstrated. 
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1. Introduction 
The research described in this thesis is focused on the development of phase-tagged 
organogermanes to achieve: (i) ‘safety-catch’ germyl-Stille cross coupling with aryl 
bromides to furnish biphenyls and styrenes and (ii) parallel synthesis of 
iodobisarylpyrazole-based cannabinoid receptor (CB1) inverse agonists via 
ipso-iododegermylation.  
Phase-tagged arylgermanes have been demonstrated to be robust and facile coupling 
partners that can withstand a wide range of chemical manipulation procedures as 
exemplified by a novel synthesis of the anti-fungal agent boscalid and its 
derivatives. In addition, alkenyl germanes have been shown to be competent partners 
for cross coupling with aryl bromides to give styrenes. 
The iododegermylation method was developed to provide ‘proof-of-concept’ for 
liberation of radio-active CB1 inverse agonists for positron emission tomography 
(PET) and single photon emission computed tomography (SPECT).  
The following sections of this introduction provide pertinent background information 
to several key areas of chemistry that relate directly to the above work as presented 
later in this thesis. 
 
1.1 Solid-Phase Methods in Organic Synthesis 
Since the first introduction of solid-phase peptide and oligosaccharide synthesis by 
Merrifield in 1963,1 solid-phase organic synthesis (SPOS) has been widely adopted 
by organic chemists to achieve combinatorial synthesis of structurally diverse 
pharmaceutical molecular libraries. The key concept for SPOS methodology is to 
tether a simple molecule onto an insoluble polymer-support and then build-up 
complexity by planned chemical transformations and then cleave the final product 
off the resin (Merrifield’s protocol). There are several advantages of SPOS over 
normal solution phase approaches. One major benefit is the facile separation and 
purification of intermediates by simple filtration of the reaction mixture. Moreover, 
due to this ease of purification, all transformations applied during SPOS can be 
achieved using a large excess of reagents to drive reactions to completion. In addition, 
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a so-called ′pseudo-dilution effect′2 is pronounced and facilitates macrocyclisation in 
SPOS relative to in solution phase synthesis. For example in 1995, Hauske 
introduced an acid-labile carbamate linker to deliver, high purity products following 
macrocyclisation of ′drug-like′ libraries mediated by Pd(0) under mild conditions. All 
of the macrocycles (20- to 24-membered rings) were liberated from the resins under 
traceless cleavage conditions and obtained in good overall yields (Scheme 1.1.1).3 
 
Scheme 1.1.1 Hauske’s macrocyclisation on a solid-support resins.3 
Although Merrifield’s protocol for SPOS has many advantages over conventional 
solution phase reactions, it has some drawbacks: functionalised resins are difficult to 
characterise and reactions are difficult to monitor in real time in comparison with 
solution phase chemistry; reaction rates can be slow; extra steps are necessary to 
anchor and to release substrates from the resin; convergent synthetic strategies are 
not applicable; and certain reactions can only be carried out on specific types of 
resin. 
Some of these disadvantages can be overcome by introducing solid-supported 
reagents which are reactive chemicals immobilised on a polymer-support resin for 
carrying out chemical transformations in solution (Ley’s protocol).4 This concept 
also encompasses the development of solid-supported scavengers to remove excess 
organic or metallic reagents from solution phase reactions. Solid-supported reagents 
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and scavengers facilitate in situ purification of reaction mixtures, leaving the desired 
products in solution for convenient identification. Conventional multi-step 
transformations in solution can be performed using sequential solid-supported 
reagents and scavengers to telescope workup and purification procedures. In addition, 
this approach can also be applied to convergent syntheses to achieve higher reaction 
yields than in the corresponding linear counterparts. 
Ley demonstrated the former facet by employing solid-supported reagents to effect 
the clean and efficient total synthesis of several natural products (e.g. oxomartidine 
and epimartidine) (Scheme 1.1.2).5 
 
Scheme 1.1.2 Ley’s total synthesis of ()-oxomaritidine and ()-epimaritidine.5 
Both the Merrifield and the Ley approaches to SPOS have been widely applied in 
automated combinatorial and parallel synthesis in industry for rapidly preparing 
drug-like small molecules for property screening (e.g. as new pharmaceuticals). 
However, slower conversion rates than for the corresponding transformations in 
solution remains a weakness due to the biphasic interactions between the polymer 
and solution. 
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1.2 Fluorous-Phase Technology in Organic Synthesis 
To circumvent the drawbacks inherent to solid-supported technologies, alternative 
approaches using homogeneous ′beadless′ phase-tagged chemistry have been 
introduced to facilitate separation whilst retaining solution phase kinetics. Among all 
of these beadless approaches, fluorous phase-tag anchoring of substrates to enable 
easy separation, monitoring, analysis and characterisation has become the method of 
choice. Fluorous-phase synthesis was pioneered by Zhu6 followed by extensive 
studies in this field by Horváth and Rabái,7 and by Curran.8 
The unique chemical interactions between perfluoroalkyl chains and fluorous-rich 
environments is the essential element in fluorous synthesis. Perfluoroalkyl chains 
[CF3(CF2)m(CH2)n which will be abbreviated as Rf in this thesis] consist of two parts: 
the perfluoroalkyl and the alkyl domains. The perfluoroalkyl part dominates the 
affinity of the whole molecule with a fluorous phase to effect easy separation; the 
alkyl part isolates the electron deficient perfluoroalkyl domain from reaction sites of 
anchored substrates. Generally, Rf-tags are chemically inert to reaction conditions. 
The term ′heavy fluorous′ is applied to molecules bearing more than 60 % fluorine 
by weight, whereas ′light fluorous′ indicates those with less than 40 % of fluorine by 
weight. 
 
1.2.1 Application of heavy fluorous-tags in organic synthesis 
Heavy fluorous compounds display high affinity for fluorous solvents and form 
biphasic layers with organic solvents at certain temperature ranges. At elevated 
reaction temperatures, monophasic behaviour is observed and reactions proceed as in 
conventional solution phase conditions. Upon cooling down, biphasic behaviour is 
observed and the organic and fluorous compounds are partitioned into the two layers, 
allowing them to be separated (Figure 1.2.1).7,9 
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Figure 1.2.1 Fluorous biphasic reaction system for in situ separation of organic product from fluorous 
compounds.7,9 
Fluorous solvents are of higher density than organic solvents and water, and 
specifically solvate Rf-tagged compounds. This property is employed for fluorous 
liquid-liquid extractions (F-LLE). Heavy fluorous compounds can be separated from 
organic and water-soluble components by a triphasic liquid-liquid extraction 
procedure (Figure 1.2.2).10  
 
Figure 1.2.2 Three-phase fluorous liquid-liquid extraction (F-LLE).10 
Curran reported a triphasic fluorous liquid-liquid extraction procedure to demonstrate 
how a Rf-tag could be attached and then released from a substrate to facilitate 
purification of intermediates during addition of a Grignard reagent to an aldehyde.8 
The Rf-tagged intermediate was retained in the fluorous layer (FC-72) of the three 
phase extraction, whereas the Rf-tag-ree desired product was released into the 
organic layer in high yield and purity (Scheme 1.2.1). 
organic 
aqueous 
fluorous 
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Scheme 1.2.1 Curran’s three-phase F-LLE concept to effect a simple separation.8 
However, to achieve high partition coefficients of Rf-tagged components in F-LLE, a 
large number of fluorine atoms (60 or more) are required. Consequently, these heavy 
Rf-tagged molecules are not atom economic for synthesis. 
 
1.2.2 Recent developments in light fluorous-tagged chemistry 
In order to meet the criteria for the development of atom economic and automated 
phase-tagged methodology, light Rf-tags were introduced. Due to the low affinity of 
light Rf-tagged compounds for fluorous solvents, they are not efficiently separated 
by triphasic fluorous liquid-liquid extraction. Curran therefore addressed the 
separation of light Rf-tagged molecules by introducing fluorous solid-phase 
extraction (F-SPE)11 and reverse phase fluorous HPLC (RP F-HPLC).12 These 
technologies constitute more reliable and rapid technologies than F-LLE, and have 
been automated in industry for high-throughput organic synthesis and combinatorial 
chemistry.13-15  
Light Rf-tagged compounds generally have similar physical properties to their tag- 
free congeners (e.g. polarity, reactivity and solubility) and can be envisaged to give a 
comparable outcome when applying literature conditions reported in solution phase 
without serious modification. Moreover, reactions, intermediates and products with a 
light Rf-tag can be monitored and characterised by TLC, IR, NMR and MS, and can 
be easily separated from non Rf-tagged compounds by F-SPE. 
The stationary phase of an F-SPE cartridge is a Rf-chain grafted reverse phase silica 
gel. FluoroFlash are commercial and the F-SPE cartridges are available in various 
loading capacity with Rf length of C8F17. This method relies on strong interactions 
between the Rf-chains on the stationary phase and on the Rf-tagged compounds. 
Perfluoroorganic compounds have strong affinity to fluorous solvents and fluorous 
reverse-phase silica gel. This is probably resulting from the extremely low surface 
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tension (γ) of perfluoroorganic compounds in comparison with ordinary organic 
solvents (e.g. γMeCN = 28.5; γTHF = 26.9; γMeOH = 22.4 at 25 oC) and water (γwater = 72). 
The low surface tension of perfluoroalkanes have the tendency to aggregate forming 
films by excluding solvent from between the perfluoro chains on the Rf-tagged 
compounds and those on the fluorous stationary phase of the F-SPE cartridge. This is 
prevalent under the solvent system with high surface tension (fluorophobic solvents). 
As such, this promotes the van der waals forces of the perfluoroalkyl functionalities, 
resulting in high affinity of the two fluorous components.16 
Upon loading a mixture of Rf-tagged and non-fluorous components onto a 
pre-conditioned F-SPE cartridge, the non-fluorous compound can be washed off with 
fluorophobic solvents (typically 50:50 → 80:20 MeOH-H2O, γMeOH(aq) = 35.5 and 
27.4, respectively).17 By decreasing the percentage of water, the surface tension of 
the mobile phase is reduced and that alters the behaviour of this system into 
fluorophilic solvents (e.g. 100% MeOH, MeCN or THF). Fluorophilic solvents are 
pervasive between perfluoroalkanes hence breaking the interaction amongst them. 
Therefore, the Rf-tagged compound is then eluted by these solvents. 
An example using the F-SPE procedure to separate an Rf-tagged orange dye from a 
non-fluorous blue dye is shown below (Figure 1.2.3).10 
 
Figure 1.2.3 An F-SPE demonstration of the separation of a Rf-tagged dye (orange) and non-fluorous 
dye (blue).10 
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Our group has reported a proof-of-concept study for isotope containment during the 
preparation of potentially 14C labelled 4-phenylpiperidine pharmacophores by use of 
a light Rf-tagged germanium linker to devolatilise labelled-bromobenzene and allow 
use of the F-SPE method to purify all intermediates (Scheme 1.2.2).18 
 
Scheme 1.2.2 Spivey’s proof-of concept study using a light Rf-tagged germanium linker to achieve 
devolatilisation of potentially [14C]-labelled bromobenzene and rapid purification during synthesis of 
pharmacophores.18 
 
1.3 Biaryls - Importance and Synthesis 
Biaryls are pervasive structural motifs in natural products,19 agrochemicals,20 and 
dyes. Polyaromatics are key structures in dye-sensitized solar cells (DSSCs)21 and 
organic light-emitting devices (OLEDs).22 Biaryl scaffolds introduced in drug-like 
small molecules have been used to increase inhibitor-receptor binding affinities23 and 
for inhibition of protein-protein interactions24 during the development of new drugs. 
Statistical data reveals that greater than 4.3% of all pharmaceutics bear this subunit.23 
In addition, biaryls are found in many organocatalysts (e.g. Spivey’s chiral DMAP)25 
and ligands (e.g. Noyori’s BINAP,26 BINOL27 and Kocovsky’s NOBIN28) for 
asymmetric synthesis. Recently, a family of dialkylbiaryl phosphine ligands have 
been developed by Buchwald29 that form highly reactive complexes with transition 
metals such as Pd(0) for applications in catalytic chemistry (Scheme 1.3.1). 
 9
PPh2
PPh2
OH
OH
BINAP BINOL
N
R2
Spivey's chiral DMAP
P(R4)2
R1
R2
R3
Buchwald's ligands
N(R1)2
NH2
OH
NOBIN
 
Scheme 1.3.1 Examples of organocatalysts and ligands containing biaryl units. 
The below section briefly reviews methods to the construction of aryl-aryl bonds 
including via copper mediated coupling reactions, nucleophilic substitution and 
aryne intermediates. More recent approaches involving palladium catalysed 
cross-coupling of aryl halides with organostannanes (Stille coupling), organosilanes 
(Hiyama-Denmark coupling) and organogermanes (germyl-Stille coupling) will be 
discussed in Chapter 2 of this thesis. 
 
1.3.1 Copper mediated biaryl bond formation 
1.3.1.1 The Ullmann Reaction 
The formation of aryl-aryl bonds is a crucial transformation in synthetic chemistry. 
The first research into biaryl bond formation research was reported by Ullmann in 
190130 and since then, hundreds of methods of biaryl coupling have been reported. 
Ullmann reported subjecting aryl halides with an excess amount of copper powder at 
elevated temperature (over 200 oC) to give a symmetrical biaryl and a copper halide 
(Scheme 1.3.2).30 
 
Scheme 1.3.2 Ullmann’s biaryl formation using Copper powder.30 
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Employing dimethylformamide (DMF) as solvent and using pre-activated copper 
powder, which is made from reduction of CuI with potassium, allows this reaction to 
proceed at lower temperature (about 100 oC).  
Mechanistic studies of the Ullmann coupling reveal two possible pathways: (1) 
through arylcopper intermediates formed by oxidative addition of Cu(0) to aryl 
halides giving ArCu(II) followed by reduction with Cu(0) to give ArCu(I). The 
ArCu(I) then oxidatively adds to another molecule of aryl halide affording an 
Ar-Cu(III)X-Ar reactive intermediate which undergoes reductive elimination to 
furnish biaryls and Cu(I)X;31 or (2) via Cu(0) initialling the formation of aryl radicals 
followed by bi-aryl radical coupling to form aryl-aryl bonds32 (Scheme 1.3.3). 
 
Scheme 1.3.3 Two possible mechanisms for the Ullmann reaction. 
Atropisomerically enriched biaryls can be obtained by introduction of a chiral group 
on the aryl halides prior to Ullmann-type coupling. For example, Meyers reported 
formation of various biaryls by Ullmann-type coupling between two (S)-oxazoline 
functionalised aryl bromides. A good diastereomeric ratio (93:7) of the desired 
(S)-biaryl resulted from a steric repulsion by the two isopropyl groups on the two 
oxazolines in the Aryl*-Cu(III)Br-Aryl* intermediate. The thermodynamically 
favoured (S)-biaryl was obtained after reductive elimination and was applied in the 
total synthesis of ellagitannins (Scheme 1.3.4).33 
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Scheme 1.3.4 Meyers’ asymmetric Ullmann-type biaryl coupling en route to ellagitannin.33 
Unsymmetrical biaryls can be obtained by direct subjection of carefully-selected aryl 
halides to optimised Ullmann coupling conditions. A large excess of one aryl halide 
component is required to achieve good reaction yields. However, difficult to control 
reaction conditions and tedious purification procedures limit the application of this 
method in synthesis.34 
 
1.3.1.2 Unsymmetrical biaryl formation using arylcuprates 
A more practical strategy for unsymmetrical biaryl formation using bisarylcuprates 
was reported by Lipshutz in 1993. By employing two pre-formed aryllithium 
reagents sequentially and a stoichiomertic amount of Cu(I)CN at low temperature, a 
higher order (H.O.) bisarylcuprate [Ar1Ar2Cu(CN)Li2] intermediate was formed 
which upon in situ oxidation with a molecule of oxygen gave the desired biaryls. 
Electron-rich, neutral, sterically hindered and heterocyclic biaryls were prepared by 
this method in excellent yields (Scheme 1.3.5).35  
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Scheme 1.3.5 Lipshutz’s method for the synthesis of unsymmetrical biaryls by oxidative coupling of 
in situ generated of H.O. bisarylcuprates.35 
 
1.3.1.3 Decarboxylative coupling 
More recently, Gooßen has developed a more concise and convenient catalytic biaryl 
coupling method by employing arylcarboxylic acids and CuI to achieve Pd(0) 
catalysed decarboxylative cross-coupling with aryl bromides at elevated temperature 
(Scheme 1.3.6).36  
 
Scheme 1.3.6 Gooßen’s Copper-mediated decarboxylative cross-coupling catalysed by Pd(0).36 
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Biaryls were formed in good to quantitative yields when electron-deficient and 
heteroaromatic carboxylic acids were coupled with electron-deficient and 
electron-rich aryl bromides. Cross-coupling of sterically demanding aryl bromides 
required excess CuCO3 and the use of KF as an additive. However, electron-rich 
arylcarboxylic acids gave inferior yields even when using excess CuCO3.  
Mechanistic studies revealed that CuI directly facilitated decarboxylation of the 
arylbenzoate salts to give reactive arylcopper intermediates (ArCu) which 
immediately undergo transmetalation with the arylpalladium species derived from 
Pd(0) oxidative addition to the aryl halide. Upon reductive elimination, biaryls are 
obtained with regeneration of Pd(0) (Scheme 1.3.7).37 
 
Scheme 1.3.7 The proposed mechanism for Gooßen’s decarboxylative cross-coupling reaction.37 
As both the copper salt and Pd(0) are administrated in just catalytic amounts for most 
substrates, CO2 is the only by-product from the reaction and no pre-formed 
organometallic coupling partners are required, this direct decarboxylative 
cross-coupling method is suited to industrial scale biaryl-forming processes. 
 
1.3.2 Biaryl formation by nucleophilic aromatic substitution (SNAr)  
Aryl halides cannot participate in direct bimolecular nucleophilic substitution (SN2) 
reactions as aliphatic halides can. Instead, aryl halides and certain other aryls 
containing electron-withdrawing groups (e.g. NO2, oxazoline, ester, sulfonyl) at the 
ortho- and/or para-positions can participate in nucleophilic substitution reactions 
through a stepwise addition-elimination mechanism. The addition-elimination 
process is referred to as the SNAr reaction mechanism. The addition of the 
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nucleophile to the electron-deficient aromatic ring at the ipso-position of the halide 
substituent is usually the rate-determining step and so is particularly favoured the 
following order: F > Cl > Br > I. 
By employing aryllithium or aryl Grignard reagents as the nucleophile, biaryls can be 
prepared by this route. With the introduction of a suitable chiral auxiliary on the 
substrates, axial chirality of the biaryl can be controlled.38 For example, Hattori has 
described a method for the preparation of racemic NOBIN derivatives by SNAr using 
a naphthyl Grignard reagent and 1-alkoxy-2-nitronaphthalene. However, employing 
an optically pure menthoxyl chiral auxiliary in place of the methoxy group an 
asymmetric SNAr reaction resulted to give the product in moderate yield (51 %) and 
enantioselectivity (78 % ee).39  
Our group is currently developing a potentially more efficient approach for the 
preparation of enantiomerically enriched NOBIN by employing an axial chiral 
DMAP to effect a kinetic resolution of racemic NOBIN prepared by Hattori’s method 
(Scheme 1.3.8). 
 
Scheme 1.3.8 Spivey’s approach to the resolution of NOBIN prepared by an achiral SNAr reaction. 
 
1.3.3 Biaryl formation via aryne intermediates 
Arynes such as benzyne are generally generated by elimination of a suitable leaving 
group ortho to a carbanion on an aromatic system. The aryne intermediates are 
highly reactive towards nucleophilic addition to furnish substituted aromatics and 
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can be used to form biaryls. Buchwald introduced a concise and practical method for 
the preparation of dialkylbiaryl phosphine ligands through a benzyne intermediate. 
The benzyne intermediate was generated by direct formation of the Grignard reagent 
from 2-bromochlorobenzene followed by elimination of chloride after which the 
benzyne was trapped by another aryl Grignard reagent giving a biaryl carbanion and 
then sequentially reacted with chlorodialkylphosphine to furnish the desired biaryl 
phosphine ligands in moderate overall yields (Scheme 1.3.9).40 
 
Scheme 1.3.9 Buchwald’s procedure for the preparation of dialkylbiaryl phosphine ligands.40 
This procedure has been applied on a multi-kilogram scale for commercialisation of 
the Buchwald ligands. 
 
1.4 Molecular imaging chemistry 
Molecular imaging refers to multidisciplinary technologies encompassing medicine, 
chemistry, pharmacology and nuclear medicine to monitor and visualise living 
biological subjects in real time. Molecular imaging generally involves administering 
specific biomarkers or radiolabelled tracers into living organisms for characterisation 
and quantification of biological processes or for pathological diagnosis at the cellular 
or subcellular level by tomographic image generation.41  
There are several modalities that are currently used for molecular imaging such as 
computed tomography with X-rays (CT), magnetic resonance imaging (MRI), 
positron emission tomography (PET), single photon emission computed tomography 
(SPECT), optical imaging and ultrasound examination. These technologies are 
non-invasive, high resolution procedures that can be employed in routine operations 
which are widely used for clinical diagnosis, pathological research and recently in 
new drug development.42 By combining tomographic technologies (e.g. PET-CT, 
SPECT-CT and PET-MRI), real time detection at the molecular or cellular level with 
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high spatial resolution is possible. To elaborate biological processes more precisely 
in living subjects, high affinity, target-directed biomarkers or radioactive ligands are 
essential and the development of these relies on synthetic chemistry. 
The basic concepts and recent advances in PET and SPECT are briefly described in 
the following section. Development of synthetic radiolabelling methodology will be 
discussed in Chapter 3 of this thesis. 
 
1.4.1 Basic concept and advances in PET 
PET scanning was first achieved by Kuhl and Edwards in 1964.43 PET requires a 
radiolabelled imaging agent containing nuclei that decay by emission of a positron 
(+). The emitted positron only travels a certain short distance in tissues before being 
annihilated with an electron to produce two photons with 511 keV energy. These 
-rays radiate in opposite directions (180o0.25o). Detection of the two -rays 
generated simultaneously from positron annihilation by an array of detectors 
followed by coincidence processing allows image reconstruction and display on a 
screen (Figure 1.4.1). 
HO
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Figure 1.4.1 PET processing (the image was reproduced and modified from the original source).44 
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The probe molecules for PET scanning are normally positron decay nuclei labelled 
pharmaceuticals. The radioisotopes generally used for direct replacement of a cold 
nucleus in a commercial drug are 11C, 14O, 15O, 13N and 124I. The isotopic 
replacement has no significant affect on the physicochemical and pharmacokinetic 
properties of the drug. As there is no positron emitting isotope of hydrogen, 
substitution of a hydrogen atom or a hydroxyl group with the 18F isotope is a 
common tactic. The fluorine atom has similar van der Waal’s radius as a hydrogen 
atom (1.35 Å cf. 1.20 Å respectively), so no critical steric effects result from the 
fluorine-hydrogen replacement. However, as fluorine is the most electronegative 
atom, electronic and lipophilic characteristics of the F-replaced pharmaceutical are 
altered.  
Pharmacological studies indicate that the affinity of F-replaced drugs for certain 
targets may be enhanced due to their decreased lipophilicity as compared to the 
parent compound in certain cases. In addition, the 18F isotope emits positron of low 
energy resulting in a short positron range and consequently high spatial resolution. 
The half-life (t1/2) of the 18F isotope is 109 minutes which allows multistep chemical 
transformations for compound preparation and relative long tracing time in vivo 
(Table 1.4.1).45 
Nuclei t1/2 (min) 
Maximum 
energy (MeV) Mode of decay
Example of drugs and its specific 
applications 
18F 109 0.64 + (97 %) EC (3 %)a 
6-[18F]-fluoro-L-DOPA 
Presynaptic dopaminergic system 
Parkinson’s disease 
11C 20.3 0.97 + (99 %) [
11C]-raclopride 
Dopamine D2/D3 receptors 
13N 10 1.20 + (100 %) [
13N]-cisplatin 
Glioblastoma; tumour 
124I 4.2 days 2.14 + (25 %) EC (75 %) 
124I-AZGP 
Tumour hypoxia tracer 
15O 2 1.74 + (100 %) H2
15O 
Solid tumour blood perfusion  
aElectron capture decay; 124I-AZGP: [124I]-iodo-azomycin galactopyranoside 
Table 1.4.1 Common radionuclides for PET imaging, examples and applications in living subjects. 
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The concentration of tracer in tissues required for recording a PET image is in the 
range 1-10 pM (10-12 mol/L) and PET detection has no depth limit for the 
radiolabelled probes. PET scanning can also provide quantitative drug concentration 
data in living subjects. However, low spatial resolution and high expense (due to the 
requirement for most positron isotopes to be generated in situ from a cyclotron) 
relative to alternative imaging methods limits the current applications of PET. 
Nevertheless, PET is a powerful tomographic technology in medical research and 
clinical diagnosis. 
 
1.4.2 Molecular imaging with SPECT 
The technology for SPECT is similar to PET. The radioisotopes used in SPECT 
however decay with direct emission of -rays. These are collected by detectors 
named gamma-cameras which comprise an array of scintillators converting the 
emitted -rays into visible light. Electronic signals are generated based on the 
intensity of the visible light which, following image reconstruction, are displayed as 
tomographic images. 
In general, the -emitting isotopes for SPECT imaging probes have a longer half-life 
time than the positron-emitting nuclei used in PET scanning. As a consequence, more 
sophisticated chemical transformations and modifications from precursor compounds 
to install the isotope onto pharmaceuticals are possible (Table 1.4.2). 
Nuclei t1/2 
γ energy 
(keV) 
Examples of drugs and specific applications 
99mTc 6 h 140 (89 %)
99mTc-DTPA 
Brain, kidneys 
123I 13.2 h 159 (83 %)
123I--CIT 
Dopaminergic system 
201Tl 73 h 
167 (10 %),
80 (20 %), 
71 (47 %) 
201TlCl 
Bronchioloalveolar cell carcinoma (BAC) 
111mIn 2.83 d 245 (94 %)
111mIn-octreotid 
Somatostain receptors 
Table 1.4.2 Radionuclides for SPECT imaging, examples and applications. 
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Unlike the high energy -rays collected by the PET detector, the SPECT detector is 
sensitive to low energy -rays directly decaying from the radioisotope labelled probe 
compound. As a result, scattering and attenuation of the signal by the surrounding 
matrix affects the sensitivity and resolution of SPECT. Therefore, both the sensitivity 
(10-100 pm cf. 1-10 pm) and spatial resolution of SPECT is less than that of PET. 
However, SPECT-CT hybrid systems are currently being developed which allow 
these differences to be minimised.  
The advantages of SPECT over PET imaging include the lower cost for SPECT 
imaging and the possibility of using simultaneous multi-isotopic probes for imaging 
in vivo. This is possible because the -rays from separated isotopically labelled 
compounds can be distinguished by their different emission energies. This is not 
possible for a PET system as the -rays from different nuclei have the same emitted 
energy  (Figure 1.4.2).46 
 
Figure 1.4.2 Simultaneous multi-isotopic SPECT-CT image of a mouse: the thyroid (123I, blue), heart 
(201TI, green) and bones (99mTc, orange), co-registered with a CT scan (yellow).46 
Modern molecular imaging modalities such as PET, PET-CT, SPECT and SPECT-CT 
provide comprehensive schemes for visualising targets in living subjects and have 
been adopted by the pharmaceutical industry for smart drug development 
programmes.  
 
 
 20
2. Development of novel aryl- and alkenyl- cross-coupling reactions 
based on light fluorous-tagged organogermanes 
Transition metal catalysed cross-coupling reactions have been developed and applied 
to the synthesis of a wide rage of aryl-containing compounds such as biaryls and 
styrenes for several decades. Amongst the transition elements, Pd has the 
extraordinary ability to catalyse the formation of carbon-carbon bonds between 
unsaturated centres.47 
Pd is a late transition metal that forms d8 and d10 complexes in a low oxidative state 
that are highly polarisable. Thus, it is categorised as being soft and easily accepts 
electrons to fill its empty d-orbitals (the LUMO) and therefore performs as a Lewis 
acid (electrophile). Meanwhile its fully occupied non-bonding d-orbitals (the HOMO) 
are available to donate electrons as a Lewis base (nucleophile). The dual electronic 
aptitude of Pd results in high affinity towards non-polarised -enriched substrates 
(e.g. alkenes, alkynes and arenes) forming -palladium complexes followed by 
insertion and cross-coupling reactions (Scheme 2.1.1).48  
 
Scheme 2.1.1 The Dewar-Chatt-Duncanson (DCD) model of -Pd complexation with an alkenyl 
halide.48 
The use of Pd(0)-mediated cross-coupling between aryl halides and pre-formed aryl 
organometallics has received the most attention. These reactions include the Stille 
reaction (organostannes),49 the Suzuki reaction (organoborates),50 the Negishi 
reaction (organozincs),51 the Hiyama reaction (organosilanes),52 and the Kumada 
reaction (Grignard reagents).53 The Sonogashira reaction54 and the Heck reaction55 
are related processes for coupling aryl halides with alkynyl and alkenyl components 
respectively (Scheme 2.1.2).  
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Scheme 2.1.2 Summary of transition metal-catalysed cross-coupling reactions. 
In the Negishi reaction, organozincs are used which are moisture sensitive, as are the 
Grignard reagents used in the Kumada reactions. Although the Suzuki reaction is 
used widely for cross-coupling reactions because it uses non-hazardous 
organoboranes as substrates, homo-coupling products often accompany the desired 
cross-coupling products and in many cases cause difficulties for purification by 
column chromatography.56 Even though many organoborane building blocks are 
commercially available, the preparation and purification of customised 
organoboranes for coupling purposes is often tedious. 
In this section, Pd-mediated cross-coupling reactions involving group 14 elements 
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will be reviewed with a focus on advances in organosilane and organogermane based 
coupling protocols as an alternative approach to the Stille coupling. 
 
2.1 Pd-catalysed cross-coupling reactions of organostannanes (The Stille 
reaction) 
Pd-catalysed cross-coupling of organostannanes with aryl- or alkenyl- halides is 
referred to as Stille coupling. Because organostannes are stable to moisture and air, 
and are tolerant to various functional groups, Stille coupling represents a facile 
method for construction of biaryl or styrenyl systems. The high reactivity of 
organostannanes in Stille coupling is due to the polarised carbon-tin bond. Therefore, 
pre-activation of the substrate is not generally required for Stille coupling to take 
place. However, organostannanes are labile to strong nucleophiles and organolithium 
reagents and so the organostannane functionality can only be installed in the 
molecule immediately prior to the coupling step. The main drawbacks of Stille 
coupling are the toxicity of organostannanes and of the tin-containing by-products, 
particularly when Stille coupling is used on a large scale.  
 
2.1.1 The mechanism the Stille reaction 
A general catalytic cycle for aryl-aryl cross-coupling has been proposed (Scheme 
2.1.3).57,58 
PdL2
oxidative addition
Ar2 X
Ar1-M
Ar1 = Aryl
M = SnR3, B(OR)2, SiR3
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Ar1 Ar2
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-2L
Pd LAr2
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Pd XAr2
L
L
Ar1
Ar2 L
r.d.s
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Scheme 2.1.3. A general catalytic cycle for Pd(0)-catalysed cross-coupling reactions.57,58   
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Firstly, the pre-catalyst PdL4 (18e-) eliminates two ligands to form the nucleophilic 
Pd(0)-catalyst, PdL2 (14e-), which reacts with the electrophilic aryl halide through 
oxidative addition to give a 16-electron cis-Pd(II)-complex which subsequently 
isomerises to the more stable trans-Pd(II)-complex. The trans-Pd(II)-complex 
undergoes transmetalation with the organometallic component (Ar1-SnR3 in the case 
of the Stille coupling) with concomitant release of the corresponding organometallic 
halide (XMR3). This transmetalation step is usually the rate determining step in this 
catalytic cycle. In the final step of the catalytic cycle, the biaryl is formed via a 
reductive elimination process and the active Pd(0)-catalyst is regenerated. These 
individual steps are examined in more detail below. 
 
2.1.2 Generation of reactive Pd(0) complexes from Pd(II) precursors 
An 18-electron Pd(0) precursor such as Pd(PPh3)4 is required to participate in the 
catalytic cycle. Dissociation of two coordinated ligands is necessary to form a 
reactive 14-electron Pd(0) catalyst. There are alternative methods to obtain 14e- Pd(0) 
catalysts in situ by reduction of Pd(II) pre-catalysts with phosphine ligands,59,60 
sacrificial organometallics61, or amines in the reaction mixture (Scheme2.1.4).  
 
Scheme 2.1.4. Examples of in situ generation of activated Pd(0) from Pd(II) pre-catalysts.  
Most Pd(II) pre-catalysts are bench-stable reagents and more stable to air than their 
Pd(0) congeners. Consequently, employing Pd(II) pre-catalysts for coupling reactions 
is a routine procedure. 
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2.1.3 The oxidative addition 
Pd(0) complexes are nucleophilic and undergo oxidative addition with aryl halide or 
aryl pseudohalide electrophiles to give a 16-electron Pd(II)-complexes. The rate of 
oxidative addition follows the order: Ar-I > Ar-OTf  Ar-Br >>Ar-Cl. Although aryl 
chloride building blocks are more readily available and cost less than the 
corresponding bromides, iodides and triflates, they are not often appropriate coupling 
partners for practical chemistry due to their sluggish oxidative addition rate, however 
appropriate choice of ligands can help in this regard (vide infra). 
For example, Buchwald has developed some highly reactive Pd(0) catalytic systems 
by introducing dialkylbiaryl phosphines as ligands to achieve the Suzuki coupling of 
non-activated aryl chlorides with arylboronic acids to give biaryls in excellent yields 
at room temperature (Scheme 2.1.5).62  
 
Scheme 2.1.5. Buchwald’s Suzuki coupling with aryl chlorides using DavePhos as ligand.62 
These bulky, strongly -donating phosphine ligands coordinate to Pd(0) resulting in 
an electron-rich Pd(0) centre which facilitates oxidative addition. The principles used 
for designing of these biaryl ligands and the functions of the substituents have been 
elaborated by Buchwald (Scheme 2.1.6).29 
 
Scheme 2.1.6. Buchwald’s dialkylbiaryl phosphine ligands and the functions of their structural 
features.29 
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Although the dialkylbiaryl phosphine ligands were initially designed for Suzuki 
coupling, these versatile ligands are compatible and profitable for other 
cross-coupling protocols catalysed by palladium including amination of aromatic 
rings because these protocols have similar catalytic cycles.63  
Aryl pseudohalides are alternative coupling partners. Pseudohalides include: triflate 
(OTf), nonaflate (ONf), methanesulfonate (OMs), 4-toluenesulfonate (4-TsO) and 
diazonium salts (N2+). Amongst these, organotriflates are the most commonly used in 
Pd-catalysed cross-coupling reactions. However, the reactivity of aryl triflates 
towards oxidative addition of Pd(0) differs from aryl halides and addition of LiCl is 
often essential.64 Comprehensive studies on additives for coupling with 
organotriflates indicated that LiCl can either accelerate or retard reaction rates by 
various mechanisms.65,66 The effect of LiCl on the catalytic cycle is discussed in the 
following section.  
 
2.1.4 The transmetalation 
The transmetalation step is the second step of the cross-coupling catalytic cycle and 
usually the rate-determining step of the whole processes. There are two proposed 
mechanisms: dissociative and associative.  
In the dissociative pathway, the 16 electron Pd(II) complex eliminates a ligand to 
form a 14 electron T-shape Pd(II) complex prior to transmetalation with an 
arylstannane. The arylstannane acts as a nucleophile towards the 14 electron Pd(II) 
complex with concomitant electrophilic cleavage of the C-Sn bond. This is described 
as an SE2 transition state mechanism. This mechanism produces a trans Pd(II) 
complex which is isomerised into a cis conformation for reductive elimination. The 
trans-to-cis isomerisation process is achieved by a dissociative mechanism via the 
T-shape intermediate. The SE2 transmetalation dissociative pathway was originally 
proposed by Stille (Scheme 2.1.7).61 
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Scheme 2.1.7. Stille’s proposed dissociative mechanism for transmetalation through a 14-electron 
T-shaped intermediate.61 
Although the dissociative pathway through a 14-electron, three-coordinate complex 
has been observed commonly in Pt chemistry,67 the evidence in the case of Pd is not 
compelling and as a result Espinet has proposed a transmetalation step which goes 
through an associative pathway.56,66 In the associative pathway, the 16 electron Pd(II) 
complex interacts with the arylstannane nucleophile via either a cyclic or an open 
transition state to generate the Ar1Ar2PdL2 complex. 
The cyclic transition state is preferred when the X substituent is a halide in a 
moderately coordinating solvent. The strong coordination between the halide and the 
SnR3 group polarises the C-Sn bond and enhances the nucleophility at the 
ipso-carbon of the arylstannane. A 4-membered cyclic transition state is formed 
which facilitates the transmetalation. The structural features of the cyclic transition 
state are the retention of configuration at the ipso-position of Ar1 and the cis 
geometry between the Ar1 and Ar2 groups. Therefore, the cis Ar1Ar2PdL2 
intermediate yielded by the 4-membered cyclic transition state is ready for the 
subsequent reductive elimination to furnish biaryls (Scheme 2.1.8).68 
 
Scheme 2.1.8. Espinet’s proposed associative mechanism for transmetallation through a 4-membered 
cyclic transition state.68 
The open transition state associative pathway is favoured when the X substituent of 
the Ar2PdIIL2X complex is triflate (OTf) for example, in a polar solvent (e.g. DMF or 
NMP). A solvato [Ar2PdIIL2S]OTf complex is formed which interacts with the 
arylstannane via an associative 5-coordinate open transition state allowing the Ar1 
group to replace the solvent ligand giving a trans Ar1PdAr2L2 complex which is 
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subsequently isomerised into a cis Ar1Ar2PdL2 species (Scheme 2.1.9).68 
 
Scheme 2.1.9. Espinet’s proposed associative mechanism for transmetallation through an open 
transition state.68 
As indicated above, cross-coupling of aryl triflates (Ar2OTf) with organostannanes 
can be promoted by employing LiCl as additive.64 However, Farina noted that the 
addition of LiCl to Stille reactions with organic triflates can enhance or inhibit their 
progress.65,66  
Espinet has investigated the effect of LiCl on Stille coupling of aryl triflates. In 
weakly coordinating solvents (e.g. THF) and in the absence of LiCl, the 
rate-determining step of the catalytic cycle is oxidative addition of Pd(0) to the 
Ar2OTf furnishing an Ar2PdIIL2OTf complex which subsequently forms a solvato 
Ar2PdIIL2(THF) intermediate. This intermediate is reluctant to participate in the 
following transmetalation step. LiCl promotes this step by rapidly displacing the 
solvent ligand to give a more reactive Ar2PdIIL2Cl intermediate (route A, Scheme 
2.1.10). 
By contrast, in highly polar, strongly coordinating solvents (e.g. NMP), the solvato 
Ar2PdIIL2(NMP) complex rapidly undergoes transmetalation with organostannanes. 
Therefore, LiCl is normally not required for coupling organotriflates in strongly 
coordinating solvents (route B, Scheme 2.1.10).69,70 
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Scheme 2.1.10. Espinet’s proposed mechanism of coupling with aryl triflates and the involvement of 
LiCl in different solvent systems.69 
Hartwig has proposed that LiCl enhances the rate of oxidative addition by increasing 
the dielectric constant of the reaction media. This can also explain why LiCl is not a 
promoter for reactions in highly polar solvent systems.71 
 
2.1.5 The reductive elimination 
The reductive elimination is the final step of the catalytic cycle to furnish the desired 
biaryls or cross-coupling products. The cis 14-electron T-shape Ar1Ar1PdL 
intermediate produced from associative transmetalation via cyclic or open transition 
states is required for reductive elimination. This step is promoted by polar media 
which are able to stabilise the cis T-shape intermediate and facilitate trans-to-cis 
isomerisation. In addition, the dissociation of a ligand from the Ar1Ar2PdL2 complex 
to give the T-shape Ar1Ar2PdL species is believed to be the rate-determining step of 
the reductive elimination process.72  
Employing bulky electron-rich ligands such as dialkylbiaryl phosphine ligands is 
beneficial for both oxidative addition and reductive elimination steps.29 The 
advantages of using bulky electron-rich ligands can be attributed to steric73 and 
electronic74 effects. 
The efficiency of reductive elimination to afford biaryls is sensitive to the electron 
density of the two aromatics and the -donating behaviour of the ligand on the Pd(II) 
intermediate. Hartwig concluded that more electron rich aromatics on the Pd(II) 
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complex facilitate the reductive elimination as does a significant electronic difference 
between the two aromatics undergoing reductive elimination. Additionally, strong 
-donating ligands on the Ar1Ar2PdL complex induce a concerted reductive 
elimination more rapidly than weak -donating ligands.74 
 
2.1.6 The role of copper additives 
The addition of CuI as a co-catalyst to enhance the rate of Stille cross-coupling 
reactions was first mentioned by Marino in 1988,75 and the ‘copper effect’ has been 
investigated by Farina,76 Espinet77 and Baldwin.78 This effect is now believed to 
accrue from the formation of a reactive arylcuprate intermediate (Ar1Cu) from the 
corresponding arylstannane prior to Cu to Pd transmetalation in highly polar solvents 
such as DMF and NMP (Scheme 2.1.11).  
 
Scheme 2.1.11. Baldwin’s Sn to Cu pre-transmetalation prior to Cu to Pd transmetalation for the Stille 
coupling in the presence of CuI.78 
In particular, the synergistic effect of CuI and F- in cross-coupling as described by 
Baldwin seems to be practically efficient.78 
 
2.1.2 Phase-tagged organostannanes in cross-coupling reactions 
Transition metal catalysed cross-coupling reactions for stitching building blocks 
together and increasing molecular complexity have been repeatedly demonstrated to 
be synthetically valuable. By merging recent developments in SPOS with palladium 
catalysed cross-coupling reactions, phase-tagged cross-coupling strategies provide 
for rapid elaboration of biaryl libraries and natural products. 
Metal-catalysed SPOS cross-coupling reactions encompass (1) tagged-electrophiles 
(organic halides); (2) tagged-nucleophiles (organometallics) and (3) tagged-transition 
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metal catalysts. Employing phase-tagged organostannanes for Stille coupling 
reactions is attractive in view of the toxicity and tedious purification of the reagents 
in solution. The latter two phase-tagged methods provide the possibility to recycle 
and regenerate tagged-coupling partners or catalysts.79  
The first phase-tagged Stille coupling was reported in 1994 by Deshpande who 
coupled polymer-supported aryl iodides with organostannanes with a catalytic 
amount of Pd(0) and AsPh3 to give the desired products in excellent yields.80 Ellman 
also demonstrated Stille coupling between polymer-supported arylstannanes and acyl 
chlorides en route to a 1,4-benzodiazepine library (Scheme 2.1.12).81  
 
Scheme 2.1.12. Ellman’s SPOS of 1,4-benzodiazepine derivatives using Stille coupling.81 
However, these two approaches have drawbacks accruing from the formation of 
hazardous tin waste which requires further treatment. Several methods were 
developed to graft organostannanes onto polymer supports,82,83 fluorous phases84 and 
ionic liquids and allow traceless cleavage to yield the expected organic products 
whilst the toxic and environmentally hazardous tin-containing moieties were retained 
on the phase tags.  
Espinet developed co-polymerised norbornenyl (copoly-NB) grafted with 
dialkylstannanyl chloride as a precursor for cross-coupling. The products were 
separated by simple filtration and the remaining copoly-NB bound tin halide was 
recycled and regenerated for further applications. The tin content in solution was 
found on average to be just 0.04 % by weight over 5-coupling cycles (Scheme 
2.1.13).83  
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Scheme 2.1.13 Espinet’s recyclable polymer-supported organostannanes for Stille coupling.83  
Fluorous phase tagging has also been applied for Stille coupling. For example, 
Curran coupled heavy fluorous-tagged organostannanes with organic halides assisted 
by microwave irradiation to yield the desired products in good yield and in short 
reaction times. Purification was performed by tri-phasic fluorous liquid-liquid 
extraction (F-LLE) with water, CH2Cl2 and FC-84. The non-fluorous organic 
compounds were retrieved from the CH2Cl2 layer, the fluorous-tagged tin halide 
by-products were contained in the FC-84 layer, and the inorganic salts resided in the 
water layer (Scheme 2.1.14).84  
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Scheme 2.1.14 Curran’s fluorous-tagged organostannanes for the Stille coupling and separation by 
tri-phasic F-LLE.84  
The tagged-tin moieties retained in the FC-84 were anticipated to be able to be 
recovered and regenerated, although the authors did not report this. 
Stille cross-coupling pervades many academic research fields for the construction 
complex molecules from simple building blocks. In spite of the efforts expended to 
immobilise organostannane coupling partners onto phase-tags in order to minimise 
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tin contamination, safety issues limit application of the methods in large scale 
pharmaceutical production. Consequently, alternative non-hazardous, low-cost and 
versatile organometallics for cross-coupling are in high demand. 
 
2.2 Pd-catalysed cross-coupling reactions of organosilanes 
In contrast to organostannanes, organosilanes are non-toxic and bench-stable 
reagents which can act as nucleophiles in cross-coupling with aryl and alkenyl 
electrophiles to furnish biaryls, styrenes and polyalkenes. This methodology was 
pioneered by Hiyama85 and Denmark86 and is often known as Hiyama-Denmark 
cross-coupling. 
Hiyama-Denmark cross-coupling occurs via a similar catalytic cycle (oxidative 
addition, transmetalation and reductive elimination) to that described for Stille 
coupling. However, in contrast to the polarised C-Sn bond in organostannanes which 
undergoes facile transmetalation with an Ar2PdLX complex, the C-Si bond in 
organosilanes is less polarized and so tetravalent organosilanes are resistant to 
transmetalation.  
To enhance the reactivity of organosilanes in cross-coupling and allow their 
application in synthesis, Hiyama first recognised that nucleophilic promoters were 
required to render appropriate substrates hypervalent and hence more susceptible to 
cross-coupling. The extracoordination ability of Si results from the vacant 3d orbitals 
which can mix with the valence shell electrons to form sp3d and sp3d2 hybridisations. 
These hybrid orbitals accommodate extra bonds to the Si centre giving penta- and 
hexavalency, respectively. The pivotal hypervalency of Si dominates the reactivity of 
Si-complexes by altering the electron density of the Si centre. The Lewis acidity of 
the Si centre is proportional to the hypervalency. The less s character in the 
hybridisation of the Si, the stronger the Lewis acidity. These structural and reactivity 
features are illustrated below (Scheme 2.2.1).87  
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Scheme 2.2.1 Structural and reactivity features of hypervalent Si complexes.87  
Organosilanes can be activated by anionic nucleophiles such as tetrabutylammonium 
fluoride (TBAF), tetramethylammonium fluoride (TMAF), 
tris(dimethylamino)sulfonium trimethyldifluorosilicate (TASF), CsF, KF, potassium 
trimethylsilanolate (KOTMS), Ag2O, NaOH and even Cs2CO3. Due to the strong 
Si-F bond (560 kJ/mol), fluoride ions generally provide the highest yield of 
cross-coupling products. Transmetallation is generally believed to be the 
rate-determining step in Hiyama-Denmark cross-coupling and this step proceeds via 
either an SE2 four-membered cyclic or an SE2 open transition state (Scheme 
2.2.2).88,89  
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Scheme 2.2.2. Proposed pathways for transmetalation during Hiyama-Denmark cross-coupling 
promoted by fluoride ions.88,89 
There are various strategies for preparation of organosilane derivatives that can act as 
substrates for in situ activation and sequential cross-coupling to furnish the desired 
products. 
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2.2.1 Fluoride promoted reactions 
In 1989, Hiyama first reported examples of fluoride ion promoted cross-coupling of 
various alkenyl- and alkynyl trimethylsilanes with aryl and alkenyl halides in good 
yields.85 However, inferior outcomes were obtained when attempting to couple 
styrenyl- and allyl trimethylsilanes with organic halides. Hiyama therefore 
introduced alkenyl fluoromethylsilanes as substrates for Pd-catalysed cross-coupling 
reactions activated by fluoride ions. He studied the influence of the fluoro-substituent 
on the Si centre. Alkenyl monofluorodimethylsilanes were found to be more effective 
coupling substrates than the corresponding difluoromonomethylsilanes. Additionally, 
trimethyl- and trifluorosilanes were chemically inert towards the cross-coupling 
conditions (Scheme 2.2.3).90  
 
Scheme 2.2.3. Hiyama’s of cross-coupling of alkenyl fluorosilanes with 1-iodonaphthalene and the 
influence of fluoro-substituents.90  
Hiyama applied this method for aryl-aryl bond formation by employing aryl 
fluoromethylsilanes and aryl iodides in the presence of a fluoride ion source. 
Coupling of less active aryl fluorosilanes with aryl iodides required a higher loading 
level of Pd-catalyst and elevated temperatures in comparison with alkenyl-type 
coupling conditions. The optimised conditions for aryl fluorosilane cross-coupling 
with organic iodides can be summarised as follows: (1) two fluoro-substituents on Si 
are essential; (2) fluoride ions are important for coupling efficiency, and (3) using 
untransferable ethyl- or propyl groups on the Si centre gives better results than 
methyl analogues. A noticeable amount of methylated aryl by-product was found 
when aryl difluoromethylsilane was used for cross-coupling, whereas ethyl- and 
propyl derivatives gave biaryl product exclusively. Trifluorosilanes were completely 
inactive as had been observed in coupling with alkenyl derivatives.  
The scope of this method was demonstrated by cross-coupling ArSiF2Et and 
ArSiF2nPr with various aryl iodides giving biaryls in moderate to excellent yields 
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(Scheme 2.2.4).91  
Ph-SiFnR(3-n) + I Ac
[allylPdCl]2 (5 mol%)
KF (2.0 eq.)
DMF, 100 oC
Ph Ac
R = Me n = 0 24 h 12 %
R = Me n = 1 24 h 15 %
R = Me n = 2 12 h 68 %
R = Me n = 3 24 h 0 %
R = n-Pr n = 2 12 h 87 %
+ I
[allylPdCl]2 (5 mol%)
KF (2.0 eq.)
DMF, 80-100 oC
SiF2R
R1 R2 R2R1
R = Et or n-Pr 45-94 %  
Scheme 2.2.4. Hiyama’s cross-coupling of aryl fluorosilanes with aryl iodides.91  
Aryl-aryl coupling reactions employing dichlorosilane derivatives were also 
achieved by Hiyama. The performance of ArSiCl2Et compounds is in fact superior to 
that of their ArSiF2Et analogues in coupling with a variety of aryl iodides for the 
preparation of highly functionalised biaryls as extremely low Pd catalyst loading 
levels are required (0.5 mol% cf. 5 mol% whilst employing ArSiF2Et as substrates).92  
In 1997, Shibata reported a protocol for aryl-aryl cross-coupling by employing aryl 
trimethoxysilanes which were prepared by nucleophilic addition of aryllithium or 
aryl Grignard reagents to tetrachlorosilane followed by solvolysis with MeOH. Upon 
pre-treatment of the aryl trimethoxysilanes with TBAF, activated pentavalent aryl 
fluorotrimethoxysilicates were generated which participated in cross-coupling with a 
variety of aryl bromides catalysed by a catalytic amount of Pd(OAc)2 with PPh3 as a 
ligand. Electron deficient, neutral and rich aryl trimethoxysilanes coupled smoothly 
with aryl bromides bearing diverse functionalities to give biaryls in good yields. It is 
noteworthy that no homo-coupling products were detected and the other 
side-products were found in very limited amounts (Scheme 2.2.5).93  
 
Scheme 2.2.5. Shibata’s cross-coupling aryl trimethoxysilanes with aryl bromides facilitated by 
TBAF.93  
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In 1999, Denmark designed alkenylsilacyclobutanes (siletanes) as efficient coupling 
precursors for cross-coupling with activation by fluoride ions. The driving force for 
coupling was originally envisaged to accrue from released angle strain of the 
silacyclobutane moiety (79o cf. 109o bond angle in the sp3 Si) during formation of the 
corresponding activated pentavalent fluorosilanes. However, it was subsequently 
found that these initial pentavalent fluorosilanes were transformed into dimeric 
fluorosiloxane intermediates, and these are in fact the active coupling intermediates 
(Scheme 2.2.6).92-94 
 
Scheme 2.2.6. Denmark’s fluoride promoted silacyclobutane cross-coupling.94,95  
Alkynyl- and alkenyl methylsilacyclobutanes are easily prepared and act as useful 
precursors of reactive intermediates for cross-coupling. Although aryl 
methylsilacyclobutanes might be envisaged to be coupled with aryl halides via 
similar dimeric fluorosiloxane intermediates, they proved to be too stable to be 
activated efficiently by fluoride ions and couple poorly.  
Aryl siletanes bearing at least one heteroatom-substituent on Si are required to allow 
cross-coupling.96 Even so, the reactivity of aryl siletanes is lower than alkenyl 
derivatives so harsher conditions are required to carry out cross-coupling reactions. 
Harsher conditions lead to undesired side-products such as those resulting from 
homo-coupling and protodesilylation, although the use of appropriate ligands can 
suppress these side-reactions.97  
Denmark developed 4-anisyl halosilacyclobutanes to study the reactivity of this type 
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of aryl-aryl cross-coupling. Preliminary results revealed that coupling of 4-anisyl 
chlorosilacyclobutane with iodobenzene was promoted by TBAF to give the desired 
biaryl in just 7 % yield, whereas the more electronegative fluoride substituted 
congener coupled in 25 % yield under the same conditions (Scheme 2.2.7).86  
 
Scheme 2.2.7. Pd-catalysed cross-coupling of (4-anisyl)halosilacyclobutanes with iodobenzene 
promoted by fluoride ions.86 
Using optimised conditions, 4-anisyl chlorosilacyclobutane couples efficiently with 
electron-rich, neutral, -deficient heterocyclic and sterically hindered aryl iodides 
furnishing biaryls in excellent yields (Scheme 2.2.8).86 
 
Scheme 2.2.8. Aryl-aryl cross-coupling of 4-anisyl chlorosilacyclobutane with functionalised aryl 
iodides.86 
Aryl silanes such as halosilanes, trialkoxysilanes, silacyclobutanes (siletanes) and 
halosilacyclobutanes have been demonstrated to successfully serve as practical 
substrates to achieve cross-coupling with organic halides catalysed by Pd(0) and 
promoted by a source of nucleophile to form a pentavalent reactive intermediate. In 
order to constitute practical aryl-aryl cross-coupling reactions, at least one 
heteroatom on the arylsilane is essential.  However, the drawback and limitation of 
these arylsilane surrogates is that they are labile to moisture, acidic and basic 
conditions, and unable to be purified by column chromatography. Recently, 
all-carbon-substituted alkenyl silanes (e.g. alkenyl 2-pyridyl-98 and alkenyl 2-thienyl 
silanes)99 have been developed as coupling partners, in which the 
heterocyclic-substituents on the Si act as precursors to hydroxyl groups after 
treatment with a source of fluoride ions. The corresponding alkenyl silanols are 
therefore formed in situ as the active intermediates for coupling. The improved 
stability of all-carbon-substituted alkenyl silanes overcomes the drawbacks and 
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limitations encountered when using heteroatom-substituted silanes as coupling 
partners directly. The coupling processes are referred to as ‘safety-catch’ silanes. 
In 2003, Hiyama discovered that allyl groups on silanes are converted into hydroxyl 
groups upon activation by fluoride ions. Aryl triallylsilanes were shown to be stable 
for a long periods of time to treatment with 1 M NaOH(aq.) and briefly stable while 
subjected to 1 M HCl(aq.). However, treatment with TBAF in DMSO-H2O (10:1) 
furnished aryl silanol analogues which coupled with similar efficiencies as aryl 
siletanes. Pentavalent fluorosilicate intermediates formed in situ were suggested to be 
the active species for effective coupling.100 This protocol is compatible with aryl 
bromides bearing various electronic and steric demands and gives the desired biaryls 
in excellent yields (Scheme 2.2.9).101  
 
Scheme 2.2.9. Hiyama’s use of aryl triallylsilanes as surrogates for silanols for cross-coupling with 
aryl bromides facilitated by TBAF.101  
In 2006, Murata reported a series of silylation reactions between (2-furyl)- and 
(2-thienyl)methylhydrosilanes and aryl iodides catalysed by Pd(0) to afford the 
corresponding aryl silanes. These silanes were suggested to be stable towards many 
chemical manipulations and serve as effective precursors to aryl silanols for 
cross-coupling reactions. This protocol provides a convenient and efficient method 
for the preparation of stable all-carbon-substituted silane-based coupling agents. For 
example, treatment of di(2-furyl)methylhydrosilane with iodobenzene in the presence 
of Pd(dba)3．CHCl3 and tri(2-Tol)3P gave phenyl di(2-furyl)methylsilane in 82 % 
yield. (Scheme 2.2.10).102  
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Scheme 2.2.10. Murata’s silylation of aryl iodides by cross-coupling with (2-furyl)- and 
(2-thienyl)methylhydrolsilanes.102  
Upon treatment of phenyl di(2-furyl)methylsilane with TBAF and H2O, the 2-furyl 
groups coordinate with TBAF through an ionic interaction and deliver fluoride ion 
onto the Si centre mediating cleavage of the furan and formation of a pentavalent 
fluorosilicate.103,104 The in situ formed fluorosilicate intermediate then cross-couples 
with e.g. 1-bromo-4-(trifluoromethyl)benzene catalysed by PdCl2(dppf) to give the 
biaryl product in 76 % yield (Scheme 2.2.11).102  
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Scheme 2.2.11. Murata‘s cross-coupling of phenyldi(2-furyl)methylsilane and 
1-bromo-4-trifluoromethylbenzene.102  
 
2.2.2 Fluoride-free organosilane-based cross-coupling reactions 
Although fluoride ion promoted Pd-catalysed organosilane-based cross-coupling 
protocols have shown some advantages and display high efficiency preparing biaryls, 
these methods are not applicable to substrates containing silyl protecting groups. In 
addition, fluoride ions are generally required in excess which presents difficulties for 
large-scale operation. Consequently, methods that do not require a fluoride activator 
are demanded.  
In 1997, Hiyama first reported NaOH as a Lewis base activator to mediate 
cross-coupling of alkenyl- and aryl dichloroethylsilanes with aryl halides to give 
styrenes and biaryls at temperature lower than 60 oC with low catalyst loading (0.5 - 
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1 mol%). The KF-promoted cross coupling protocol required harsher conditions (i.e. 
80-120 oC) and high Pd loading level (5 mol%),92 for example, cross-coupling of 
4-anisyl dichloroethylsilane with 2-bromopyridine in the presence of NaOH and 
catalytic amount of Pd(0) in THF at 60 oC gave the corresponding biaryl in 64 % 
yield whereas, KF promoted coupling reaction with the same halide using the 
difluoroethylsilane congener under catalytic conditions in DMF at 120 oC produced 
the biaryl in just 23 % yield. Moreover, silyl protection groups were tolerated under 
the coupling promoted by NaOH. In the case of coupling trimethylsilyl (TMS) 
protected alkenylchloroethylsilanes with aryl bromides, 2-TMS-styrenes were 
obtained in good yields (Scheme 2.2.12).105 
 
Scheme 2.2.12. Hiyama’s cross-coupling of aryl- and alkenyl dichloroethylsilanes with aryl halides 
promoted by NaOH.105  
Hiyama also investigated cross-coupling of aryl silanols106 and silanediols100 with 
aryl halides activated by Ag2O. Aryl silanediols proved more reactive than the 
corresponding silanols which required longer reaction times and gave only moderate 
yields. By contrast, Ag2O promoted cross-coupling of silanediols derivatives with 
aryl iodides gave high yields. Furthermore, it is noteworthy that only a 
substoichiometric amount of Ag2O was required in contrast with large excess of 
NaOH required (85 mol% cf. 6.0 eq.). 
Hiyama suggested that the high affinity of silver salts for halides meant that Ag2O 
acts as a halophilic activator which interacts with the halides in the Ar2PdIIXL2 
complex, via a 6-membered transition state, polarising the Pd-halogen bond such that 
a cationic Pd-centre is formed. This might explain the superior coupling of aryl 
iodides relative to aryl bromides Moreover, Ag2O may concomitantly coordinate to 
the silanediol rendering it pentavalent and therefore more reactive towards 
transmetalation (Scheme 2.2.13).100 
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Scheme 2.2.13. Hiyama’s cross-coupling of aryl silanediols with aryl iodides via a proposed reactive 
pentavalent intermediate formed by the bifunctional Ag2O activator.100  
In 2008, Denmark developed a series of high performance fluoride-free 
cross-coupling reactions of alkenyl- and aryl dimethylsilanols (SiMe2OH) with 
organic halides under basic conditions. These methods employed various inexpensive 
Brønsted bases such as KOTMS, CsOH, NaOt-Bu, NaH and NaHMDS as activators 
which form organosilanolate salts that promote the transmetalation step. Depending 
on the conditions, dimethylsilanoates are formed by reversible deprotonation, 
irreversible deprotonation, isolation, or via silanolate exchange (Scheme 2.2.14).107  
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Scheme 2.2.14. Denmark’s four methods for cross-coupling organosilanols with aryl halides promoted 
by Brønsted bases.107  
Denmark performed experiments to elucidate mechanistic and kinetic features of 
these reactions. Based on examination of the turnover-limiting step in cross-coupling 
of 1-heptenyl dimethylsilanol with 2-iodothiophene, Denmark concluded that the 
major role of the organosilanolate salts was to accelerate the rate of 
transmetalation.108 
Two possible transmetalation mechanisms were considered: route (a) where the 
transmetalation proceeded via the tetracoordinated 2-thienyl-Pd(II) silanolate 
intermediate, and route (b) where another molecule of deprotonated silanolate salt 
acts as a nucleophile attacking the tetracoordinated intermediate leading to a 
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pentavalent 2-thienyl-Pd(II) siloxane salt which facilitates an intramolecular 
transmetalation (Scheme 2.2.15).107  
 
Scheme 2.2.15. Denmark’s proposed mechanisms for silanolate transmetallation.107  
A first-order rate dependence on silanolate even when employing a stoichiomertic 
amount of Pd(0) catalyst revealed that the transmetalation occurred directly through 
route (a). The proposed nucleophilic activation of the arylPd(II) silanolate 
intermediate by a second molecule of silanolate to form the pentavalent arylPd(II) 
siloxane salt (route b) would have displayed second-order dependence in silanolate. 
The high reactivity of Brønsted base promoted silanol cross-coupling protocols 
appears therefore to be due to the formation of an arylPd(II) silanolate complex 
containing a Si-O-Pd linkage which undergoes rapid transmetalation. The structure 
of a complex containing a Si-O-Pd bond was elucidated by X-ray crystallography 
from an independently synthesised arylPd(II) aryl silanolate complex. Re-subjection 
of this isolated intermediate to the coupling conditions, without promoter, gave a 
quantitative yield of a biaryl.107  
 
2.2.3 Phase-tagged organosilanes in cross-coupling reactions 
No examples of phase-tagged organosilanes being used in synthesis have been 
reported but Hiyama has coupled soluble aryl difluoroalkylsilanes with 
solid-supported 4-iodobenzoic acid using TBAF as the promoter. TFA was used to 
effect traceless cleavage off the resin and the corresponding biaryl carboxylic acids 
were obtained in quantitative yield in the case of using aryl difluorocyclohexylsilanes 
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(Table 2.2.1).109,110  
 
Entry R R1 X Yield (%) 
1 Et 4-OMe F >99 
2 cyclohexyl 4-OMe F 98  
3 Et 4-F F mixture of products 
4 cyclohexyl 4-F F 94  
5 Et 2-OMe Cl 82 
6 cyclohexyl 2-OMe F >99 
Table 2.2.1. Hiyama’s cross-coupling of aryl halosilanes with solid-supported 4-iodobenzoic 
acid.109,110  
 
2.3 Pd-catalysed cross-coupling of organogermanes  
Although in the same group as Si and Sn, Ge derivatives have been studied less 
extensively for cross-coupling. This is probably because of the higher cost and lower 
reactivity of organogermanes compared to organosilanes and organostannanes. 
Nevertheless, with several advantages over organosilanes and organostannanes, such 
as low-toxicity111-115 and high tolerance to chemical manipulations, organogermanes 
deserve to be more widely used in organic synthesis. 
Organogermanes exhibit better stability towards strongly nucleophilic and basic 
conditions because C-Ge bonds are less polarised than C-Si and C-Sn bonds. This is 
because Ge is the closest in electronegativity to C amongst the group 14 elements (C, 
2.55; Si, 1.90; Ge, 2.01; Sn, 1.96 on the Pauling scale).114 Although Ge is located a 
row below Si in the periodic table, it is more electronegative as a result of d-block 
contraction (also know as scandide contraction) in which the filled 3d electrons 
cannot shield efficiently the increasing nuclear charge for those elements which are 
positioned immediately after the first row of transition metals. This results in Ge 
having a small atomic radius and a relatively high electronegativity.116 As a result, 
strong activation of organogermanes is required to achieve Ge hypervalency which is 
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probably essential for cross-coupling. Nevertheless, the less polarised C-Ge bond as 
compared to C-Sn and C-Si bonds provides a broader stability profile and allows for 
a wider range of chemical transformations prior to cross-coupling. 
In 1990, Kikukawa published the first Pd-catalysed cross-coupling of alkenyl 
trimethylgermanes with arenediazonium tetrafluoroborates (ArN2+BF4-) to give 
coupling products in good yields. However, the stereo- and regiochemistry of the 
products did not transfer cleanly from the configuration of the germane substrates 
(Table 2.3.1).117  
 
Entry Germanes ArN2BF4 Yield  Product ratio 
 (E)- : (Z)- : α-  (%) (E)- : -sub. 
1 94 : 6 : 0 4-Me-C6H4 82 52 : 48 
2 94 : 6 : 0 Ph 83 66 : 34 
3 94 : 6 : 0 4-NO2- C6H4 81 85 : 15 
4 18 : 82 : 0 4-Me-C6H4 85 64 : 36 
5 18 : 82 : 0 Ph 88 73 : 27 
6 18 : 82 : 0 4-NO2- C6H4 95 88 : 12 
7 0 : 0 : 100 4-Me-C6H4 85 100 : 0 
8 0 : 0 : 100 Ph 92 100 : 0 
9 0 : 0 : 100 4-NO2- C6H4 88 100 : 0 
Table 2.3.1. Kikukawa’s cross-coupling of styrenyl germanes with arenediazonium 
tetrafluoroborates.117  
Cross-coupling of (E)- or (Z)-styrenyl trimethylgermanes with various 
arenediazonium salts gave a significant amount of -substituted styrenes via a 
cine-coupling pathway. Notably, regardless of the stereochemistry of the styrenyl 
germanes, (E)-stilbenes were obtained as the major ipso-coupling products (entries 
1-6). The -substituted styrenyl germane exhibit noteworthy regio- and 
stereoselectivity to furnish (E)-stilbenes exclusively in good yields (entries 7-9). 
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Kosugi described the first arylgermane-based cross-coupling reactions in 1996. He 
cross-coupled a series of aryl-, alkenyl-, alkynyl- and allyl-2,8,9-tricarbagermatranes 
with 4-bromotoluene in the presence of Pd2(dba)3.CHCl3 as catalyst with various 
phosphine ligands to give biaryls (Table 2.3.2).118  
 
Entry R Ligand Yield (%) 
1 nButyl PPh(2-Tol)2 8 
2 Allyl PPh3 88 (77)a 
3 Phenyl (2-Tol)3P 95 (85)a 
4 Vinyl (2-Tol)3P 82 
5 1-Ethoxyvinyl PPh(2-Tol)2 59 
6 Phenylethynyl PPh(2-Tol)2 67 
a Isolated yields   
Table 2.3.2. Kosugi’s cross-coupling of 2,8,9-tricarbagermatranes and 4-bromotoluene.118  
These cross-coupling reactions gave moderate to excellent yields except in the case 
where R was butyl (entry 1). Notably the reactions proceeded in the absence of 
fluoride ions due to the trans-annular coordination between the N and Ge which 
enhances the reactivity of the tricarbagermatranes by rendering the Ge centre 
permanently hypervalent. 
In 2002, Oshima reported a convenient method for Pd-catalysed germylation of aryl 
iodides by tri(2-furyl)germane giving the corresponding arylgermanes for use as 
cross-coupling partners (Table 2.3.3).119 
 
Entry Ar1X Yield (%) 
1 PhI 83 
2 4-OMeC6H4I 80 
3 4-MeC6H4I 85 
Table 2.3.3. Oshima’s Pd-catalysed germylation of aryl halides with tri(2-furyl)germane.119  
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The coupling proceeded well with aryl iodides but was sensitive to sterically 
demanding and aryl bromide substrates which gave inferior yields (entries 4-6). The 
2-furyl groups act as precursors to hydroxy groups in a similar manner to the 
2-heteroarylsilane cases discussed previously.103,104 After refluxing the aryl 
tri(2-furyl)germanes with TBAF in THF for 5 h, 1H and 19F NMR spectra indicated 
that the three furyl-substituents had been replaced by hydroxyl and fluoride groups 
leading to [ArGe(OH)3F]- as reactive intermediates for cross-coupling with various 
aryl halides, catalysed by Pd2dba3 and P(2-furyl)3 as ligand to yield biaryls (Table 
2.3.4).119 
 
Entry Ar1 Ar2X Yield (%) 
1 4-OMe PhI 90 
2 4-OMe PhBr 100 
3 4-OMe 3-CF3-C6H4-Br 80 
4 4-OMe 1-iodonaphthalene 70 
5 4-OMe 3-MeO-C6H4-I 59 
6 4-OMe 4-Me-C6H4-I 56 
7 H PhI 61 
8 H 3-CF3-C6H4-Br 64 
9 H 1-iodonaphthelene 52 
10 3-OMe PhI 59 
11 3-OMe 3-CF3-C6H4-Br 64 
12 3-OMe 1-iodonaphthalene 65 
Table 2.3.4. Oshima’s cross-coupling of tri(2-furyl)arylgermanes 94 and aryl halides.119  
Both iodobenzene and bromobenzene gave excellent yields (entries 1 and 2). Aryl 
halides bearing electron-withdrawing groups gave higher yields than 
electron-donating groups (cf. entries 3, 5 and 6). Steric effects were also significant: 
3-anisylsubstituted arylgermane afforded lower yields of biaryls than its 4-anisyl 
analogue (cf. entries 2 vs. 4 and 10 vs. 12). 
No examples of phase-tagged organogermanes being used in synthesis had been 
reported prior to the work described in this thesis. 
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2.4  Preliminary Results – Prior work in the group 
The germyl-Stille cross-coupling reaction has been developed in our group first by 
Chris Gripton (Spivey group, 1999-2004)120 and then by Joseph Hannah (Spivey 
group, 2002-2006).121 Gripton found that aryl dihaloalkylgermanes but not aryl 
monohalodialkylgermanes or trialkylgermanes cross-coupled with 
bis(3,5-trifluoromethyl)bromobenzene in the presence of Pd2dba3 and PPh3 to give 
the corresponding biphenyl in 36 % yield (Table 2.4.1).120,122 
 
Reagents and conditions: i) Pd2dba3, PPh3, CsF, THF, reflux, 24 h. 
Entry X Y Yield (%)a 
1 Me Me 0 
2 Me Cl 0 
3 Cl Cl 36 
a: GC/MS results  
Table 2.4.1. Gripton’s demonstration of the effect of halogen substituents at germanium on 
cross-coupling.120,122  
Hannah found that the dihydroxy germane generated in situ by treating a related 
dichloroalkylarylgermane with aqueous Na2CO3 also coupled with 
bis(3,5-trifluoromethyl)bromobenzene under Gripton’s conditions to give biphenyl in 
35 % yield. Additionally, he found that treatment of the dichloroalkylarylgermane 
with copper(II) fluoride gave a 1:1 mixture of difluoroalkylarylgermane and 
dichloroalkylarylgermane, which cross-coupled in 45 % yield (Table 2.4.2).121 
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Reagents and conditions: i) PdCl2(MeCN)2, (10 mol %), dppp (15 mol%), KF, DMF, 120 oC, 16 h. 
Entry X Yield (%) 
1 OH 35 
2 F/Cla 45 
a: 1:1 mixture of dichloro- and difluorogermane 
Table 2.4.2. Hannah’s use of dihydroxy and difluoro germanes for cross-coupling.121 
These results suggested that more electronegative atoms at Ge give higher yields of 
cross-coupling products. Consequently, a photooxidation process was developed to 
access difluorogermanes. Light fluorous-tagged (Rf-tagged) arylgermane was found 
to be ‘activated’ by irradiation with a high pressure Hg lamp in the presence of 
copper(II) tetrafluoroborate to give a presumed difluoroalkylarylgermane 
intermediate with liberation of two equivalents of 2-(methoxymethyl)naphthalene. 
Cross-coupling of this crude reaction mixture with three aryl bromides gave biaryl 
products in two cases (Table 2.4.3).121 
 
Reagents and conditions: i) Cu(BF4)2 (4 eq.), Pyrex tube, argon purged, hυ, MeOH : MeCN = 1:3, 1 h; 
ii) PdCl2(MeCN)2 (10 mol%), dppp (15 mol%), KF, DMF, 120 oC, 16 h. 
Entry Ar Yield (%)a
1 3,5-(CF3)2C6H3- 42 
2 1-naphthyl 15 
3 4-BnOC6H4- - 
Table 2.4.3. Hannah’s photolysis/cross-coupling of Rf-tagged arylgermane.121  
The overall yields of the photolysis/cross-coupling reactions were however lower 
than those using the isolated dichloroalkylarylgermanes as substrates. Nevertheless, 
these preliminary results provided proof-of-principle for the sequential 
photoactivation/cross-coupling strategy using trialkylarylgermanes as substrates.  
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2.5 Aims and objectives 
The overall aim of the project was to develop the photoactivation/cross-coupling 
reaction of the Rf-tagged trialkylarylgermanes with aryl bromides into a powerful 
method for the synthesis of biaryls. In particular, the yields needed to be optimised, 
the scope and limitations delineated, the utilisation of the Rf-tag for rapid purification 
explored and the stability of the arylgermane precursors needed to be demonstrated. 
Additionally, application of the method in target synthesis was envisaged to highlight 
the above features.  
Towards these ends, the following specific objectives for the project were identified: 
1) To prepare an Rf-tagged arylgermane as a model compound for 
optimisation of the efficiency of both the photoactivation and 
cross-coupling processes. 
2) To identify the intermediate yielded by the photolysis of this model 
germane so as to aid optimisation of the subsequent coupling reactions. 
3) To delineate the scope of the cross-coupling method by using various 
Rf-tagged arylgermanes as substrates for biaryl formation with a range of 
aryl halides under the optimised conditions. 
4) To evaluate the stability profile of an Rf-tagged arylgermane compound 
under various reaction conditions. 
5) To apply the method to the synthesis of a bioactive target compound. It was 
envisaged that carrying an arylgermane through a number of steps prior to 
coupling would underscore the chemical stability of these derivatives. 
Progress towards these objectives is described in the following sections. 
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2.6 Results and Discussion 
The first priority was to optimise the method for performing the cross-coupling 
reactions. Re-synthesis of Rf-tagged trialkylgermane 6a, as used by Hannah, was 
required for this purpose.  
Rf-tagged trichlorogermane 3 was therefore prepared in 60 % yield by treatment of 
germanium(II) chloride． 1,4-dioxane complex 1 with fluorous-tagged iodide 2. 
Insertion of dichlorogermylene liberated from this complex into the carbon-iodine 
bond occurs smoothly simply upon heating. The trichlorogermane 3 was then treated 
with 4-methoxyphenylmagnesium bromide in THF to give the tri(4-anisyl)germane 
intermediate which was dissolved in conc. HCl to effect cleavage of two molecules 
of anisole and give 4-anisyl dichlorogermane 4 in 87 % yield (Scheme 2.6.1). 
 
Scheme 2.6.1. The synthesis of dichlorogermane 4. 
Reagents and conditions: i) sealed tube, 150 oC, 16 h; ii) conc. HCl, rt, 16 h; iii) 
4-methoxyphenylmagnesium bromide 0.5 M in THF, reflux, 4 h; iv) conc. HCl, RT,16 h. 
4-Anisyl dichlorogermane 4 was then treated with 2-naphthymethyl Grignard reagent, 
which was generated in situ from 2-bromomethylnaphthalene 5, and stirred for 2 h at 
room temperature to obtain Rf-tagged 4-anisyl germane 6a in 71 % yield (Scheme 
2.6.2). 
Br
Ge
OMe
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5  
Scheme 2.6.2.  Synthesis of the Rf-tagged arylgermane 6a. 
Reagents and conditions: i) Mg, THF, RT, 2 h. 
The Rf-tagged 4-anisyl germane 6a could be stored indefinitely and was employed as 
a model compound to investigate the photolysis reaction and also as a stock 
precursor for the preparation of other arylgermanes (vide infra). 
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2.6.1 Mechanism of photoactivation of Rf-tagged aryl germanes and structural 
elucidation of the reactive germane intermediates 
The purpose of the two naphthylmethyl groups on the Ge is to function as 
all-carbon ′dummy′ groups that can be oxidatively cleaved to provide two 
heteroatoms at the Ge centre. The ′activation′ process which was developed by 
Hannah to achieve this transformation was via photolysis of arylgermane 6a with a 
high pressure Hg lamp in the presence of Cu(BF4)2. In order to improve the 
efficiency of the sequential activation-cross coupling protocol and elucidate the 
structure of the proposed reactive intermediate which was tentatively assigned as 
difluorogermane 7, the 4-anisyl germane 6a was subjected to photolysis with 4 eq. of 
Cu(BF4)2 in MeOH-MeCN (1:3). After irradiation with a high pressure Hg lamp for 
1 h, the 1H NMR spectrum of the crude product revealed 
2-(methoxymethyl)naphthalene 8, a trace of 2-naphthaldehyde 9 and several signals 
assumed to be attributable to the expected difluorogermane 7 (Scheme 2.6.3).  
 
Scheme 2.6.3.  Photolysis of fluorous-tagged arylgermane 6a – use of Cu(BF4)2. 
Reagents and conditions: i) Cu(BF4)2 (4 eq.), Pyrex tube, argon purged, hυ, MeOH : MeCN = 1:3, 1 h. 
The high pressure Hg lamp provides an intense, wide band of emission from 200 to 
600 nm (approximately 125 watts output). Unlike the output of a low pressure Hg 
lamp, the lines provided by this lamp are weak below 280 nm and the major lines are 
at 313, 365, 404, 435, 546 and 577 nm.123 The most intense output is at 365 nm. In 
order to cut out shorter wavelengths and to avoid undesired reactions, a filter is 
needed. Our photolysis reactions were carried out in Pyrex tubes with a 1 mm wall 
thickness. For several conventional glass filters, the percentage of transmission is 
listed in Table 2.6.1.124  
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Filters The percentage of transmission  
  20% 50% 90% 
Quartz < 200 nm < 200 nm 240 nm 
Vycor 200 nm 220 nm 280 nm 
Corex 270 nm 290 nm 360 nm 
Pyrex 290 nm 300 nm 360 nm 
Table 2.6.1. The percentage of transmission for glass filters (1 mm thickness).124  
It can be seen that the cut-off wavelength for a Pyrex tube is below 360 nm. 
Therefore, light impinging on the reaction solution in our experiments is 
predominately of 360 nm or above. The high energy far UV region is filtered out by 
the Pyrex flask. This minimises the possibility of unwanted photochemical reactions 
following absorption by the arylgermane moiety. 
The photochemical process is initiated by photocleavage of one benzylic C-Ge bond. 
A mechanism for this process can be proposed based on the work of Fleming, who 
studied primarily the excited state photocleavage of benzylic C-S bonds (Scheme 
2.6.4).125,126 
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Scheme 2.6.4. Fleming’s proposed mechanism of photocleavage of benzylic C-X bonds.125,126  
Irradiation of compound 10 results in the formation of the excited state intermediate 
11. This can undergo either single electron transfer (SET) to form intermediates 12 or 
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13 or undergo homolytic cleavage to form bi-radical intermediate 14. The bi-benzyl 
product 16 is produced by radical coupling and is accompanied by the formation of 
other products via radical intermediates.  
Based on this mechanism, there are three possible pathways for the formation of ion 
pair intermediate 15: by heterolytic cleavage of excited state 11, by homolytic 
cleavage of intermediate 12 or by SET from bi-radical 14. Fleming found that 
electron-donating groups (EDGs) at the meta- position of the aryl ring of the ion pair 
intermediate 15 significantly enhanced solvolysis to give the final product 17. This 
substituent effect was also reported by Zimmerman who analysed the excited states 
of benzylic compounds and concluded that the electron density of EDG-substituted 
aryl rings in the excited state are higher at the meta- than at the para-position.127 
Hence, meta-EDGs can tilt the equilibrium in favour of the photosolvolysis product 
17, this phenomenon is named as the meta effect.  
A study of photodissociation for benzylic group 14 organometallic compounds in the 
presence of Cu(II) salts was published by Mizuno in 1988. Benzyltrialkylsilanes 18 
were irradiated with a high pressure Hg lamp and Cu(BF4)2 in MeOH-CH3CN (1 : 3) 
as solvent with a quartz filter (cut off < 200 nm) to afford methyl benzyl ether 19 
accompanied by Cu(I) salts (Scheme 2.6.5).128 
 
Scheme 2.6.5. Mizuno’s photocleavage of benzyltrialkylsilanes.128  
This is an alternative method to convert benzylsilanes into methyl ethers (and 
potentially to the corresponding alcohols) without the involvement of peroxide 
oxidants or the need for a phenyl silane as required for the Fleming-Tamao 
reaction.129  
(Naphthylmethyl)trialkylsilanes and (phenanthrylmethyl)trialkylsilanes were also 
formed by Mizono to undergo photosolvolysis reactions and for these substrates a 
Pyrex filter could be employed to give related methyl aryl ethers in excellent yields. 
The corresponding benzyltrialkylgermanes and benzyltrialkylstannanes were also 
studied. Their reactivity was found to follow the order: organostannanes > 
organogermanes > organosilanes. The following mechanism of solvolysis was 
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suggested (Scheme 2.6.6).128 
 
Scheme 2.6.6. Mizuno’s mechanism for of benzyltrialkyl group 14 metal photosolvolysis reactions.128  
Unlike Fleming, Mizuno suggested that excited state intermediate 21 undergoes 
homolytic cleavage or SET to form arylmethyl radical 23, which is then oxidised by 
Cu(II) yielding the arylmethyl cation 25. The photosolvolysis product, methoxy 
arylmethyl ether 26, is formed by addition of methanol to arylmethyl cation 25. The 
Cu(II) acts as an oxidant to trap an electron from the arylmethyl radical 23 and to 
force the reaction towards the formation of arylmethyl cation 25.  
By combining the ideas of Fleming and Mizuno, the following process of photolysis 
for the Rf-tagged arylgermane 6a can be proposed (Scheme 2.6.7). 
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Scheme 2.6.7. Proposed mechanism for photolysis of Rf-tagged arylgermane 6a. 
The radical cation 28 is formed from the excited sate intermediate 27 through SET 
from the Cu(II) salt. Heterolytic cleavage then gives cation 30 and naphthylmethyl 
radical 29. The germyl cation 30 is trapped by fluoride ion from the tetrafluoroborate 
to give the mono fluoronated arylgermane 31 which then undergoes the same process 
again to give the mono fluoro aryl germyl cation 34. This reacts with 
tetrafluoroborate to give activated difluoro arylgermane 7.  
The naphthylmethyl radical 29 is either oxidised by Cu(II) to give a benzylic cation 
which reacts with MeOH to form 2-(methoxymethyl)naphthalene 8, or reacts with 
singlet oxygen (1O2), produced by the action of UV light on dissolved oxygen in the 
solution, to give naphthylmethyl peroxide 37 which dehydrates to give 
2-naphthaldehyde 9. This latter pathway can be prevented by vigorous degassing 
with argon prior to UV irradiation. Nevertheless, the formation of singlet oxygen in 
the reaction mixture was found not to affect the efficiency of the overall 
photoactivation process or the subsequent cross-coupling reaction and was not 
performed routinely. 
The crude product of the photolytic activation process (i.e. Scheme 2.6.3) containing 
the presumed difluoro arylgermane 7 was subjected to cross-coupling with 
3,5-bis(trifluoromethyl)bromoenzene, catalysed by PdCl2(MeCN)2 in DMF at 120 oC 
as described by Hannah121 (Method A). Biphenyl 38a was obtained in 53 % yield 
(Scheme 2.6.8).  
 
Scheme 2.6.8. Cross-coupling of difluoro fluorous-tagged arylgermane 6c with 
3,5-bis(trifluoromethyl)bromobenzene. 
Reagents and conditions: i) Method A: PdCl2(MeCN)2, dppp, KF, DMF, 120 oC. 
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The photoactivation of fluorous-tagged arylgermane 6a was also carried out using 
copper(II) triflate under the same conditions as described above to give a mixture 
tentatively assigned as the ditriflate 39 and 2-(methoxymethyl)naphthalene 8 (as 
identified by GC-MS). The formation of 2-(methoxymethyl)naphthalene 8 is a key 
indicator of success of the photoactivation process. 
This crude ditriflate 39 was then cross-coupled with 
3,5-bis(trifluoromethyl)bromobenzene as before to obtain biphenyl 38a in 28 % yield 
(Method A) (Scheme 2.6.9).  
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Scheme 2.6.9. Photolysis of fluorous-tagged arylgermane 6a – use of Cu(OTf)2. 
Reagents and conditions: i) Cu(OTf)2 (4 eq.), Pyrex tube, Argon, hυ, MeOH : MeCN = 1:3, 1 h; ii) 
3,5-bis-(trifluoromethyl) bromobanzene, Method A: PdCl2(MeCN)2, dppp, 3,5-(CF3)2C6H3Br, KF, 
DMF, 120 oC. 
As this was an inferior yield to that obtained when using Cu(BF4)2 as the activating 
agent, the latter was used in all subsequent reactions.   
 
2.6.1.1 The photoreactor 
The above photolysis reactions were carried out using a cardboard box as a reaction 
chamber with a gap of 30 cm between the Pyrex tube and a 125 Watt Cathodeon high 
pressure Hg vapour lamp (type HPK 125). A 30 cm light path was necessary to 
prevent over-heating of the reaction solution. This was the prototype photoreactor 
set-up as used by Hannah. Long periods of photolysis were not possible with this 
set-up as this caused extensive evaporation of solvent. 
In order to enhance and optimise the efficiency of photolysis and to solve the 
over-heating, a photoreactor was constructed from an upright computer tower. Using 
this apparatus the temperature in the Pyrex tube is maintained below 35 oC after 
exposure to the UV lamp for over 2 h with a 6-cm light path. The short light path 
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enhances the UV intensity significantly which is beneficial for photolysis. 
The main features of the photoreactor are: (a) five 12V rotary cooling fans are 
installed two of which are speed-adjustable (Figure 2.6.1a); (b) a set of concave 
reflectors focus the UV light on the Pyrex tube and a digital temperature sensor 
(Figure 2.6.1b); (c) a 6-cm light path is possible (Figure 2.6.1c) and (d) the reactor 
can be sealed so that all the UV light is contained within in the chamber (Figure 
2.6.1d). 
 
           
        
 
 
(a) an overview of the photoreactor      (b) a set of reflectors and digital thermosensor 
 
 
 
 
        (c) a 6-cm light path                  (d) sealed reactor with outer shield. 
Figure 2.6.1. Features of the Tseng photoreactor. 
This photoreactor has enhanced photo-efficiency and cooling relative the set-up used 
by Hannah. Moreover, with the more powerful cooling system it is possible to 
maintain the photolysis at lower temperature than in the previous apparatus. This 
reduces the opportunity for undesired thermal pathways and pyrolysis of the 
activated arylgermane products. After the optimisation process described below, all 
photolysis reactions were performed in this photoreactor under optimised and 
normalised conditions. 
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2.6.1.2 Optimisation of photolysis efficiency and attempts to identity the reactive 
photolysis products 
19F Nuclei are the second most sensitive nuclei for NMR spectroscopy after protons 
with a sensitivity of 0.83 relative to 1H. They also have spin quantum number + 1/2. 
Consequently, we considered that 19F NMR would be a powerful tool to aid our 
understanding of the photochemical activation process and to help elucidate the 
structures of the germane intermediates. 
According to the proposed mechanism of photolysis (cf. Scheme 2.6.7), this process 
is expected to proceed in a stepwise manner. This suggests that it should be possible 
to capture the mono-fluoronated arylgermane 31. In order to address this point, 
Rf-tagged arylgermane 6a was photolysed for a short period of time (15 min) and 
then the resulting crude product, following solvent evaporation, was submitted for 
both 1H and 19F NMR spectroscopy. No starting arylgermane 6a remained as judged 
by inspection of the 1H NMR spectrum but the major constituent still contained a 
2-naphthylmethyl group. Analysis of the 19F NMR spectrum revealed a signal at F 
-203 ppm which was distinct from those peaks representing the perfluoroalkyl chain 
(F-80 ~ -125 ppm). The signal at F -203 ppm was assigned as corresponding to a 
germyl monofluoride species. Moreover, the MS (EI+ mode) of this product 
displayed a peak at m/z = 788, as expected for the mono-fluoro arylgermane 31 
(Scheme 2.6.7). 
The 19F NMR of mono-fluoro germane 31 was not entirely pure and contained three 
low intensity but distinct signals located at F-162 ~ -165 ppm. It was considered 
that these might correspond to down-stream products of photolysis, such as the 
difluoro arylgermane 7. To test this hypothesis, the mono-fluoro arylgermane 31 was 
resubjected into the photolysis conditions for another 30 min. 19F NMR of the crude 
mixture following this process clearly indicated that the intensity of the peak at F 
-203 ppm had decreased whilst the three peaks at around F-164 ppm had increased. 
Assuming that the growing peaks corresponded to the difluoro arylgermane, it was 
clear that the second photooxidation was a more sluggish process than the first (from 
arylgermane 6a to mono-fluoro germane 31). An additional 1 h of exposure to the 
UV light was sufficient to complete the conversion; the peak for the mono-fluoro 
germane at F -203 ppm had disappeared, whereas the three major signals at 
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F-162.6, -163.0 and -164.3 ppm were strong with a minor set of peaks at F -162.0, 
-162.3 and -162.7 ppm also now apparent (Figure 2.6.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6.2. 19F NMR spectra of mono-fluoro germane 31 and ‘di-fluoro germane’ 7 with expansion 
at F -161 ~ -165 ppm for the latter. 
The presence of three peaks in the 19F NMR spectrum of the ′difluoro germane′ was 
an unexpected outcome and indicated the photoactivated arylgermane was not a 
single component. Extensive efforts were made to isolate and characterise these 
intermediates including the use of F-SPE and crystallisation techniques. 
Unfortunately, none of these were successful. The mixture was inseparable and so 
our attention turned to using 19F NMR to characterise the mixture. 
In view of their inseparability and constant relative integration two possibilities were 
considered: i) these three peaks were on three different germane species; or ii) the 
two downfield peaks (at F-162.6 and -163.0 ppm) were from one molecule and the 
C8F17 Ge
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7
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further upfield peak (at F -164.3 ppm) was from another component in equilibrium 
with the other. In order to address this, 19F NMR spectra of the mixture were 
recorded on two spectrometers operating at different field strengths. Superimposed 
NMR traces across the region of interest are shown below (Figure 2.6.3)  
 
Figure 2.6.3. 19F NMR spectra of ‘di-fluoro germane’ 7 at 376.5 and 470.5 MHz (red and blue traces, 
respectively) in the region -162 ~ -165 ppm. 
These 19F NMR spectra revealed that there are two major components assigned as 
compounds b and c and one minor compound a that co-exist in this mixture. The 
peaks for compound b superimposed perfectly as did the other three minor peaks 
corresponding to compound a. By contrast, the peak for compound c at F -164.3 
ppm shifted its position indicating that this signal was from a separate species. 
Possible structures for these intermediates were proposed as a difluorogermane dimer 
which can exist in two isomeric forms a and b and a monomer c.  
A Diffusion-Ordered Spectroscopy (DOSY) NMR experiment can resolve signals 
from different components in a mixture based on their different translational 
diffusion coefficients and has been employed to characterise reactive intermediates 
formed in situ during reactions.130 The diffusion coefficient (D) of a molecule is 
correlated to its size, shape, volume, molecular weight and tumbling speed. A large 
diffusion coefficient is characteristic of a high mobility, low molecular mass 
component. 
In the event, the 2D 19F DOSY spectrum of the photolysis product solution clearly 
showed that compound b (D = 5.19×10-10 m2/s) and compound c (D = 7.79×10-10 
a a a 
b b
c 
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m2/s) have similar diffusion coefficients which are larger than that of compound a (D 
= 4.10×10-10). This is consistent with a and b corresponding to two dimeric forms of 
the difluorogermane and compound a being the momer (Figure 2.6.4). 
 
Figure 2.6.4. 19F DOSY spectrum of the mixture obtained from photolysis of arylgermane 6a. 
Although the diffusion coefficient is proportional to the molecular weight of a 
molecule, internal reference molecules are required to achieve accurate diffusion 
coefficient-molecular mass conversions by the Stokes-Einstein equation.131  
The structures of the photolysis products were therefore proposed to be these shown 
below (Scheme 2.6.10). 
 
Scheme 2.6.10. Proposed structures of the dimers and monomer of the difluoro germane 7.  
 
D = 5.19×10-10 
D = 4.10×10-10 
D = 7.79×10-10 
a a a
b b c 
c 
b 
a 
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The cyclic ‘head-to-head’ dimer b contains two magnetically inequivalent fluorine 
environments accounting for the two signals seen in the 19F NMR. This structure 
would be expected to benefit from attractive π-π interactions between the aryl rings 
as well as attractive FF interactions between the fluorous tags. The 
corresponding ′head-to-tail′ dimer would display a similar spectrum but is 
presumably not formed because these interactions are absent. 
Organotin difluoride compounds are known to aggregate through double Sn-F-Sn 
bridges to form four-membered cyclic structures analogues to those proposed 
above.132,133 However, organogermane compounds with two Ge-F-Ge bridges are, to 
the best of our knowledge, unknown.  
The open dimer a is proposed to be in equilibrium with dimer b. This dimer contains 
one Ge-F-Ge bridge resulting in three chemically non-equivalent fluorine 
environments. Although ring-strain is released upon opening in the dimer a, the open 
dimer a is expected to be a minor component of equilibrating mixture because of a 
propensity to re-close to form cyclic dimer b. 
To investigate the self-assembling and equilibrating behaviour of the 
difluorogermane, the preparation of this intermediate was undertaken by substitution 
of dichlorogermane 4 with two different sources of fluoride: AgF and AgBF4.134 Both 
the resulting crude product mixtures were examined by 19F NMR spectroscopy. Both 
the spectra exhibited identical signal patterns as observed following the photolysis 
experiments (as described above). This provides strong evidence for the 
self-assembly of the equilibrating difluoro germane species (Scheme 2.6.11). 
 
Scheme 2.6.11. Nucleophilic substitution of dichlorogermane 4 with AgF and AgBF4. 
 Reagents and conditions: i) AgF, Et2O, rt, 16 h; ii) AgBF4, Et2O, rt, 16 h. 
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2.6.1.3 Conclusions 
Photolytic activation of aryl bis(2-naphthymethyl)germanes has been carried out in a 
new photoreactor. This photoreactor was constructed from a PC case and provides 
enhanced photo-efficiency and cooling capacity via rotatory fans relative to the 
previous set-up. This avoids pyrolysis of the activated products.  
The photocleavage of the first of the two 2-naphthymethyl substituents is complete 
within 15 ~ 20 min in the presence of 4 equivalents of Cu(BF4)2 in a mixed 
MeOH-MeCN solvent system. The mono-fluoro germane intermediate 31 was 
isolated and fully characterised.  
Monitoring by 19F NMR during subsequent photolysis revealed that the mono-fluoro 
germane intermediate is converted to the difluoro germane 7 more slowly (UV 
exposure time > 1 h). The mono-fluoro germane provides a single peak in the 19F 
spectrum due to its Ge-F unit whereas the difluorogermane, unexpectedly, provides a 
more complex set of peaks in the region F -161 ~ -165 ppm.  
1D and 2D 19F NMR spectra of difluoro germane 7 revealed it to exist in solution as 
three components, proposed to be a monomer c a head-to-head cyclic dimer b and an 
open dimer a. 
Independent preparation of difluoro germane 7 by substitution of dichlorogermane 4 
in the presence of two different fluoride sources gave identical 19F NMR spectra to 
those obtained from photolysis of aryl bis(2-naphthymethyl)germane.  
Henceforward in this thesis the difluorogermane photolysis products will be depicted 
as monomer form c in schemes but the presence of an equilibrating mixture of 
species is implied.  
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2.6.2 Delineation of the scope and limitations of germyl-Stille cross-coupling 
reactions promoted by copper(I) iodide 
2.6.2.1 Development of new conditions for germyl Stille coupling  
Li et al. have reported that the efficiency of the Hiyama reaction can be improved by 
using bulky, electron-rich phosphine ligands such as tri-2-tolyl phosphine [P(2-Tol)3], 
TBAF as the nucleophilic promoter and PdCl2(MeCN)2 as the catalyst.134 Therefore, 
these conditions were applied to our germyl-Stille coupling reaction. Thus, following 
photolysis of arylgermane 6a in the presence of Cu(BF4)2 as usual, cross-coupling 
with 3,5-bis(trifluoromethyl)bromobenzene was performed using the new conditions. 
Biphenyl 38a was obtained in 60 % yield (Method B; Scheme 2.6.12). This yield is 
higher than previously obtained (53 %, cf. Scheme 2.6.8). 
 
Scheme 2.6.12. Sequential photoactivation/cross-coupling reaction of arylgermane 6a with 
3,5-bis(trifluoromethyl)bromobenzene using Li’s conditions.134  
Reagents and conditions: i) Cu(BF4)2 (4 eq.), Pyrex tube, argon purged, hυ, MeOH : MeCN = 1:3, 1 h; 
ii) Method B: PdCl2(MeCN)2 (10 mol%), P(2-Tol)3 (15 mol%), 3,5-(CF3)2C6H3Br, TBAF, DMF, 120 
oC, 16 h. 
The addition of CuI as a co-catalyst to enhance the rate of Stille cross-coupling 
reactions discussed in the previous section (Scheme 2.1.11) is now generally 
accepted as the copper effect. This is the result of pre-transmetalation of the 
arylstannane component into an arylcopper intermediate which undergoes more rapid 
transmetalation with the ArPdIIL complex than the precursor stannane itself to yield 
the final coupling products. It was envisaged that the germyl-Stille cross-coupling 
reaction could be facilitated by an analogous copper effect. 
Hence, the affect of adding CuI to our germyl-Stille reaction was investigated. 
Difluoro arylgermane 7 was cross-coupled with 3,5-bis(trifluoromethyl)- 
bromobenzene using P(2-Tol)3, TBAF and  PdCl2(MeCN)2 in the presence of CuI as 
additive to give biphenyl 38a in 68 % yield (Method C, Scheme 2.6.13). This yield is 
higher than the previous methods (cf. 53 % using Method A; 60 % using Method B). 
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Scheme 2.6.13. Optimised cross-coupling of arylgermane 6a with 3,5-bis 
(trifluoromethyl)bromobenzene – with CuI co-promoter.78  
Reagents and conditions: i) Cu(BF4)2 (4 eq.), Pyrex tube, argon purged, hυ, MeOH : MeCN = 1:3, 1 h; 
ii) Method C: PdCl2(MeCN)2 (10 mol%), P(2-Tol)3 (15 mol%), 3,5-(CF3)2C6H3Br, TBAF, CuI, DMF, 
120 oC, 16 h. 
Although both Gripton and Hannah (Tables 2.4.1 and 2.4.2, respectively) had 
concluded that two heteroatoms on the Ge centre were required for successful 
cross-coupling, it was considered prudent at this juncture to check that this was 
indeed the case for the fluorogermanes. 
Consequently, mono-fluoro germane 31, generated by short UV irradiation (~15 min) 
of arylgermane 6a, was cross-coupled with 3,5-bis(trifluoromethyl)bromobenzene 
under Method C conditions to afford biphenyl 38a in a yield of just 45 %. By 
contrast, cross-coupling of difluoro germane 7, which was obtained from prolonged 
UV exposure until the peak corresponding to the mono-fluoro germane (F -203 ppm) 
had disappeared, under identical conditions gave the biphenyl 38a in 96 % yield 
(Scheme 2.6.14).  
 
Scheme 2.6.14. Reactivity of mono-fluoro and difluoro germane for cross-coupling with 3,5-bis 
(trifluoromethyl)bromobenzene. 
Reagents and conditions: i) Cu(BF4)2, Pyrex tube, argon purged, hυ, MeOH : MeCN = 1:3, ii) Method 
C: PdCl2(MeCN)2 (10 mol%), P(2-Tol)3 (15 mol%), 3,5-(CF3)2C6H3Br, TBAF, CuI, DMF, 120 oC, 16 
h. 
These results demonstrated that although the mono-fluoro germane was competent 
for cross-coupling, its difluoro congener is a more efficient cross-coupling partner 
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and that provided full conversion to this reactive species is ensured by monitoring by 
19F NMR, excellent cross-coupling yields can be attained.  
The optimised photoactivation conditions were found to involve photolysis of the 
aryl bis(2-naphthymethyl)germanes 6 with 4 equivalents of Cu(BF4)2 for 1 h 
followed by addition of another 4 equivalents of Cu(BF4)2 and irradiation for a 
further 1 h (i.e. 2 h overall).  
It is this difference in the protocol for photooxidation that accounts for the improved 
yield between the ‘Method C’ coupling in Scheme 2.6.13 and in Scheme 2.6.14 (i.e. 
68 % vs 96 % yield). 
 
2.6.2.2 Elaboration of the scope of germyl-Stille coupling reactions 
Having optimised the photoactivation conditions and subsequent cross-coupling, our 
attention turned to delineating the scope of the germyl-Stille cross-coupling reaction. 
A range of Rf-tagged arylgermanes were prepared in good yields by treating 
Rf-tagged germyl bromide 40 with appropriate aryl lithium and Grignard reagents. 
The aryl lithium reagents were generated in situ by lithium-halogen exchange on aryl 
bromides with tBuLi (Table 2.6.2). 
 
Entry R1 Product Yield (%) 
1 4-CH3  6b 87a 
2 H  6c 83a 
3 4-Cl  6d 80b 
4 2-OMe  6e 87b 
5 4-CF3 6f 84b 
a Grignard reagent; b organolithium reagent 
Table 2.6.2. Preparation of fluorous-tagged arylgermanes. 
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The optimised cross-coupling conditions (Method C) were then employed for the 
preparation various biaryls using these Rf-tagged arylgermanes and various aryl 
bromides with electron-donating and electron-withdrawing groups (Table 2.6.3).135  
 
Entry R1 R2 Product Yield (%) 
1 4-OMe 6a 3,5-bis(CF3) 38a 96 
2 4-OMe 6a 4-Cl 38b 85 
3 4-OMe 6a 4-benzoxy 38c 65 
4 4-OMe 6a 1-naphthylene 38d 74 
5 4-CH3 6b 3,5-bis(CF3) 38e 84 
6 4-CH3 6b 4-Cl 38f 69 
7 4-CH3 6b 4-benzoxy 38g 48 
8 4-CH3 6b 1-naphthylene 38h 71 
9 H 6c 3,5-bis(CF3) 38i 74 
10 H 6c 4-Cl 38j 63 
11 H 6c 4-benzoxy 38k 40 
12 H 6c 1-naphthylene 38l 60 
13 4-Cl 6d 3,5-bis(CF3) 38m 71 
14 4-Cl 6d 4-benzoxy 38n 42 
15 4-Cl 6d 1-naphthylene 38o 75 
16 2-OMe 6e 3,5-bis(CF3) 38p 65 
17 2-OMe 6e 4-Cl 38q 57 
18 2-OMe 6e 4-benzoxy 38r 11* 
19 2-OMe 6e 1-naphthylene 38s 27 
20 4-CF3 6f 3,5-bis(CF3) 38t 26* 
21 4-CF3 6f 4-Cl 38u 11* 
* GC-MS yield 
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Table 2.6.3. Scope of germyl-Stille type photoactivation/cross-coupling reactions with various 
Rf-tagged arylgermane and aryl bromides.135  
Reagents and conditions: i) Cu(BF4)2 (4+4 eq.), Pyrex tube, argon purged, hυ, MeOH : MeCN = 1:3, 2 
h; ii) Method C: PdCl2(MeCN)2 (10 mol%), P(2-Tol)3 (15 mol%), TBAF, CuI, DMF, 120 oC, 16 h. 
By employing these optimised cross-coupling conditions with efficient 
photoactivation much better results were achieved than previously. For example, the 
yield of biphenyl 38a was 96 % over two steps (entry 1) and the yield of biphenyl 
38d was raised to 74 % (cf. 15 % by Hannah;121, entry 4). Importantly, it emerged 
from this work that the photoactivation process displayed no significant 
time-dependence as a function of the electronic nature of the arylgermane substrates. 
This obviates the need to optimise the photolysis period for each substrate; the 2 h 
protocol is generally suitable. 
The selectivity of this reaction for cross-coupling of aryl bromides over aryl 
chlorides is revealed by examination of the case of 1-bromo-4-chlorobenzene (entry 
2) which gave 4-chloro-4’-methoxy-1,1’-biphenyl 38b exclusively; no 
4-bromo-4’-methoxy-1,1’-biphenyl could be detected by GC-MS (Figure 2.6.5). 
 
 
 
 
 
 
 
 
 
NB: the peak with retention time 13.301 min is the phosphine ligand. 
Figure 2.6.5. GC-MS chromatogram and mass spectrum of 4-chloro-4’-methoxy- 1,1’-biaryl 38b. 
The MS parent peaks (M+) for the 4-chloro-4’-methoxy-1,1’-biaryl 38b is at m/z 
218/220 with an unambiguous 3 to 1 peak ratio due to the isotope pattern of chlorine 
(35Cl : 37Cl).  
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The overall trend relating the electronic nature of the reaction partners for 
germyl-Stille coupling revealed by Table 2.6.3 is congruous with the general 
situation found in Stille and Hiyama cross-coupling reactions: (a) 
electron-withdrawing groups on the aryl bromide result in higher yields of biphenyls 
(cf. entries 1-3 and 5-7); (b) electron-donating groups on the fluorous-tagged 
arylgermane result in higher yields of biphenyls (cf. entries 1-3 and 9-11) with the 
exception of the 2-OMe substituent for which steric hindrance interferes (cf. entries 
1-4 and 16-19). With strong electron-withdrawing groups on the arylgermane, 
inferior yields of biphenyls are obtained (e.g. entries 20 and 21).  
To explore the compatibility of germyl-Stille cross-coupling with alternative aryl 
(pseudo)halide electrophiles, Rf-tagged arylgermane 6a was employed as a substrate 
for photoactivation/cross-coupling with 1-naphthyl chloride, -iodide and -triflate 
under Method C conditions using LiCl as an additive. The resulting biaryl 38d was 
quantified by GC/MS using the common by-product, 2-(methoxymethyl)naphthalene 
38d from the photolysis as an internal standard (Table 2.6.4). 
 
Entry X Yield (%)a 
1 Cl  < 1a 
2 Br 74b 
3 I  12a 
4 OTf  - 
a GC yield; b isolated yield; used for calibration the GC/MS outcomes 
Table 2.6.4. Screening for compatibility of the germyl-Stille cross-coupling with various aryl 
(pseudo)halides. 
Reagents and conditions: i) Cu(BF4)2 (4+4 eq.), Pyrex tube, argon purged, hυ, MeOH : MeCN = 1:3, 2 
h; ii) Method C: PdCl2(MeCN)2, P(2-Tol)3, TBAF, CuI, LiCl, DMF, 120 oC, 16 h. 
In the light of the aforementioned chemoselective coupling of 1-bromo-4- 
chlorobenzene substrate (cf. Figure 2.6.5), it was not surprising to find that no 
significant amount of biaryl 38d was detected when the aryl chloride was employed 
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as a coupling partner (entry 1). Cross-coupling with the aryl iodide gave a 
surprisingly poor yield of 12 % (entry 3 cf. 74% for the bromide). In addition, the 
aryl triflate was found to be unreactive towards this cross-coupling protocol (entry 
4). 
 
2.6.2.3 Exploration of the stability profiles of Rf-tagged arylgermanes 
As discussed above, better chemical tolerance of the C-Ge bond in comparison with 
C-Si and C-Sn bonds is expected due to the lesser polarity across C-Ge bonds as 
compared to the other two bonds. Vasella exploited these differences to demonstrate 
the orthogonal deprotection of trimethylsilyl (TMS) and trimethylgermyl (TMG) 
protected diynes. The TMS group was removed under fluoridolytic and basic 
conditions whereas the TMG group was removed upon treatment with CuBr in 
THF/MeOH (Scheme 2.6.15).136 
 
Scheme 2.6.15. Vasella’s demonstration of selective removal of TMG and TMS-protected alkynes.136 
Turner (Spivey group, 2000-2003)137 also showed that α-silyl and α-germyl 
thiophenes could be orthogonally deprotected using fluoride and acid respectively.138 
A systematic study of the stability of our Rf-tagged arylgermanes was carried out 
using common reaction conditions, encountered during synthesis. 
9-Methylanthracene 41 and 4,4’-di-tert-butyl-1,1’-biphenyl 42 were used as internal 
standards.139,140 All reactions employed 5 equivalents of reagents at RT for 3 h and 
were analysed by HPLC. The ratio of the peak areas was quantified between 
arylgermane 6c and internal standards 41 or 42. The percentage recovery of germane 
6c was compared to blank controls in the appropriate solvent (Table 2.6.5). 
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Entry Conditions Internal Standard Average recovery of 6c (%) 
1 Mercaptoethanol DBU, DMF 41 102 
2 20 % Piperidine, DMF 41 101 
3 2 % Hydrazine, DMF 41 104 
4 NaBH4, THF 41 107 
5 LiAlH4, THF 41 104 
6 TBAF, THF 41 102 
7 50 % TFA, CH2Cl2 41 20 
8 3-CPBA, CH2Cl2 42 76 
N.B. The recovery was averaged for two runs.; Deviation is set at ±15 % (see experimental section) 
 
HPLC conditions: Column: XTerra RP-8, 4.6 mm × 150mm, 5μ; mobile phase: MeCN/H2O = 
80:20; flow rate = 1ml/min; Detection at 245 nm; injection volume: 2μL. 
Table 2.6.5. Stability tests on arylgermane 6c. 
Inspection of Table 2.6.5 reveals that arylgermane 6c can tolerate basic, reductive 
and several common deprotection conditions (entries 1-5). The inertness of the 
arylgermane linkage to these conditions is notable and contrasts with the poor 
stability of arylstannanes and arylsilanes. Most importantly, the arylgermane is 
chemically inert towards exposure to fluoride ions (entry 6). This profile provides 
compatibility with fluoridolytic conditions for deprotection of silyl ethers. It is 
expected that this will allow these derivatives to be used for the synthesis of complex 
target molecules. However, the compound was partially degraded by strong acid 
(50% trifluoroacetic acid/CH2Cl2, entry 7) and oxidative conditions 
(3-CPBA/CH2Cl2, entry 8). Nevertheless, Rf-tagged arylgermanes are envisaged to 
be stable towards exposure to just 1 equivalent of 3-CPBA or other oxidants at low 
temperature. 
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2.6.2.4 Conclusions 
New conditions for germyl-Stille cross-coupling reactions have been developed and 
have been found to give better results than previously. Optimised photoactivation 
conditions were found which were appropriate for all substrates tested. 
A survey of the electronic and steric requirements for cross-coupling shows that the 
best coupling partners are electron-rich arylgermanes and electron-poor aryl 
bromides. However, almost all combinations will couple in reasonable yields. 
Furthermore, the stability of arylgermanes towards nucleophilic, basic and reductive 
conditions (but not acidic and oxidative conditions) should make these derivatives of 
significant utility in synthesis.  
In the next section, our endeavours to demonstrate the utility of this new method for 
the synthesis of some agrochemical fungicides are described. 
 
2.6.3 Towards the synthesis of boscalid by germyl-Stille cross-coupling 
Boscalid (43) is a versatile fungicide designed and commercialised by BASF.141 It is 
widely used on food crops such as lettuce, beans, berries, bulb vegetables, carrots 
and fruiting vegetables primarily as protection against Sclerotinia drop disease.142 
Boscalid targets an enzyme in fungi’s mitochondria named succinate ubiquinone 
reductase, which is part of the electron transport complex II . As part of the oxidative 
phosphorylation pathway, complex II effects dehydrogenation of succinate with 
concomitant formation of ubiquinol (UQH2) from ubiquinone (UQ).143 Boscalid 
inhibits this electron transfer pathway and consequently the energy respiration cycle 
resulting in cell death. In addition, complex II also participates in the citric acid cycle, 
which supplies precursors for amino acid synthesis and other building blocks. 
Therefore, boscalid acts a dual-functional fungicide significantly reducing the risk of 
cross-resistance.  
Boscalid and its analogues were considered interesting target molecules to 
underscore the robustness of arylgermane derivatives and demonstrate the concept of 
iterative chemical synthesis using phase-tagged substrates. Analysis of the skeleton 
of boscalid reveals a biaryl aniline subunit which forms an amide bond with a 
2-chloronicotinic acid unit. It was proposed to construct the biaryl aniline subunit by 
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employing a germyl Stille cross-coupling (Scheme 2.6.16). 
 
Scheme 2.6.16. Proposed disconnection for boscalid (43). 
At the outset, it was planned to prepare an N-protected ortho-aniline containing 
arylgermane, to cross-couple this compound with 1-bromo-4-chlorobenzene, to 
deprotect the aniline nitrogen to give 2-amino-4’-chlorobiphenyl 44 and then to 
complete the synthesis by amide coupling with 2-chloronicotinic acid. 
Before attempting this synthesis, it was decided to prepare an authentic sample of 
2-amino-4’-chlorobiphenyl 44 by coupling N-benzoyl-2-trimethylstannyl aniline 46 
with 1-bromo-4-chlorobenzene using a Stille coupling process. To this end, 
N-benzoyl-2-bromoaniline 45 was treated with n-butyllithium in THF at -100 oC and 
then trimethylstannyl chloride was added to quench the resulting aryllithium species 
(Scheme 2.6.17).144  
 
Scheme 2.6.17. Attempted synthesis of N-benzoyl-2-trimethylstannyl aniline 46. 
Reagents and conditions: i) nBuLi (2.5 eq.), THF, -100 oC, 30 min; ii) Me3SnCl, 
-100 oC to RT, 2 h. 
However, analysis of the MS fragmentation pattern and the 1H and 13C NMR spectra 
of the resulting reaction mixture revealed that the product was in fact 
N-(2-(1-hydroxy-1-phenylpentyl)phenyl)benzamide 52. A possible mechanism for its 
formation is shown below (Scheme 2.6.18).  
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Scheme 2.6.18. Proposed mechanism of formation of N-(2-(1-hydroxy-1-phenylpentyl)- 
phenyl)benzamide 52. 
This reaction pathway could not be prevented by the use of Barbier conditions (in 
which the Me3SnCl was present prior to addition of the n-BuLi) so we  explored 
direct ortho-lithiation of N-pivaloylanilide.145 Thus, 2-trimethylstannyl- 
N-pivaloylanilide 54 was produced in 67 % yield by treatment of N-pivaloylanilide 
53 with n-butyllithium followed by quenching with trimethylstannyl chloride.146,147 
To obtain the authentic biphenyl 55, and also to compare the relative reactivity 
towards cross-coupling of organostannes and organogermanes, 2-trimethylstannyl 
pivalanilide 54 was cross-coupled with 4-chloro-bromobenzene using the conditions 
of Baldwin to give biphenyl 55 in 58 % yield (Scheme 2.6.19).148  
 
Scheme 2.6.19. Synthesis of the authentic biphenyl 55 by direct lithiation followed by Stille 
cross-coupling 
Reagents and conditions: i) nBuLi (2.5 eq.), TMEDA, THF, 0 oC, 2.5 h; ii) Me3SnCl (2 eq.), 0 oC to 
RT, 16 h; iii) i) Pd(PPh3)4, CsF, CuI, DMF, 40 oC, 16 h. 
Following this successful preparation of the trimethylstannyl pivalanilide 54, the 
same approach was explored for synthesis of the corresponding arylgermane 57 
(Scheme 2.6.20).145  
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Scheme 2.6.20. Preparation of 2-pivalanilidyl fluorous-tagged arylgermane 57. 
Reagents and conditions: i) nBuLi (2.5 eq.), TMEDA, THF, 0 oC, 2.5 h; ii) 0 oC to RT, 16 h 
The reaction was successful but a by-product containing an n-butyl group 
contaminated the desired 2-pivalanilidyl fluorous-tagged arylgermane 57 as 
evidenced by many aliphatic signals in the region between δ 1.0 and 1.5 ppm in the 
1H NMR spectrum. 
Although contaminated with this unidentified by-product, germane 57 was subjected 
to photolysis under the usual conditions. However, neither of the two key 
by-products, 2-(methoxymethyl)naphthalene 8 and 2-naphthaldehyde 9, could be 
detected by TLC or GC-MS. Instead, the photolysis reaction gave an unknown 
product with high polarity rather than activated difluoro germane. Nevertheless, the 
mixture of products was subjected to cross coupling with 4-chlorobromobenzene 
using the standard coupling conditions. By comparing the 1H NMR spectrum of the 
reaction mixture with that of the authentic product biphenyl 55, it was clear that no 
cross-coupling had occurred (Scheme 2.6.21). 
 
Scheme 2.6.21. Attempted synthesis of biphenyl 55 via germyl-Stille cross-coupling. 
Reagents and conditions: i) Cu(BF4)2 (4 eq.), Pyrex tube, Argon purged, hυ, MeOH : MeCN = 1:3, 1 h; 
ii) Method A: PdCl2(MeCN)2 (10 mol%), dppp (15 mol%), 4-ClC6H4Br, KF, DMF, 120 oC, 16 h. 
The most likely cause of this failure of the photolysis reaction was considered to be 
the presence of the amide function and so it was decided to remove the N-pivaloyl 
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group to allow cross-coupling of the unprotected aniline derivative. Consequently, 
we next explored conditions for removal of the N-pivaloyl group using 
N-pivaloylanilide 53 as a model substrate (Table 2.6.6) 
 
Entry Conditions Outcome 
1 3N HCl(aq) / dioxane 100 oC, 16 h149 
~ 50% conversion;  
aniline 58, no amine 59 
2 10 M HCl / EtOH 80 oC, 16 h150 
~ 50% conversion;  
aniline 58, no amine 59 
3 48 % HBr(aq) / EtOH 80 oC, 16 h151 
~ 50% conversion;  
aniline 58, no amine 59 
4 35 % H2SO4 EtOH, 80 oC, 16 h152 
> 50% conversion; 
aniline 58, no amine 59 
5 LiAlH4 THF, 0 oC ~ reflux, 3 h153 
100 % conversion, 
 trace of aniline 58, amine 59 
was the major product. 
6 LiAlH4 THF, 0 oC ~ RT, 16 h153 
100 % conversion, 
 trace of aniline 58, amine 59 
was the major product. 
7 
H2NNH2 
EtOH, 120 oC, sealed tube 
16 h154 
 < 20% conversion; 
No aniline 58,  
trace of amine 59 
Table 2.6.6. Attempted deprotection of pivalanilide 53. 
N-Pivaloylanilide 53 was treated with 3N HCl in dioxane, 10M HCl in EtOH, 48% 
HBr(aq) in EtOH and 35% H2SO4 in EtOH at reflux (entries 1-4).153 However, in all 
cases only ~ 50 % of the N-pivaloylanilide 53 was deprotected to give aniline 58 
after 16 h. By contrast, N-pivaloylanilide 53 was reduced with LiAlH4 to afford 
amine 59 in high yield (entries 5 and 6).153 In addition, attempted deprotection using 
hydrazine, resulted in less than 20 % of N-pivaloylanilide 53 being converted to give 
traces of amine 59 but no aniline 58 (entry 7).154 Since none of these deprotection 
conditions were efficient we decided to employ an alternative ortho-directing aniline 
derivative. 
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The trifluoroacetyl amide of aniline was envisioned to be deprotected more readily 
than its pivaloyl analogue. Thus, 2-bromotrifluoroacetanilide 60 was prepared by 
treatment of 2-bromoaniline with trifluoroacetic anhydride in 95 % yield. 
2-Bromo-trifluoroacetanilide 60 was then deprotonated with MeLi (1 eq.) at -78 oC, 
treated with tBuLi (2.2 eq) to effect bromine-lithium exchange, and then reacted with 
fluorous-tagged germyl bromide 61 to afford 2-trifluoroacetanilidyl fluorous-tagged 
arylgermane 62 (Scheme 2.6.22).155  
 
Scheme 2.6.22. The preparation of 2-trifluoroacetanilidyl fluorous-tagged arylgermane 62. 
Reagents and conditions: i) MeLi (1 eq.), tBuLi (2.2 eq.), -78 oC, 30 min ; ii) -78 oC to RT, 16 h. 
The germyl bromide 61 was used in this reaction because Catherine Noban (Spivey 
group 2001-2005)156 had found that germyl bromides often give better results than 
germyl chlorides as electrophiles with organolithium reagents. Again, the product 
was contaminated with an unidentified aliphatic containing by-product. Nevertheless, 
the MS spectrum showed a strong peak at m/z 950 (M-141) corresponding to the 
expected mass ion of the product following loss of a naphthylmethyl group.  
It was hoped that the unknown by-product might be separable after removal of the 
trifluoroacetyl group. Consequently, 2-trifluoroacetanilidyl fluorous-tagged 
arylgermane 62 was subjected to several deprotecting conditions to achieve 
hydrolysis of the trifluoroacetyl group (Table 2.6.7). 
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Entry Conditions Time Outcome 
1 K2CO3(s) MeOH, rt 2 days No reaction 
2 Sat. K2CO3(aq) THF, 40 oC 16 h No reaction 
3 40 % NaOH(aq) TBAI, THF, 60 oC 2 days No reaction 
Table 2.6.7. Attempted deprotection of 2-trifluoroacetanilidyl fluorous-tagged arylgermane 62. 
None of these conditions effected to hydrolysis of the 2-trifluoroacetanilidyl 
Rf-tagged arylgermane 62, whereas an individual qualitative study of deprotection of 
2-bromotrifluoroacetanilide 60 proceeded smoothly under the conditions described in 
entry 2. 
In 2006, Cai proposed that strong chelation between an ortho-amide and a main 
group metal could strongly impede hydrolysis.157 It is possible that the trifluoroacetyl 
group in arylgermane 62, being ortho to the germanium centre, is particularly 
resistant to hydrolysis due to this effect (Scheme 2.6.23).157  
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Scheme 2.6.23. Proposed association between the trifluoroacetamide carbonyl and the 
trialkylgermanium centre in arylgermane 62 and Cai’s chelation model.157  
The 2-trifluoroacetanilidyl fluorous-tagged arylgermane 62 itself was subjected to 
photolysis in the presence of Cu(BF4)2 under the usual conditions. As for the 
corresponding 2-pivalanilidyl fluorous-tagged arylgermane 57, the key side-products 
2-(methoxymethyl)naphthalene 8 and 2-naphthaldehyde 9 could not be detected by 
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TLC or GC-MS and a high polarity product was found. The unknown compound was 
subsequently employed crude for cross coupling with 1-bromo-4-chlorobenzene 
under standard conditions. However, no biphenyl 64 could be found after purification 
by column chromatography (Scheme 2.6.24). 
 
Scheme 2.6.24. Attempted synthesis of biphenyl 64 via germyl-Stille cross-coupling. 
Reagents and conditions: i) Cu(BF4)2 (4 eq.), Pyrex tube, argon purged, hυ, MeOH : MeCN = 1:3, 1 h; 
ii) Method A: PdCl2(MeCN)2 (10 mol%), dppp (15 mol%), 4-ClC6H4Br, KF, DMF, 120 oC, 16 h. 
To circumvent the difficult hydrolysis of the ortho-trifluoroacetyl group in 
2-trifluoroacetanilidyl fluorous-tagged arylgermane 62 and to substantiate the 
proposed chelation as being the reason for its resistance to photolysis, the 
3-trifluoroacetanilidyl fluorous-tagged arylgermane 66 was prepared by 
deprotonation of 3-iodo-trifluoroacetanilide 65 with NaH at RT, treatment with tBuLi 
at -100 oC to effect iodine-lithium exchange, and then reaction with germyl bromide 
61 in THF. The mixture was left for 16 h at RT to give 3-trifluoroacetanilidyl 
fluorous-tagged arylgermane 66 in 46 % yield (Scheme 2.6.25). 
 
Scheme 2.6.25. The preparation of 3-trifluoroacetanilidyl fluorous-tagged arylgermane 66. 
Reagents and conditions: i) NaH 60 % in mineral oil (1 eq.), RT, 1 h, tBuLi (2.2 eq.), -100 oC, 30 min ; 
ii) -78 oC to RT, 16 h. 
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The 3-trifluoroacetanilidyl fluorous-tagged arylgermane 66 was successfully 
hydrolysed under basic conditions using TBAI as phase-transfer catalyst at 60 oC for 
2 days forming 3-amino fluorous-tagged arylgermane 67 in 54 % yield (Scheme 
2.6.26). 
 
Scheme 2.6.26. The hydrolysis of 3-trifluoroacetanilidyl fluorous-tagged arylgermane 66. 
Reagents and conditions: i) 40 % NaOH(aq), TBAI, THF, 60 oC, 48 h. 
This deprotection of the N-trifluoroacetyl group emphasises the stability of 
arylgermanes under strongly basic conditions for prolonged periods of time which is 
in contrast to organosilane and organostannane congeners which would not to be 
compatible with these conditions. Moreover, the success of this deprotection, and not 
the previous one, lends credence to the notion that there is a stabilising interaction 
between the Ge centre and the amide when these are situated ortho to each other 
(although this could conceivably also be a steric effect).  
Unfortunately, 3-amino fluorous-tagged arylgermane 67 reacted with Cu(BF4)2 in the 
photolysis reaction resulting in the solution turning dark red. This is probably due to 
the free amine coordinating tightly to the Cu(II). To verify this hypothesis some 
control reactions were performed with 3-iodo-trifluoroacetanilide, 
trifluoroacetanilide and aniline itself (Table 2.6.8). 
Entry Substrate Reagent Outcome 
1 3-Iodo-trifluoroacetanilide Cu(BF4)2 
No colour change 
(pale blue solution) 
2 Trifluoroacetanilide  Cu(BF4)2 
No colour change 
(pale blue solution) 
3 Aniline Cu(BF4)2 solution turns dark red 
Table 2.6.8. Treatment of various anilines with Cu(BF4)2 in MeCN. 
Only the unprotected aniline interacted with Cu(II) to afford a red solution (entry 3). 
The protected amines were inert (entries 1 and 2). 
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Despite the formation of the dark red coloured Cu(II)-3-amino fluorous-tagged 
arylgermane complex, the photolysis reaction was carried out as usual followed by 
attempted cross-coupling with 1-bromo-4-chlorobenzene. No desired biphenyl 
product could be detected by GC-MS. The same outcome was obtained using the 
3-trifluoroacetanilidyl fluorous-tagged arylgermane 66 as a substrate for the same 
sequential photoactivation/cross-coupling protocol (Scheme 2.6.27).  
 
Scheme 2.6.27. Attempted synthesis of biphenyls 68 and 69 via germyl-Stille cross-coupling. 
Reagents and conditions: i) Cu(BF4)2 (4 eq.), Pyrex tube, argon purged, hυ, MeOH : MeCN = 1:3, 1 h; 
ii) Method A: 1-bromo-4-chlorobenzene, PdCl2(MeCN)2 (10 mol%), dppp (15 mol%), KF, DMF, 120 
oC, 16 h 
To avoid the complex formation between Cu(II) and the 3-amino fluorous-tagged 
arylgermane 67, the free amine group was protected with pivalaldehyde catalyzed by 
4-TsOH and molecular sieves (3 Å) to give imine protected fluorous-tagged 
arylgermane 70.158 Imine protected fluorous-tagged arylgermane 70 was then 
subjected to photolysis without further purification; there was no colour change. The 
residue was injected into the GC-MS to confirm that the key by-products, 
2-(methoxymethyl)naphthalene 8 and 2-naphthaldehyde 9 had been formed. There 
were traces of these compounds present so the product mixture was subjected to 
cross-coupling in the usual manner. However, no desired biphenyl 71 could be 
detected by GC-MS after purification by column chromatography (Scheme 2.6.28). 
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Scheme 2.6.28. In situ protection/activation/attempted cross-coupling of 3-pivalyimineyl 
fluorous-tagged arylgermane 70. 
Reagents and conditions: i) pivalaldehyde, 4-TsOH, 3 Å M.S, CH2Cl2, RT, 48 h; ii) Cu(BF4)2 (4 eq.), 
Pyrex tube, Argon purged, hυ, MeOH : MeCN = 1:3, 1 h; iii) Method A: PdCl2(MeCN)2 (10 mol%), 
dppp (15 mol%), 4-ClC6H4Br, KF, DMF, 120 oC, 16 h. 
It was disappointing that none of the aniline derivatives would undergo 
photolysis/cross-coupling. The reason is probably because of inhibition of the 
photoactivated electron-transfer by the amine or acetamide group on the 
fluorous-tagged arylgermane.  
A new approach was clearly required and so the following revised strategy for the 
synthesis of boscalid (43) was proposed. In this approach, it was planned to employ 
Rf-tagged 4-chloro-arylgermane 6d as a substrate for coupling with 
2-bromo-N-trifluoroacetamide 60 to form biphenyl 44 (Scheme 2.6.29). 
 
Scheme 2.6.29. Revised disconnection for boscalid (43). 
The photolysis/cross-coupling of 4-chloro fluorous-tagged arylgermane 6d under the 
usual conditions gave the desired biphenyl 64 in 35 % yield along with 
homo-coupling product, 4,4’-dichlorobiphenyl 72  as the major product (53 % yield, 
Scheme 2.6.30). 
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Scheme 2.6.30. Synthesis of the biphenyl 64. 
Reagents and conditions: i) Cu(BF4)2 (4 eq.), Pyrex tube, argon purged, hυ, MeOH : MeCN = 1:3, 1 h; 
ii) Method C: PdCl2(MeCN)2 (10 mol%), P(2-Tol)3 (15 mol%), CuI ,TBAF, DMF, 120 oC, 16 h. 
4,4’-Dichlorobiphenyl 72 was the first homo-coupling product that we had identified 
from self-coupling of a fluorous-tagged arylgermane. In the literature, Suzuki 
homo-coupling reactions have been studied by Wong159 and by Marcial;160 and Stille 
self-coupling reactions have been investigated by Farina.66  
A catalytic cycle for the arlyboronic acid-based homo-coupling reaction was 
proposed by Marcial (Scheme 2.6.31).160  
 
Scheme 2.6.31. Marcial’s mechanism for Suzuki homo-coupling.160  
The homo-coupling pathway is considered to be oxidative coupling and takes place 
when the rate of cross-coupling is relatively slow. However, the rate of 
homo-coupling can be accelerated by the presence of air, oxygen or redox agents 
such as Cu(II).66 Similarly, Stille homo-coupling products can be obtained by using 
Pd(II) as a catalyst and Cu(II) as co-oxidant.161  
Consequently, in reviewing the conditions used in the synthesis of boscalid, the 
homo-coupling reaction was probably accelerated by Cu(II) which was produced by 
the oxidation of the CuI promoter by traces of air dissolved in the DMF.  
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Clearly, the rate of cross-coupling between arylgermane 6d and the 2-bromo-N- 
trifluoroacetamide 60 is slow. Assuming that the acetamide was possibly responsible 
for the low rate, a revised approach was drawn up in which 2-bromonitrobenzene 
was employed as the coupling partner (Scheme 2.6.32).  
 
Scheme 2.6.32. Final disconnection for boscalid. 
4-Chloro-2’-nitrobiphenyl 73 was synthesised in 61 % yield under the optimised 
photolysis/cross-coupling conditions. Examination of the crude biphenyl products 
revealed that no homo-coupling product 72 was detectable. It is noteworthy that the 
relatively sterically hindered aryl bromide coupled well in this case.   
Reduction was achieved by SnCl2 to give the corresponding 
4-chloro-2’-aminobiphenyl 44 in 88 % yield. DCC coupling was then employed to 
form the amide bond between 4-chloro-2’-aminobiphenyl 44 and 
2-chloro-3-nicotinic acid to furnish the target molecule boscalid (43) in 65 % yield 
(Scheme 2.6.33).162  
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Scheme 2.6.33. The synthesis of boscalid (43).162  
Reagents and conditions: i) Cu(BF4)2 (4+4 eq.), Pyrex tube, argon purged, hυ, MeOH : MeCN = 1:3, 
2 h; ii) Method C: PdCl2(MeCN)2 (10 mol%), P(2-Tol)3 (15 mol%), CuI ,TBAF, DMF, 120 oC, 16 h.; 
iii) SnCl2, conc. HCl, EtOH/THF, RT, 16 h; iv) DCC, cat. DMAP, CH2Cl2, RT, 16 h. 
Since this successful approach to boscalid (43) no longer required our arylgermane to 
survive any synthetic steps prior to photolytic activation/cross-coupling, we decided 
to demonstrate the compatibility of the fluorous-tagged arylgermanes with synthetic 
manipulations prior to cross-coupling by preparing some alkynyl-substituted 
derivatives of boscalid. 2-Chloro-N-[4'-(3-methoxy-3-methylbut-1-ynyl)- 
biphenyl-2-yl]nicotinamide (74a) and 2-chloro-N-(4'-prop-1-ynylbiphenyl-2-yl)- 
nicotinamide (74b), which contain alkynyl substituents in place of the chloro 
substituent found in boscalid, have been described in a Syngenta patent162 as being 
‘second generation’ boscalid-type fungicides. It was planned to employ Sonogashira 
coupling in the preparation of these compounds (Scheme 2.6.34).135  
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Scheme 2.6.34. Proposed disconnection for alkynyl boscalid derivatives 74 and 75. 
The plan was to introduce the phase-tagged cross-coupling partner early in the 
synthetic route, exploit the phase-tag to enable facile purification of intermediates, 
and then activate and cross-couple to furnish the desired molecule. 
To manifest this idea, two Sonogashira reactions were carried out between 
fluorous-tagged 4-iodoarylgermane 78 and 2-methylbut-3-yn-2-ol (78→79, 68%) 
and ethynyltrimethylsilane (78→80, 52%) catalysed by Cu(I) and Pd(0).163 The 
success of these transformations verified that arylgermanes are orthogonal to 
Pd-catalysed coupling conditions prior to photoactivation as we expected. 
Deprotection of the 2-hydroxypropyl group by KOH (79→81, 98 %) and 
deprotection of the TMS group (by fluoridolysis, 80→81, 67 %), yielded a common 
ethynylarylgermane 81. The success of these transformations demonstrated the 
orthogonality of the arylgermanes towards fluoridolysis and basic conditions, again 
as expected (Scheme 2.6.35).  
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Scheme 2.6.35. Sonogashira/germyl-Stille coupling of unmasked alkynes. 
Reagents and conditions: i) alkynes, Pd(OAc)2, PPh3, CuI, nBuNH2; ii) Method D: KOH, 80 °C; iii) 
Method E: K2CO3, KF. 
However, neither 3-methyl-3-hydroxybutynylarylgermane 79 nor 
ethynylarylgermane 81 participated in photolysis/cross-coupling with 
2-bromonitrobenzene; no desired biphenyls 82 and 83 could be found, although the 
key by-products of photolysis 8 and 9 were identified by GC/MS in both cases 
(Scheme 2.6.36).  
 
Scheme 2.6.36. Attempted to achieve germyl-Stille coupling of alkyne-containing alkynyl 
arylgermanes 79 and 81.. 
Reagents and conditions: i) Cu(BF4)2 (4+4 eq.), Pyrex tube, argon purged, hυ, MeOH : MeCN = 1:3, 2 
h; ii) Method C: PdCl2(MeCN)2 (10 mol%), P(2-Tol)3 (15 mol%), CuI ,TBAF, DMF, 120 oC, 16 h. 
The unsuccessful cross-coupling of these two substrates may reflect instability of 
their alkynyl functionalities under the catalytic conditions. In particular, 
ethynylarylgermane 81 could be generated in situ by basic pyrolysis of 
3-methyl-3-hydroxybutynylarylgermane 79 in the presence of a nucleophile (e.g. 
TBAF at 120 oC, Method C conditions). To circumvent these issues, methylation of 
compounds 79 and 81 was carried out using NaH-Me2SO4 (79→84, 87 % yield)164 
and nBuLi/MeOTf (81→87, 87 % yield)165,166 to give the desired 
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alkynylarylgermanes 84 and 87, respectively. These two alkynylarylgermanes were 
then subjected to photolysis/cross-coupling with 2-bromonitrobenzene under 
standard conditions to give the desired biphenyls 85 and 88 in 50 % and 54 % yield, 
respectively. The biphenyls 85 and 88 were reduced by SnCl2 to give 
4-(3-methyl-3-methoxybutynyl)-2’-aminobiphenyl 86 in 80 % yield and 
4-propynyl-2’aminobiphenyl 89 in 80 % yield. Finally, DCC coupling with 
2-chloro-3-nicotinic acid gave alkynyl boscalid analogues, 
2-chloro-N-[4'-(3-methoxy-3-methylbut-1-ynyl)biphenyl-2-yl]nicotinamide (74, 68 
% yield) and 2-chloro-N-(4'-prop-1-ynylbiphenyl-2-yl)nicotinamide (75, 59 % yield) 
(Scheme 2.6.37).  
 
 
Scheme 2.6.37. Synthesis pathways for alkynyl analogues of boscalid 74 and 75.162  
Reagents and conditions: i) NaH, Me2SO4, THF; ii) nBuLi, DMPU, MeOTf, THF, -78 oC; iii) 
Cu(BF4)2 (4+4 eq.), Pyrex tube, argon purged, hυ, MeOH : MeCN = 1:3, 2 h; iv) Method C: 
2-bromo-nitrobenzene, PdCl2(MeCN)2 (10 mol%), P(2-Tol)3 (15 mol%), CuI ,TBAF, DMF, 120 oC, 
16 h; v) SnCl2, conc. HCl, EtOH/THF, RT, 16 h; vi) DCC, cat. DMAP, CH2Cl2, RT, 16 h. 
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The stability of the Rf-tagged arylgermanes towards the various reaction conditions 
employed during the synthesis of the above boscalid analogues, such as the NaH and 
nBuLi used for the methylation of compound 79 and 81, and the fluoridolysis and 
basic pyrolysis procedures used for the formation of compound 81, reveal 
remarkable tolerance of these compounds towards reaction conditions of routine use 
in synthesis. Moreover, this methodology displays high performance in both linear 
and parallel synthetic design for rapidly diversifying target molecules whilst 
benefiting from facile purification by F-SPE. 
Precedent in the literature for the concept demonstrated above is relatively rare. 
There is an emerging body of work from the Molander labs relating to the use of aryl 
and alkenyl trifluoroborate salts as robust precursors for Suzuki coupling.167 
However, purification of these trifluoroborate salts and their intermediates prior to 
cross-coupling can only be achieved by means of crystallisation which is unsuitable 
for micro-scale use. More recently, Burke has shown that N-methyliminodiacetic 
acid (MIDA) boronate-based coupling partners can be used in multistep 
synthesis.168,169 Upon treatment of MIDA-boronates with aqueous basic conditions 
(NaOH(aq)/THF or NaHCO3(aq)/MeOH, RT), the corresponding boronic acids are 
liberated for cross-coupling with electrophiles. However, the MIDA-boronate-based 
coupling substrates are less stable to strong nucleophiles (e.g. LiAlH4, TBAF and 
metal alkoxides as compared to arylgermanes, cf. Table 2.6.5). Nevertheless, the 
MIDA-tagged boronates have proved very useful for the synthesis of bioactive 
products.169  
 
2.6.4. Conclusions 
The scope of the sequential germyl-Stille photoactivation/cross-coupling reaction has 
been investigated under optimised photolysis and cross-coupling conditions. 
Coupling yields are strongly affected by the electronic nature of both the nucleophilic 
and the electrophilic aryl partners. Electron-rich arylgermanes cross-couple 
particularly well with electron-deficient aryl bromides. In addition, the stability 
profile of an Rf-tagged phenylgermane has been delineated. The tolerance of the 
arylgermane unit towards strongly basic and nucleophilic conditions for extended  
periods of time is good. 
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The key biaryl agrochemical boscalid 43 and two of its analogues have been 
synthesised using the germyl-Stille cross-coupling reaction. The successful approach 
developed differs from the original synthetic route envisaged because amine and 
acetamide groups on the Rf-tagged arylgermane were found to be unsuitable for the 
photolysis/cross-coupling reactions. The synthetic routes to boscalid analogues 
2-chloro-N-[4'-(3-methoxy-3-methylbut-1-ynyl)biphenyl-2-yl]nicotinamide (74) and 
2-chloro-N-(4'-prop-1-ynylbiphenyl-2-yl)nicotinamide (75) demonstrate that the 
fluorous-tagged arylgermanes can survive various chemical manipulations including 
Sonogashira coupling and butyllithium treatment. This underscores the concept of 
iterative chemical manipulation of the Rf-tagged arylgermanes prior to activation and 
coupling: the arylgermane coupling precursors are chemically stable, easy to handle 
and readily purified. 
 
2.6.5 Development of alkenyl germyl-Stille cross-coupling reactions for 
stereocontrolled styrene synthesis 
Pd-catalysed cross-coupling of alkenyl organosilanes and organostannanes have been 
used for the alkenylation of wide ranges of aromatics and to effect macrocyclisation 
during natural product synthesis.57 Alkenyl organometallics are generally of higher 
reactivity as compared to the corresponding aryl congeners with respect to 
transmetalation with Ar2PdIIXL complexes. However, as well as directly undergoing 
transmetalation with Ar2Pd(II) complexes to give ipso cross-coupling products, 
alkenyl organometallics can also undergo electrophilic carbopalladation under certain 
circumstances resulting in stereo- and regioisomeric mixtures. 
Following our successful demonstration of the utility of aryl-aryl germyl-Stille 
coupling reactions for the synthesis of boscalid and analogues, our attention was 
focused on alkenyl-aryl cross-coupling using alkenyl germanes as coupling 
substrates. The initial reaction parameters for this protocol were those optimised 
conditions employed for aryl-aryl germyl-Stille coupling reactions. 
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2.6.5.1 Synthesis of Rf-tagged (E)-alkenyl germanes via hydrogermylation  
Alkenyl group 14 metal reagents are magnificent tools for derivatisation of 
molecules by transition metal-catalysed cross-coupling reactions or by 
ipso-electrophilic demetallation to furnish alkenyl-substituted products. Efficient 
regio- and stereocontrolled synthesis of the alkenylmetal reagents can usually be 
achieved by hydrometalation of alkynes.170  
Hydrostannation and hydrosilylation of terminal alkynes are well documented for the 
preparation of alkenyl stannanes and silanes for Pd-catalysed cross-coupling 
reactions. This transformation can be achieved by radical initiated addition of 
hydrostannanes (or hydrosilanes) to alkynes, by analogous transition metal catalysed 
processes (e.g. using Pd, Rh and Pt complexes), or thermally. Regio- and 
stereoselectivity can be most easily controlled for the metal catalysed cases by the 
means of carefully controlling the ligands and conditions of the reaction.171,172 
Similarly, alkenylgermanes can be prepared by hydrogermylation of germanium 
hydrides with terminal alkynes facilitated by Pd,173 Pt174 or Rh complexes175-177 or by 
Lewis acids under mild reaction conditions.  
Rf-tagged alkenylgermane 91 was chosen as a model molecule to explore sequential 
photoactivation/cross-coupling. Following a procedure reported by Wada, upon 
treatment germane hydride 90 with 4-phenylbutyne in the presence of 
RhCl(CO)(PPh3)2 as a catalyst, (E)-alkenylgermane 91 was obtained in 96 % yield 
(Scheme 2.6.38).175  
 
Scheme 2.6.38. Synthesis of Rf-tagged (E)-alkenyl germane 91 by hydrogermylation.  
Reagents and conditions: i) RhCl(CO)(PPh3)2, galvinoxyl, CH2Cl2, 40 oC, 24 h; ii) RhCl(CO)(PPh3)2, 
CH2Cl2, 40 oC, 24 h. 
 
The stereochemistry of the alkene was confirmed by the characteristic J = 18.5 Hz 
vicinal coupling constant between the trans alkene protons. 
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Wada reported that hydrogermylation of tributylgermanium hydride with 
phenylacetylene catalysed by the RhCl(CO)(PPh3)2 complex gave good 
regioselectivity for -adducts (93 % vs. 7 % -adducts) but with moderate 
stereoselectivity (E : Z = 70 : 23).175 With radical inhibitor galvinoxyl as an additive, 
Wada found that the regio- and stereoselectivity of the (E)--adduct was improved 
(99 % of -adduct with E : Z = 91 : 8).175 For our reaction, the (E) stereochemistry of 
the exclusive product alkenyl germane 91 was verified by a large vicinal coupling 
constant with 3J = 18.5 Hz in its 1H NMR spectrum. However, the desired product 
could not be separated as a pure substance from galvinoxyl-derived contaminates.  
Fortunately, identical regio- and stereoselectivity were observed when the 
hydrogermylation was carried out in the absence of galvinoxyl but otherwise 
identical conditions. (E)-Alkenyl germane 91 was formed exclusively in 96 % yield. 
The high regio- and stereoselectivities probably reflects suppression of the -adduct 
by virtue of the steric hindrance provided by the bulky bis(2-naphthylmethyl) groups 
on the germanium hydride 90. 
The regio- and stereoselectivity of hydrometallation reactions mediated by 
transition-metals are influenced by the metal-complex employed, the source of the 
metal hydride and the other parameters. Nevertheless, a catalytic pathway of 
hydrogermylation mediated by a Rh(I)-complex was proposed by Esterulas.176 
Trialkylgermanium hydride was proposed to undergo oxidative addition with the 
Rh(I) complex to afford a H-Rh(III) germane intermediate in which the polarised 
H-Rh bond undergoes facile hydrorhodiation of the alkyne via polar addition. The 
polar addition step is the regiochemistry determining step and exhibits strong 
dependence on the substrate and Rh-complex. The resulting -alkenylrhodium 
germane intermediate then undergoes reductive elimination to furnish the desired 
alkenyl germane and the regenerate Rh(I)-complex (Scheme 2.6.39).176  
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Scheme 2.6.39. Esterulas’ proposed mechanism of Rh-catalysed hydrogermylation of alkynes to 
afford (E)--alkenyl germanes.176  
(E)-Styrenyl germane 92 was also prepared by hydrogermylation in the absence of 
galvinoxyl (Scheme 2.6.40).  
 
Scheme 2.6.40. Synthesis of Rf-tagged (E)-alkenyl germane 92 by hydrogermylation. 
Reagents and conditions: i) RhCl(CO)(PPh3)2, CH2Cl2, 40 oC, 24 h. 
Highly stereoselective (E)--alkenyl germane formation was observed, the 
stereochemistry again being confirmed by the characteristic J = 19.0 Hz vicinal 
coupling constant between the trans alkene protons. 
 
2.6.5.2 Exploring the scope and selectivity of alkenyl germyl-Stille 
cross-coupling  
(E)-alkenyl germane 91 was subjected to photolysis using the previously optimised 
protocol. As before, three signals at ca. -164 ppm were apparent in the 19F NMR 
spectrum of the intermediate coincident with the conclusion of the photolysis of 
period. It was therefore assumed that as in the arylgermane cases, a dimer and a 
monomer of the difluoro alkenyl germane had been formed and that these co-existed 
in the solution. That this situation mirrors closely that found for the arylgermanes 
suggests that the FF interactions may be dominant in dictating the formation of the 
head-to-head topology of the dimer rather than π-π interactions. Based on the vicinal 
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coupling constant (3J = 18.5 Hz) of the alkenyl subunit the 1H NMR spectrum of this 
alkenyl difluorogermane, no photoinduced isomerisation occurred during this 
photoactivation process. Thus, the (E)-alkenyl difluoro germane intermediate was 
submitted to the sequential cross-coupling reaction without further purification. 
Coupling with 3,5-bis(trifluoromethyl)bromobenzene afforded a coupling product 
93a in 65 % yield. Its 1H NMR spectrum exhibited vicinal coupling pattern which 
could not be readily reconciled with (E)-β-styrene geometry due to second order 
distortion resulting from the two protons being close in chemical shift. Two 
alternative possible structural assignments were considered: an -substituted or a 
(Z)-configured β-styrene.  
In order to determine the regiochemistry of this product, ozonolysis of the styrene 
followed by reductive cleavage of the resulting ozonides was undertaken with in situ 
reaction with 4-anisidine. Imine 94 was isolated in 78 % yield but the other fragment 
was not detected. The formation of imine 94 excluded the possibility of the product 
being an -substituted styrene. Therefore, the product of the reaction was concluded 
to be either the expected (E)-β-styrene or the (Z)-β-styrene 93a (Scheme 2.6.41). 
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Scheme 2.6.41. Ozonolysis/reductive cleavage then imine formation on styrene 93a-proof of 
regiochemistry. 
Reagents and conditions: i) O3, CH2Cl2, -78 oC, 15 min; ii) PPh3, CH2Cl2, 0 oC – rt, 1 h; iii) 
4-anisidine, CH2Cl2, 2 h. 
1D and 2D 1H NMR experiments could not unambiguously distinguish there two 
possibilities either. GC-MS analysis revealed the ratio of isomers to be 98 : 2 
(Scheme 2.6.42). Eventually, the major isomer of this reaction was proven to be the 
expected (E)-β-styrene by a 4th year project student in the group (Mungyuen Li, 
Spivey group, 2008-2009). He prepared authentic samples of the E and Z configured 
alkenes 93c (see Table 2.6.9) which displayed the same ambiguous NMR feature.178 
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Scheme 2.6.42. Alkenyl germyl-Stille cross-coupling with 3,5-bis(trifluoromethyl)bromobenzene 
affording (E)-styrene 93a. 
Reagents and conditions: i) Cu(BF4)2, Pyrex tube, argon purged, hυ, MeOH : MeCN = 1:3, ii) Method 
C: PdCl2(MeCN)2 (10 mol%), P(2-Tol)3 (15 mol%), TBAF, CuI, DMF, 120 oC, 16 h. 
(E)-Alkenyl germane 91 was next employed as a substrate for cross-coupling with a 
series of aryl bromides varying in electronic nature. All the resulting crude product 
mixtures were examined by the means of 1H NMR and GC-MS analysis for the 
determination of isomer ratios (Table 2.6.9). 
 
Entry R2 Product Yield  Isomer ratio 
   (%) (E)- : (Z)- : - 
1 3,5-bis(CF3)a 93a 65 98 : 2 : 0 
2 4-CNa 93b 65 99 : 1 : 0 
3 4-Aca 93c 59 100 : 0 : 0 
4 3,5-di(CH3) 93d 63 93 : 5 : 2 
5 4-Me 93e 72 80 : 8 : 12 
6 4-OMe 93f 40 67 : 13 : 20 
7 4-Cl 93g 52 73 : 1 : 26 
8 4-F 93h 58 93 : 2 : 5 
9 2-NO2 93i 48 80 : 20 : 0 
a The 1H NMR spectra of these compounds are difficult to assign due to second order effects resulting 
from the vicinal alkenyl protons bearing very similar chemical shifts (see Text). 
Table 2.6.9. Germyl-Stille cross-coupling of (E)-alkenyl germane 91 with various aryl bromides. 
Reagents and conditions: i) Cu(BF4)2, Pyrex tube, argon purged, hυ, MeOH : MeCN = 1:3, ii) Method 
C: PdCl2(MeCN)2 (10 mol%), P(2-Tol)3 (15 mol%), TBAF, CuI, DMF, 120 oC, 16 h 
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It can be seen that the expected (E)-alkenes are produced in all cases. Although 
styrenes were obtained with high (E)-selectivity by coupling with electron-deficient 
aryl bromides, the selectivity achieved by coupling with electron-rich substrates was 
unsatisfactory. Since we were keen to develop a method that would provide styrenes 
of (E)-configurations with high selectivity optimisation studies were carried out 
using alkenyl germane 91 and 4-bromotoluene. Various supporting ligands were 
screened for their effects on this reaction (Table 2.6.10). 
 
Entry L Yield  Isomer ratio 
  (%) (E)- : (Z)- : - 
1 L1 65 94 : 5 : 1 
2 L2 62 98 : 1 : 1 
3 L3a 71 100 : trace : trace 
4 L4 42 100 : trace : trace 
a addition of iPr2NEt (15 %mol) 
Table 2.6.10. Screening of phosphine ligands to effect (E)-stereoselective styrene formation 
Reagents and conditions: i) Cu(BF4)2, Pyrex tube, argon purged, hυ, MeOH : MeCN = 1:3, ii) 
PdCl2(MeCN)2 (10 mol%), ligands (15 mol%), TBAF, CuI, DMF, 120 oC, 16 h. 
Gratifyingly, all the ligands screened gave improved (E)-selectivity in this reaction as 
compared to the original conditions using P(2-Tol)3 as a ligand (cf. Table 2.6.38, 
entry 5). Sterically hindered electron-rich ligand t-BuXPhos (L1) and P(nBu)3 (L2) 
both gave high levels of (E)-selectivity (entries 1 and 2). Superior (E)-selectivity still 
was obtained by employing PCy3．HBF4 (L3) and dppp (L4) as ligands (entries 3 and 
4). However, an inferior coupling yield (42 %) resulted when using the dppp ligand 
and so PCy3．HBF4 (L3) is the preferred ligand for mediating (E)-styrene formation 
with good reaction yields when cross-coupling with electron-rich aryl bromides. 
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Cross-coupling of (E)-alkenyl germane 91 with electron-deficient 
4-bromoacetophenone using PCy3 ．HBF4 (L3) as a ligand still gave the high 
(E)-selectivity as observed previously albeit in a poor reaction yield (Scheme 2.6.43).  
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Scheme 2.6.43. Use of PCy3．HBF4 ligand in (E)-selective cross-coupling with germane 91. 
Reagents and conditions: i) Cu(BF4)2 (2 x 4eq.), Pyrex tube, argon purged, hυ, 2 h, MeOH : MeCN = 
1:3, ii) PdCl2(MeCN)2 (10 mol%), PCy3HBF4 (15 mol%), i-Pr2NEt (15 %mol), TBAF, CuI, DMF, 120 
oC, 16 h. 
In order to see how general the above trends were, the (E)-styrenyl germane 92 was 
investigated for cross-coupling with selected aryl bromides (Table 2.6.11). 
 
Entry R2 Product Yield  Isomer ratio 
   (%) (E)- : (Z)- : - 
1 3,5-bis(CF3) 96a 58 82 : 17 : 1 
2 4-CN 96b 60 90 : 10 : 0 
3 4-Ac 96c 66 100 : 0 : 0 
4 4-Me 96d 52 99 : 1 : 0 
Table 2.6.11. Germyl-Stille cross-coupling of alkenyl germanes with aryl bromides. 
Reagents and conditions: i) Cu(BF4)2, Pyrex tube, argon purged, hυ, MeOH : MeCN = 1:3, ii) Method 
C: PdCl2(MeCN)2 (10 mol%), P(2-Tol)3 (15 mol%), TBAF, CuI, DMF, 120 oC, 16 h 
A similar stereoselectivity profile was found when coupling styrenyl germane 92 
with aryl bromides. For this substrate too, (E)-stilbenes were obtained as the major 
stereoisomers irrespective of the electronic demand of the aryl bromide partners 
(entries 1-4).  
The presence of various isomers during the Pd-catalysed cross-coupling of 
(E)-alkenyl germanes with aryl bromides undoubtedly reflects the fact that there are 
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(at least) two mechanistically distinct pathways by which coupling can occur in 
alkenyl group 14 metal cross-coupling reactions: (a) a direct transmetallation route as 
proposed for the aryl-aryl coupling (i.e. germyl-Stille coupling) leading to 
(E)--styrenes; and (b) a regioselective carbopalladation route (i.e. Heck reaction) 
followed by nucleophile-assisted elimination of the germane moiety and Pd(0) 
affording  (cine) and/or  (ipso) styrenes (Scheme 2.6.44). 
 
Scheme 2.6.44. Proposed reaction pathways for alkenyl group 14 metal cross-coupling reactions. 
In general, cross-coupling of alkenylsilanes and alkenylstannanes with aryl 
(pseudo)halides are highly selective and to furnish coupled products with retention of 
the regio- and stereochemistry of the alkenylmetals employed [i.e. (E)-substrates → 
(E)-products; (Z)-substrates → (Z)-products]. The high selectivity is attributed to 
rapid transmetalation with the Ar2PdII complex (route a) followed by reductive 
elimination.96 However, some instances in which coupling of (Z)- or -substituted 
alkenylmetals with aryl (pseudo)halides gave thermodynamically favoured 
(E)-alkene products have been reported.179,180 These cases proceed via 
carbopalladation (route b) presumably because the transmetallation pathway is 
relatively slow. Kikukawa’s cross-coupling of alkenyl germanes with 
arenediazonium salts discussed earlier (Table 2.3.1) is a case in point.117 To suppress 
the carbopalladation route, Corey found that addition of Cu(I) salts can effectively 
accelerate route a by pre-transmetallation to give an alkenylcopper intermediate 
which then undergoes rapid transmetallation with the Ar2PdII complex.179  
Although the formation of (E)-alkenes from (Z)- or -substituted substrates has been 
well documented,180-183 formation of (Z)-alkenes from (E)-coupling partners is rare in 
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the literature. An example has been reported by Blart who found that cross-coupling 
of an (E)-alkenylsilane with 4-anisyl iodide gave a mixture of styrenes in 80 % yield 
in which (Z)- and -substituted products were identified as being present in the same 
ratio.184 
Divergence between the two coupling pathways, at least for alkenylsilanes and 
stannanes, has been suggested to be influenced by the reactivity of the particular 
alkenyl metal reagent and the catalyst system employed.185 The transmetalation 
pathway a usually predominates when the alkenyl metal is comprised of an alkene 
bearing a non-hindered group at the β-position that can readily migrate. Hence, the 
transmetalation process would be expected to proceed rapidly in the case of both the 
alkenyl germane 91 and the styrenyl germane 92. Consequently, (E)-stilbenes are the 
major products in all cases. 
The experimental results suggest that the carbopalladation route does however 
operate to a limited degree in several cases. Two orientations for addition of the 
Ar2PdIIBrL complex to the difluoroalkenyl germanes are possible. Regioselective 
formation of intermediate 97 (via route b) or 98 (via route b′) is likely to be 
influenced by steric and electronic factors.186  
Although the carbocation β to the Ge centre in the intermediate 98 will be stabilised 
by hyperconjugation from the Ge-C bond (C-Ge  pvac), the electronegative fluorine 
atoms on the Ge centre will diminish the stabilisation contributed by this -effect. As 
a result, route b′ appears to be a disfavoured pathway by which -styrenes are 
formed via cine-substitution as minor products when electron-rich substrates are 
used.92 This minor carbopalladation route could probably be suppressed by using 
different ligands. 
The regioselective carbopalladation (via route b) is a slightly more favourable 
pathway that affords intermediate 100 leading to -substituted styrenes as final 
products (Scheme 2.6.45). 
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Scheme 2.6.45. Proposed mechanism for cross-coupling of (E)-alkenyl germanes with 
electron-deficient aryl bromides to leading (Z)-styrenes via a Pd-carbene intermediate. 
Carbopalladation of the alkenyl germane with the Ar2PdIIBrL complex should 
proceed in a syn-fashion to give intermediate 100. Facile syn-elimination of Pd-H 
affords a -Pd-H complex 101 which then re-adds to the alkene yielding intermediate 
102. Subsequent, -degermylation facilitated by fluoride ions leads to Busacca-type 
palladium carbene complex 103 in which the geometry of the styrene is as shown in 
the projection 103′.187 Upon 1,3-hydride shift and reductive elimination of Pd(0), 
(Z)-styrenes 93 are formed. 
It is also possible that the (Z)-styrene products are formed by directly syn-elimination 
of the germane moiety and Pd(0) from intermediate 100′ but a driving force for this 
is not apparent. Clearly, further experiments need to be carried out in order to clarity 
these mechanistic interpretations. 
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2.6.5.3 Conclusion 
Rh-catalysed hydrogermylation has been performed to prepare (E)-alkenyl germanes 
with high regio- and stereoselectivity in excellent yields. Photoactivation of these 
(E)-substrates proceeded under the optimised conditions and no photoinduced 
double-bond isomerisation occurred.  
Coupling of the photoactivated (E)-alkenyl germanes with aryl bromides in the 
presence of Pd catalysts resulted in the formation of mixture of isomeric alkene 
products in which the expected (E)-isomers predominated in all cases. Although 
measurable amounts of (Z) and sometimes α substituted isomers were formed, these 
could be suppressed by appropriate choice of conditions. Mechanisms that can 
account for these results have been discussed. 
 
2.7 Future work 
Although the structures of the photoactivated difluoro germanes have been assigned 
as a mixture of monomer and dimer co-existing in the system according to 19F and 1H 
NMR spectroscopic analysis, it is planed to further elucidate their structure by X-ray 
crystallography. It is also planned to adapt the developed germyl-Stille 
cross-coupling method for the synthesis of libraries of biaryls by parallel synthesis 
using UV light delivered to 96 well plate arrays using optical fibres. It is further 
planned to exemplify this method by using Sharpless click chemistry and 
germyl-Stille coupling to prepare libraries of bioactive biaryl triazoles (Scheme 
2.7.1).188  
 
Scheme 2.7.1. Proposed approach to biaryl libraries using Sharpless click chemistry/germyl Stille 
coupling reactions. 
It is also intended to carry out mechanistic studies to elucidate the reaction pathway 
and scope of the cross-coupling of (E)-alkenylgermanes with aryl bromides to give 
styrenes. 
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3. Development of ipso-iododegermylation as a method for 
radio-labelling 
3.1 Introduction 
3.1.1 Introduction to cannabinoid receptors 
Cannabinoid receptors obtained their name as a result of their response to 
cannabinoid drugs e.g. 9-tetrahydrocannabinol (9-THC) from Cannabis sativa 
(marijuana) and its synthetic analogues. These receptors have been classified as 
belonging to the rhodospin family of G protein-coupled receptors (GPCRs). Two 
subtypes of receptors were identified: cannabinoid receptor type 1 (CB1) and type 2 
(CB2). The CB1 receptor abounds in the brain and central nervous system (CNS), 
whereas the CB2 is found mainly in the immune system.189  
Human CB1 receptors are encoded by an amino sequence of 472 residues deduced 
by complementary DNA encoding190 and molecular cloning of the receptor.191 As for 
other proteins belonging to the rhodospin family, the receptor has 7 transmembrane 
helical (TMH) domains of which the TMH-4 and 5 domains are responsible for the 
high affinity ligand binding site.192  
Recently studies on the physiological roles of the CB1 receptor disclosed strong 
correlations with inhibition of adenylyl cyclase, pain control, regulation of ion 
channels, modulation of energy intake, and various other signal transduction 
pathways.193,194 Among these functions, the most promising feature of this receptor’s 
regulatory profile is its role in energy regulation and metabolism. Animal models 
have revealed that CB1 knock-out mice are leaner than wild-type species.195 
Therefore, blocking the CB1 receptor provides a potential therapeutic strategy for 
treatment of obesity, metabolic syndrome, drug additions and addiction to 
smoking.195  
 
3.1.2 Antagonists and inverse agonists of CB1 receptors 
The Sanofi-Aventis compound SR141716A, also know as rimonabant, displays 
nanomolar inhibition of the CB1 receptor and micromolar inhibition of the CB2 
receptor. SR141716A is a diarylpyrazole-based ligand which was the first efficient 
 104
competitive antagonist for selective blocking of the CB1 receptors. It was discovered 
in 1994.196 An analogue, AM251, which has an iodine-substituent in place of a 
chlorine atom in the 5-phenyl ring of rimonabant, has similar inhibitory activity and 
selectivity for CB1 whilst also providing an opportunity to introduce a radio-iodine 
isotope to allow visualisation of the CNS by PET or SPECT.193,194 Although 
ring-constrained analogue NESS0327 has been reported to have the highest affinity 
for the CB1 receptor (fentomolar) during in vitro tests, it showed no inhibition when 
administered orally.197,198 This outcome is probably due to poor biodistribution of the 
compound in vivo. Recently, extensive studies have been reported towards the 
development of novel CB1 ligands by changing the central core of rimonabant to an 
imidazole, triazole, or phenyl unit (O-183). Other development programmes have 
produced non-rimonabant-based scaffolds as promising therapeutic scaffolds e.g. 
CP-945598 (Pfizer), MK-0364 (Merck) and AVE-1625 (Sanofi-Aventis) (Scheme 
3.1.1). 
 
Scheme 3.1.1. Drug-like potential CB1 antagonists 
Clinical trials of rimonabant for treatment of obesity were promising and the 
compound was approved by the European Medicines Agency for sale in Europe as 
Acomplia in 2006. Although few side-effects were reported during the trial, several 
serious psychiatric disorder cases emerged once the drug was available clinically. 
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Consequently, this drug was withdrawn from the market in 2008 and many ongoing 
projects targeting the CB1 receptor as a strategy for developing anti-obesity drugs 
were also terminated.199 
 
3.1.3 Conformational analysis of rimonabant and computational modelling of its 
binding features with the CB1 receptor 
Amongst several potent anti-obesity drugs either on the market or in development, 
SR141716A has received the most attention and been subjected to the most 
comprehensive pharmacological studies. As a result, it is now categorised as an 
inverse agonist* of the CB1 receptor exhibiting negative intrinsic activity to the 
endocannabinoid system.200-202 Conformational analysis of rimonabant reveals that it 
has several distinct conformational minima (Scheme 3.1.2).203  
 
Scheme 3.1.2. Rimonabant docked in the helical binding site of the CB1 receptor and a general 
inverse agonist-receptor interaction model.203 
In particular, conformations in which torsional angle 1 about the bond between the 
pyrazole ring and the acyl hydrazine carbonyl is s-trans, and the torsional angle 2 
about the N-N bond of the hydrazine unit, is in one of four specific values are 
favoured. The torsional angles 3 and 4 describe the conformation of the two aryl 
groups, and these vary depending on the substituents on these rings.204  
                                                 
* Agonist: a term used to describe a type of ligand or drug that binds to a receptor and stimulates its 
activity. Inverse agonist: a term used to describe a type of ligand or drug that binds to a receptor and 
illicits the opposite response to an agonist (i.e. reduces its intrinsic/constitutive activity to sub-basal 
levels). Antagonist: A term used to describe a type of ligand or drug that binds to a receptor and 
blocks all ligand-induced activity (i.e. it will restore basal intrinsic/constituitive activity). 
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Computational modelling by docking of rimonabant in a minimised energy 
conformation with the TMH domains of CB1 suggested an essential salt bridge 
between the carbonyl moiety and Lys192Asp366.205 Further computational binding 
analysis based on structure-activity relationships (SAR) of similar pharmacophores 
to rimonabant allowed a general model for CB1 inverse agonist binding to be 
constructed. 
Besides the crucial salt bridge formed between the carbonyl group of rimonabant and 
Lys192Asp366, the binding interactions were reinforced by - stacking interactions 
between the two substituted phenyl groups and the aromatic-rich TMH 3-6 regions of 
the CB1 receptor. In addition, a lipophilic interaction was contributed by the 
piperidinyl group and by the hydrophobic cavity comprised of Val196, Phe170, 
Leu387 and Met384.  
It is not clear what mechanism caused the psychiatric effects. However, as the 
endocannabinoid system is known to be involved in our ability to manage stress and 
anxiety, prohibition of this pathway may result in depression. Elaboration of the 
psychiatric functions controlled by the endocannabinoid system will be necessary if 
the effects caused by blocking the receptor are to be fully understood.  
 
3.1.4 Conventional methods for preparation of radio-labelled pharmaceuticals 
for imaging the CB1 receptor 
Non-invasive examination of the brain by molecular imaging technologies such as 
PET and SPECT require high-affinity radio-labelled ligands as tracers. The scaffold 
of rimonabant constitutes a promising starting point for the development of such 
tracers. 
 
3.1.4.1 Radio-labelling of the rimonabant scaffold by nucleophilic substitution 
According to the general binding model of rimonabant with the CB1 receptor, 
labelling tactics have been focused on introducing labels at the 4-methyl, 5-aryl and 
3-carboxamide moieties in order to retain the bioactivity of the modified tracers. In 
addition, minor modifications to the substrate provide opportunities to enhance 
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lipophilicity and affinity to achieve better biodistribution.  
Mathews reported the preparation 18F and 11C-labelled analogues by means of 
nucleophilic substitution reactions.206,207 Galety described replacing the 3-acyl 
hydrazine unit with a [18F]-4-fluorophenyl amide unit; the 
[18F]-4-fluorophenylaniline was obtained by a SNAr reaction of dinitrobenzene with 
18F anions.208 Pharmacological data for these tracer candidates revealed good 
inhibition of the CB1 receptor in their unlabelled form. Moreover, the 18F and 
11C-labelled ligands provided high quality scanning images. However, the short 
half-life of these radio-nuclei limited the range of possible applications for these 
tracers (Scheme 3.1.3). 
 
Scheme 3.1.3 Mathews’ (a and b) and Galety’s approaches (c) for preparation of radio-labelled 
rimonabant analogues for PET scanning.206-208  
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3.1.4.2 Radio-labelling of rimonabant by ipso-iododestannylation  
As indicated previously, [123I]-AM251 exhibits similar binding affinity to rimonabant 
and has been used in animal models for SPECT scanning. Another candidate, 
[123I]-AM281 was also prepared for this purpose and was the first SPECT agent for 
visualising the human cannabinoid system.209 The general method used to synthesise 
aryl iodinated CB1 ligands is to employ ipso-iododestannylation of the 
corresponding aryltributylstannane precursors with various iodonium electrophiles 
such as a mixture of KI and chloroamine-T or molecular iodine. The arylstannanes 
are generally prepared by coupling of the corresponding aryl bromides with 
hexabutyldistannane using a catalytic amount of Pd(0). [I124]-AM281 for PET 
imaging was prepared in this fashion (Scheme 3.1.4).210  
 
Scheme 3.1.4. Preparation of radio-iodinated imaging agents via ipso-iododestannylation.210 
Tedious post-reaction purification procedures are critical and necessary to remove Sn 
and Pd containing residues prior to administration of the labelled analogues for in 
vivo trials. The time required for this purification degrades the quality of the 
tomographic images due to attenuation of the activity of the radio-iodinated 
compounds. Additionally, preparation of these analogues for screening as potential 
imaging agents relies on individual synthetic processes in solution.211  
 
3.1.5 Mechanism of ipso-halodemetallation 
The stabilisation of -carbocations by group 14 organometallics is known as the 
-effect.212 The stabilisation accrues from orbital overlap of the C-M orbital with the 
empty p orbital of the carbocation (pvac). This phenomenon is known as 
hyperconjugative stabilisation. Eaborn conducted kinetic studies to rank the 
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reactivity of aryl-group 14 metal bonds with electrophiles. The relative rate of 
cleavage the aryl-metal bonds with acid was as follows: R3Sn-Ar is cleaved 104 times 
faster than R3Ge-Ar which is cleaved 102 times faster than R3Si-Ar.213  
Upon treatment of aryl group 14 organometallics with electrophiles, an sp2 
hybridised carbocation is generated to the C-M bond in the Wheland intermediate 
and this is stabilised by C-M→pvac hyperconjugation. Subsequently, the C-M bond is 
cleaved by nucleophilic attack at the metal centre by the electrophile counter-ion to 
afford an ipso-substituted aromatic and the metallic residue. This process is known as 
ipso-halodemetallation when halonium ions are involved. The reaction is highly 
regioselective as the result of the strong -effect (Scheme 3.1.5). 
 
Scheme 3.1.5. Mechanism of ipso-halodemetallation. 
 
3.2 Preliminary Results – Prior work in the group 
The development of a new protocol to facilitate iodination of diarylpyrazole CB1 
ligands by ipso-iododegermylation of a germyl-linker bound precursor was initiated 
by Teyrnon Jones (Spivey group, 2000-2004)214 with the original plan being to look 
at both solution and solid-phase approaches. Jones had been able to prepare the 
diarylpyrazole germane linker in 99 % yield by using iPrMgCl mediated 
iodine-magnesium exchange on AM251 then transmetallation with a model linker 
arylgermyl chloride. This pyrazole germane was chosen as a precursor for the 
investigation of ipso-iododegermylation reactions (Scheme 3.2.1).  
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Scheme 3.2.1. Jones’ preparation of an arylpyrazole germane adduct to investigate 
ipso-iododegermylation reactions.214  
Reagents and conditions: i) iPrMgCl, -40 oC-RT, 2 h; ii) THF, RT, 16 h. 
An analogue of solid-supported diarylpyrazole germyl linker was also prepared by 
the same method using Hypogel-200 as the polymer support (Scheme 3.2.2).  
 
Scheme 3.2.2. Jones’ immobilisation of diarylpyrazole acyl hydrazide on germyl Hypogel-200 
functionalised resin.214  
Reagents and conditions: i) iPrMgCl, -25 oC-RT, 2 h; ii) THF, RT, 16 h. 
ipso-Iododegermylation was attempted on the solution model system using NaI in 
combination with various oxidants as well as with ICl (Table 3.2.1). 
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Entry Conditions Outcome 
1 NaI, Dichloramine T, AcOH, 1 h, RT No AM251 
No Ge-linker recovered 
2 NaI, Chloramine T, AcOH, 1 h RT AM251 and oxidised 
by-product formed 
3 NaI, H2O2, MeOH, 1 h, RT AM251 and oxidised 
by-product formed 
4 NaI, SelectfluorTM, MeOH, RT, 0,5 h No reaction 
5 ICl, CH2Cl2, 1 h, RT 36 % yield of AM251 and 
oxidised by-product formed 
Table 3.2.1 Jones’ attempted electrophilic iodination mediated pyrazole-germane cleavage to furnish 
AM251.214  
No AM251 was found using the combination of NaI-dichloroamine T (DCT) in 
HOAc at RT although the pyrazole germane substrate was consumed (entry 1). 
NaI-chloroamine T and NaI-H2O2 combinations gave the desired AM251 but 
contaminated with unidentified by-products due to over oxidation (entries 2 and 3). 
No reaction occurred when NaI was used with SelectfluorTM as an oxidant (entry 4). 
Treatment of the pyrazole germane at high dilution with ICl solution in CH2Cl2 gave 
a 36 % yield of AM251 contaminated with several by-products (entry 5). The 
diarylpyrazole germane resin was also subjected to the ICl conditions but none of the 
desired product was found in the filtrate. 
To identify the over oxidation process, compound AM251 was subjected to DCT in 
MeOH for 1 h. This reaction gave the corresponding methyl ester in 97 % yield 
(Scheme 3.2.3). 
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Scheme 3.2.3. Jones’ DCT facilitated oxidative cleavage of the acyl hydrazide with AM251.211 
Reagents and conditions: i) DCT, MeOH, RT, 1 h. 
This experiment demonstrated that achieving ipso-iododegermylation on this 
substrate using NaI as the source of label was going to require an oxidant which 
could oxidise iodide to iodonium but not effect oxidative cleavage of the acyl 
hydrazide. 
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3.3 Aims and objectives 
We became interested in developing a novel strategy for efficient, transition metal 
free, parallel synthesis of iodinated CB1 ligands based upon ipso-iododegermylation 
of solid supported arylgermane precursors. ‘Proof-of-concept’ for this notion is 
described in the following sections. 
Cognisant of the findings described above, it was envisaged to develop a new 
protocol for immobilisation of diarylpyrazole units onto solid-supported germyl 
functionalised resins that could allow diversification in a parallel fashion on the resin. 
Iodinated rimonabant analogues 105 were expected to be furnished in a pure form 
following electrophilic iodination under appropriate conditions (Scheme 3.3.1). 
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Scheme 3.3.1. Proposed approach to iodinated rimonabant analogues 105. 
 
Towards these ends, the following, specific objectives for the project were identified: 
1) To build a diarylpyrazole germane model molecule in solution with an ester 
at C-3 to allow for further functionalisation. 
2) To screen suitable conditions to facilitate ipso-iododegermylation leading to 
the desired products. 
3) To immobilise the diarylpyrazole unit onto a solid-support and conduct 
parallel synthesis of iodinated rimonabant analogues. 
Progress towards these objectives is described in the following section. 
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3.4 Result and discussion 
3.4.1 Synthesis of AM281 in solution phase via ipso-iododegermylation 
It was planned to prepare a rimonabant analogue containing an aryl iodide for 
attachment to the solid support via a germyl-linker and having an ester at C-3 to 
allow for variation of the functionality at this position after immobilisation but before 
ipso-iododegermylation. It was envisaged that the immobilisation step could be 
achieved using Knochel’s iodine-magnesium exchange procedure which requires an 
aryl iodide as substrate. Thus, preparation of 4-iodopropiophenone as starting 
material was demanded.  
Commercially available 4-bromopropiophenone was converted into 
4-iodopropiophenone by Buchwald’s catalytic aromatic Finkelstein reaction in the 
presence of NaI and CuI as a catalyst.215 4-Iodoacetophenone was enolised with 
LHMDS at 0 oC and then quenched with diethyl oxalate to afford β-ketoester lithium 
salt. The lithium salt was treated with 2, 4-dichlorohydrazine hydrochloride in 95 % 
EtOH with 0.5 mL of conc. HCl and stirred for 16 h at RT followed by re-suspension 
in glacial acetic acid and refluxing for another 16 h to furnish iodoarylpyrazole ethyl 
ester 106 in 82 % over three steps (Scheme 3.4.1).211  
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Scheme 3.4.1. The preparation of 1,5-diaryl pyrazolyl ethyl ester 106. 
Reagents and conditions: i) NaI, CuI, N,N’-dimethylethylenediamine, 1,4-dioxane, 100 oC, 16 h;     
ii) LHMDS, 0 oC, 1 h then ethyl oxalate, rt, 16 h; iii) 2, 4-dichlorohydrazine hydrochloride, 95 % 
EtOH, conc. HCl (0.5 mL), rt, 16 h then HOAc, reflux, 16 h. 
Germyl linker precursor 107 was prepared according to the literature procedure 
published by our group.138 Alkylation of the phenolic hydroxyl group with an 
ethoxyethyl (EE) group followed by subjection to conc. HBr afforded germyl 
bromide linker 108 in 61 % overall yield over 6 steps from GeCl4. The EE group on 
this germyl linker is designed to mimic the PEG graft on HypoGel-200 resin 
(Scheme 3.4.2). 
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Scheme 3.4.2. The preparation of germyl bromide linker 108. 
Reagents and conditions: i) sealed tube, 150 oC, 16 h; ii) conc. HCl, rt, 16 h; iii) 
4-methoxyphenylmagnesium bromide 0.5 M in THF, reflux, 4 h; iv) conc. HCl, rt,16 h; v) 
methyllithium, -40 oC – rt, 16 h; vi) 1-chloro-2-ethoxyl ethane, K2CO3, DMF, 80 oC, 24 h; vii) conc. 
HBr, CH2Cl2, rt, 16 h. 
Attempts to prepare diarylpyrazole germane 109 by means of iodine-metal exchange 
of iodoarylpyrazole ethyl ester 106 at low temperature then cannulation of the 
resulting aryl metal species into a solution of germyl bromide linker 108 were 
unsuccessful. Various of organometallics such as iPrMgCl, iPrMgCl-LiCl complex216 
and tBuLi were employed but neither expected product nor starting materials were 
recovered, despite the fact that iPrMgCl had been employed previously to perform a 
closely similar transformation in the case of iodoarylpyrazole acyl hydrazide by 
Jones as described above (Scheme 3.4.3). 
 
Scheme 3.4.3. Attempts to prepare diarylpyrazole germane 109 via iodine-metal exchange of 
iodoarylpyrazole ethyl ester 106 mediated by various organometallics. 
Reagents and conditions: i) iPrMgCl or iPrMgCl-LiCl complex, THF, -40 oC-RT 2 h; ii) tBuLi, -78 oC, 
2h; iii) THF, RT, 16 h. 
Inspection of the MS spectrum from the crude reaction mixture from the reaction 
using tBuLi as metalating reagent revealed the possibility that formation of the 
diarylpyrazole tert-butyl ketone 110 was occurring. This suggested that the ethyl 
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ester at C-3 in the pyrazole substrate 106 was susceptible to nucleophilic addition 
even at the low temperatures employed. It was decided to employ a sterically 
hindered tert-butyl ester to suppress this undesired side-reaction. Moreover, as 
Oshima has used iPrnBu2MgLi to mediate metalation of polyfunctionalised aryl 
bromides,217 we decided to employ this reagent on the bromo diarylpyrazole which 
could be obtained directly from commercially available starting material. 
Consequently, bromodiarylpyrazole ethyl ester 111 was prepared in 88 % overall 
yield according to the same procedures shown for the iodide analogue in Scheme 
3.4.1. 
Bromoarylpyrazole ethyl ester 111 was then saponified to give bromoarylpyrazole 
carboxylic acid 112 which was converted to tert-butyl ester 113 in 84 % yield by 
using tert-butyl 2,2,2-trichloroacetimidate (TBTA) and a catalytic amount of 
BF3-Et2O in cyclohexane at RT for 16 h (Scheme 3.4.4).218  
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Scheme 3.4.4. The preparation of bromoarylpyrazole tert-butyl ester 113. 
Reagents and conditions: i) NaOH, THF-H2O (4:1 v/v), 70 oC, 6 h; ii) tert-butyl 
2,2,2-trichloroacetimidate, cat. BF3-Et2O, cyclohexane, RT, 16 h. 
The pyrazole tert-butyl ester 113 was subjected to metalation with Oshima’s 
bimetallic reagent followed by cannulation to a solution of arylgermane bromide 108 
in THF at -78 oC before warming to RT. This gave the desired diarylpyrazole 
germane 114 in 12 % yield. By pre-mixing the pyrazole tert-butyl ester 113 and the 
germyl bromide 108 to achieve in situ metalation/functionalisation of germane 
bromide 108,156 a 40 % yield of the target pyrazole germane 114 was obtained using 
the iPrnBu2MgLi complex. Moreover, pyrazole germane could also be prepared in up 
to 52 % yield using these Barbier conditions with tBuLi as the metalating reagent 
(Scheme 3.4.5). 
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Scheme 3.4.5. Preparation of diarylpyrazole germane 114. 
Reagents and conditions: method F: iPrnBu2MgLi, THF, -78 oC-RT, 16 h; method G: tBuLi, THF,  
-78 oC-RT, 16 h. 
Direct amidation of the tert-butyl ester in pyrazole germane 114 with 
N-aminomorpholine under basic conditions gave the corresponding acyl hydrazide 
115 in 95 % yield (Scheme 3.4.6). 
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Scheme 3.4.6. Amidation of pyrazole germane 115. 
Reagents and conditions: i) N-aminomorpholine, LHMDS, THF, RT, 2 h. 
Acyl hydrazide 115 was used as a model substrate on which to screen suitable 
conditions to achieve ipso-iododegermylayion. The previous unsuccessful attempts 
using this substrate reported by Jones were plagued by over oxidation of the acyl 
hydrazide moiety leading to formation of methyl ester containing products and 
relative carboxylic acid derivatives.214 Oxidative acyl hydrazide cleavage has been 
studied by Smith, who has proposed that the process is initiated by formation of an 
acyl radical intermediate with extrusion of nitrogen gas. The acyl radical then suffers 
further oxidation to give an acyl cation which is rapidly trapped with nucleophiles 
giving carboxylic acid derivatives (Scheme 3.4.7).219  
 
Scheme 3.4.7. Smith’s proposed mechanism for oxidative acyl hydrazide cleavage.219  
New oxidation conditions needed to be identified that would mediate cleavage of the 
aryl-Ge bond but avoid degradation of the acyl hydrazide moiety. 
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ipso-Iododegermylation conditions based on many electrophilic iodination conditions 
were evaluated (Table 3.4.1). 
 
Entry Conditionsa Yield (%) 
1 NaI, chloramine T, AcOH, 16 h, rt 0c 
2 I2, CCl4, 16 h, rt 0c 
3 NaI, FeCl3, 16 h, rt 0c 
4 ICl, 16 h, rt 0c 
5 NH4I, Oxone, 16 h, rt 0c 
6 NaI, 3-CPBA, 16 h, rtb 0d 
7 NaI, AcO2H, AcOH, 16 h, rtb 0d 
8 I2, 3-CPBA, HOAcb 0d 
9 NIS, TFA (cat.), HOAc, 16 h, rt 0d 
10 I2, HOAc, rt, 16 h 15e 
11 I2, TFA-HOAc, 16 h, rtf 63e 
12 NaI, NCS,TFA-AcOH, 30 min, rtf 85 
a All reactions were carried out with 2 eq of reagents. b slow addition of peracids c No reaction 
occurred, recovery of S.M. d decomposition of S.M. e concomitant with by-product 116 (see text). f 
TFA-HOAc (1:3 v/v). 
Table 3.4.1 Screening for ipso-iododegermylation of acyl hydrazide 115 in solution phase.  
Initial studies employed iododestannylation conditions reported by Gatley using 
I2/CCl4220 and chloramine-T/NaI221 at RT for 16 h (entries 1 and 2). However, none 
of these conditions gave the desired iodinated aryl pyrazole AM281 (105a); starting 
material was recovered. Identical results were obtained using NaI/FeCl3,222 
NH4I/Oxone223 and ICl as iodination agents (entries 3-5), although interestingly ICl 
has been reported to prepare aryliodides from arylsilanes,224 which are generally less 
reactive than arylstannanes and arylgermanes.213 Nevertheless, arylgermane linker 
115 was recovered quantitatively from all these reactions. 
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Next, attention focused on investigating peracids as alternative oxidants for 
ipso-iododegermylation. Accordingly, arylgermane-linker 115 was treated with 
NaI/3-CPBA,225 NaI/AcO2H and I2/3-CPBA. In all cases, slow addition of the 
peracids to the reaction mixtures was employed. Unfortunately, neither iodinated aryl 
pyrazole AM281 (105a) nor unreacted arylgermane 115 could be isolated following 
these reactions (entries 6-8). A similar outcome was also observed when 
N-iodosuccimide (NIS) was used with catalytic amount of TFA (entry 9).  
Moerlein has described ipso-iododegermylation of arylgermanes using I2 promoted 
by HOAc. The success at this protocol is probably due to the polarization of I2 by the 
acid and stabilization of the transition state of the reaction by HOAc.226  
Upon subjecting arylgermane-linker 115 to I2-HOAc, a slow reaction (16 h) was 
observed which yielded the iodinated aryl pyrazole AM281 (105a) in 15 % yield 
along with ipso-protodegermylation by-product 116 in 10 % yield (entry 10). The 
by-product is presumably formed due to protonolysis under these acidic conditions. 
This positive result encouraged us to optimize the conditions. TFA was used as 
co-solvent to enhance the polarization of I2, and iodinated aryl pyrazole AM281 
(105a) was obtained in 63 % yield. Again, the protonated contaminated 116 was 
isolated in 10 % yield (entry 11). 
Further optimization of the reaction was achieved by using NaI and 
N-chlorosuccimide (NCS) in the TFA-HOAc reaction medium for 30 min, affording 
iodinated aryl pyrazole AM281 (105a) in 85 % yield. No by-product 116 could be 
detected under these conditions (entry 12).227 This significantly optimised protocol is 
ideal for the final approach toward parallel synthesis of iodinated rimonabant 
analogues 105 using a germyl-functionalised solid support as it is rapid and uses NaI 
as the source of iodine. Radioactive NaI is much more readily available than other 
iodination reagents. 
 
3.4.2 Solid-phase, parallel synthesis of iodinated rimonabant analogues  
Building upon the successful development of conditions for ipso-iododegermylation 
in solution, it was necessary to apply the same chemistry on the solid-phase. 
Hypogel-200 resin was chosen for this task. Hypogel is a PEG grafted polystyrene 
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resin with better swelling properties in hydrophilic solution than Merrifield resin. 
The swelling property of the chosen resin was envisioned to be an essential 
parameter to reproduce our iodination reaction which proceeds in a highly polar 
solvent system. 
Conversion of Hypogel-OH (0.8 mmolg-1) to Hypogel-Br 117 (0.8 mmolg-1) 
proceeded quantitatively using a combination of PPh3 and CBr4 in CH2Cl2. 
Attachment of germyl linker 107 was achieved using Williamson etherification,138 
and the resulting resin was converted into the germyl bromide resin 118 utilising 48 
% HBr in CH2Cl2 (Scheme 3.4.8).  
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Scheme 3.4.8. Preparation of germyl functionalised resin 118. 
Reagents and conditions: i) PPh3, CBr4, CH2Cl2, 0 oC-RT, 24 h; ii) 117, K2CO3, DMF, 80 oC, 24 h; iii), 
conc. HBr, CH2Cl2, RT, 16 h. 
Immobilisation of diarylpyrazole 113 onto the germyl functionalised resin 118 was 
achieved according to the method developed in solution (see Scheme 3.4.5) via 
bromine-lithium exchange on the pyrazole substrate 113 in the presence of the 
germyl bromide resin 118. Amidation of the forming resin 119 with selected 
hydrazines and amines facilitated by LHMDS, allowed synthesis of a library of five 
functionalised diarylpyrazolyl resins 120a-e (Scheme 3.4.9). 
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Scheme 3.4.9. Parallel preparation of C-3 functionalised pyrazole resins 120a-e. 
Reagents and conditions: i) tBuLi, THF, -78 oC-RT, 16 h; ii) R3NH2, LHMDS, THF, RT, 16 h. 
The Ge resins were swollen in separate vessels with CH2Cl2 in reaction cartridges in 
the presence of NaI, before addition of a solution of NCS in TFA-HOAc at RT. After 
filtering off the resin beads, iodinated rimonabant analogues 105a-e were isolated 
from reaction mixture in good yields (Table 3.4.2). 
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Entry Substrate Time (h) Product Yielda (%) Overall yieldb (%) 
1 a 1 AM281 (105a) 63 38 
2 b 1 AM251 (105b) 60 33 
3 c 1 105c 60 33 
4 d 1 105d 55 28 
5 e 6 105e 42 19 
6 b 5 min AM251 (105b) 8 (1st run) 4.4 
7 b 5 min AM251 (105b) 5 (2nd run) 2.8 
aisolation yields of the ipso-iododegermylation step 
bdeductive from immobilisation of diarylpyrazole 113 onto the germyl resin 118 to aryl pyrazole 105 
Table3.4.2. Parallel preparation of iodinated C-3 functionalised pyrazoles. 
Reagents and conditions: i) NaI, NCS, TFA-HOAc (1:3 v/v), RT. 
The ipso-iododegermylation of aryl pyrazolyl germane resins 120a-d were 
completed within 1 h (entries 1-4) whereas, the 4-fluoroanilinyl functionalised 
pyrazolyl resin 120e required significantly longer (6 h, entry 5).  
A short exposure of resin 120b to the iodination conditions furnished iodinated aryl 
pyrazole AM251 (105b) in 8 % after column chromatography (entry 6). In addition, 
re-subjecting the resin 120b used for entry 6 to the iodination conditions for 5 min 
gave an additional 5 % of the desired product. These results confirmed that the 
protocol should be suitable for ‘hot chemistry’ and provide sufficient quantities of 
radio iodinated tracer within a short period of time for imaging.  
Analysis of the crude iodinated aryl pyrazole AM251 (105b) directly after filtration 
by means of HPLC (UV detector set at 254 nm) revealed a 75 % purity of the desired 
product contaminated with the succinimide by-product from the NCS. As it is crucial 
to remove by-products prior to injection for in vivo tests, an efficient and rapid 
separation process needed to be developed.  
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It was decided to develop a nucleophilic scavenger resin to effect in situ removal of 
the succinimide. Hydrazine-functionalised Hypogel-200 was initially selected for 
this purpose. Thus, treatment of Hypogel-Br 117 with hydrazine hydrate and K2CO3 
in DMF for 16 h gave a resin of this type. To test the scavenging ability of this 
hydrazine resin, a freshly prepared crude mixture of iodinated aryl pyrazole AM251 
(105b) was treated with the resin in refluxing EtOH for 1 h. The resin was then 
filtered off, and the organic fraction was subjected to HPLC to quantify its purity. 
The chromatograph showed fairly efficient removal of succinimide (only 5 % 
remaining in the mixture) but the trace also showed new impurities in the sample. 
Polystyrene and Merrifield-based hydrazine resin gave the same outcome. The new 
impurities were non-polar and highly UV active moieties apparently arising from 
degradation of the polymer-supports. A literature search revealed that the liberation 
of these residues from resins under similar reaction or cleavage conditions has been 
noted previously.228,229  
Gratifyingly, treatment of the crude reaction mixture containing iodinated aryl 
pyrazole AM251 (105b) with a Si-propyl hydrazine solid-support 121 gave a clean 
HPLC trace free from the aforementioned impurities, and quantified as containing 
iodinated aryl pyrazole AM251 (105b) in 96 % purity* (Scheme 3.4.10). 
 
Scheme 3.4.10. Sequential preparation/purification of iodinated rimonabant analogue using a Si-based 
succinimide scavenger 121. 
Reagents and conditions: i) NaI, NCS, TFA-HOAc (1:3 v/v), RT, 1 h; ii) EtOH, 80 oC, 1 h; iii) 
NH2NH2 hydrate, K2CO3, DMF, 80 oC, 24 h. 
                                                 
* The HPLC chromatogram for pure AM251 shows three distinct peaks (see Experimental section, 
Schemes 4.3.1 and 4.3.2.). The relative intensity of these peaks varies depending on the pH of the 
eluent system used. We presume that these peaks correspond to rotamers about τ1 and/or τ2 (see 
Scheme 3.1.2). 
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The success of this rapid, one-pot functionalisative cleavage and purification 
protocol augurs well for the development of an efficient procedure to prepare 
radio-labelled rimonabant analogues for PET and SPECT imaging. 
 
3.5 Conclusion 
A novel protocol for the parallel preparation of cannabinoid receptor ligands from a 
functionalised Ge-based resin 119 has been developed. Treatment of this resin with 
various amines and hydrazines afforded novel resin-bound amide and aryl hydrazide 
derivatives 120 which upon ipso-iododegermylation by NaI/NCS in TFA-HOAc 
afford the required ligands 105 cleanly and in good yield. A small library of iodinated 
CB1 ligands was prepared by this protocol which exhibited high performance and 
reliability. 
The succinimide by-product can be removed in situ by employing the hydrazine resin 
121 to give pure iodinated ligands. This proof-of-concept protocol should be readily 
applied in the preparation of radio-labelled ligands for in vivo studies. 
 
3.6 Future work 
It remains to further optimise the ipso-iododegermylation process to reduce the 
reaction time and to prepare a wider array of derivatives for evaluation. In addition, 
It is envisioned to employ radio NaI (Na123I or Na124I) for the cleavage and explore 
the efficiency of the resulting radio-ligands as imaging reagents. 
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4. Experimental section 
4.1 General directions 
Solvents and reagents: see the appendixes 1 and 2. Chromatography: Flash 
chromatography (FC) was carried out on Silica gel (BDH Silica gel for flash 
chromatography) according to the method described by Still,230 or by using either 
Isolute Flash Silica (1 g, 5 g, 50 g). TLC was performed on aluminium backed silica 
gel plates (Merck Silica gel 60 F254) which were developed with UV fluorescence 
(254 nm and 365 nm) and KMnO4(aq)/  1H NMR spectra: These were recorded at 
270, 400 or 500 MHz on Jeol 270 GSX, Bruker-DRX 400, AV-400 or AV-500 
instruments respectively. Chemical shifts (H) are given in parts per million (ppm) as 
referenced to the appropriate residual solvent peak. Broad signals are assigned as br. 
All spectra were compared with reference spectra of authentic products and reagents. 
13C NMR spectra: These were recorded at 100.6 MHz on Bruker AV-400 instrument 
or at 125.1 MHz on a Bruker AV-500 instrument. Chemical shifts (C) are given in 
parts per million (ppm) as referenced to CHCl3, and are assigned as s, d, t, and q, for 
C, CH, CH2, and CH3 respectively. The 13C signals for the Rf-tag were assigned by 
running a partially 13C{19F} decoupled spectrum in the casese of Rf-tagged germanes 
(see Appendix 3, A 3.3). 19F NMR spectra: There were recorded at 376 MHz on 
Bruker-DRX 400, AV-400 instruments respectively. Chemical shifts (F) are given in 
parts per million (ppm) as referenced to CCl3F. Mass Spectra: Low resolution and 
high-resolution spectra were recorded on a VG Prospec spectrometer, with molecular 
ions and major peaks being reported. Intensities are given as percentages of the base 
peak. Molecular weights are calculated using 74Ge, 35Cl and 79Br isotopes. HRMS 
values are valid to 5ppm. GC/MS: Analyses were carried out using a Trio-1 with 
HP 5890 gas chromatograph. Isomeric ratio of styrenes: On the occasions where 
the geometrical (E and Z) and regioisomers () of styrenes could not be isolated 
pure, they were identified using 1H NMR spectroscopic analysis of the mixture and 
their relative ratio was determined using GC-MS analysis. Melting points: Analyses 
were carried out using a Khofler hot stage and are uncorrected. 
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4.2 Development of novel aryl- and alkenyl- cross-coupling reactions based on 
light fluorous-tagged organogermanes 
 
Germanium(II) chloride 1,4-dioxane complex 1231 
 
A stirred solution of germanium(IV) chloride (37.6 g, 175.3 mmol, 20 mL) and 
tetramethyldisiloxane (TMDS) (25.08 g, 186.7 mmol, 33 mL) in 1,4-dioxane (50 mL) 
was heated to 100 oC for 3 h. After cooling to 0 oC, the resulting white precipatates 
was collected by filtration and washed with cold CHCl3 (3 × 20 mL). After drying 
under vacuum, dichlorogermylene·1,4-dioxane complex 1 was obtained as white 
needles (35.3, 87 %). 
 
Trichloro-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)germane 3121 
 
1H,1H,2H,2H-Perfluorodecyl iodide 2 (12.5 g, 41.56 mmol) and 
dichlorogermylene·1,4-dioxane complex 1 (5.00 g, 41.56 mmol) were heated in a 
Carius tube at 150 C for 24 h. After cooling to RT, the reaction mixture was diluted 
with CH2Cl2 (500 mL) and added dropwise to H2O (500 mL).  The resulting white 
precipitate was collected by filtration, washed with H2O (300 mL) then CH2Cl2 (300 
mL) and dried under suction.  The dried precipitate was stirred in conc. HCl (37% 
w/v) for 16 h and then extracted with CH2Cl2 (5 100 mL). The combined organic 
extracts were dried over MgSO4 and concentrated in vacuo to give trichlorogermane 
3 as a brown oil (9.70 g, 78%). 1H NMR (400 MHz; CDCl3): 2.20 (m, 2H, 
CH2CH2Ge), 2.47 (m, 2H, CH2CH2Ge); 13C NMR (100.7 MHz; CDCl3):  22.1 (t), 
25.0 (t, JCF 23.0), 108.6 (s), 110.5 (s), 113.5 (s), 114.4 (s), 115.7 (s), 116.9 (s), 117.3 
(s), 118.6 (s); 19F NMR (376 MHz; CDCl3):  - 126.5 [s, 2F,CF2(CH2)2], -123.2 (s, 
2F), -122.6 (s, 2F), -121.8 (s, 4F, 4 CF2), -121.6 (s, 2F), -115.3 (s, 2F), -80.7 [s, 3F, 
CF3(CF2)7(CH2)2]; IR υmax (neat) 2930, 1440, 1365, 1245, 905, 825 cm-1; m/z (CI+) 
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(rel. intensity) 606 [(M-F)+, 41], 590 (4), 464 (33), 158 (23), 109 (20). 
 
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorodecyl)-tris(4-methoxyphenyl)
germane121 
C8F17
Ge
OMe
3
Chemical Formula: C31H25F17GeO3
Exact Mass: 842.0744
Molecular Weight: 841.1413  
To a solution of trichlorogermane 3 (5.00 g, 6.88 mmol) in THF (15.0 mL) was 
added a solution of para-anisyl methoxyphenylmagnesiumbromide (15.5 mL, 31.0 
mmol, 0.5 M).  The resulting reaction mixture was stirred at reflux for 3 h.  The 
yellow reaction mixture was cooled to 0 C before quenching dropwise with 
methanol until effervescence ceased. The reaction mixture was diluted with Et2O 
(20.0 mL) and washed with water (2 × 20.0 mL). The combined organic extracts 
were dried over MgSO4 and the solvent was removed in vacuo. Sublimation of 
4,4’bismethoxybiphenyl from the residue (100 C /0.1mmHg using a Kugelrohr) 
followed by purification by FC (petrol/CH2Cl2 50/50 → CH2Cl2) and drying under 
high vacuum gave tris-4-anisylgermane as a white amorphous solid (3.96 g, 70%).  
mp 55-57 C; Rf 0.35 (petrol/CH2Cl2, 70/30);  1H NMR (400 MHz; CDCl3): 1.63 
(m, 2H, CH2CH2Ge), 2.19 (m, 2H, CH2CH2Ge), 3.81 (s, 9H, 3 × ArOCH3), 6.94 (d, J 
= 8.5 Hz, 6H, ArH), 7.37 (d, J = 8.5 Hz, 6H, ArH); 13C NMR (100.7 MHz; CDCl3) 
3.7 (t), 27.0 (t, JCF 23.0), 55.0 (3q), 114.0 (6d), 118.9 (3s), 126 (6d), 160.6 (3s), 
eight carbons not observed; 19F NMR (376 MHz; CDCl3): - 126.3 (s, 2F), -123.2 (s, 
2F), -122.7 (s, 2F), -122.1 (s, 4F, 2  CF2), -121.9 (s, 2F), -115.3 (s, 2F), -80.8 [s, 3F, 
CF3(CF2)7(CH2)2];  IR υmax (neat) 3020, 1440, 1365, 1245, 900, 835 cm-1; m/z (EI+) 
(rel. intensity) 841 (M+, 9), 735 (42), 715 (24), 395 (100); HRMS (EI+) calc’d. for 
C31H2474GeO3F17 842.0744, found 842.0721 ( 2.7 ppm). 
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Dichloro-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)-(4-methoxyp
henyl)germane 4121 
 
To a solution of tris-para-anisylgermane (5.00 g, 5.944 mmol) in 1,4 dioxane (5.00 
mL) was added a solution of HCl (60.0 mL, 240 mmol, 4.0 M).  The reaction 
mixture was stirred for 5 h and the solvent was then removed in vacuo to give 
dichlorogermane 4 as a white amorphous solid (3.60 g, 87%). 1H NMR (400 MHz; 
CDCl3):  (m, 2H, CH2CH2Ge), 2.45 (m, 2H, CH2CH2Ge), 3.81 (s, 3H, 
ArOCH3), 6.92 (d, J = 8.5 Hz, 2H, ArH), 7.35 (d, J = 8.5 Hz, 2H, ArH); 13C NMR 
(100.7 MHz; CDCl3) 15.3 (t), 25.4 (t, JCF = 23.0 Hz), 55.3 (q), 108.2 (s), 110.1 (s), 
113.0 (s), 114.2 (s), 114.8 (2d), 115.7 (s), 116.6 (s), 117.1 (s), 118.0 (s), 125.1 (s), 
133.7 (2d) 162.7 (s); 19F NMR (376 MHz; CDCl3): - 126.2 (s, 2F), -123.3 (s, 2F), 
-122.7 (s, 2F), -122.1 (s, 4F, 2  CF2), -121.9 (s, 2F), -115.4 (CF2)6CF2CF3], -80.8 (t, 
3F, (CF2)6CF2CF3); IR υmax (KBr) 3035, 2975, 1595, 1505, 1455, 1200, 960, 825 
cm-1; m/z (EI+) (rel. intensity) 698 (M+, 47), 663 (4), 295 (12), 251 (100), 235 (16); 
HRMS (EI+) calc’d. for C17H1174GeOCl2F17 697.9127, found 697.9125 ( 0.3 ppm). 
 
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorodecyl)-(4-methoxyphenyl)bis(nap
hthalen-2-ylmethyl)germane 6a121 
 
To oven dried magnesium turnings (0.704 g, 29.0 mmol) in Et2O (25.0 mL) was 
added 2-bromomethylnaphthalene 5 (5.97 g, 27.0 mmol) to initiate Grignard reagent 
formation. To this solution was added a solution of dichlorogermane 4 (3.60 g, 5.15 
mmol) in Et2O (2.00 mL) dropwise and the resulting mixture stirred for 2.5 h. A sat. 
solution NH4Cl was added to the reaction mixture until no effervescence occurred 
and the solvent was then removed in vacuo. The residue taken up in Et2O (30.0 mL) 
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and washed with water (2 × 10.0 mL) and was dried over MgSO4.  
2-methylnaphthalene was sublimed from the residue (60 C/0.1mmHg using a 
Kugelrohr) then bis(2-naphthyl)ethylene was removed from the residue by 
recrystalisation with Et2O (16.0 mL) at 0 C, filtration through cotton plug and 
washed with hexane (2 × 10.0 mL). Solvents were then removed from the filtrate in 
vacuo and purification by FC (petrol/CH2Cl2, 95/5 → 80/20) gave 
bis(naphthylmethyl)germane 6a as a yellow amorphous solid (3.35 g, 71%). mp 
189-190 C; Rf 0.30 (petrol:EtOAc, 95/5); 1H NMR (400 MHz; CDCl3): 1.16 (m, 
2H, CH2CH2Ge), 1.87 (m, 2H, CH2CH2Ge), 2.73 (s, 4H, 2  GeCH2NP), 3.85 (s, 3H, 
OCH3), 6.95 (d, J = 6.7 Hz, 2H, ArH), 7.09 (dd, J = 6.7, 1.8 Hz, 2H, ArH), 7.27 (d, J 
= 6.7 Hz, 2H, ArH), 7.37 (s, 2H, ArH), 7.39-7.47 (m, 4H, ArH), 7.64 (d, J = 7.7 Hz, 
2H, ArH), 7.70 (d, J = 8.4 Hz, 2H, ArH), 7.80 (d, J = 7.7 Hz, 2H, ArH); 13C NMR 
(100.7 MHz; CDCl3) 2.2 (t), 22.8 (t, JCF = 23.0 Hz), 26.4 (2t), 55.0 (q), 108.4 (s), 
110.2 (s), 110.7 (2s), 111.02 (s), 113.4 (s), 114.2 (2d), 115.0 (s), 118.1 (s), 124.8 (2d), 
125.8 (2d), 126.0 (2d), 127.0 (2d), 127.4 (2d), 127.6 (2d), 128.0 (2d), 131.3 (2s), 
133.8 (2s), 135.1 (2d), 136.7 (3s), 160.6 (s); 19F NMR (376 MHz; CDCl3): -125.2 
(s, 2F), -122.5 (s, 2F), -121.7 (s, 2F), -120.9 (m, 6F), -115.4 [quintet, J = 14.8 Hz, 2F, 
(CF2)6CF2CF3], -79.8 (t, J = 10.0 Hz, 3F, (CF2)6CF2CF3); IR υmax (neat) 3031, 2925, 
1628, 1590, 1422, 1282, 1245, 1200,1146, 820 cm-1; m/z (EI+) (rel. intensity) 910 
(M+, 9), 769 (89), 436(3), 341 (52), 141 (100); HRMS (EI+) calc’d. for 
C39H2974GeF17O 910.1159, found 910.1145 ( 1.6 ppm). 
 
Bromo-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)-bis(naphthalen
-2-ylmethyl)germane 40 
 
To a solution of para-anisyl germane 6a (0.102 g, 0.112 mmol) in CH2Cl2 (10.0 mL) 
was added a solution of conc. HBr (2.0 mL, 48% wt.).  The resulting biphasic 
reaction mixture was stirred at rt for 12 h, extracted with Et2O (3 × 20.0 mL). The 
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combined organic extracts were dried over MgSO4 and evaporated in vacuo to give 
bromogermane 40 as a brown amorphous solid (0.087 g, 88%). mp 172-174 C; 1H 
NMR (400 MHz; CDCl3):  1.38 (m, 2H, C8F17CH2CH2Ge), 1.93 (m, 2H, 
C8F17CH2CH2Ge), 2.97 (d, J = 12.7 Hz, 2H, GeCH2NP), 3.01 (d, J = 12.7 Hz, 2H, 
GeCH2NP), 7.21 (dd, J = 6.6, 1.8 Hz, 2H, ArH), 7.42-7.49 (m, 6H, ArH), 7.68 (dd, J 
= 6.6, 1.8 Hz, 2H, ArH), 7.76 (d, J = 8.4 Hz, 2H, ArH), 7.81 (dd, J = 6.6, 1.8 Hz, 2H 
ArH); 13C NMR (100.7 MHz; CDCl3) 7.5 (t), 26.4 (t, JCF = 23.0 Hz), 28.3 (2t), 
110.2 (s), 110.6 (2s), 110.7 (s), 110.9 (3s), 117.1 (s), 125.4 (2d), 126.3 (2d), 126.4 
(2d), 126.9 (2d), 127.1 (2d), 127.7 (2d), 128.5 (2d), 131.7 (2s), 133.6 (2s), 133.7 (2s); 
19F NMR (376 MHz; CDCl3) -125.2 (s, 2F), -122.6 (s, 2F), -121.8 (s, 2F), -121.0 
(m, 6F), -115.0 [quintet, J = 15.1 Hz, 2F, (CF2)6CF2CF3], -79.8 [t, J = 9.4 Hz, 3F, 
(CF2)6CF2CF3]; IR υmax (neat) 3055, 2990, 1600, 1420, 1265, 895, 750 cm-1; m/z 
(FAB+) (rel. intensity) 882 (M+, 1), 803 (1), 141 (100); HRMS (ESI+) calc’d. for 
C32H2379BrF1774Ge (MH+) 882.9924, found 882.9932 ( 1.0 ppm). 
 
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorodecyl)bis(naphthalen-2-ylme
thyl)para-tolylgermane 6b 
C8F17
Ge
Me
Chemical Formula: C39H29F17Ge
Exact Mass: 894.1210
Molecular Weight: 893.2604
6b  
To a solution of bromogermane 40 (0.800 g, 0.955 mmol), in Et2O (10.0 mL) at 0 C 
was added a solution of para-tolylmagnesiumbromide (4.75 mL, 4.75 mmol, 1.0 M) 
dropwise. The reaction mixture was stirred at 0 C for 1 h and then at rt for over 14 h. 
The resulting solution was diluted with Et2O (20.0 mL) and a solution of 1.0 M 
NH4Cl was added to the reaction mixture until no effervescence occurred. Following 
extraction with (2 × 20.0 mL) of Et2O, the combined organic extracts were dried over 
MgSO4 and evaporated in vacuo to give green oily residue which was purified by FC 
(hexane/EtOAc, 97/3) to give pure 4-tolyl germane 6b as a brown oil (0.773 g, 87%). 
1H NMR (400 MHz; CDCl3):  1.20 (m, 2H, CH2CH2Ge), 1.89 (m, 2H, CH2CH2Ge), 
2.45 (s, 3H, GeC6H4CH3), 2.76 (s, 4H, 2  GeCH2NP), 7.13 (d, 2H, J = 8.4 Hz, ArH), 
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7.25 (d, 2H, J = 6.8 Hz, ArH), 7.31 (d, 2H, J = 7.6 Hz, ArH), 7.41–7.50 (m, 6H, ArH), 
7.68 (d, 2H, J = 7.6 Hz, ArH), 7.73 (d, 2H, J = 8.4 Hz, ArH), 7.83 (d, 2H, J = 7.6 Hz, 
ArH); 13C NMR (100.7 MHz; CDCl3) 1.9 (t), 21.4 (q), 22.5 (2t), 26.3 (t, JCF 23.4 
Hz), 108.5 (s), 110.2 (s), 110.69 (2s), 110.72 (s), 111.0 (s), 111.1 (s), 118.0 (s), 124.8 
(2d), 125.7 (2d), 126.0 (2d), 127.0 (2d), 127.4 (2d),127.6 (2d), 128.0 (2d), 129.2 (2d), 
131.3 (2s), 132.7 (s), 133.8 (2d+s), 136.7 (3s), 139.2 (s); 19F NMR (376 MHz; 
CDCl3):  -126.6 (s, 2F), -123.9 (s, 2F), -123.1 (s, 2F), -122.3 (m, 6F), -116.7 
[quintet, J = 15 Hz, 2F, (CF2)6CF2CF3], -81.2 [t, J = 10 Hz, 3F, (CF2)6CF2CF3]; IR 
υmax (neat) 3024, 2980, 1600, 1510, 1420, 1265, 895, 745 cm-1; m/z (EI+) (rel. 
intensity) 894 (M+, 25), 753 (44), 322 (43), 282 (47), 211 (66), 141 (100); HRMS 
calc’d. for C39H2974GeF17 894.1209, found 894.1244 ( 3.8 ppm). 
 
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorodecyl)bis(naphthalen- 
2-ylmethyl)germane 6c 
 
C8F17
Ge
Chemical Formula: C38H27F17Ge
Exact Mass: 880.1053
Molecular Weight: 879.2338
6c  
To a solution of bromogermane 40 (0.50 g, 0.567 mmol), in THF (10.0 mL) at 0 C 
was added a solution of phenylmagnesiumbromide (0.68 mL, 1.7 mmol, 2.5 M) 
dropwise. The reaction mixture was stirred at 0 C for 1 h and then at rt for over 14 h. 
The resulting solution was diluted with Et2O (20.0 mL) and a solution of 1.0 M 
NH4Cl was added to the reaction mixture until no effervescence occurred. Following 
extraction with (2 × 20.0 mL) of Et2O, the combined organic extracts were dried over 
MgSO4 and evaporated in vacuo to give green oily residue which was purified by FC 
(hexane/EtOAc, 97/3) to give pure phenylgermane 6c as a pale yellow oil (0.4122 g, 
83 %). 1H NMR (400 MHz; CDCl3): 1.19 (m, 2H, CH2CH2Ge), 1.89 (m, 2H, 
CH2CH2Ge), 2.76 (s, 4H, 2  GeCH2NP), 7.09 (dd, J = 8.4, 1.2 Hz, 2H, ArH), 
7.73–7.49 (m, 11H, ArH), 7.65 (d, J = 7.4 Hz, 2H, ArH), 7.71 (d, J = 8.4 Hz, 2H, 
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ArH), 7.81 (d, J = 7.4 Hz, 2H, ArH); 13C NMR (100.7 MHz; CDCl3) 1.9 (t), 22.5 
(2t), 26.3 (t, JCF 23.4 Hz), 108.3 (s), 110.2 (2s), 110.7 (2s), 111.0 (2s), 111.1 (s), 
118.0 (s), 124.8 (2d), 125.7 (2d), 126.1 (2d), 127.0 (2d+s), 127.4 (2d), 127.6 (2d), 
128.1 (2d), 128.4 (2d), 129.3 (d), 131.3 (2s), 133.7 (2s), 133.8 (2d), 136.5 (2s); 19F 
NMR (376 MHz; CDCl3): -125.2 (s, 2F), -122.6 (s, 2F), -121.8 (s, 2F), -121.0 (m, 
6F), -115.4 [quintet, J = 14.7 Hz, 2F, (CF2)6CF2CF3], -79.8 [t, J = 9.7 Hz, 3F, 
(CF2)6CF2CF3]; IR υmax (neat) 3030, 2985, 1600, 1415, 1265, 895, 750 cm-1; m/z 
(FAB+) (rel. intensity) 739 [(M-NpCH2)+, 2], 459 (1), 141 (100); HRMS (FAB+) 
calc’d. for C27H18F1774Ge [(M-NapCH2)+] 739.0845, found 739.0870 ( 3.4 ppm). 
 
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorodecyl)bis(naphthalen-2- 
ylmethyl)(4-chlorophenyl)germane 6d 
C8F17
Ge
Cl
Chemical Formula: C38H26ClF17Ge
Exact Mass: 914.0663
Molecular Weight: 913.6789
6d  
To a solution of 4-chloro-1-bromoenzene (0.4038 g, 2.10 mmol) in THF (10.0 mL) at 
-78 oC was added a solution of tBuLi (3.3 mL, 4.62 mmol, 1.4M in pentane) 
dropwise resulting in a yellow solution. The solution was stirred at -78 oC for 30 min 
to achieve lithium-halogen exchange. The resulting solution mixture was added 
bromogermane 40 (0.62 g, 0.703 mmol) at -78 oC and stirred for 1 h than warming to 
RT for 16 h. The reaction mixture was diluted with Et2O (20.0 mL) and a solution of 
1.0 M NH4Cl was added to the reaction mixture until no effervescence occurred. 
Following extraction with (2 × 20.0 mL) of Et2O, the combined organic extracts were 
dried over MgSO4 and evaporated in vacuo to give green oily residue which was 
purified by FC (hexane/EtOAc, 97/3) to give pure (4-chlorophenyl)germane 6d as a 
pale yellow oil (0.514 g, 80 %). 1H NMR (400 MHz; CDCl3): 1.20 (m, 2H, 
CH2CH2Ge), 1.84 (m, 2H, CH2CH2Ge), 2.74 (s, 4H, 2  GeCH2NP), 7.07 (dd, J = 
6.7, 1.7 Hz, 2H, ArH), 7.25 (d, J = 8.2 Hz, 2H, ArH), 7.36 (d, J = 7.7 Hz, 2H, ArH), 
7.42-7.49 (m, 6H, ArH), 7.66 (d, J = 7.7 Hz, 2H, ArH), 7.71 (d, J = 8.2 Hz, 2H, ArH), 
7.81 (d, J = 7.7 Hz, 2H, ArH); 13C NMR (100.7 MHz; CDCl3) 1.8 (t), 22.4 (2t), 
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26.2 (t, JCF = 23.5 Hz), 108.3 (s), 110.2 (s), 110.7 (3s), 110.97 (s), 111.01 (s), 117.9 
(s), 125.0 (2d), 125.7 (2d), 126.2 (2d), 127.0 (2d), 127.2 (2d), 127.6 (2d), 128.2 (2d), 
128.6 (2d), 131.3 (2s), 133.7 (2s), 134.7 (s), 135.1 (2d), 135.7 (s), 136.1 (2s); 19F 
NMR (376 MHz; CDCl3): -125.2 (s, 2F), -122.5 (s, 2F), -121.8 (s, 2F), -121.0 (m, 
6F), -115.4 [quintet, J = 15 Hz, 2F, (CF2)6CF2CF3], -79.8 [t, J = 10 Hz, 3F, 
(CF2)6CF2CF3]; IR υmax (neat) 3050, 2980, 1595, 1405, 1265, 1090, 895, 750 cm-1; 
m/z (FAB+) (rel. intensity) 773 [(M-NpCH2)+, 1], 429 (1), 401 (2), 141 (100); HRMS 
(FAB+) calc’d. for C27H1735ClF1774Ge [(M-NapCH2)+] 772.9954, found 772.9952 ( 
-0.2 ppm). 
 
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorodecyl)bis(naphthalen-2- 
ylmethyl)(2-methoxyphenyl)germane 6e 
 
To a solution of 2-methoxy-1-bromobenzene (0.3324 g, 1.78 mmol) in THF (10.0 
mL) at -78 oC was added a solution of tBuLi ( 2.6 mL, 3.64 mmol, 1.4M in pentane) 
dropwise resulting in a yellow solution. The solution was stirred at -78 oC for 30 min 
to achieve lithium-halogen exchange. The resulting solution mixture was added 
bromogermane 40 (0.5234 g, 0.593 mmol) at -78 oC and stirred for 1 h than warmed 
up to RT for 16 h. The reaction mixture was diluted with Et2O (20.0 mL) and a 
solution of 1.0 M NH4Cl was added to the reaction mixture until no effervescence 
occurred.  Following extraction with (2 × 20.0 mL) of Et2O, the combined organic 
extracts were dried over MgSO4 and evaporated in vacuo to give green oily residue 
which was purified by FC (hexane/EtOAc, 95/5) to give pure 
(2-methoxyphenyl)germane 6e as a pale yellow oil (0.4706 g, 87 %); 1H NMR (400 
MHz; CDCl3): 1.19 (m, 2H, CH2CH2Ge), 1.89 (m, 2H, CH2CH2Ge), 2.78 (s, 4H, 2 
 GeCH2NP), 3.69 (s, 3H, OCH3), 6.89 (d, J = 8.4 Hz, 1H, ArH), 7.02 (t, J = 7.2 Hz, 
1H, ArH), 7.10 (d, J = 8.4 Hz, 2H, ArH), 7.34-7.39 (m, 3H, ArH), 7.40-7.46 (m, 5H, 
ArH), 7.62 (d, J = 8.0 Hz, 2H, ArH), 7.68 (d, J = 8.4 Hz, 2H, ArH), 7.79 (d, J = 7.7 
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Hz, 2H, ArH); 13C NMR (100.7 MHz; CDCl3) 2.7 (t), 22.7 (2t), 26.6 (t, JCF 23.2 
Hz), 54.7 (q), 108.4 (s), 110.2 (s), 110.7 (2s), 109.6 (2d), 111.0 (2s), 111.1 (s), 118.2 
(s), 121.0 (2d), 124.5 (s), 124.6 (2d), 125.7 (2d), 125.9 (2d), 127.0 (2d), 127.5 (2d+s), 
127.8 (2d), 131.1 (d), 131.2 (s), 133.7 (2s), 134.9 (d), 137.3 (2s), 162.8 (s); 19F NMR 
(376 MHz; CDCl3): -125.1 (s, 2F), -122.6 (s, 2F), -121.8 (s, 2F), -121.0 (m, 6F), 
-115.3 [quintet, J = 14.7 Hz, 2F, (CF2)6CF2CF3], -79.8 [t, J = 9.8 Hz, 3F, 
(CF2)6CF2CF3]; IR υmax (neat) 3030, 2980, 1595, 1510, 1410, 1265, 895, 750 cm-1; 
m/z (FAB+) (rel. intensity) 769 [(M-NpCH2)+, 1], 463 (1), 341 (5), 141 (100); HRMS 
(FAB+) calc’d. for C28H20F1774GeO [(M-NapCH2)+] 765.0480, found 765.0480 ( 0 
ppm). 

(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorodecyl)bis(naphthalen- 
2-ylmethyl)(4-trifluoromethylphenyl)germane 6f121 
 
To oven dried magnesium turnings (0.032 g, 1.34 mmol) in THF (33.0 mL) was 
added para-trifluoromethylbromobenzene (1.23 g, 1.23 mL, 1.34 mmol) and the 
reaction mixture was stirred for 2 h to initiate Grignard reagent formation. To the 
resulting orange coloured reaction mixture was added a solution of a solution of 
bromogermane 40 (0.500 g, 0.567 mmol) in THF (2.00 mL) dropwise and the 
reaction mixture was stirred for 4 h. A sat. solution of NH4Cl was added to the 
reaction mixture until no effervescence occurred and the reaction mixture was 
partitioned between Et2O (40.0 mL) and water (10.0 mL), extracted with CH2Cl2 (2 × 
10.0 mL) and dried over MgSO4. Purification by FC on silica (petrol → 
petrol/EtOAc, 95/5) gave 4-trifluoromethylphenylgermane 6f as a colourless oil 
(0.451 g, 84%). Rf 0.31 (petrol/ EtOAc, 95/5); 1H NMR (400 MHz; CDCl3):  1.21 
(m, 2H, CH2CH2Ge), 1.83 (m, 2H, CH2CH2Ge), 2.76 (s, 4H, 2  GeCH2NP), 7.06 
(dd, J = 6.6, 1.8 Hz, 2H, ArH), 7.35 (s, 2H, ArH), 7.40-7.48 (m, 6H, ArH), 7.61 (t, J 
= 8.7 Hz, 4H, ArH), 7.70 (d, J = 8.4 Hz, 2H, ArH), 7.79 (d, J = 7.5 Hz, 2H, ArH); 13C 
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NMR (101 MHz; CDCl3) 1.9 (t), 22.4 (2t), 26.2 (t, JCF = 22.5 Hz), 108.4 (s), 110.2 
(s), 110.64 (2s), 110.67 (s), 110.95 (s), 110.99 (s), 117.9 (s), 124.77 (s), 124.81 (2d), 
125.0 (2d), 125.8 (2d), 126.2 (2d), 127.0 (2d), 127.1 (2d), 127.6 (2d), 128.2 (2d), 
131.3 (2s), 133.7 (2s), 134.2 (2d), 135.8 (3s); 19F NMR (376 MHz; CDCl3): -125.2 
(s, 2F), -122.6 (s, 2F), -121.8 (s, 2F), -121.0 (m, 6F), -115.4 [quintet, J = 15.1 Hz, 2F, 
(CF2)6CF2CF3], -79.8 [t, J = 10.0 Hz, 3F, (CF2)6CF2CF3], -62.0 (s, 3F, ArCF3); IR 
υmax (neat) 3020, 2985, 1595, 1420, 1265, 900, 740 cm-1; m/z (EI+) (rel. intensity) 
948 (M+, 55), 807 (71), 787 (16), 769 (20), 549 (23), 141 (100); HRMS (EI+) calc’d. 
for C39H2674GeF20 948.0927, found 948.0962 ( 3.7 ppm). 
 
General method for photoactivation of arylgermanes: 
 
To a solution of the arylgermane (0.076 mmol) in MeCN/MeOH (3/1 v/v, 20 mL) in 
a Pyrex Schlenk tube (1 mm thick) was added powdered Cu(BF4)2·nH2O (0.304 
mmol). The resulting mixture was purged with argon for 30 min before irradiating 
using a 125 W high pressure Hg lamp for 1 h. A further portion of powdered 
Cu(BF4)2·nH2O (0.304 mmol) was then added and the solution irradiated for a further 
1 h. After this time, the solvent was removed in vacuo, the residue was taken up in 
CH2Cl2 (20.0 mL), washed with water (2 × 8.0 mL) and dried over MgSO4 to give 
the crude difluoroarylgermane. 
The progress of the photolysis can be conveniently monitored by 19F NMR. For 
example, for the photolysis of arylgermane 6a: 
The 19F NMR after 15 min displays a singlet at F -202.4 ppm which corresponds to 
the mono-germyl fluoride (4-methoxyphenyl)-(naphthalen-2-ylmethyl)germyl 
fluoride 31: 1H NMR (400 MHz; CDCl3): 1.43 (m, 2H, CH2CH2Ge), 2.11 (m, 2H, 
CH2CH2Ge), 3.03 (m, 2H, GeCH2Nap), 3.84 (s, 3H, OCH3), 6.99 (d, J = 6.7 Hz, 2H, 
ArH), 7.26 (d, J = 6.7 Hz, 1H, ArH), 7.40 (d, J = 6.7 Hz, 2H, ArH), 7.40-7.52 (m, 
2H, ArH), 7.59 (s, 1H, ArH), 7.72-7.85 (m, 3H, ArH); 13C NMR (100.7 MHz; 
CDCl3)  6.1 (t), 25.1 (t), 26.3 (t), 55.1 (q), 108.7 (s), 110.6 (s), 111.1 (s), 111.1 (s), 
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111.4 (3s), 114.5 (2d), 118.4 (s), 125.1 (d), 126.27 (d), 126.31 (d), 127.1 (2d), 127.6 
(d), 128.5 (d), 131.6 (s), 133.1 (s), 133.7 (s), 134.3 (2d), 161.7 (s), 1 × (s) carbon 
signal absent 19F NMR (376 MHz; CDCl3): -202.4 (s, GeF), -125.2 (s, 2F), -122.5 
(s, 2F), -121.8 (s, 2F), -120.9 (m, 6F), -115.3 [quintet, J = 14.8 Hz, 2F, 
(CF2)6CF2CF3], -79.8 (t, J = 10.0 Hz, 3F, (CF2)6CF2CF3); m/z (EI+) (rel. intensity) 
788 (M+, 1), 530 (70), 281 (70), 57 (100)}. 
After 2 h the peak for this mono-germyl fluoride has disappeared and the 19F NMR 
displays three singlets at F 164.3, -163.0, -162.6 ppm which correspond to the 
difluorogermane and derivatives thereof (see discussion section 2.6.1.2). 19F NMR 
(376 MHz; CDCl3): -164.3 (s), -163.0 (s), -162.6 (s),-126.2 (s, 2F), -123.3 (s, 2F), 
-122.7 (s, 2F), -122.1 (s, 4F, 2  CF2), -121.9 (s, 2F), -115.4 (CF2)6CF2CF3], -80.8 (t, 
3F, (CF2)6CF2CF3). {m/z (EI+) (rel. intensity) 666 (M+, 1), 410 (25), 328 (30), 149 
(60), 57 (100); HRMS (EI+) calc’d. for C17H1174GeF19O (M+) 665.9718, found 
665.9701 ( 2.7 ppm). 
The by-product of the photooxidation, 2-naphthylmethyl methyl ether 8, shows the 
following diagnostic 1H NMR signals: 1H NMR (400 MHz; CDCl3):  3.41 (s, 3H, 
OMe), 4.62 (s, 2H, ArCH2), 7.40-7.48 (m, 3H, ArH), 7.75-7.83 (m, 4H, ArH). 
If the solution has not been efficiently deoxygenated, some 2-naphthaldehyde 9 
forms and shows the following diagnostic 1H NMR signals: 1H NMR (400 MHz; 
CDCl3):  7.55-7.63 (m, 2H, ArH), 7.88-7.96 (m, 4H, ArH), 8.35 (s. 1H, ArH), 10.22 
(s, 1H, ArCHO); m/z (EI+) (rel. intensity) 156 (M+, 100), 127 (90), 91(20), 58 (50). 
 
Preparation of difluoro germane 7 by nucleophilic substitution reactions (Scheme 
2.6.11) 
To a solution of dichlorogermane 4 (20.2 mg, 0.029 mmol) in Et2O (5.00 mL) was 
added of AgF or AgBF4 (2.5 eq). The reaction mixture was stirred at RT for 16 h 
followed by diluted with Et2O (20.0 mL) and washed with water (2 × 20.0 mL). The 
combined organic extracts were dried over MgSO4 and the solvent was removed in 
vacuo. The crude 19F NMR spectra indicated essentially identical peaks at F -162 ~ 
-165 ppm as observed following photolysis (as described above). 
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General methods for cross-coupling of photoactivated germanes with aryl 
bromides: 
 
4-Methoxy-3’,5’-bis-(trifluoromethylbiphenyl) 38a232 
 
Method A: The crude difluoroarylgermane from the photolysis of arylgermane 6a 
(113.8 mg, 0.1486 mmol) for 1 h with 4 equivalents of Cu(BF4)2·nH2O and powdered 
potassium fluoride (65.6 mg, 1.13 mmol) were dissolved in DMF (1 mL) and stirred 
at rt for 1 h. PdCl2(MeCN)2 (4.5 mg, 0.015 mmol) and dppp (9.2m g, 0.0229 mmol) 
was dissolved in DMF (2 mL) and stirred at rt for 1 h to give the active catalytic 
species. The catalyst solution and 3,5-bis(trifluoromethyl)bromobenzene (43.5 mg, 
0.1486 mmol, 25.6 L) was then added to the difluoroarylgermane solution and the 
resulting mixture heated at 120 oC for 16 h. The crude reaction mixture was diluted 
with Et2O (20.0 mL) and washed with water (3 × 10.0 mL), the combined organic 
extracts were dried over MgSO4 and evaporated in vacuo. Purification by FC 
(hexane/EtOAc, 97/3) gave 4-methoxy-3’,5’-bis-(trifluoromethyl)biphenyl 38a ( 25.3 
mg, 53 %) as a clear liquid; 1H NMR (400 MHz; CDCl3):  3.88 (s, 3H, OCH3), 7.03 
(d, J = 8.8 Hz, 2H, ArH), 7.55 (d, J = 8.8 Hz, 2H, ArH), 7.81 (s, 1H, ArH), 7.91 (s, 
2H, ArH). 19F NMR (376 MHz; CDCl3): -62.8 (s, 6F, 2  CF3). HRMS calc’d. for 
C15H10F6O 320.0636, found 320.0635 ( -0.3 ppm). 
Method B: according for method of Li,233 the crude difluoroarylgermane from the 
photolysis of arylgermane 6a (56.6 mg, 0.074 mmol) for 1 h with 4 equivalents of 
Cu(BF4)2·nH2O and TBAF (70 mg, 0.22 mmol) were dissolved in degassed DMF (2 
mL) and stirred for 30 min. PdCl2(MeCN)2 (1.9 mg, 0.007 mmol) and P(2-Tol)3 (3.2 
mg, 0.0105 mmol) was dissolved degased DMF (1 mL) for 30 min to give the active 
catalytic species. The catalyst solution was added to the difluoroarylgermane solution 
followed by adding 3,5-bis(trifluoromethyl)bromobenzene (43.4 mg, 0.148 mmol, 
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25.5 L) and heated at 120 oC for 16 h under nitrogen atmosphere. The resulting 
solution was diluted with Et2O (20.0 mL) and washed with water (3 × 10.0 mL), the 
combined organic extracts were dried over MgSO4 and evaporated in vacuo. 
Purification by FC (hexane/EtOAc, 97/3) gave biphenyl 38a (14.2 mg, 60 %). 
Analytical data as shown above. 
Method C: The crude difluoroarylgermane from the photolysis of arylgermane 6a 
(47.0 mg, 0.07 mmol) for 1 h with 4 equivalents of Cu(BF4)2·nH2O and TBAF (60 
mg, 0.19 mmol) was dissolved in degassed DMF (2 mL) and stirred for 30 min. 
PdCl2(MeCN)2 (2 mg, 0.007 mmol) and P(2-Tol)3 (3.6 mg, 0.0105 mmol) were 
dissolved degassed DMF (1 mL) for 30 min the active catalytic species. The catalyst 
solution was added to the difluoroarylgermane solution followed by adding 
3,5-bis(trifluoromethyl)- bromobenzene (37.3 mg, 0.14 mmol, 22 L) and CuI ( 14 
mg, 0.07 mmol). The resulting mixture heated at 120 oC for 16 h under nitrogen 
atmosphere. The crude reaction mixture was diluted with Et2O (20.0 mL) and washed 
with water (3 × 10.0 mL), the combined organic extracts were dried over MgSO4 and 
evaporated in vacuo. Purification by FC (hexane/EtOAc, 97/3) gave biphenyl 38a 
(15.2 mg, 68 %). Analytical data as shown above. 
 
Cross-coupling of mono-fluoro arylgermane 31 with 3,5-bis(trifluoromethyl)- 
bromobenzene 
 
Using method C, the crude mono-fluoro arylgermane from the photolysis of 
arylgermane 6a ( 55.0 mg, 0.083 mmol) for 15 min, TBAF (78.2 mg, 0.248 mmol), 
PdCl2(MeCN)2 (2.2 mg , 0.0083 mmol), P(2-Tol)3 (3.8 mg, 0.0125mmol), 3,5-bis 
(trifluoromethyl)bromobenzene (48.6 mg, 0.166 mmol) and CuI ( 16.6 mg, 0.083 
mmol) were employed. Purification by FC (hexane/EtOAc, 97/3) gave biphenyl 38a 
(11.9 mg, 45 %). Analytical data as shown above. 
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The scope of aryl germyl-Stille cross-coupling reactions 
 
Table 2.6.3, entry 1: 4-Methoxy-3’,5’-bis-(trifluoromethylbiphenyl) 38a 
Using method C, the crude di-fluoro arylgermane (54.6 mg, 0.082 mmol) from the 
photolysis of arylgermane 6a for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(77.5 mg, 0.246 mmol), PdCl2(MeCN)2 (2.1 mg, 0.0082 mmol), P(2-Tol)3 (3.7 mg, 
0.0123mmol), 3,5-bis(trifluoromethyl)-bromobenzene (48.1 mg, 0.164 mmol) and 
CuI ( 16.6 mg, 0.083 mmol) were employed. Purification by FC (hexane/EtOAc, 
97/3) gave biphenyl 38a (11.9 mg, 96 %)*. Analytical data as shown above. 
 
Table 2.6.3, entry 2: 4-Chloro-4'-methoxybiphenyl 38b234 
 
Using method C, the crude difluoroarylgermane (54.6 mg, 0.082 mmol) from the 
photolysis of arylgermane 6a for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(77.5 mg, 0.246 mmol), PdCl2(MeCN)2 (2.1 mg , 0.0082 mmol), P(2-Tol)3 (3.7 
mg ,0.0123mmol), 4-chloro-bromobenzene (31.3 mg, 0.164 mmol) and CuI ( 16.4 
mg, 0.082 mmol) were employed. Purification by FC (hexane/EtOAc, 97/3) gave 
4-chloro-4'-methoxybiphenyl 38b as a pale yellow oil (15.3 mg, 85 %). 1H NMR 
(400 MHz; CDCl3): 3.85 (s, 3H, OCH3), 6.96-6.99 (m, 2H, ArH), 7.37-7.39 (m, 
2H, ArH), 7.46-7.51 (m, 4H, ArH); 13C NMR (100.7 MHz; CDCl3) q), 114.3 
(2d), 127.9 (2d), 128.0 (2d), 128.8 (2d), 132.4 (s), 132.6 (s), 139.2 (s), 159.2 (s); 
HRMS calc’d. for C13H11ClO 218.0498, found 218.0499 (0.3 ppm). 
 
 
                                                 
* The significantly increased yield in this experiment (96 %) as compared to the one on the previous 
page also using Method C (68 %) reflects the longer photolysis period with more Cu(BF4)2 (see 
Scheme 2.6.13)  
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Table 2.6.3, entry 3: 4-Methoxy-4’-(phenylmethoxy)biphenyl 38c 
 
Using method C, the crude difluoroarylgermane (63.7 mg, 0.096 mmol) from the 
photolysis of arylgermane 6a for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(92.5 mg , 0.294 mmol), PdCl2(MeCN)2 (2.5 mg , 0.0096 mmol), P(2-Tol)3 (4.4 mg, 
0.014 mmol), 1-((4-bromophenoxy)- methyl)benzene (51.5 mg, 0.196 mmol) and 
CuI (18.6 mg, 0.093 mmol) were employed. Purification by FC (hexane/EtOAc, 
97/3) gave 4-methoxy-4’-(phenylmethoxy)biphenyl 38c as a pale yellow oil (18.1 mg, 
65 %). 1H NMR (400 MHz; CDCl3): 3.85 (s, 3H, OCH3), 5.11 (s, 2H, ArOCH2Ph), 
6.97 (d, J = 8.6 Hz, 2H, ArH), 7.04 (d, J = 8.6 Hz, 2H, ArH), 7.32-7.36 (m, 1H, 
ArH), 7.41 (t, J = 7.4 Hz, 2H, ArH), 7.46-7.50 (m, 6H, ArH); 13C NMR (100.7 MHz; 
CDCl3)  55.3 (q), 70.1 (t), 114.2 (d), 115.1 (3d), 127.5 (2d), 127.8 (4d), 128.0 (d), 
128.6 (2d), 133.4 (s), 133.7 (s), 137.0 (s) 157.9 (s), 158.7 (s); IR υmax (neat) 3027 
(C-H), 2988 (C-H) 1567 (C=C), 980, 870 cm-1; m/z (EI+) (rel. intensity) 290 (M+, 
60), 199 (100), 149 (35), 91 (60); HRMS calc’d. for C20H18O2 290.1307, found 
290.1303 (-1.3 ppm). 
 
Table 2.6.3, entry 4: 1-(4-Methoxyphenyl)naphthalene 38d233 
 
Using method C, the crude difluoroarylgermane (137.0 mg, 0.206 mmol) from the 
photolysis of arylgermane 6a for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(189.9 mg, 0.603 mmol), PdCl2(MeCN)2 (5.3 mg, 0.0206 mmol), P(2-Tol)3 (9.4 mg, 
0.0308 mmol), 1-bromonaphthalene (83 mg, 0.401 mmol, 55.9 L) and CuI ( 40.1 
mg , 0.201 mmol) were employed. Purification by FC (hexane/EtOAc, 97/3) gave 
1-(4-methoxyphenyl)naphthalene 38d as a pale yellow oil (35.7 mg, 74 %). 1H NMR 
(400 MHz; CDCl3): 3.90 (s, 3H, OCH3), 7.04 (d, J = 8.6 Hz, 2H, ArH), 7.40-7.46 
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(m, 4H, ArH), 7.47-7.54 (m, 2H, ArH), 7.84 (d, J = 8.2 Hz, 1H, ArH), 7.92 (d, J = 9.2 
Hz, 2H, ArH); 13C NMR (100.7 MHz; CDCl3) 55.3 (q), 113.7 (2d), 125.4 (d), 125.7 
(d), 125.9 (d), 126.0 (d), 126.9 (d), 127.3 (d), 128.2 (d), 131.1 (2d), 131.8 (s), 133.1 
(s), 133.8 (s), 139.9 (s), 158.9 (s); HRMS calc’d. for C17H14O 234.1045, found 
234.1041 (-ppm). 
 
Table 2.6.3, entry 5: 4-Methyl-3’,5’-bis-(trifluoromethyl)biphenyl 38e235 
 
Using method C, the crude difluoroarylgermane (95.6 mg, 0.147 mmol) from the 
photolysis of arylgermane 6b for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(137.6 mg, 0.437 mmol), PdCl2(MeCN)2 (3.8 mg, 0.0146 mmol), P(2-Tol)3 (6.6 mg, 
0.0217 mmol), 3,5-bis(trifluoromethyl)-bromobenzene (85.3 mg, 0.291 mmol, 50.2 
L) and CuI (29.1 mg, 0.146 mmol) were employed. Purification by FC 
(hexane/EtOAc, 97/3) gave 4-methyl-3’,5’-bis-(trifluoromethyl)biphenyl 38e as a 
pale yellow (37.4 mg, 60 %). 1H NMR (400 MHz; CDCl3): 2.43 (s, 3H, ArCH3), 
7.31 (d, J = 8.0 Hz, 2H, ArH), 7.51 (d, J = 8.0 Hz, 2H, ArH), 7.82 (s, 1H, ArH), 7.99 
(s, 2H, ArH); 13C NMR (100.7 MHz; CDCl3) 21.2 (q), 120.6 (2s), 122.1 (d), 126.9 
(2d), 127.0 (2d), 130.0 (2d), 131.8 (s), 132.2 (s), 135.3 (s), 139.0 (s), 143.2 (s); 
HRMS calc’d. for C15H10F6 304.0687, found 304.0681 ( -ppm) 
 
Table 2.6.3, entry 6: 4-Chloro-4’-methylbiphenyl 38f236 
 
Using method C, the crude difluoroarylgermane (72.8mg, 0.115 mmol) from the 
photolysis of arylgermane 6b for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(108.4 mg, 0.344 mmol), PdCl2(MeCN)2 (3.0 mg, 0.0116 mmol), P(2-Tol)3 (5.7 mg, 
0.0173 mmol), 4-chloro-bromobenzene (43.9mg, 0.229 mmol) and CuI (22.9 mg, 
0.115 mmol) were employed. Purification by FC (hexane/EtOAc, 97/3) gave 
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4-chloro-4’-methylbiphenyl 38f as a pale yellow oil (15.9 mg, 69 %). 1H NMR (400 
MHz; CDCl3): 2.40 (s, 3H, ArCH3), 7.24 (s, 1H, ArH), 7.37-7.40 (m, 2H, ArH), 
7.41-7.48 (m, 3H, ArH), 7.49-7.52 (m, 2H, ArH); 13C NMR (100.7 MHz; CDCl3) 
21.1 (q), 126.8 (2d), 128.17 (2d), 128.21 (d), 128.8 (d), 129.0 (d), 129.6 (d), 133.0 
(s), 137.1 (s), 137.4 (s), 139.6 (s); HRMS calc’d. for C13H11Cl 202.0549, found 
202.0557 (ppm). 
 
Table 2.6.3, entry 7: 4-Methyl-4’-(phenylmethoxy)biphenyl 38g 
 
Using method C, the crude difluoroarylgermane (82.3 mg, 0.127 mmol) from the 
photolysis of arylgermane 6b for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(120 mg, 0.381 mmol), PdCl2(MeCN)2 (3.3 mg, 0.0127 mmol), P(2-Tol)3 (5.8 mg, 
0.0191 mmol), 1-((4-bromophenoxy)methyl)benzene (78.5 mg, 0.298 mmol) and CuI 
(25.5 mg, 0.128 mmol) were employed. Purification by FC (hexane/EtOAc, 97/3) 
gave 4-methyl-4’-(phenylmethoxy)biphenyl 38g as a pale yellow (16.9 mg, 48 %). 1H 
NMR (400 MHz; CDCl3): 2.38 (s, 3H, ArCH3), 5.11 (s, 2H, ArOCH2Ph), 7.04 (d, J 
= 8.7 Hz, 2H, ArH), 7.22 (d, J = 8.0 Hz, 2H, ArH), 7.30-7.36 (m, 1H, ArH), 
7.38-7.42 (m, 2H, ArH), 7.43-7.47 (m, 4H, ArH), 7.51 (d, J = 8.7 Hz, 2H, ArH); 13C 
NMR (100.7 MHz; CDCl3) 21.1 (q), 70.1 (t), 115.1 (2d), 126.6 (2d), 127.5 (2d), 
128.0 (3d), 128.6 (2d), 129.4 (2d), 134.0 (s), 136.4 (s), 137.0 (s), 137.9 (s), 158.1 (s); 
IR υmax (neat) 3025, 2850, 1530, 900, 750 cm-1; m/z (EI+) (rel. intensity) 274 (M+, 
30), 183 (20), 141 (25), 91 (100); HRMS calc’d. for C20H18O 274.1358, found 
274.1359 (0.5 ppm). 
 
Table 2.6.3, entry 8: 1-(4-Methylphenyl)naphthalene 38h237 
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Using method C, the crude difluoroarylgermane (119 mg, 0.183 mmol) from the 
photolysis of arylgermane 6b for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(176mg, 0.559 mmol), PdCl2(MeCN)2 (4.7 mg, 0.0181 mmol), P(2-Tol)3 (8.3 mg, 
0.0272 mmol),  1-bromonaphthalene (77.4 mg, 0.373 mmol, 52 L) and CuI (37.1 
mg, 0.186 mmol) were employed. Purification by FC (hexane/EtOAc, 97/3) gave 
1-(4-methylphenyl)naphthalene 38h as a pale yellow oil (28.3 mg, 71 %). 1H NMR 
(400 MHz; CDCl3): 2.47 (s, 3H, ArCH3), 7.32 (d, J = 7.9 Hz, 2H, ArH), 7.40-7.48 
(m, 4H, ArH), 7.49-7.55 (m, 2H, ArH), 7.86 (d, J = 8.2 Hz, 1H, ArH), 7.93 (t, J = 9.1 
Hz), 2H, ArH); 13C NMR (100.7 MHz; CDCl3) 21.2 (q), 125.4 (d), 125.7 (d), 125.9 
(d), 126.1 (d), 126.9 (d), 127.4 (d), 128.2 (d), 129.0 (2d), 129.3 (2d), 131.7 (s), 133.8 
(s), 136.9 (s), 137.8 (s), 140.2 (s); HRMS calc’d. for C17H14 218.1096, found 
218.1098 ( 1.1 ppm). 
 
Table 2.6.3, entry 9: 3’,5’-bis(Trifluoromethyl)biphenyl 38i235 
 
Using method C, the crude difluoroarylgermane (70.3 mg, 0.111 mmol) from the 
photolysis of arylgermane 6c for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(104.6 mg, 0.332 mmol), PdCl2(MeCN)2 (2.9 mg, 0.0111 mmol), P(2-Tol)3 (5.1 mg, 
0.0167 mmol), 3,5-bis(trifluoromethyl)bromobenzene (64.9 mg, 0.222 mmol, 38.2 
L) and CuI (22.1 mg, 0.0111 mmol) were employed. Purification by FC 
(hexane/EtOAc, 97/3) gave 3’,5’-bis(trifluoromethyl)biphenyl 38i as a pale yellow 
oil (23.7 mg, 74 %). 1H NMR (400 MHz; CDCl3): 7.45-7.54 (m, 2H, ArH), 
7.61-7.63 (m, 1H, ArH), 7.86 (s, 1H, ArH), 8.01 (d, J = 10.0 Hz, 2H, ArH), 8.03 (s, 
2H, ArH); HRMS calc’d. for C14H8F6 290.0530, found 290.0523 ( -2.5 ppm). 
 
Table 2.6.3, entry 10: 4-Chlorobiphenyl 38j238 
 
Using method C, the crude difluoroarylgermane (61 mg, 0.096 mmol) from the 
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photolysis of arylgermane 6c for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(90.7 mg, 0.288 mmol), PdCl2(MeCN)2 (2.5 mg, 0.0096 mmol), P(2-Tol)3 (4.4 mg, 
0.0145 mmol), 4-chloro-bromobenzene (36.8 mg, 0.192 mmol) and CuI (19.1 mg, 
0.096 mmol) were employed. Purification by FC (hexane/EtOAc, 97/3) gave 
4-chlorobiphenyl 38j as a pale oil ( 11.6 mg, 63 %). 1H NMR (400 MHz; CDCl3): 
7.34-7.40 (m, 1H, ArH), 7.41-7.45 (m, 3H, ArH), 7.47-7.48 (m, 2H), 7.49-7.56 (m, 
3H, ArH); 13C NMR (100.7 MHz; CDCl3) 127.0 (d), 127.6 (d), 128.2 (2d), 128.4 
(d), 128.9 (d), 129.0 (3d), 133.7 (s), 134.6 (s), 136.6 (s); HRMS calc’d. for C12H9Cl 
188.0393, found 188.0385 ( -4.1 ppm). 
 
Table 2.6.3, entry 11: 4-(Phenylmethoxy)biphenyl 38k233 
 
Using method C, the crude difluoroarylgermane (109.9 mg, 0.173 mmol) from the 
photolysis of arylgermane 6c for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(163.5 mg, 0.519 mmol), PdCl2(MeCN)2 (4.5 mg, 0.0173 mmol), P(2-Tol)3 (7.9 mg, 
0.026 mmol), 1-((4-bromophenoxy)methyl)benzene (91.1 mg, 0.346 mmol) and CuI 
(34.2 mg, 0.171 mmol) were employed. Purification by FC (hexane/EtOAc, 97/3) 
gave 4-(phenylmethoxy)biphenyl 38k as a pale oil (17.8 mg, 40 %). 1H NMR (400 
MHz; CDCl3): 5.12 (s, 2H, ArH), 7.05 (d, J = 8.8 Hz, 2H, ArH), 7.30 (t, J = 7.3 Hz, 
1H, ArH), 7.35 (d, J = 7.1 Hz, 1H, ArH), 7.38-7.48 (m, 6H, ArH), 7.51-7.56 (m, 4H, 
ArH); 13C NMR (100.7 MHz; CDCl3) 70.1 (t), 115.1 (2d), 126.67 (d), 126.73 (2d), 
127.5 (2d), 128.0 (d), 128.2 (2d), 128.6 (2d), 128.7 (2d), 134.2 (s), 135.7 (s), 140.1 
(s), 158.3 (s); HRMS calc’d. for C19H16O 260.1201, found 260.1190 ( -4.3 ppm). 
 
Table 2.6.3, entry 12: 1-Phenylnaphthalene 38l237 
 
Using method C, the crude difluoroarylgermane (30.5 mg, 0.048 mmol) from the 
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photolysis of arylgermane 6c for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(45.4 mg, 0.144 mmol), PdCl2(MeCN)2 (1.2 mg, 0.0046 mmol), P(2-Tol)3 (2.1 mg, 
0.0069 mmol), 1-bromonaphthalene (20 mg, 0.096 mmol, 13.4 L) and CuI (9.6 mg, 
0.048 mmol) were employed. Purification by FC (hexane/EtOAc, 97/3) gave 
1-phenylnaphthalene 38l as a pale yellow oil (5.8 mg, 60 %). 1H NMR (400 MHz; 
CDCl3): 7.41-7.45 (m, 3H, ArH), 7.47-7.55 (m, 6H, ArH), 7.86 (d, J = 8.0 Hz, 1H, 
ArH), 7.91 (dd, J = 8.0, 3.1 Hz, 2H, ArH); 13C NMR (100.7 MHz; CDCl3) 
d), 125.8 (d), 126.0 (2d), 126.9 (d), 127.2 (d), 127.6 (d), 128.2 (3d), 130.1 
(2d), 130.2 (s), 133.8 (s), 140.2 (s), 140.7 (s); HRMS calc’d. for C16H12 204.0903, 
found 204.0903 ( 0 ppm). 
 
Table 2.6.3, entry 13: 4-Chloro-3’,5’-bis-(trifluoromethyl)biphenyl 38m235 
 
Using method C, the crude difluoroarylgermane (34.6 mg, 0.052 mmol) from the 
photolysis of arylgermane 6d for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(48 mg, 0.152 mmol), PdCl2(MeCN)2 (1.3 mg, 0.005 mmol), P(2-Tol)3 (2.3 mg, 
0.0075 mmol), 3,5-bis(trifluoromethyl)- bromobenzene (30.6 mg, 0.105 mmol, 18 
L) and CuI (10 mg, 0.05 mmol) were employed. Purification by FC (hexane/EtOAc, 
97/3) gave 4-chloro-3’,5’-bis-(trifluoromethyl)biphenyl 38m as a pale yellow oil 
(11.9 mg, 71 %). 1H NMR (400 MHz; CDCl3): 7.47-7.50 (m, 2H, ArH), 7.51-7.57 
(m, 2H, ArH), 7.87 (s, 2H, ArH); HRMS calc’d. for C14H7ClF6 324.0140, found 
324.0137 (-1.1 ppm). 
 
Table 2.6.3, entry 14: 4-Chloro-4’-(phenylmethoxy)biphenyl 38n 
 
Using method C, the crude difluoroarylgermane (50.3 mg, 0.075 mmol) from the 
photolysis of arylgermane 6d for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(71 mg, 0.225 mmol), PdCl2(MeCN)2 (1.9 mg, 0.0073 mmol), P(2-Tol)3 (3.3 mg, 
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0.011 mmol), 1-((4-bromophenoxy)methyl)- benzene (39.5 mg, 0.150 mmol) and 
CuI (15 mg, 0.075 mmol) were employed. Purification by FC (hexane/EtOAc, 97/3) 
gave 4-chloro-4’-(phenylmethoxy)biphenyl 38n as a pale yellow oil (9.3 mg, 42 %). 
1H NMR (400 MHz; CDCl3): 5.14 (s, 2H, ArOCH2Ph), 7.05 (d, J = 8.7 Hz, 2H, 
ArH), 7.31-7.42 (m, 5H, ArH), 7.44-7.50 (m, 6H, ArH); 13C NMR (100.7 MHz; 
CDCl3) 70.1 (t), 115.1 (d), 126.7 (d), 127.5 (d), 127.7 (d), 127.9 (2d), 128.0 (2d), 
128.3 (d), 128.6 (d), 128.8 (d), 128.9 (d), 129.1 (d), 132.6 (s), 132.7 (s), 136.8 (s), 
139.2 (s), 158.5 (s); IR υmax (neat) 3035, 2895, 1550, 870, 740 cm-1; m/z (EI+) (rel. 
intensity) 296 [(M37Cl)+, 30], 294 [(M35Cl)+, 88), 139 (30), 84 (60), 49 (100); HRMS 
calc’d. for C19H15ClO 294.0811, found 294.0807 (-1.5 ppm). 
 
Table 2.6.3, entry 15: 1-(4-Chlorophenyl)naphthalene 38o239 
Chemical Formula: C16H11Cl
Exact Mass: 238.0549
Molecular Weight: 238.7115
38o
Cl
 
Using method C, the crude difluoroarylgermane (79.3 mg, 0.115 mmol) from the 
photolysis of arylgermane 6d for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(108.6 mg, 0.345 mmol), PdCl2(MeCN)2 (3.0 mg, 0.0116 mmol), P(2-Tol)3 (5.3 mg, 
0.017 mmol), 1-bromonaphthalene (47.8 mg, 0.230 mmol, 32.1 L) and CuI ( 2.9 mg, 
0.115 mmol) were employed. Purification by FC (hexane/EtOAc, 97/3) gave 
1-(4-chlorophenyl)naphthalene 38o as a pale yellow oil (20.6 mg, 75 %). 1H NMR 
(400 MHz; CDCl3): 7.39-7.41 (m, 5H, ArH), 7.49-7.55 (m, 3H, ArH), 7.85 (d, J = 
8.5 Hz, 1H, ArH), 7.88 (d, J = 8.3 Hz, 1H, ArH), 7.92 (d, J = 7.9 Hz, 1H, ArH); 13C 
NMR (100.7 MHz; CDCl3) 125.3 (d), 125.6 (d), 125.7 (d), 126.2 (d), 126.9 (d), 
128.0 (d), 128.3 (d), 128.5 (2d), 130.1 (s), 131.3 (2d), 133.3 (s), 133.8 (s), 138.9 (s), 
139.1 (s); HRMS calc’d. for C16H11Cl 238.0549, found 238.0541 (-3.9 ppm). 
 
 
 
 
 147
Table 2.6.3, entry 16: 2-Methoxy-3’,5’-bis-(trifluoromethyl)biphenyl 38p 
 
Using method C, the crude difluoroarylgermane (50.6 mg, 0.076 mmol) from the 
photolysis of arylgermane 6e for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(71.8 mg, 0.228 mmol), PdCl2(MeCN)2 (2.0 mg, 0.0078 mmol), P(2-Tol)3 (3.6 mg, 
0.012 mmol), 3,5-bis(trifluoromethyl)bromobenzene (44.5 mg, 0.152 mmol, 26.2 L) 
and CuI (15.2 mg, 0.076 mmol) were employed. Purification by FC (hexane/EtOAc, 
97/3) gave 2-methoxy-3’,5’-bis-(trifluoromethyl) biphenyl 38p as a pale yellow oil 
(15.7 mg, 65 %). 1H NMR (400 MHz; CDCl3): 3.82 (s, 3H, OCH3), 7.02 (d, J = 8.3 
Hz, 1H, ArH), 7.08 (t, J = 7.1 Hz, 1H, ArH), 7.33 (dd, J = 7.6, 1.7 Hz, 1H, ArH), 
7.41 (td, J = 8.3, 1.7 Hz, 1H, ArH), 7.82 (s, 1H, ArH), 7.98 (s, 2H, ArH); 13C NMR 
(100.7 MHz; CDCl3) 55.6 (q), 111.3 (2d), 120.6 (2s), 121.2 (d), 127.5 (s), 129.7 
(2d), 130.2 (d), 130.6 (d), 131.0 (2s), 140.5 (s), 156.0 (s); IR υmax (neat) 3020, 1605, 
1440, 900, 740 cm-1; m/z (EI+) (rel. intensity) 320 (M+, 70), 305 (20), 285 (30), 236 
(40), 84 (70), 49 (100); HRMS calc’d. for C15H10F6O 320.0636, found 320.0632 
(-1.2 ppm). 
 
Table 2.6.3, entry 17: 2-Methoxy-4’chloro-1,1’-biphenyl 38q238 
 
Using method C, the crude difluoroarylgermane (95.1 mg, 0.144 mmol) from the 
photolysis of arylgermane 6e for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(135.3 mg, 0.430 mmol), PdCl2(MeCN)2 (3.7 mg, 0.014 mmol), P(2-Tol)3 (6.6 mg, 
0.022 mmol), 4-chloro-bromobenzene (55.1 mg, 0.288 mmol) and CuI (28.7 mg, 
0.144 mmol) were employed. Purification by FC (hexane/EtOAc, 97/3) gave 
2-methoxy-4’chloro-1,1’-biphenyl 38q as a pale yellow oil (17.8 mg, 57 %). 1H NMR 
(400 MHz; CDCl3): s, 3H, OCH3), 7.02 (d, J = 8.0 Hz, 1H, ArH), 7.08 (t, J = 
7.5 Hz, 1H, ArH), 7.30-7.44 (m, 2H, ArH), 7.46 (d, J = 8.0 Hz, 2H, ArH), 7.52 (d, J 
= 8.0 Hz, 2H, ArH); 13C NMR (100.7 MHz; CDCl3) 55.5 (q), 111.2 (2d), 120.9 
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(2s), 121.2 (d), 127.4 (s), 129.6 (2d), 130.4 (d), 130.6 (d), 131.0 (2s), 140.2 (s), 156.3 
(s); HRMS calc’d. for HRMS calc’d. for C13H11ClO 218.0498, found 218.0496 
(0.9 ppm). 
 
Table 2.6.3, entry 18: 2-Methoxy-4’-(phenylmethoxy)biphenyl 38r 
Chemical Formula: C20H18O2
Exact Mass: 290.1307
Molecular Weight: 290.3557
38r
OMe
OBn
 
Using method C, the crude difluoroarylgermane (132.9 mg, 0.200 mmol) from the 
photolysis of arylgermane 6e for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(188.7 mg, 0.599 mmol), PdCl2(MeCN)2 (5.2 mg, 0.020 mmol), P(2-Tol)3 (9.1 mg, 
0.03 mmol), 1-((4-bromophenoxy)methyl)benzene (105.1 mg, 0.400 mmo) and CuI 
(39.8 mg, 0.200 mmol) were employed. The crude mixture was analysed by GC-MS 
[Column: SGE25QC3/BP5 25 m × 0.25 mm; Carrier gas: He; Oven temp: 60 °C (3 
min),60 °C → 300 °C over12 min]. A yield of 11% for biphenyl 38r was deduced 
from the ratio of peak intensities for 2-(methoxymethyl)naphthalene 8 (Rt 8.1 min, 
m/z 172) vs. biphenyl 38r (Rt 13.3 min, m/z 290). m/z (EI+) (rel. intensity) 290 (M+, 
20), 91 (100); HRMS (EI+) calc’d. for C20H18O 290.1307, found 290.1301, -2.0 
ppm. 
 
Table 2.6.3, entry 19: 1-(2-Methoxyphenyl)naphthalene 38s 
Chemical Formula: C17H14O
Exact Mass: 234.1045
Molecular Weight: 234.2925
38s
OMe
 
Using method C, the crude difluoroarylgermane (44.0 mg, 0.066 mmol) from the 
photolysis of arylgermane 6e for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(62.5 mg, 0.198 mmol), PdCl2(MeCN)2 (1.7 mg, 0.007 mmol), P(2-Tol)3 (3.0 mg, 
0.0098 mmol), 1-((4-bromophenoxy)methyl)benzene (27.5 mg, 0.133 mmol, 18.5 L) 
and CuI (13.2 mg, 0.066 mmol) were employed. Purification by FC (hexane/EtOAc, 
97/3) gave 1-(2-methoxyphenyl)naphthalene 38s as a pale yellow oil (4.1 mg, 27 %). 
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1H NMR (400 MHz; CDCl3): 3.70 (s, 3H, OCH3), 7.06 (t, J = 8.1 Hz, 1H, ArH), 
7.09 (dd, J = 7.5, 1.0 Hz, 1H, ArH), 7.29 (dd, J = 7.5, 1.8 Hz, 1H, ArH), 7.37-7.46 
(m, 4H, ArH), 7.53 (d, J = 8.1 Hz, 1H, ArH), 7.58 (d, J = 8.5 Hz, 1H, ArH), 7.87 (t, J 
= 9.1 Hz, 2H, ArH); 13C NMR (100.7 MHz; CDCl3) 55.6 (q), 110.9 (2d), 120.5 
(2d), 125.3 (s), 125.5 (s), 125.6 (2d), 126.4 (d), 127.3 (s), 127.6 (d), 128.1 (d), 129.0 
(s), 131.9 (2d), 153.2 (s); HRMS calc’d. for C17H14O 234.1045, found 234.1045 (0 
ppm). 
 
Table 2.6.3, entry 20: 4-Trifluoromethyl-3’,5’-bis-(trifluoromethyl)biphenyl 
38t139,140 
 
Using method C, the crude difluoroarylgermane (52.0 mg, 0.074 mmol) from the 
photolysis of arylgermane 6f for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(70.2 mg, 0.223 mmol), PdCl2(MeCN)2 (2.0 mg, 0.0077 mmol), P(2-Tol)3 (3.5 mg, 
0.0115 mmol), 3,5-bis-trifluoromethylbromobenzene (43.5 mg, 0.149 mmol, 25.6 L) 
and CuI (14.8 mg, 0.074 mmol) were employed. The crude mixture was analysed by 
GC-MS and the yield (26 %) was deduced by the ratio of peak intensity between the 
2-(methoxymethyl)naphthalene 8 and the peak for the 
2-trifluoromethyl-3’,5’-bis-(trifluoromethyl)biphenyl 38t with m/z 358. HRMS calc’d. 
for C15H7F9 358.0404, found 358.0386 (-5.0 ppm). 
 
Table 2.6.3, entry 21: 4-Trifluoromethyl-4’-chloro-1,1’-biphenyl 38u240 
Using method C, the crude difluoroarylgermane (46.1 mg, 0.066 mmol) from the 
photolysis of arylgermane 6f for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF (62 
mg, 0.197 mmol), PdCl2(MeCN)2 (1.7 mg, 0.0066 mmol), P(2-Tol)3 (3 mg, 0.0099 
mmol), 4-chlorobromobenzene (25.1 mg, 0.131 mmol) and CuI (13 mg, 0.066 mmol) 
were employed. The crude mixture was analysed by GC-MS [Column: 
SGE25QC3/BP5 25 m × 0.25 mm; Carrier gas: He; Oven temp: 60 °C (3 min),60 °C 
→ 300 °C over12 min]. A yield of 11% for biphenyl 38u was deduced from the ratio 
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of peak intensities for 2-(methoxymethyl)naphthalene 8 (Rt 8.0 min, m/z 172) vs. 
biphenyl 38u (Rt 10.2 min, m/z 256). m/z (EI+) (rel. intensity) 256 (M+, 50), 141 
(100), 115 (45); HRMS (EI+) calc’d. for C13H835ClF3 (M+) 256.0267, found 256.0265, 
-0.6 ppm. 
 
Cross-coupling of arylgermane 6a with a variety of aryl (pseudo)halides (Table 
2.6.4) 
Using method C, the crude di-fluoro arylgermane (120.6 mg, 0.1814 mmol) from the 
photolysis of arylgermane 6a for 2 h with 8 equivalents of Cu(BF4)2·nH2O was 
charged parallel into three separated vessels (40.2 mg, 0.060 mmol) along with 
TBAF (56.7 mg, 0.180 mmol), PdCl2(MeCN)2 (1.6 mg , 0.006 mmol), P(2-Tol)3 (2.7 
mg ,0.009mmol) and CuI (12.0 mg, 0.06 mmol). 1-Chloronaphthalene (19.5 mg, 0.12 
mmol), 1-iodonaphthalene (30.5 mg, 0.12 mmol) and 1-naphthalenyl triflate (33.1 
mg, 0.12 mmol) were employed. The crude mixture was quantified by GC-MS using 
2-(methoxymethyl)naphthalene 8 as an internal standard for evaluation of reaction 
efficiency. The ratio between biaryl 38d and 2-(methoxymethyl)naphthalene 8 
obtained by bromonaphthalene was deemed as 100 % in comparison with the 
outcomes furnished by the other analogues. 
 
Stability profiling of fluorous-tagged phenylgermane 6c (Table 2.6.5) 
Stability tests were carried out using 8 different conditions on fluorous-tagged 
arylgermane 6c as substrate with 9-methylanthrance 41 and 
4,4’-di-tert-butyl-1,1’-biphenyl 42 as internal standard.146 To a solution of 
fluorous-tagged arylgermane 6c (5 mg), internal standard 41 or 42 (1 mg) in reaction 
solvents (5mL) at RT for 3 h. The reaction mixtures were quenching with water (5 
mL) and diluted with Et2O (5 mL) followed by extracted with Et2O (10 mL  5). The 
organic layer was dried by N2 flow. The residue was dissolved with acetonitrile (5 
mL) and analysed by HPLC. HPLC conditions:  
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Agilent 1100 HPLC; Column: XTerra RP8 4.6 mm × 150mm, 5μ; Mobile phase: 
MeCN/H2O = 80:20; Flow rate: 1 mL/min; Detection: UV diode array at 245 nm; 
Injection volume: 2μL 
The ratio of the peak areas was calculated for substrate 6c and internal standard 41 or 
42. In The percentage recovery of compound 6c was compared to blank tests in 
appropriate solvents using in these different conditions. The chromatographs of the 
blank tests were shown as below (Figure 4.1). 
 
 
 
 
 
 
 
 
 
No. Conditionsa Ref. Rec. 6c/%
 
(Run 1)a 
Rec. 6c/% 
(Run 2)a 
Rec.6c/% 
(Mean)a 
1 HS(CH2)2OH, DBU, DMF 41 109 95 102 
2 Piperidine/DMF (20% v/v) 41 111 91 101 
3 Hydrazine/DMF (2% v/v) 41 114 93 104 
4 NaBH4, THF 41 106 107 107 
5 LiAlH4, THF 41 97 110 104 
6 TBAF, THF 41 101 103 102 
7 TFA/CH2Cl2 (50% v/v) 41 18 22 20 
8 m-CPBA, CH2Cl2 42 75 76 76 
a% recovery of 6c by HPLC vs. the internal standards. 
Figure 4.1. Showing stability profile of fluorous-tagged phenylgermane 6c  
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Synthesis of boscalid and analogues by germyl-Stille cross-coupling 
N-Benzoyl-2-bromoaniline 45241 
 
To a solution of 2-bromoaniline (0.20 g, 1.16 mmol) in CH2Cl2 (10.0 mL), DMAP 
(0.0142 g, 0.116 mmol) and Et3N (0.35 g, 3.48 mmol, 0.49 mL) was added benzoyl 
chloride (0.18 g, 1.28 mmol, 0.15 mL) under 0 oC.  The resulting reaction mixture 
was stirred at 0 oC for 3 h. The yellow reaction was quenching dropwise with water 
until effervescence ceased. The reaction mixture was diluted with Et2O (20.0 mL) 
and washed with water (2 × 20.0 mL). The combined organic extracts were dried 
over MgSO4 and the solvent was removed in vacuo followed by purification by FC 
(hexane/EtOAc 80/20) and drying under high vacuum gave 
N-benzoyl-2-bromoaniline 45 as white needles (0.296 g, 92 %). mp 106-108 C;  1H 
NMR (270 MHz; CDCl3):  7.09-7.25 (m, 2H, ArH), 7.31-7.38 (m, 2H, ArH), 
7.39-7.49 (m, 2H, ArH), 7.58-7.68 (m, 1H, ArH), 7.81 (dd, J = 7.1, 1.7 Hz, 2H, ArH), 
8.12 (dd, J = 7.2, 1.3 Hz, 1H, ArH). 
 
N-(2-(1-Hydroxy-1-phenylpentyl)phenyl)benzamide 52 
 
To a solution of N-benzoyl-2-bromoaniline 45 (0.10 g, 0.362 mmol) in THF (10.0 
mL) at -100 oC was added a solution of nBuLi (0.32 mL, 0.724 mmol, 2.5 M in 
hexanes) dropwise resulting in a yellow solution. The solution was stirred at -100 oC 
for 30 min before addition of trimethylstannyl chloride (0.22 g, 1.09 mmol) at -100 oC 
and stirred for 1 h than warmed up to RT for 16 h. The reaction mixture was diluted 
with Et2O (20.0 mL) and a solution of 1.0 M NH4Cl was added to the reaction 
mixture until no effervescence occurred. Following extraction with (2 × 20.0 mL) of 
Et2O, the combined organic extracts were dried over MgSO4 and evaporated in vacuo 
to give a white residue which was purified by FC (hexane/EtOAc, 90/10) to give the 
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N-(2-(1-hydroxy-1-phenylpentyl)phenyl)benzamide 52 as white needles (0.053 g, 41 
%). mp 156-158 C;  1H NMR (500 MHz; CDCl3):  0.89 (t, J = 7.3 Hz, 3H, CH3), 
1.19 (m, 1H, H-3), 1.34 (m, 2H, H-4), 1.49 (m, 1H, H-3), 2.24 (tdd, J = 11.8, 4.7, 1.8 
Hz, 1H, H-2), 2.32 (tdd, J = 11.8, 4.7, 1.8 Hz, 1H, H-2), 3.09 (s, 1H, OH), 7.11-7.20 
(m, 4H, ArH), 7.25-7.28 (m, 2H, ArH), 7.34-7.41 (m, 3H, ArH), 7.44-7.51 (m, 2H, 
ArH), 7.63 (dd, J = 7.2, 1.1 Hz, 2H, ArH), 8.39 (d, J = 7.6 Hz, 1H, ArH), 9.93 (s, 1H, 
NH); 13C NMR (100.7 MHz; CDCl3)  14.0 (q), 23.0 (t), 25.8 (t), 42.7 (t), 79.5 (s), 
123.2 (d), 123.3 (d), 125.5 (2d), 126.7 (d), 127.0 (2d), 127.1 (d), 128.1 (2d), 128.3 
(2d), 128.6 (d), 131.4 (d), 134.5 (s), 135.0 (s), 137.7 (s), 144.7 (s), 165.0 (s); IR υmax 
(neat) 3294 (brs, OH), 3050 (C-H), 2940 (C-H), 1656 (C=O), 1584 (C=C), 1527, 
1449, 751, 700 cm-1; m/z (CI+) (rel. intensity) 360 (M+, 15), 302 (25), 236 (35), 105 
(100), 77 (40); HRMS (CI+) calc’d. for C24H25NO2 [M+H]+ 360.1964, found 
360.1961 (0.7 ppm). 
 
N-Pivaloylanilide 53146 
HN
O
Chemical Formula: C11H15NO
Exact Mass: 177.1154
Molecular Weight: 177.2429
53  
To a solution of aniline (0.20 g, 2.15 mmol) in CH2Cl2 (10.0 mL) was added pivaloyl 
chloride (0.39 g, 3.22 mmol, 0.40 mL) and NaOH (10 mL, 25 %) under 0 oC. The 
resulting reaction mixture was stirred at 0 oC for 4 h. The reaction mixture was 
diluted with Et2O (20.0 mL) and washed with water (2 × 20.0 mL). The combined 
organic extracts were dried over MgSO4 and the solvent was removed in vacuo. 
Purification by FC (hexane/EtOAc 85/15) and drying under high vacuum gave 
N-pivaloylanilide 53 as white needles (0.37 g, 97 %);  1H NMR (270 MHz; CDCl3): 
 1.30 (s, 9H, 3  CH3), 7.08 (tt, J = 7.6, 1.3 Hz, 1H, ArH), 7.30 (t, J = 7.6 Hz, 2H, 
ArH), 7.51 (d, J = 7.6 Hz, 2H, ArH). 
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2-Trimethylstannyl-N-pivaloylanilide 54146,147 
 
To a solution of N-pivaloylanilide 53 (0.10 g, 0.564 mmol) and TMEDA (0.066 g, 
0.564 mmol, mL) in THF (10.0 mL) at -20 oC was added a solution of nBuLi (0.5 mL, 
1.25 mmol, 2.5 M in hexnaes) dropwise resulting in a yellow solution. The solution 
was stirred at -20 oC for 30 min before addition of trimethylstannyl chloride (0.34 g, 
1.71 mmol) at -20 oC, stirring for 1 h and then warming to RT for 16 h. The reaction 
mixture was diluted with Et2O (20.0 mL) and a solution of 1.0 M NH4Cl was added 
to the reaction mixture until no effervescence occurred. Following extraction with (2 
× 20.0 mL) of Et2O, the combined organic extracts were dried over MgSO4 and 
evaporated in vacuo to give white residue which was purified by FC (hexane/EtOAc, 
90/10) to give 2-trimethylstannyl-N-pivaloylanilide 54 as white needles (0.064 g, 67 
%) with recovery of N-pivaloylanilide 53 (0.05g, 50 %); 1H NMR (270 MHz; CDCl3): 
 0.49 (s, 9H, 3  SnCH3), 1.29 (s, 9H, 3  CH3), 7.07 (t, J = 7.7 Hz, 1H, ArH), 7.29 
(t, J = 7.7 Hz, 2H, ArH), 7.37 (brs, 1H, NH), 7.50 (d, J = 7.7 Hz, 1H, ArH). 
 
4-Chloro-2’-N-pivaloylanilinylbiphenyl 55 
 
To a solution of 2-trimethylstannyl-N-pivaloylanilide 54 (0.05 g, 0.147 mmol), CsF 
(0.447 g, 0.294 mmol, mL), CuI (0.001 g, 0.005 mmol) and Pd(PPh3)4 (0.004 g, 
0.003 mmol) in DMF (10.0 mL) was added 4-chloro-bromobenzene (0.014 g, 0.073 
mmol) at rt. The solution was evacuated/ purged with N2 for five times and heated to 
40 oC for 16 h.155 The reaction mixture was diluted with Et2O (20.0 mL) and a 
solution of 1.0 M NH4Cl was added to the reaction mixture until no effervescence 
occurred. Following extraction with (2 × 20.0 mL) of Et2O, the combined organic 
extracts were dried over MgSO4 and evaporated in vacuo to give a white residue 
which was purified by FC (hexane/EtOAc, 90/10) to give 
4-chloro-2’-N-pivaloylanilinylbiphenyl 55 as white needles (0.012 g, 58 %); 1H 
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NMR (270 MHz; CDCl3): 1.08 (s, 9H, 3  CH3), 7.14 (d, J = 7.7 Hz, 2H, ArH), 
7.24-7.39 (m, 3H, ArH), 7.45 (d, J = 8.2 Hz, 2H, ArH), 8.29 (d, J = 8.2 Hz, 1H, ArH); 
HRMS (EI) calc. for C17H18ClNO 287.1077, found 287.1077 (0 ppm). 
 
Chloro-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-heneicosafluorododecyl) 
bis(naphthalen-2-ylmethyl)germane 56 
 
To a solution of (3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-heneicosafluoro- 
dodecyl)-(4-methoxyphenyl)bis(naphthalen-2-ylmethyl)germane (0.50 g, 0.495 
mmol) in CH2Cl2 (20.0 mL) was added a solution of conc. HCl (10 mL, 37 % wt.). 
The resulting biphasic reaction mixture was stirred at rt for 12 h, extracted with Et2O 
(3 × 20.0 mL). The combined organic extracts were dried over MgSO4 and 
evaporated in vacuo to give chlorogermane 56 as a brown amorphous solid (0.455 g, 
98 %). mp 175-177 C; 1H NMR (270 MHz; CDCl3):  1.25 (m, 2H, 
C10F21CH2CH2Ge), 1.83 (m, 2H, C10F21CH2CH2Ge), 2.88 (d, J = 12.6 Hz, 2H, 
GeCH2NP), 2.90 (d, J = 12.6 Hz, 2H, GeCH2NP), 7.21 (m, 2H, ArH), 7.42-7.49 (m, 
6H, ArH), 7.68 (m, 2H, ArH), 7.76 (m, 2H, ArH), 7.81 (m, 2H ArH). 
 
Bromo-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-heneicosafluorododecyl) 
bis(naphthalen-2-ylmethyl)germane 61 
 
According the method of Noban,156 to a solution of 
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-heneicosafluorododecyl)- 
(4-methoxypgenyl)bis(naphthalen-2-ylmethyl)germane (0.120 g, 0.119 mmol) in 
CH2Cl2 (5.0 mL) was added a solution of conc. HBr (2.0 mL, 48% wt.). The 
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resulting biphasic reaction mixture was stirred at rt for 12 h, extracted with Et2O (3 × 
20.0 mL). The combined organic extracts were dried over MgSO4 and evaporated in 
vacuo to give bromogermane 61 as a brown amorphous solid (0.087 g, 88%); 1H 
NMR (400 MHz; CDCl3):  1.39 (m, 2H, C10F21CH2CH2Ge), 1.93 (m, 2H, 
C10F21CH2CH2Ge), 2.97 (d, J = 12.6 Hz, 2H, GeCH2NP), 3.00 (d, J = 12.6 Hz, 2H, 
GeCH2NP), 7.21 (dd, J = 6.6, 1.8 Hz, 2H, ArH), 7.42-7.49 (m, 6H, ArH), 7.68 (dd, J 
= 6.6, 1.8 Hz, 2H, ArH), 7.76 (d, J = 8.4 Hz, 2H, ArH), 7.81 (dd, J = 6.6, 1.8 Hz, 2H 
ArH). 
 
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-Heneicosafluorododecyl) 
-(2-N-pivaloylacetanilidyl)bis(naphthalen-2-ylmethyl)germane 57 
 
To a solution of N-pivaloylanilide 53 (0.05 g, 0.282 mmol) in Et2O (10.0 mL) at -20 
oC was added a solution of nBuLi (0.283 mL, 0.706 mmol, 2.5M in hexanes) 
dropwise resulting in a yellow solution. The solution was stirred at -20 oC for 30 min 
before addition of chlorogermane 56 (0.05 g, 0.053 mmol) at -20 oC, stirring for 1 h 
and then warming to RT for 16 h. The reaction mixture was diluted with Et2O (20.0 
mL) and a solution of 1.0 M NH4Cl was added to the reaction mixture until no 
effervescence occurred. Following extraction with (2 × 20.0 mL) of Et2O, the 
combined organic extracts were dried over MgSO4 and evaporated in vacuo to give 
green oily residue which was purified by FC (hexane/EtOAc, 90/10) to give 
2-(N-pivaloylacetanilidyl)germane 57 contaminated with an inseparable by-product 
as a pale yellow oil (0.036 g); 1H NMR (270 MHz; CDCl3): 0.79-0.84 (m, 11H, 3  
CH3 + by-product ), 1.24-1.31 (m, 8H, CH2CH2Ge + by-product ), 1.78 (m, 2H, 
C10F21CH2CH2Ge), 2.74 (s, 4H, 2  GeCH2NP), 7.11 (dd, J = 8.4, 1.8 Hz, 2H, ArH), 
7.31-7.41 (m,10H, ArH), 7.64 (d, J = 7.6 Hz, 2H, ArH), 7.70 (d, J = 8.4Hz, 2H, ArH), 
7.68 (d, J = 8.4 Hz, 2H, ArH), 7.76 (d, J = 7.2 Hz, 2H, ArH). 
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2-Bromo-trifluoroacetanilide 60155 
 
To a solution of 2-bromoaniline (0.50 g, 2.91 mmol) in CH2Cl2 (10.0 mL), DMAP 
(0.035 g, 0.291 mmol) and Et3N (1.38 g, 13.7 mmol, 1.9 mL) was added 
trifluoroacetic anhydride (1.35 g, 6.44 mmol, 0.91 mL) at 0 oC.  The resulting 
reaction mixture was stirred at 0 oC for 3 h. The reaction mixture was quenching 
dropwise with water until effervescence ceased.  The reaction mixture was diluted 
with Et2O (20.0 mL) and washed with water (2 × 20.0 mL). The combined organic 
extracts were dried over MgSO4 and the solvent was removed in vacuo followed by 
purification by FC (hexane/EtOAc 80/20) and drying under high vacuum gave 
2-bromo-trifluoroacetanilide 60 as white needles (0.73 g, 95 %). mp 60-61 C;  1H 
NMR (270 MHz; CDCl3):  7.11 (td, J = 7.7, 1.4 Hz, 1H, ArH), 7.38 (td, J = 8.2, 1.4 
Hz, 1H, ArH), 7.60 (td, J = 8.2, 1.4 Hz, 1H, ArH), 8.30 (dd, J = 8.2, 1.4 Hz, 1H, 
ArH), 8.45 (brs, 1H, NH). 
 
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-Heneicosafluorododecyl)-(2-N-trif
luorotrifluoroacetanilidyl)bis(naphthalen-2-ylmethyl)germane 62 
 
To a solution of 2-bromotrifluoroacetanilide 60 (0.029 g, 0.109 mmol) in THF (10.0 
mL) at -78 oC was added a solution of MeLi (71 L, 0.114 mmol, 1.6 M in diethyl 
ether) for 30 min to deprotonation of amide. A solution of a solution of tBuLi (338 
L, 0.491 mmol, 1.45M in pentane) was added dropwise resulting in a yellow 
solution. The solution was stirred at -78 oC for 30 min before addition of 
bromogermane 61 (0.051 g, 0.054 mmol) at -78 oC and stirred for 1 h than warmed 
up to RT for 16 h. The reaction mixture was diluted with Et2O (20.0 mL) and a 
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solution of 1.0 M NH4Cl was added to the reaction mixture until no effervescence 
occurred. Following extraction with (2 × 20.0 mL) of Et2O, the combined organic 
extracts were dried over MgSO4 and evaporated in vacuo to give a yellow oily 
residue which was purified by FC (hexane/EtOAc, 90/10) to give 
2-(N-trifluorotrifluoroacetanilidyl)germane 62 contaminated with an inseparable 
by-product as a pale yellow oil (0.036 g); 1H NMR (270 MHz; CDCl3): 0.82-0.85 
(m, 4H, by-product ), 1.15-1.29 (m, 12H, CH2CH2Ge + by-product ), 1.78 (m, 2H, 
C10F21CH2CH2Ge), 2.76 (s, 4H, 2  GeCH2NP), 7.06 (dd, J = 8.9, 1.0 Hz, 2H, ArH), 
7.35-7.49 (m,10H, ArH), 7.61 (d, J = 6.7 Hz, 2H, ArH), 7.70 (d, J = 8.4Hz, 2H, ArH), 
7.71 (d, J = 8.5 Hz, 2H, ArH), 7.77 (d, J = 7.4 Hz, 2H, ArH). 
 
3-Iodo-trifluoroacetanilide 65242 
HN
O
CF3
I
Chemical Formula: C8H5F3INO
Exact Mass: 314.9368
Molecular Weight: 315.0311
65  
To a solution of 3-iodoaniline (0.42 g, 1.92 mmol) in CH2Cl2 (10.0 mL)and Et3N 
(0.47 g, 4.69 mmol, 0.65 mL) was added trifluoroacetic anhydride (0.803 g, 3.82 
mmol, 0.54 mL) at 0 oC. The resulting reaction mixture was stirred at 0 oC for 3 h. 
The reaction mixture was quenching dropwise with water and diluted with Et2O (20.0 
mL) and washed with water (2 × 20.0 mL). The combined organic extracts were 
dried over MgSO4 and the solvent was removed in vacuo followed by purification by 
FC (hexane/EtOAc 80/20) and drying under high vacuum gave 
3-iodo-trifluoroacetanilide 65 as white plates (0.602 g, 98 %). mp 74-75 C; 1H 
NMR (270 MHz; CDCl3):  7.11 (d, J = 8.1 Hz, 1H, ArH), 7.55 (t, J = 7.8 Hz, 2H, 
ArH), 7.85 (brs, 1H, NH), 7.95 (s, 1H, ArH). 
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3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-Heneicosafluorododecyl) 
-(3-N-trifluorotrifluoroacetanilidyl)bis(naphthalen-2-ylmethyl)germane 66 
 
To a solution of 3-iodotrifluoroacetanilide 65 (0.055 g, 0.175 mmol) in THF (10.0 
mL) at 0 oC was added NaH (0.007 g, 0.175 mmol, 60 % in mineral oil). After 
stirring at 0 oC for 30 min, the solution was cooled to -78 oC and a solution of tBuLi 
(315 L, 0.437 mmol, 1.4M in pentane) was added dropwise resulting in a yellow 
solution. The solution was stirred at -78 oC for 30 min before addition of 
bromogermane 61 (0.050 g, 0.054 mmol) at -78 oC, stirring for 1 h and then warming 
to RT for 16 h. The reaction mixture was diluted with Et2O (20.0 mL) and a solution 
of 1.0 M NH4Cl was added to the reaction mixture until no effervescence occurred. 
Following extraction with (2 × 20.0 mL) of Et2O, the combined organic extracts were 
dried over MgSO4 and evaporated in vacuo to give yellow oily residue which was 
purified by FC (hexane/EtOAc, 90/10) to give 
3-(N-trifluorotrifluoroacetanilidyl)germane 66 as a pale yellow oil (0.0254 g, 46 %); 
1H NMR (270 MHz; CDCl3): 0.82-0.85 (m, 4H, by-product ), 1.15-1.29 (m, 12H, 
CH2CH2Ge + by-product ), 1.78 (m, 2H, C10F21CH2CH2Ge), 2.76 (s, 4H, 2  
GeCH2NP), 7.11 (d, J = 8.1 Hz, 1H, ArH), 7.32-7.52 (m,10H, ArH), 7.60 (d, J = 6.7 
Hz, 2H, ArH), 7.72 (d, J = 8.4Hz, 2H, ArH), 7.74 (d, J = 8.5 Hz, 2H, ArH), 7.77 (d, J 
= 7.4 Hz, 1H, ArH). 
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3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-Heneicosafluorododecyl)- 
(3-aminophenyl)bis(naphthalen-2-ylmethyl)germane 67 
 
To a solution of 3-(N-trifluorotrifluoroacetanilidyl)germane 66 (0.025 g, 0.023 mmol) 
and TBAI (0.001 g, 0.003 mmol) in THF (5.0 mL) was added NaOH(aq) ( 40 %, 5.0 
mL). The solution was heated to 60 oC for 48 h. The reaction mixture was diluted 
with Et2O (20.0 mL) and a solution of 1.0 M NH4Cl was added to the reaction 
mixture. Following extraction with Et2O (2 × 20.0 mL), the combined organic 
extracts were dried over MgSO4 and evaporated in vacuo to give yellow oily residue 
which was purified by FC (hexane/EtOAc, 85/15) to give (3-aminophenyl)germane 
67 as a pale yellow oil ( 0.0123 g, 54 %); 1H NMR (270 MHz; CDCl3): 1.16 (m, 
2H, CH2CH2Ge), 1.78 (m, 2H, C10F21CH2CH2Ge), 2.74 (s, 4H, 2  GeCH2NP), 3.82 
(brs, 2H, NH2), 7.08 (d, J = 8.1 Hz, 1H, ArH), 7.29-7.45 (m,10H, ArH), 7.56 (d, J = 
6.7 Hz, 2H, ArH), 7.70 (d, J = 8.4Hz, 2H, ArH), 7.72 (d, J = 8.5 Hz, 2H, ArH), 7.74 
(d, J = 7.4 Hz, 1H, ArH). 
 
3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-Heneicosafluorododecyl)- 
(3-N-pivalyimineyl)bis(naphthalen-2-ylmethyl)germane 70 
C10F21 Ge
N70
 
To a solution of (3-anilinyl)germane 67 (0.0123 g, 0.124 mmol) and 4-TsOH (0.001 
g, 0.006 mmol) in CH2Cl2 (5.0 mL) in the presence of 3 Å MS (10 mg) was added 
pivalaldehyde (0.011 g, 0.129 mmol, 14 L). The solution was stirred at rt for 48 h. 
The reaction was monitored by TLC. After the starting material had been consumed, 
the mixture was diluted with Et2O (20.0 mL) and a solution of 1.0 M NH4Cl was 
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added to the reaction mixture. Following extraction with Et2O (2 × 20.0 mL), the 
combined organic extracts were dried over MgSO4 and evaporated in vacuo to give a 
pale yellow oil which was subjected into photolysis/cross-coupling reaction without 
further purification. 
 
N-(4’-Chlorobiphenyl-2-yl)-2,2,2-trifluoroacetamide 64 and 
4,4’-Dichloro-1,1’biphenyl 72243 
64
Cl
HN
F3C
O
Chemical Formula: C14H9ClF3NO
Exact Mass: 299.0325
Molecular Weight: 299.6756
Cl Cl
Chemical Formula: C12H8Cl2
Exact Mass: 222.0003
Molecular Weight: 223.0979
72
 
Using method C, the crude difluoroarylgermane from the photolysis of arylgermane 
6d (35.7 mg, 0.053 mmol) for 1 h with 4 equivalents of Cu(BF4)2·nH2O, TBAF (50.4 
mg, 0.16 mmol), PdCl2(MeCN)2 (1.4 mg, 0.005 mmol), P(2-Tol)3 (2.5 mg, 0.081 
mmol), 2-bromo-trifluoroacetanilide 60 (28.6 mg, 0.1.7 mmol) and CuI (10.2 mg, 
0.051 mmol) were employed. Purification by FC (hexane/EtOAc, 97/3) gave: 
N-(4’-Chlorobiphenyl-2-yl)-2,2,2-trifluoroacetamide 64 as a pale yellow oil (5.6 mg, 
35 %); 1H NMR (400 MHz; CDCl3): 6.77 (dd, J = 7.9, 1.0 Hz, 1H, ArH), 6.83 (td, 
J = 7.6, 1.0 Hz, 1H, ArH), 7.09 (dd, J = 7.6, 1.5 Hz, 1H, ArH), 7.17 (td, J = 7.6, 1.5 
Hz, 1H, ArH), 7.38-7.46 (m, 3H, ArH), 7.48 (brs, 1H, NH), 8.27 (d, J = 8.2 Hz, 1H, 
ArH); 13C NMR (100.7 MHz; CDCl3) 115.7 (d), 118.7 (d), 119.2 (s), 126.3 (s), 
128.8 (d), 129.0 (2d), 130.3 (d), 130.5 (2d), 133.1 (s), 137.9 (s), 143.4 (s), 160.2 (s); 
IR υmax (neat) 3345 (N-H), 3084 (C-H), 2935 (C-H), 1745 (C=O), 1585 (C=C), 1068, 
810 cm-1;; m/z (EI+) (rel. intensity) 301 [(M37Cl)+, 25], 299 [(M35Cl)+, 76], 230 (20), 
167 (55), 149 (50), 55 (100); HRMS calc’d. For C14H9ClF3NO 299.0325, found 
299.0322 (-1.0 ppm). 
4,4’-dichloro-1,1’-biphenyl 72 as a colourless oil (6.3 mg, 53 %); 1H NMR (400 
MHz; CDCl3): 7.45 (d, J = 8.2 Hz, 4H), 7.37 (d, J = 8.2 Hz, 4H); HRMS calc’d. 
For C12H8Cl2 222.0003, found 221.9998 (-2.1 ppm). 
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4-Chloro-2’-nitrobiphenyl 73 
 
Using method C, the crude difluoroarylgermane (37.7 mg, 0.056 mmol) from the 
photolysis of arylgermane 6d, TBAF (53.3 mg, 0.169 mmol), PdCl2(MeCN)2 (1.5 mg, 
0.006 mmol), P(2-Tol)3 (2.6 mg, 0.0087 mmol), 2-bromo-nitrobenzene (22.8 mg, 
0.113 mmol) and CuI (11.2 mg, 0.056 mmol) were employed. Purification by FC 
(hexane/EtOAc, 94/6) gave 4-chloro-2’-nitrobiphenyl 73 as a colourless oil (8.1 mg, 
61 %). 1H NMR (400 MHz; CDCl3): 7.27 (d, J = 7.0 Hz, 2H, ArH), 7.40-7.44 (m, 
3H, ArH), 7.53 (td, J = 7.8, 1.3 Hz, 1H, ArH), 7.65 (td, J = 7.6, 1.2 Hz, 1H, ArH), 
7.90 (dd, J = 8.2, 1.0 Hz, 1H, ArH); 13C NMR (100.7 MHz; CDCl3) 
124.3dd), 128.9 (2d), 129.3 (2d), 131.8 (d), 132.5 (d), 134.5 (s), 135.2 
(s), 135.9 (s), 149.0 (s); IR υmax (neat) 3054, 2986, 1588, 1535, 1472, 1265, 1009, 
818, 738 cm-1; m/z (EI+) (rel. intensity) 235 [(M37Cl)+, 15], 233 [(M35Cl)+, 45], 199 
(70), 156 (80), 141 (100); HRMS calc’d. for C12H8ClNO2 233.0244, found 233.0241 
(-1.1 ppm). 
 
4-Chloro-2’-ylaminebiphenyl 44244 
 
To a solution of 4-chloro-2’-nitrobiphenyl 73 (15 mg, 0.064 mmol) in THF-EtOH 
(1:1, 10 mL) was added tin(II) chloride (122 mg, 0.64 mmol) and conc. HC (1 mL), 
the reaction mixture was stirred for 16 h. A sat. solution of K2CO3 was added to the 
reaction mixture and the reaction mixture was partitioned between Et2O (40.0 mL) 
and water (10.0 mL), extracted with CH2Cl2 (2 × 10.0 mL) and dried over MgSO4.  
Purification by FC (hexane/EtOAc, 90/10) gave 4-chloro-2’-ylaminebiphenyl 44 as a 
colourless oil (10.3 mg, 88 %). 1H NMR (400 MHz; CDCl3): 3.73 (brs, 2H, NH2), 
6.77 (dd, J = 7.9, 1.0 Hz, 1H, ArH), 6.83 (td, J = 7.6, 1.0 Hz, 1H, ArH), 7.09 (dd, J = 
7.6, 1.5 Hz, 1H, ArH), 7.17 (td, J = 7.6, 1.5 Hz, 1H, ArH), 7.38-7.46 (m, 4H, ArH); 
13C NMR (100.7 MHz; CDCl3) 115.7 (d), 118.7 (d), 126.3 (s), 128.8 (d), 129.0 
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(2d), 130.3 (d), 130.5 (2d), 133.1 (s), 137.9 (s), 143.4 (s); IR υmax (neat) 3475, 3383, 
3083, 1886, 1616, 1472, 1087, 1008, 810, 744 cm-1; m/z (EI+) (rel. intensity) 205 
[(M37Cl)+, 9], 203 [(M35Cl)+, 25], 167 (25), 49 (30), 84 (90), 49 (100); HRMS calc’d. 
for C12H10ClN 203.0502, found 203.0501 (-0.4 ppm). 
 
Boscalid (43)162  
 
To a solution of 4-chloro-2’-ylaminebiphenyl 44 (20.0 mg, 0.098 mmol) in CH2Cl2 
(10 mL) was added  2-chloro-3-nicotinic acid (17.3 mg, 0.098 mmol), DMAP (0.5 
mg, 0.004 mmol) and DCC (22.3 mg, 0.108 mmol), the reaction mixture was stirred 
for 16 h. A sat. solution of K2CO3 was added to the reaction mixture and the reaction 
mixture was partitioned between Et2O (40.0 mL) and water (10.0 mL), extracted with 
CH2Cl2 (2 × 10.0 mL) and dried over MgSO4. Purification by FC (hexane/EtOAc, 
75/25) gave boscalid 43 as a colourless oil (22.1 mg, 65 %). 1H NMR (400 MHz; 
CDCl3): 7.27 (d, J = 4.8 Hz, 2H, ArH), 7.31-7.36 (m, 3H, ArH), 7.41-7.47 (m, 3H, 
ArH), 8.13 (dd, J = 7.7, 1.2 Hz, 1H, ArH), 8.16 (brs, 1H, NH), 8.41 (d, J = 8.2 Hz, 
1H, ArH), 8.44 (dd, J = 4.6, 1.7 Hz, 1H, ArH); 13C NMR (100.7 MHz; CDCl3) 
122.1 (d), 122.9 (d), 125.3 (d), 128.9 (d), 129.3 (2d), 130.2 (d), 130.8 (2d), 131.0 
(s), 132.2 (s), 134.3 (s), 134.4 (s), 136.2 (s), 140.1 (d), 146.6 (s), 151.3 (d), 162.5 (s); 
IR υmax (neat) 3338 (N-H), 3084 (C-H), 2935 (C-H), 1887 (comb), 1656 (C=O), 1580 
(C=C), 1472, 810 cm-1; m/z (EI+) (rel. intensity) 347 [(M37,37Cl) + H+, 10], 345 
[(M37,35Cl) + H+, 35], 343 [(M35,35Cl) + H+, 40], 309 (15), 225 (100); HRMS (CI+) 
calc’d. for C18H13Cl2N2O [M+H]+ 343.0405, found 343.0409 (1.1 ppm). 
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(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorodecyl)bis(naphthalen- 
2-ylmethyl)(4- iodophenyl)germane 78 
 
To a solution of 1,4-diiodobenzene (0.1258 g, 0.382 mmol) in THF (10.0 mL) at -78 
oC was added a solution of tBuLi (0.546mL, 0.764 mmol, 1.4M in pentane) dropwise 
resulting in a dark red solution. The solution was stirred at -78 oC for 30 min before 
addition of bromogermane 40 (0.281 g, 0.319 mmol) at -78 oC, stirring for 1 h and 
then warming to RT for 16 h. The reaction mixture was diluted with Et2O (20.0 mL) 
and a solution of 1.0 M NH4Cl was added to the reaction mixture until no 
effervescence occurred. Following extraction with (2 × 20.0 mL) of Et2O, the 
combined organic extracts were dried over MgSO4 and evaporated in vacuo to give 
yellow oily residue which was purified by FC (hexane/EtOAc, 97/3) to give pure 
l-(4-iodophenyl)germane 78 as a pale yellow oil (0.4706 g, 87 %). 1H NMR (400 
MHz; CDCl3): 1.20 (m, 2H, CH2CH2Ge), 1.87 (m, 2H, CH2CH2Ge), 2.77 (s, 4H, 2 
 GeCH2NP), 7.07 (dd, J = 6.7, 1.7 Hz, 2H, ArH), 7.25 (d, J = 8.2 Hz, 2H, ArH), 
7.35 (d, J = 7.7 Hz, 2H, ArH), 7.41-7.47 (m, 6H, ArH), 7.65 (d, J = 7.7 Hz, 2H, 
ArH), 7.70 (d, J = 8.2 Hz, 2H, ArH), 7.79 (d, J = 7.7 Hz, 2H, ArH); 13C NMR (100.7 
MHz; CDCl3) 1.8 (t), 22.4 (2t), 26.2 (t, JCF = 23.0 Hz), 96.2 (s), 108.3 (s), 110.2 
(s), 110.7 (3s), 110.97 (s), 111.01 (s), 117.9 (s), 125.0 (2d), 125.7 (2d), 126.2 (2d), 
127.0 (2d), 127.2 (2d), 127.6 (2d), 128.2 (2d), 128.6 (2d), 131.3 (2s), 133.7 (2s), 
135.1 (2d), 135.7 (s), 136.1 (2s); 19F NMR (376 MHz; CDCl3): -126.1 (s, 2F), 
-123.6 (s, 2F), -122.7 (s, 2F), -121.9 (m, 6F), -116.3 [quintet, J = 14.5 Hz, 2F, 
(CF2)6CF2CF3], -80.7 [t, J = 10 Hz, 3F, (CF2)6CF2CF3]; IR υmax (neat) 3035 (C-H), 
2988 (C-H) 1549 (C=C), 1421 (C-F), 1265, 1050 (C-I), 896, 740 cm-1; m/z (FAB+) 
(rel. intensity) 864 [(M-NpCH2)+, 2], 803 (1), 709 (5), 141 (100); HRMS (FAB+) 
calc’d. for C27H17F1774GeI [(M-NapCH2)+] 864.9310, found 864.9307 ( -0.3 ppm). 
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(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorodecyl)bis(naphthalen-2-ylme
thyl){4-[(3-methyl-3-hydroxybutynyl)phenyl]}germane 79 
 
According to the method of Menchi’s conditions,163 Pd(OAc)2 (1.5 mg, 0.007 mmol) 
and PPh3 (5.5 mg, 0.128 mmol) were dissolved in DMF (1.0 ML) for 30 min to give 
a solution of the active Pd(0) catalyst. The catalyst solution was added to the 
(4-iodophenyl)germane 78 (128.5 mg, 0.128 mmol) solution followed by adding 
2-methylbut-3-yn-2-ol (21.5 mg, 0.256 mmol, 25 L), CuI (2.8 mg, 0.014 mmol) and 
nBuNH2 (5 mL). The solution mixture was warmed to 55 oC for 16 h under nitrogen 
atmosphere. The resulting solution was diluted with Et2O (20.0 mL) and washed with 
water (3 × 10.0 mL), the combined organic extracts were dried over MgSO4 and 
evaporated in vacuo. Purification by FC (hexane/EtOAc, 85/15) gave germane 79 as 
a pale yellow oil ( 83.6 mg , 68 %). 1H NMR (400 MHz; CDCl3): 1.15 (m, 2H, 
CH2CH2Ge), 1.65 (s, 6H, CC(CH3)2OH), 1.81 (m, 2H, CH2CH2Ge), 2.07 (brs, 1H, 
OH), 2.72 (s, 4H, 2  GeCH2NP), 7.04 (dd, J = 8.4, 1.7 Hz, 2H, ArH), 7.27 (d, J = 
7.8 Hz, 2H, ArH), 7.34 (s, 2H, ArH), 7.36-7.46 (m, 6H, ArH), 7.62 (d, J = 7.8 Hz, 
2H, ArH), 7.67 (d, J = 8.4 Hz, 2H, ArH), 7.77 (d, J = 7.8 Hz, 2H, ArH); 13C NMR 
(100.7 MHz; CDCl3) t), 22.4 (2t), 26.2 (t, JCF = 23.2 Hz), 31.5 (2q), 65.7 (s), 
81.9 (s), 94.8 (s), 110.2 (s), 110.6 (2s), 110.7 (s), 110.9 (2s), 111.0 (s), 117.9 (s), 
123.6 (s), 124.9 (2d), 125.7 (2d), 126.1 (2d), 127.0 (2d), 127.3 (2d), 127.6 (2d), 
128.1 (2d), 131.3 (2d+2s), 133.7 (2d+2s), 136.2 (2s), 137.1 (s); 19F NMR (376 MHz; 
CDCl3): -125.2 (s, 2F), -122.6 (s, 2F), -121.8 (s, 2F), -121.0 (m, 6F), -115.4 
[quintet, J = 14.3 Hz, 2F, (CF2)6CF2CF3], -79.8 [t, J = 9.8 Hz, 3F, (CF2)6CF2CF3]; IR 
υmax (neat) 3320 (OH, br), 3054 (C-H), 2985 (C-H), 2354 (CC), 1595 (C=C), 1421 
(C-F), 895, 740 cm-1; m/z (FAB+) (rel. intensity) 821 [(M-NpCH2)+, 55], 551 (50), 
279 (45), 141 (100); HRMS (FAB+) calc’d. for C32H24F1774GeO [(M-NapCH2)+] 
821.0767, found 821.0762 ( -0.6 ppm). 
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(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorodecyl)bis(naphthalen- 
2-ylmethyl) (4-trimethylsilylethynylphenyl)germane 80 
C8F17
Ge
TMS
Chemical Formula: C43H35F17GeSi
Exact Mass: 976.1448
Molecular Weight: 975.4364
80  
Using Menchi’s conditions,163 Pd(OAc)2 (1.0 mg, 0.0045 mmol) and PPh3 (3.7 mg, 
0.014 mmol) were dissolved in DMF (1.0 ML) for 30 min to give a solution of the 
active Pd(0) catalyst. The catalyst solution was then added to a solution of 
(4-iodophenyl)germane 78 (25.0 mg, 0.025 mmol) in DMF (2 mL) followed by 
adding trimethylsilylacetylene (4.9 mg, 0.05 mmol, 7 L), CuI (2 mg, 0.01 mmol) 
and nBuNH2 (5 mL). The reaction mixture was then warmed to 55 oC for 16 h. The 
resulting solution was diluted with Et2O (20.0 mL) and washed with water (3 × 10.0 
mL), the combined organic extracts were dried over MgSO4 and evaporated in vacuo. 
Purification by FC (hexane/EtOAc, 95/5) gave 4-trimethylsilylethynylphenylgermane 
80 as a pale yellow oil (12.6 mg, 52 %). 1H NMR (400 MHz; C6D6): s, 9H, 
Si(CH3)3), 1.02 (m, 2H, CH2CH2Ge), 1.71 (m, 2H, CH2CH2Ge), 2.36 (s, 4H, 2  
GeCH2NP), 6.86 (dd, J = 8.4, 1.8 Hz, 2H, ArH), 6.93 (d, J = 8.1 Hz, 2H, ArH), 
7.18-7.20 (m, 3H, ArH), 7.21 (dd, J = 6.8, 1.4 Hz, 1H, ArH), 7.25 (dd, J = 6.8, 1.4 
Hz, 1H, ArH), 7.27 (dd, J = 6.8, 1.4 Hz, 1H, ArH), 7.46 (d, J = 5.5 Hz, 2H, ArH), 
7.53 (d, J = 8.1 Hz, 2H, ArH), 7.59 (d, J = 8.1 Hz, 2H, ArH); 13C NMR (100.7 MHz; 
C6D6) s2.1 (t), 22.5 (2t), 26.6 (t, JCF = 23.0 Hz), 95.8 (s), 105.6 (s), 105.8 
(s), 110.7 (s), 111.2 (s), 111.3 (s), 111.6 (3s), 118.6 (s), 124.7 (s), 125.3 (2d), 126.1 
(2d), 126.5 (2d), 127.3 (2d), 127.5 (2d), 128.0 (2d), 128.4 (2d), 131.9 (2d), 132.0 (2s), 
134.2 (2d), 134.4 (2s), 136.6 (2s), 138.0 (s); 19F NMR (376 MHz; C6D6): -125.1 (s, 
2F), -122.3 (s, 2F), -121.7 (s, 2F), -120.8 (m, 4F), -120.3 (s, 2F), -114.9 [quintet, J = 
15.0 Hz, 2F, (CF2)6CF2CF3], -79.9 [t, J = 9.8 Hz, 3F, (CF2)6CF2CF3]; IR υmax (neat) 
3052 (C-H), 2982 (C-H), 2360 (CC), 1592 (C=C), 1421 (C-F), 1260 (C-Si), 897, 740 
cm-1; m/z (FAB+) (rel. intensity) 835 [(M-NpCH2)+, 60], 709 (55), 313 (80), 141 
(100); HRMS (FAB+) calc’d. for C32H26F1774GeSi [(M-NapCH2)+] 835.0739, found 
835.0734 ( -0.6 ppm). 
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(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorodecyl)bis(naphthalen-2-ylme
thyl)(4-phenylethynyl)germane 81 
 
Method D: Powdered KOH (50 mg, 0.893 mmol) and 
4-((3-methyl-3-hydroxybutynyl)phenyl)germane 79 (80.0 mg, 0.083 mmol) was 
dissolved in THF (10 mL). The reaction mixture was heated at 80oC for 1 h. The 
resulting solution was diluted with Et2O (20.0 mL) and washed with water (3 × 10.0 
mL), the combined organic extracts were dried over MgSO4 and evaporated in vacuo. 
Purification by FC (hexane/EtOAc, 90/10) gave 4-phenylethynylgermane 81 (73.8 
mg, 98 %) as pale yellow oil. 1H NMR (400 MHz; CDCl3): 1.14 (m, 2H, 
CH2CH2Ge), 1.81 (m, 2H, CH2CH2Ge), 2.72 (s, 4H, 2  GeCH2NP), 3.15 (s, 1H, 
C6H4CCH), 7.04 (dd, J = 8.4, 0.8 Hz, 2H, ArH), 7.29 (d, J = 8.2 Hz, 2H, ArH), 7.34 
(s, 2H, ArH), 7.37-7.48 (m, 6H, ArH), 7.61 (d, J = 8.0 Hz, 2H, ArH), 7.68 (d, J = 8.4 
Hz, 2H, ArH), 7.77 (d, J = 7.6 Hz, 2H, ArH); 13C NMR (100.7 MHz; CDCl3) 2.1 
(t), 22.5 (2t), 26.6 (t, JCF = 23.4 Hz), 78.2 (s), 83.4 (s), 108.3 (s), 110.2 (s), 110.6 (s), 
110.9 (3s), 111.0 (s), 117.9 (s), 124.7 (s), 125.3 (2d), 126.1 (2d), 126.5 (2d), 127.4 
(2d), 127.4 (2d), 128.0 (2d), 128.3 (2d), 131.8 (2d), 132.0 (2s), 134.3 (2d), 134.3 (2s), 
136.5 (2s), 137.8 (s); 19F NMR (376 MHz; CDCl3): -125.1 (s, 2F), -122.5 (s, 2F), 
-121.8 (s, 2F), -121.0 (m, 6F), -115.3 [quintet, J = 14.8 Hz, 2F, (CF2)6CF2CF3], -79.8 
[t, J = 9.9 Hz, 3F, (CF2)6CF2CF3]; IR υmax (neat) 3253 (CC-H), 3048 (C-H), 2984 
(C-H), 2360 (CC), 1592 (C=C), 1420 (C-F), 910, 740 cm-1; m/z (FAB+) (rel. intensity) 
763 [(M-NpCH2)+, 40], 549 (15), 279 (45), 141 (100); HRMS (FAB+) calc’d. for 
C29H18F1774Ge [M-(NapCH2)+] 763.0343, found 763.0350 ( 0.9 ppm). 
Method E: To a solution of the (4-trimethylsilylethynylphenyl)germane 80 (115.6 
mg, 0.118 mmol) in MeOH-THF (1:1, 10 mL), K2CO3-KF mixture (1:1, 100 mg) 
was added and then warmed to 80oC for 8 h. The resulting solution was diluted with 
Et2O (20.0 mL) and washed with water (3 × 10.0 mL), the combined organic extracts 
were dried over MgSO4 and evaporated in vacuo. Purification by FC (hexane/EtOAc, 
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95/5) gave 4-phenylethynylgermane 81 as pale yellow oil (69.7 mg, 67 %). 
Analytical data as above. 
 
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorodecyl)bis(naphthalen-2-ylme
thyl){4-[(3-methyl-3-methoxybutynyl)phenyl]}germane 84 
 
According to Corey’s method,164 to a solution of germane 79 (32 mg, 0.0333 mmol) 
in THF. NaH (4 mg, 0.1 mmol, 60 % in mineral oil). After stirring at RT for 1 h, 
dimethylsulfate (12.7 mg, 0.1mmol, 9.5 L) was added and the reaction mixture was 
stirred at RT 16 h. The resulting solution was diluted with Et2O (20.0 mL) and 
washed with water (3 × 10.0 mL). The combined organic extracts were dried over 
MgSO4 and evaporated in vacuo. Purification by FC (hexane/EtOAc, 95/5) gave 
germane 84 as pale yellow oil (28.3 mg, 87 %). 1H NMR (400 MHz; CDCl3): 1.16 
(m, 2H, CH2CH2Ge), 1.59 (s, 6H, CC(CH3)2OCH3), 1.83 (m, 2H, CH2CH2Ge), 2.73 
(s, 4H, 2  GeCH2NP), 3.47 (s, 3H, CC(CH3)2OCH3), 7.04 (dd, J = 8.4, 1.8 Hz, 2H, 
ArH), 7.25-7.29 (m, 2H, ArH), 7.34-7.50 (m, 8H, ArH), 7.63 (d, J = 7.7 Hz, 2H, 
ArH), 7.68 (d, J = 8.4 Hz, 2H, ArH), 7.78 (d, J = 7.7 Hz, 2H, ArH); 13C NMR (100.7 
MHz; CDCl3)  1.8 (t), 22.4 (2t), 26.2 (t, JCF = 23.0 Hz), 29.7 (2q), 51.7 (q), 70.9 (s), 
83.9 (s), 92.1 (s), 108.2 (s), 110.2 (s), 110.6 (2s), 110.94 (2s), 110.98 (s), 117.9 (s), 
123.7 (s), 124.9 (2d), 125.7 (2d), 125.8 (s), 126.1 (2d), 127.0 (2d), 127.3 (2d), 127.6 
(2d), 128.1 (2d), 131.27 (2s), 131.35 (2d), 133.7 (2d+s), 136.2 (2s), 137.0 (s); 19F 
NMR (376 MHz; C6D6):  -125.1 (s, 2F), -122.6 (s, 2F), -121.8 (s, 2F), -121.0 (m, 
6F), -115.4 [quintet, J = 14.6 Hz, 2F, (CF2)6CF2CF3], -79.8 [t, J = 9.9 Hz, 3F, 
(CF2)6CF2CF3]; IR υmax (neat) 3054 (C-H), 2985 (C-H), 2360 (CC), 1605 (C=C), 
1420 (C-F), 912, 740 cm-1; m/z (FAB+) (rel. intensity) 835 [(M-NpCH2)+, 60], 551 
(60), 537 (50), 279 (60), 141 (100); HRMS (FAB+) calc’d. for C33H26F17O74Ge 
[M-(NapCH2)+] 835.0918, found 835.0913 ( -0.7 ppm). 
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(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorodecyl)bis(naphthalen-2-ylme
thyl)(4-propynylphenyl)germane 87 
 
(4-Phenylethynyl)germane 81 (73.8 mg, 0.082 mmol) and DMPU (10.6 mg, 0.083 
mmol, 10 L) were dissolved in THF (10 mL) and the solution was cooled to -40 oC. 
A solution of nBuLi (50 L, 0.09 mmol, 1.8 M in hexane ) was added dropwise to the 
solution and stirred for 1 h at this temperature to give a brown solution. 
Methyltriflate (20.3 mg, 0.124 mmol, 14 L) was added to the brown solution and 
stirred for 16 h to give (4-propynylphenyl)germane 87 as pale yellow oil (65.4 mg, 
87% ). 1H NMR (400 MHz; CDCl3): 1.21 (m, 2H, CH2CH2Ge), 1.80 (m, 2H, 
CH2CH2Ge), 2.08 (s, 3H, CCCH3), 2.71 (s, 4H, 2  GeCH2NP), 7.03 (dd, J = 8.4, 1.6 
Hz, 2H, ArH), 7.23 (d, J = 8.2 Hz, 2H, ArH), 7.33 (s, 2H, ArH), 7.35-7.42 (m, 6H, 
ArH), 7.60 (d, J = 7.8 Hz, 2H, ArH), 7.66 (d, J = 8.4 Hz, 2H, ArH), 7.76 (d, J = 7.8 
Hz, 2H, ArH); 13C NMR (100.7 MHz; CDCl3): 2.1 (t), 3.2 (q), 22.5 (2t), 26.3 (t, 
JCF = 23.2 Hz), 78.3 (s), 83.5 (s), 108.1 (s), 110.2 (s), 110.6 (s), 110.8 (3s), 111.0 (s), 
117.9 (s), 124.7 (s), 125.3 (2d), 126.1 (2d), 126.5 (2d), 127.4 (2d), 127.4 (2d), 128.2 
(2d), 128.3 (2d), 131.8 (2d), 132.0 (2s), 134.6 (2d), 134.8 (2s), 136.9 (2s), 137.7 (s); 
19F NMR (376 MHz; CDCl3): -126.1 (s, 2F), -123.5 (s, 2F), -122.7 (s, 2F), -121.9 
(m, 6F), -116.3 [quintet, J = 15.2 Hz, 2F, (CF2)6CF2CF3], -80.7 [t, J = 9.7 Hz, 3F, 
(CF2)6CF2CF3]; IR υmax (neat) 3046 (C-H), 2975 (C-H), 2355 (CC), 1594 (C=C), 
1419 (C-F), 913, 740 cm-1; m/z (FAB+) (rel. intensity) 777 [(M-NpCH2)+, 30], 549 
(15), 279 (55), 141 (100); HRMS (FAB+) calc’d. for C30H20F1774Ge [M-(NapCH2)+] 
777.0500, found 777.0498 ( -0.2 ppm). 
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4-(3-Methyl-3-methoxybutlynyl)-2’-nitrobiphenyl 85 
 
Using method C, the crude difluoroarylgermane from the photolysis of arylgermane 
84 (48.9 mg, 0.067 mmol), TBAF (63.0 mg, 0.2 mmol), PdCl2(MeCN)2 (2 mg, 
0.0077 mmol), P(2-Tol)3 (3.5 mg, 0.012 mmol), 2-bromo-nitrobenzene (27 mg, 0.134 
mmol) and CuI (13.3 mg, 0.067 mmol) were employed. Purification by FC 
(hexane/EtOAc, 90/10) gave 4-(3,3-dimethyl-3-methoxypropynyl)-2’-nitrobiphenyl 
85 as a yellow oil (9.9 mg, 50 %). 1H NMR (400 MHz; CDCl3): 1.56 (s, 6H, 2  
CH3), 3.44 (s, 3H, OCH3), 7.27 (d, J = 6.8 Hz, 2H, ArH), 7.42 (dd, J = 7.7, 1.3 Hz, 
1H, ArH), 7.48-7.50 (m, 3H, ArH), 7.63 (td, J = 7.5, 1.1 Hz, 1H, ArH), 7.88 (dd, J = 
8.1, 1.0 Hz, 1H, ArH); 13C NMR (100.7 MHz; CDCl3) 28.3 (2q), 51.8 (q), 70.9 (s), 
83.7 (s), 92.2 (s), 122.9 (s), 124.2 (d), 127.8 (2d), 128.4 (d), 131.8 (d), 131.9 (2d), 
132.0 (s), 132.4 (d), 135.7 (s), 137.2 (s); IR υmax (neat) 3055 (C-H), 2987 (C-H), 
2360 (CC), 1588 (C=C), 1537 (N=O), 1265 (N=O), 896, 738, 704 cm-1; m/z (EI+) (rel. 
intensity) 295 (M+, 20), 289 (50), 280 (100), 264 (30), 198 (30); HRMS calc’d. for 
C18H17NO3 295.1208, found 295.1207 (-0.5 ppm). 
 
4-(3-Methyl-3-methoxybutlynyl)-2’-ylamine biphenyl 86 
 
To a solution of 4-(3-methyl-3-methoxybutlynyl)-2’-nitrobiphenyl 85 (9.9 mg, 0.034 
mmol) in THF-EtOH (1:1, 10 mL) was added  tin(II) chloride (63.7 mg, 0.34 mmol) 
and conc. HC (1 mL), the reaction mixture was stirred for 16 h. A sat. solution of 
K2CO3 was added to the reaction mixture and the reaction mixture was partitioned 
between Et2O (40.0 mL) and water (10.0 mL), extracted with CH2Cl2 (2 × 10.0 mL) 
and dried over MgSO4. Purification by FC (hexane/EtOAc, 80/20) gave 
4-(3-methyl-3-methoxybutlynyl)-2’-ylaminebiphenyl 86 as a colourless oil (7.1 mg, 
80 %). 1H NMR (400 MHz; CDCl3): 1.56 (s, 6H, 2  CH3), 3.45 (s, 3H, OCH3), 
3.75 (brs, 2H, NH2), 6.77 (dd, J = 8.2, 0.7 Hz, 1H, ArH), 6.83 (td, J = 7.4, 1.0 Hz, 1H, 
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ArH), 7.11 (dd, J = 7.6, 1.5 Hz, 1H, ArH), 7.16 (td, J = 7.6, 1.5 Hz, 1H, ArH), 7.42 
(d, J = 8.3 Hz, 2H, ArH), 7.51 (d, J = 8.3 Hz, 2H, ArH); 13C NMR (100.7 MHz; 
CDCl3) 28.4 (2q), 51.7 (q), 71.0 (s), 84.0 (s), 91.4 (s), 115.7 (d), 118.8 (d), 121.6 
(s), 126.8 (s), 128.8 (d), 129.0 (2d), 130.3 (d), 132.1 (2d), 139.5 (s), 143.3 (s); IR 
υmax (neat) 3475 (N-H), 3382 (N-H), 3052 (C-H), 3021 (C-H), 2280 (CC), 1887 
(comb), 1617 (C=C), 1472, 810, 743 cm-1; m/z (EI+) (rel. intensity) 265 (M+,85), 250 
(100), 234 (50), 220 (40), 125 (30); HRMS calc’d. for C18H19NO 265.1467, found 
265.1464 (-1.0 ppm). 
 
2-Chloro-N-[4'-(3-methoxy-3-methylbut-1-ynyl)biphenyl-2-yl] nicotinamide 
74162 
 
To a solution of 4-(3-methyl-3-methoxybutynyl)-2’-ylaminebiphenyl 86 (12 mg, 
0.045 mmol) in CH2Cl2 (10 mL) was added  2-chloro-3-nicotinic acid (7.2 mg, 
0.045 mmol), DMAP (0.6 mg, 0.0049 mmol) and DCC (10.3 mg, 0.050 mmol), the 
reaction mixture was stirred for 16 h. A sat. solution of K2CO3 was added to the 
reaction mixture and the reaction mixture was partitioned between Et2O (40.0 mL) 
and water (10.0 mL), extracted with CH2Cl2 (2 × 10.0 mL) and dried over MgSO4. 
Purification by FC (hexane/EtOAc, 70/30) gave alkyne 74 as a colourless oil (12.5 
mg, 68 %). 1H NMR (400 MHz; CDCl3): 1.56 (s, 6H, 2  CH3), 3.44 (s, 3H, OCH3), 
7.27 (d, J = 6.3 Hz, 2H, ArH), 7.34-7.38 (m, 3H, ArH), 7.46 (td, J = 8.6, 2.8 Hz, 1H, 
ArH), 7.52 (d, J = 8.2 Hz, 2H, ArH), 8.14 (dd, J = 7.7, 1.9 Hz, 1H, ArH), 8.16 (brs, 
1H, NH), 8.44-8.46 (m, 2H, ArH); 13C NMR (100.7 MHz; CDCl3) 28.3 (2q), 51.8 
(q), 70.9 (s), 83.5 (s), 92.2 (s), 121.8 (d), 122.90 (d), 122.93 (s), 125.2 (d), 128.2 (d), 
129.4 (2d), 130.1 (d), 131.1 (s), 132.4 (2d), 132.6 (s), 134.3 (s), 137.6 (s), 140.1 (d), 
146.7 (s), 151.3 (d), 162.5 (s); IR υmax (neat) 3325 (N-H), 3053 (C-H), 2931 (C-H), 
2341 (CC), 1654 (C=O), 1578 (C=C), 1070, 734 cm-1; m/z (CI+) (rel. intensity) 424 
[(M37Cl) + NH4+, 1], 422 [(M37Cl) + NH4+, 3], 390 (40), 373 (100), 339 (20), 225 
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(50); HRMS (CI+) calc’d. for C24H25ClN3O2 [M+NH4]+ 422.1635, found 422.1633 
(-0.5 ppm). 
 
4-Propynyl-2’-nitrobiphenyl 88 
 
Using method C, the crude difluoroarylgermane from the photolysis of arylgermane 
87 (33.2 mg, 0.049 mmol), TBAF (46.6 mg, 0.148 mmol), PdCl2(MeCN)2 (1.5 mg, 
0.0058 mmol), P(2-Tol)3 (2.6 mg, 0.0087 mmol), 2-bromo-nitrobenzene (19.9 mg, 
0.099 mmol) and CuI (9.8 mg, 0.049 mmol) were employed. Purification by FC 
(hexane/EtOAc, 90/10) to give 4-propynyl-2’-nitrobiphenyl 88 as a pale yellow 
oil(6.3 mg, 54%). 1H NMR (400 MHz; CDCl3): 2.07 (s, 3H, CH3), 7.24 (d, J = 7.0, 
2H, ArH), 7.41-7.48 (m, 3H, ArH), 7.48 (td, J = 7.9, 1.4 Hz, 1H, ArH), 7.62 (td, J = 
7.5, 1.1 Hz, 1H, ArH), 7.86 (dd, J = 8.1, 1.1 Hz, 1H, ArH); 13C NMR (100.7 MHz; 
CDCl3) 4.4 (q), 79.2 (s), 87.1 (s), 124.1 (s), 124.2 (d), 127.8 (2d), 128.3 (d), 131.77 
(2d), 131.8 (d), 132.3 (d), 135.8 (s), 136.4 (s), 149.1 (s); IR υmax (neat) 3054 (C-H), 
2987 (C-H), 2360 (CC), 1588 (C=C), 1537 (N=O), 1265 (N=O), 896, 738, 705 cm-1; 
m/z (EI+) (rel. intensity) 237 (M+, 20), 198 (100), 168 (50), 87 (70); HRMS calc’d. 
for C15H11NO2 237.0790, found 237.0784 ( ppm). 
 
4-Propynyl-2’-ylaminebiphenyl 89 
 
To a solution of 4-propynyl-2’-nitrobiphenyl 88 (6.3 mg, 0.027 mmol) in THF-EtOH 
(1:1, 10 mL) was added tin(II) chloride (50.1 mg, 0.27 mmol) and conc. HC (1 mL) 
and the reaction mixture was stirred for 16 h.  A sat. solution of K2CO3 was added 
to the reaction mixture and the reaction mixture was partitioned between Et2O (40.0 
mL) and water (10.0 mL), extracted with CH2Cl2 (2 × 10.0 mL) and dried over 
MgSO4. Purification by FC (hexane/EtOAc, 90/10) gave 
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4-propynyl-2’-ylaminebiphenyl 89 as a colourless oil (4.4 mg, 80 %). 1H NMR (400 
MHz; CDCl3): 2.08 (s, 3H, CH3), 3.76 (brs, 2H, NH2), 6.76 (d, J = 7.9 Hz, 1H, 
ArH), 6.82 (t, J = 7.3 Hz, 1H, ArH), 7.11 (dd, J = 7.5, 1.2 Hz, 1H, ArH), 7.16 (td, J = 
7.8, 1.4 Hz, 1H, ArH), 7.39 (d, J = 8.2 Hz, 2H, ArH), 7.46 (d, J = 8.2 Hz, 2H, ArH); 
13C NMR (100.7 MHz; CDCl3) 4.4 (q), 86.3 (s), 102.3 (s), 115.8 (d), 118.8 (d), 
119.1 (s), 122.9 (s), 128.7 (d), 128.9 (2d), 130.3 (d), 131.9 (2d), 138.7 (s), 144.5 (s); 
IR υmax (neat) 3475 (N-H), 3384 (N-H), 3052 (C-H), 2984 (C-H), 2359 (CC), 1888 
(comb), 1616 (C=C), 1472, 817, 738, 704 cm-1; m/z (EI+) (rel. intensity) 207 (100), 
167 (40), 149 (85), 57 (65); HRMS calc’d. for C15H13N 207.1048, found 207.1050 
(-1.0 ppm). 
 
2-Chloro-N-(4'-prop-1-ynylbiphenyl-2-yl)nicotinamide 75162 
 
To a solution of 4-(3-methyl-3-methoxybutynyl)-2’-ylaminebiphenyl 89 (4.5 mg, 
0.022 mmol) in CH2Cl2 (5 mL) was added  2-chloro-3-nicotinic acid (6.9 mg, 0.042 
mmol), DMAP ( 0.5 mg, 0.004 mmol) and DCC (10.0 mg, 0.048 mmol) and the 
reaction mixture was stirred for 16 h.  A sat. solution of K2CO3 was added to the 
reaction mixture and the reaction mixture was partitioned between Et2O (40.0 mL) 
and water (10.0 mL), extracted with CH2Cl2 (2 × 10.0 mL) and dried over MgSO4. 
Purification by FC (hexane/EtOAc, 70/30) gave alkyne 75 as a colourless oil (4.4 mg, 
59 %). 1H NMR (400 MHz; CDCl3): 2.07 (s, 3H, CH3), 7.27 (d, J = 6.5 Hz, 2H, 
ArH), 7.33-7.39 (m, 3H, ArH), 7.46 (td, J = 8.4, 1.6 Hz, 1H, ArH), 7.50 (d, J = 8.2 
Hz, 2H, ArH), 8.12 (dd, J = 7.5, 1.9 Hz, 1H, ArH), 8.15 (brs, 1H, NH), 8.42-8.44 (m, 
2H, ArH); 13C NMR (100.7 MHz; CDCl3) 4.3 (q), 86.2 (s), 93.1 (s), 121.6 (d), 
122.8 (d), 122.9 (s), 125.0 (d), 128.0 (d), 129.2 (2d), 130.1 (d), 131.0 (s), 132.2 (2d), 
132.4 (s), 134.3 (s), 137.4 (s), 140.0 (d), 146.5 (s), 151.1 (d), 162.3 (s); IR υmax (neat) 
3325 (N-H), 3053 (C-H), 2935 (C-H), 2305 (CC), 1654 (C=O), 1580 (C=C), 1265, 
735 cm-1; m/z (CI+) (rel. intensity) 349 [(M37Cl) + H+, 5], 347 [(M35Cl) + H+, 15], 
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328 (40), 225 (100); HRMS (CI+) calc’d. for C21H16ClN2O [M+H]+ 347.0951, found 
347.0952 (1.3 ppm). 
 
Scope of alkenyl germyl-Stille cross-coupling reaction 
 
Preparation of Rf-tagged alkenyl germanes: 
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorodecyl)bis(naphthalen-2-ylme
thyl)germane 90 
 
To a solution of bromogermane 40 (0.250 g, 0.283 mmol) in THF (20.0 mL) at 0 C 
was added LiEt3BH (0.30 mL, 0.30 mmol, 1 M) dropwise. The reaction mixture was 
allowed to warm up to room temperature and stirred for 4 h. The reaction mixture 
was then quenched with NaHCO3, and extracted with Et2O (2 × 10.0 mL). The 
combined organic extracts were dried over Na2SO4, and the solvent evaporated in 
vacuo. Purification by FC eluting with (hexane/EtOAc, 95/5) followed by 
recrystallisation from hexane yielded germane 90 as a white crystalline solid (0.160 
g, 70%). mp. 63-68 oC; 1H NMR (400MHz; CDCl3):  1.03 (m, 2H, CH2CH2Ge), 
1.90 (m, 2H, CH2CH2Ge), 2.54 (dd, J = 12.8, 2.9 Hz, 2H, GeCH2Nap), 2.59 (dd, J = 
12.8, 2.9 Hz, 2H, GeCH2Nap), 4.27 (br s, 1H, Ge-H), 7.17 (dd, J = 8.5 and 2.0Hz, 
2H, ArH), 7.36-7.45 (m, 6H, ArH), 7.68 (d, J = 8.5 Hz, 2H, ArH), 7.73 (d, J = 8.5 Hz, 
2H, ArH), 7.78 (dd, J = 6.5, 2.0 Hz, 2H, ArH); 13C NMR (100MHz; CDCl3):  1.6 (t), 
21.3 (2t), 27.4 (t, JCF = 23.1 Hz), 108.2 (s), 110.2 (s), 110.6 (2s), 110.9 (2s), 111.2 (s), 
117.9 (s), 124.9 (2d), 125.4 (2d), 126.1 (2d), 127.0 (2d), 127.1 (2d), 127.6 (2d), 
128.3 (2d), 131.3 (2s), 133.8 (2s), 137.2 (2s); 19F NMR (376MHz; CDCl3):  -125.1 
(s, 2F), -122.7 (s, 2F), -121.8 (s, 2F), -121.0 (s, 4F, 2  CF2), -120.9 (s, 2F), -115.3 
(quintet, J = 15.0Hz, 2F, (CF2)6CF2CF3), -78.8 (t, J = 10.0Hz, 3F, (CF2)6CF2CF3); IR 
 max (neat): 3055, 2925, 1540, 1195, 1145, 905, 820 cm-1; m/z (EI+) (rel. intensity) 
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804 (M+, 18), 531 (11), 215 (45), 141 (100); HRMS calc’d. for C32H23F1774Ge (M+) 
804.0740, found 804.0737 ( -0.4 ppm). 
 
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorodecyl)bis(naphthalen-2-ylme
thyl)[(E)-4-phenylbut-1-enyl]germane 91 
 
Method 1:  
According to the method of Wada’s,175 to a solution of germane 90 (0.050 g, 0.062 
mmol) in CH2Cl2 (10.0 mL) was added galvinoxyl (0.025 g, 0.062 mmol), 
(Ph3P)2Rh(CO)Cl (1.0 mg, 0.001 mmol) and 4-phenyl-1-butyne (80 L, 0.620 mmol). 
The reaction mixture was refluxed at 40C for 20 h.  The reaction mixture was then 
quenched with NaHCO3, and extracted with CH2Cl2 (2 × 10.0 mL). The combined 
organic extracts were dried over Na2SO4, and the solvent evaporated in vacuo. 
Purification by FC eluting with (hexane/EtOAc, 99/1) yielded crude 
(E)-4-phenylbut-1-enyl]germane 91 as a yellow oil (0.080 g) and inseparable 
galvinoxyl derivatives. 1H NMR (400MHz; CDCl3):  1.00 (m, 2H, CH2CH2Ge), 
1.88 (m, 2H, CH2CH2Ge), 2.47 (d, J = 7.1 Hz, 1H, GeCH=CHCH2CH2Ph), 2.51 (d, J 
= 7.1 Hz, 1H, GeCH=CHCH2CH2Ph), 2.54 (s, 4H, 2  GeCH2Nap), 2.71 (t, J = 7.0 
Hz, 2H, GeCH=CHCH2CH2Ph), 5.70 (d, J = 18.5 Hz, 1H, GeCH=CH(CH2)2Ph), 
6.01 (dt, J = 18.5, 7.0 Hz, 1H, GeCH=CH(CH2)2Ph), 7.15 (d, J = 8.5 Hz, 2H, ArH), 
7.23-7.34 (m, 5H, ArH), 7.43-7.50 (m, 6H, ArH), 7.71 (d, J = 8.0 Hz, 2H, ArH), 7.75 
(d, J = 8.5Hz, 2H, ArH), 7.83 (d, J = 8.0Hz, 2H, ArH); 13C NMR (100MHz; CDCl3): 
 2.3 (t), 22.7 (t), 26.4  (t, JCF = 23.5 Hz), 108.2 (s), 110.2 (s), 110.6 (2s), 110.8 (2s), 
111.0 (s), 117.9 (s), 124.5 (d), 124.7 (2d), 125.5 (2d), 125.9 (d), 126.0 (2d), 127.0 
(2d), 127.6 (2d), 128.0 (2d), 128.1 (2d), 128.3 (2d), 128.4 (2d), 131.2 (2s), 133.7 (2s), 
135.7 (s), 137.0 (s), 141.3 (s), 148.2 (d); 19F NMR (376MHz; CDCl3):  -126.1 (s, 
2F), -123.4 (s, 2F), -122.7 (s, 2F), -121.9 (s, 6F, 3  CF2), -116.2 (quintet, J = 14.0Hz, 
2F, (CF2)6CF2CF3), -80.7 (t, J = 10.0 Hz, 3F, (CF2)6CF2CF3); IR  max (neat): 3055, 
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2925, 1630, 1505, 1440, 1240, 1210, 1150, 890, 820 cm-1; m/z (FAB+) (rel. intensity) 
793 [30, (M-CH2Np)+], 719 (10), 365 (20), 291 (20), 141 (100); HRMS calc’d. for 
C31H24F17Ge [(M-NapCH2)+] 793.0818, found 793.0799 ( -2.4 ppm). 
Method 2: 
To a solution of germane 90 (0.50 g, 0.62 mmol) in CH2Cl2 (25.0 mL) was added 
(Ph3P)2Rh(CO)Cl (12.9 mg, 0.019 mmol) and 4-phenyl-1-butyne (0.8 mL, 6.2 mmol). 
The reaction mixture was refluxed at 40 C for 24 h. The reaction mixture was then 
quenched with NaHCO3, and extracted with CH2Cl2 (2 × 10.0 mL). The combined 
organic extracts were dried over Na2SO4, and the solvent evaporated in vacuo. 
Purification by FC eluting with (hexane/EtOAc, 99/1) gave 
(E)-4-phenylbut-1-enyl]germane 91 as a yellow oil (0.56 g, 96 %). Analytical data as 
shown above. 
 
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorodecyl)bis(naphthalen- 
2-ylmethyl)[(E)-styrenyl]germane 92 
 
To a solution of germane 90 (0.32g, 0.398 mmol) in CH2Cl2 (20.0 mL) was added 
(Ph3P)2Rh(CO)Cl (8.2 mg, 0.012 mmol) and phenylacetylene (0.44 mL, 4.0 mmol). 
The reaction mixture was refluxed at 40C for 24 h. The reaction mixture was then 
quenched with NaHCO3, and extracted with CH2Cl2 (2 × 10.0 mL). The combined 
organic extracts were dried over Na2SO4, and the solvent evaporated in vacuo. 
Purification by FC eluting with pet. ether 40-60 C/Et2O (98:2) gave (E)-styrenyl 
germane 92 as a yellow oil (0.317 g, 88 %). 1H NMR (400 MHz; CDCl3):  
1.07-1.11 (m, 2H, C8F17CH2CH2Ge), 1.87-1.97 (m, 2H, C8F17CH2CH2Ge), 2.65 (s, 
4H, GeCH2Np), 6.50 (d, J = 19.0 Hz, 1H, GeCH=CHPh), 6.81 (d, J = 19.0 Hz, 1H, 
GeCH=CHPh), 7.19 (dd, J = 8.4, 1.4 Hz, 2H, ArH), 7.34-7.37 (m, 5H, ArH), 
7.40-7.48 (m, 6H, ArH), 7.68 (d, J = 7.8 Hz, 2H, ArH), 7.74 (d, J = 8.4 Hz, 2H, ArH), 
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7.81 (d, J = 7.8 Hz, 2H, ArH); 13C NMR (100.7 MHz; CDCl3):  2.5 (t), 22.2 (2t), 
26.7 (t, JCF = 23.2 Hz), 108.4 (s), 110.2 (s), 110.7 (2s), 111.0 (2s), 111.1 (s), 118.0 (s), 
126.4 (2d), 127.0 (2d), 127.4 (2d), 127.6 (2d), 128.1 (2d), 128.4 (d), 128.6 (2d), 
131.3 (2s), 133.8 (2s), 136.7 (2s), 137.5 (s), 145.7 (d); 19F NMR (376MHz; CDCl3): 
 -125.1 (s, 2F), -122.5 (s, 2F), -121.8 (s, 2F), -120.9 (m, 6F), -115.2 (quintet, J = 
14.6 Hz, 2F), -79.9 (t, J = 9.6 Hz, 3F); IR  max (neat): 3055, 3020, 2920, 1630, 1600, 
1510, 1240, 1210, 1150, 855, 820 cm-1; m/z (FAB+) (rel. intensity) 765 [5, 
(M-CH2Np)+], 662 (3), 521 (5), 141 (100), 104 (20) HRMS canc’d. for C29H20F17Ge 
[(M-NapCH2)+] 765.0505, found 765.0517 ( 1.6 ppm).  
 
General procedure for photolysis of alkenylgermanes: 
 
To a solution of the alkenylgermanes (0.102 mmol) in MeCN/MeOH (3/1 v/v, 20 mL) 
in a Pyrex Schlenk tube (1 mm thick) was added powdered Cu(BF4)2·nH2O (0.408 
mmol). The resulting mixture was purged with argon for 30 min before irradiating 
using a 125 W high pressure Hg lamp for 1 h. A further portion of powdered 
Cu(BF4)2·nH2O (0.408 mmol) was then added and the solution irradiated for a further 
1 h. After this time, the solvent was removed in vacuo, the residue was taken up in 
CH2Cl2 (20.0 mL), washed with water (2 × 8.0 mL) and dried over MgSO4 to give 
the crude difluoroalkenylgermane. 1H NMR spectrum of the crude reaction mixture 
displayed an 18.5 Hz vicinal alkenyl coupling constant indicating no photoinduced 
double bond isomerisation occurred. Additionally, 19F NMR revealed three signals at 
 -165 ~ -162 ppm. These were assigned as activated difluorogermane derivatives as 
for the arylgermane analogues (see discussion section 2.6.1.2). 
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General method for cross-coupling of photoactivated alkenylgermanes with aryl 
bromides: 
 
Table 2.6.9, entry 1: (E)-1-(3-(3,5-Bis(trifluoromethyl)phenyl)but-3-enyl)benzene 
93a 
 
Method C: The crude difluoroalkenylgermane from the photolysis of arylgermane 91 
(70.3 mg, 0.102 mmol) for 2 h with 4 equivalents of Cu(BF4)2·nH2O and TBAF (96.4 
mg, 0.306 mmol) was dissolved in degassed DMF (2 mL) and stirred for 30 min. 
PdCl2(MeCN)2 (2.6 mg, 0.0102 mmol) and P(2-Tol)3 (4.7 mg, 0.0153 mmol) were 
dissolved degassed DMF (1 mL) for 30 min the active catalytic species. The catalyst 
solution was added to the difluoroalkenylgermane solution followed by adding 
3,5-bis(trifluoromethyl)-bromobenzene (59.8 mg, 0.204 mmol, 35.2 L) and CuI 
(20.3 mg, 0.102 mmol). The resulting mixture heated at 120 oC for 16 h under 
nitrogen atmosphere. The crude reaction mixture was diluted with Et2O (20.0 mL) 
and washed with water (3 × 10.0 mL), the combined organic extracts were dried over 
MgSO4 and evaporated in vacuo. Purification by FC (hexane/EtOAc, 97/3) gave 
styrene 93a as a pale yellow oil (22.8 mg, 65 %). Although the isomers could not be 
separated and authentic sample were not available, the ratio of the isomers was 
identified by a combination of GC-MS and 1H NMR spectroscopic analysis as being 
(E) : (Z) : (α) = 98 : 2 : 0 mixture of isomers. 
(E)-isomer: 1H NMR (400MHz; CDCl3):  2.58 (dt, J = 12.8, 6.4 Hz, 1H, 
CH=CHCH2), 2.61 (dt, J = 12.8, 6.4 Hz, 1H, CH=CHCH2), 2.82 (t, J = 7.0 Hz, 2H, 
CH2Ph), 6.43-6.46 (m, 2H, CH=CHCH2), 7.21-7.33 (m, 5H, ArH), 7.69 (s, 1H, ArH), 
7.72 (s, 2H, ArH); 13C NMR (100.7 MHz; CDCl3):  34.8 (t), 35.4 (t), 120.4 (d), 
123.4 (2s, 1JC-F = 272.8 Hz, 2 × CF3), 125.8 (2d), 126.1 (d), 128.0 (d), 128.4 (2d), 
128.5 (2d), 131.8 (2s, 2JC-F = 32.7 Hz), 134.3 (d), 139.7 (s), 141.2 (s); 19F NMR 
 179
(376MHz; CDCl3):  -63.0 (s, 6F, 2  CF3); IR max (neat): 3025, 2930, 1650, 1500, 
1380, 1280, 1175, 1135 965, 895 cm-1; GC/MS retention time 9.68 min; m/z (EI+) 
344 (M+, 30), 325 (20), 253 (20), 115 (10), 91 (100); HRMS calc’d. for C18H14F6 
344.1000, found 344.0995 ( -1.4 ppm). 
(Z)-isomer: GC/MS retention time 10.87 min, m/z (EI+) 344 (M+, 20), 325 (10), 253 
(40), 115 (40), 91 (100). 
 
Ozonolysis of styrene 93a for determination of double bond regiochemistry  
 
(E)-N-(3,5-bis(trifluoromethyl)benzylidene)-4-methoxybenzenamine 94 
To a solution of styrene 93a (16 mg, 0.046 mmol) in CH2Cl2 (10 mL) was cooled to 
-78 oC and purged with ozone until a blue colour solution was observed. The mixture 
was then warmed up to RT for 10 min followed by addition of PPh3 (30.5 mg, 0.016 
mmol) in CH2Cl2 (2 mL) and stirred for 1 h after which 4-ansidine (14.3 mg, 
0.116mmol) was charged into the reaction mixture at this temperature for another 2 h. 
The resulting mixture was quenched with sat. NaHCO3 and extraction with (2 × 20.0 
mL) of Et2O, the combined organic extracts were dried over MgSO4 and evaporated 
in vacuo to give yellow residue which was purified by FC (hexane/EtOAc, 80/20) to 
give imine 94 (12.5 mg, 78 %) as a pale yellow solid. mp. 78-79 oC; 1H NMR (400 
MHz):  3.85 (s, 3H, OCH3), 6.97 (dd, J = 8.8, 1.2 Hz, 2H, ArH), 7.31 (dd, J = 8.8, 
1.2 Hz, 2H, ArH), 7.94 (br s, 1H ArH), 8.35 (br s, 2H, ArH), 8.58 (s, 1H, CH=N); 13C 
NMR (100.7 MHz; CDCl3):  55.5 (q), 114.6 (2d), 122.5 (2d), 123.1 (2s, 1JC-F = 266 
Hz, 2 × CF3), 123.9 (d), 128.2 (2d), 132.2 (2s, 2JC-F = 34.1 Hz), 138.4 (s), 143.3 (s), 
153.9 (d), 159.2 (s); IR max (neat): 3025, 2960, 2840, 1630, 1510, 1280, 1170, 1130, 
1025. 830 cm-1; m/z (EI+) 347 (M+, 100), 332 (90), 303 (30), 235 (30), 134 (20), 92 
(20); HRMS calc’d. for C16H11F6NO 347.0745, found 347.0741 ( -1.1 ppm). 
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Table 2.6.9, entry 2: 4-((E)-4-Phenylbut-1-enyl)benzonitrile 93b 
 
Using method C, the crude difluoro alkenylgermane (70.3 mg, 0.102 mmol) from the 
photolysis of alkenylgermane 91 for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(96.4 mg, 0.306 mmol), PdCl2(MeCN)2 (2.6 mg, 0.0102 mmol), P(2-Tol)3 (4.7 mg, 
0.0153 mmol), 4-cyanobromobenzene (37.1 mg, 0.204 mmol) and CuI (20.3 mg, 
0.102 mmol) were employed. Purification by FC (hexane/EtOAc, 97/3) gave styrene 
93b as a (E) : (Z) : (α) = 99 : 1 : 0 mixture of isomers (15.4 mg, 65 %) as a pale 
yellow solid. 
(E)-isomer: mp. 52-53 oC; 1H NMR (400 MHz): 2.55-2.62 (m, 2H, CH=CHCH2), 
2.83 (t, J = 7.7 Hz, 2H, CH2Ph), 6.40-6.43 (m, 2H, CH=CHCH2), 7.22-7.30 (m, 3H, 
ArH), 7.40-7.51 (m, 2H, ArH), 7.54 (d, J = 8.6 Hz, 2H, ArH), 7.65 (d, J = 8.6 Hz, 2H, 
ArH); 13C NMR (100.7 MHz; CDCl3):  35.0 (t), 35.7 (t), 126.1 (3d), 128.5 (2d), 
128.7 (2d), 128.9 (2d), 129.5 (d), 133.2 (d), 135.7 (s), 141.4 (s), 141.9 (s), 142.4 (s); 
IR max (neat): 3025, 2920, 2230, 1695, 1610, 1455, 825 cm1-; GC/MS retention time 
12.52 min, m/z (EI+) 233 (M+, 30), 141 (40), 115 (20), 91 (100); HRMS calc’d. for 
C17H15N 233.1204, found 233.1204 ( 0 ppm).  
(Z)-isomer: GC/MS retention time 11.98 min, m/z (EI+) 233 (M+, 5), 141 (10), 115 
(10), 91 (100). 
 
Table 2.6.9, entry 3: 1-(4-((E)-4-Phenylbut-1-enyl)phenyl)ethanone 93c 
 
Using method C, the crude difluoro alkenylgermane (70.3 mg, 0.102 mmol) from the 
photolysis of alkenylgermane 91 for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(96.4 mg, 0.306 mmol), PdCl2(MeCN)2 (2.6 mg, 0.0102 mmol), P(2-Tol)3 (4.7 mg, 
0.0153 mmol), 4-bromoacetophenone (40.6 mg, 0.204 mmol) and CuI (20.3 mg, 
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0.102 mmol) were employed. Purification by FC (hexane/EtOAc, 90/10) gave 
styrene 93c as a single isomer (15.1 mg, 59 %) as a pale yellow solid. mp. 55-56 oC 
1H NMR (400 MHz): 2.53-2.59 (m, 5H, CH=CHCH2+COCH3), 2.81 (t, J = 7.7 Hz, 
2H, CH2Ph), 6.35-6.48 (m, 2H, CH=CHCH2), 7.20-7.23 (m, 3H, ArH), 7.27-7.33 (m, 
2H, ArH), 7.40 (d, J = 8.3 Hz, 2H, ArH), 7.89 (d, J = 8.3 Hz, 2H, ArH); 13C NMR 
(100.7 MHz; CDCl3):  26.6 (q), 35.0 (t), 35.6 (t), 126.0 (3d), 128.4 (2d), 128.5 (2d), 
128.8 (2d), 129.6 (d), 133.2 (d), 135.6 (s), 141.4 (s), 142.3 (s), 197.6 (s); IR max 
(neat): 3085, 2930, 1675, 1600, 1270, 910, 855, 810 cm-1; m/z (EI+) 250 (M+, 40), 
207 (10), 159 (20), 115 (20), 90 (50), 43 (100); HRMS calc’d. for C18H18O 250.1358, 
found 250.1362 ( 1.7 ppm).  
 
Table 2.6.9, entry 4: 1,3-Dimethyl-5-(4-phenylbut-1-enyl)benzene 93d 
 
Using method C, the crude difluoro alkenylgermane (85.0 mg, 0.123 mmol) from the 
photolysis of alkenylgermane 91 for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(116.6 mg, 0.370 mmol), PdCl2(MeCN)2 (3.2 mg, 0.0123 mmol), P(2-Tol)3 (5.6 mg, 
0.0185 mmol), 1-bromo-3,5-dimethylbenzene (45.5 mg, 0.246 mmol, 33.4 L) and 
CuI (24.5 mg, 0.123 mmol) were employed. Purification by FC (hexane/EtOAc, 97/3) 
gave styrene 93d as a (E) : (Z) : (α) = 93 : 5 : 2 mixture of isomers (18.3 mg, 63 %) 
as a pale yellow oil. 1H NMR (400 MHz): 2.34 [(E)+(Z)+()] (3 × s, 6H, 2 × CH3), 
2.43-2.50 (E) and 2.57-2.65 [(Z)+()] (m, 2H, CH=CHCH2), 2.81-2.87 [(E)+(Z)+()] 
(m, 2H, CH2Ph), 5.09 () (s, 1H, =CH), 5.33 () (s, 1H, =CH), 6.29 (E) and 
6.26-6.31 (Z) (dt and m, J = 15.8, 6.7 Hz, 1H, CH=CHCH2), 6.41 (E) and 6.44-6.47 
(Z) (d and m, J = 15.8 Hz, 1H, CH=CHCH2), 6.91 [(E)+(Z)+()] (s, 1H, ArH), 7.02 
[(E)+(Z)+()] (s, 2H, ArH), 7.35-7.39 [(E)+(Z)+()] (m, 2H, ArH), 7.44-7.52 
[(E)+(Z)+()] (m, 3H, ArH); 13C NMR (100.7 MHz; CDCl3): [(E)+(Z)+()]  20.5 
(q), 20.7 (q), 30.5 (t), 34.8 (t), 35.9 (t), 36.1 (t), 122.5 (d), 125.9 (d), 128.3 (d), 128.4 
(d), 128.7 (d), 129.2 (s), 134.7 (s), 136.5 (s), 138.2 (s); IR max (neat): 3040, 1790, 
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1380, 1275, 1170, 1130, 960, 895 cm-1; GC-MS analysis for (E)-isomer: retention 
time 11.40 min, m/z (EI+) 236 (M+, 30), 145 (100), 115 (20), 91 (30); (Z)-isomer: 
retention time 10.62 min, m/z (EI+) 236 (M+, 10), 140 (40), 115 (30), 91 (100); 
(-isomer: retention time 11.20 min, m/z (EI+) 236 (M+, 10), 117 (100), 115 (50), 91 
(50); HRMS calc’d. for C18H20 236.1565, found 236.1560 ( -2.1 ppm). 
 
Table 2.6.9, entry 5: 1-(4-para-Tolylbut-3-enyl)benzene 93e 
 
Using method C, the crude difluoro alkenylgermane (85.0 mg, 0.123 mmol) from the 
photolysis of alkenylgermane 91 for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(116.6 mg, 0.370 mmol), PdCl2(MeCN)2 (3.2 mg, 0.0123 mmol), P(2-Tol)3 (5.6 mg, 
0.0185 mmol), 4-bromotoluene (42.1 mg, 0.246 mmol, 25.1 L) and CuI (24.5 mg, 
0.123 mmol) were employed. Purification by FC (hexane/EtOAc, 97/3) gave styrene 
93e as a (E) : (Z) : (α) = 80 : 8 : 12 mixture of isomers (19.7 mg, 72 %) as a pale 
yellow oil.  
(E)-isomer:245 1H NMR (400 MHz): 2.38 (s, 3H, CH3), 2.55 (dt, J = 15.1, 7.0 Hz, 
1H, CH=CHCH2), 2.59 (dt, J = 15.1, 7.0 Hz, 1H, CH=CHCH2), 2.81-2.86 (m, 2H, 
CH2Ph), 6.26 (dt, J = 15.8, 7.0 Hz, 1H, CH=CHCH2), 6.44 (d, J = 15.8 Hz, 1H, 
CH=CHCH2), 7.12 (d, J = 7.6 Hz, 2H, ArH), 7.24-7.30 (m, 7H, ArH); 13C NMR 
(100.7 MHz; CDCl3):  21.1 (q), 34.9 (t), 35.9 (t), 125.9 (2d), 128.3 (3d), 128.5 (2d), 
128.9 (d), 129.2 (2d), 130.2 (d), 134.9 (s), 136.6 (s), 141.8 (s); GC/MS retention time 
12.35 min, m/z (EI+) 222 (M+, 30), 131 (100), 115 (20), 91 (40). 
(Z)-isomer:245 1H NMR (400 MHz): 2.42 (s, 3H, CH3), 2.67-2.77 (m, 2H, 
CH=CHCH2), 2.79-2.86 (m, 2H, CH2Ph), 5.72 (dt, J = 11.5, 6.9 Hz, 1H, 
CH=CHCH2), 6.46 (d, J = 11.5 Hz, 1H, CH=CHCH2), 7.10-7.30 (m, 9H, ArH); 13C 
NMR (100.7 MHz; CDCl3):  21.2 (q), 30.4 (t), 37.3 (t), 126.0 (d), 128.4 (2d), 128.6 
(2d), 128.7 (2d), 129.0 (2d), 129.4 (d), 131.1 (d), 134.6 (s), 136.2 (s), 141.7 (s); 
GC/MS retention time 11.68 min, m/z (EI+) 222 (M+, 30), 129 (50), 115 (30), 91 
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(100).  
()-isomer: 1H NMR (400 MHz): 2.39 (s, 3H, CH3), 2.54-2.61 (m, 2H, 
CH=CHCH2), 2.79-2.86 (m, 2H, CH2Ph), 5.08 (s, 1H, =CH), 5.33 (s, 1H, =CH), 
7.10-7.30 (m, 9H, ArH); 13C NMR (100.7 MHz; CDCl3):  19.6 (q), 34.7 (t), 36.1 (t), 
111.9 (t), 126.5 (d), 126.8 (2d), 126.9 (2d), 128.5 (2d), 131.2 (2d), 136.2 (s), 137.2 
(s), 142.0 (s), 147.6 (s); GC-MS retention time 11.83 min, m/z (EI+) 222 (M+, 10), 
131 (100), 115 (20), 91 (20); HRMS calc’d. for C17H18 222.1409, found 222.1400 ( 
-3.8 ppm).  
 
Table 2.6.9, entry 6: 1-Methoxy-4-(4-phenylbut-1-enyl)benzene 93f 
 
Using method C, the crude difluoro alkenylgermane (85.0 mg, 0.123 mmol) from the 
photolysis of alkenylgermane 91 for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(116.6 mg, 0.370 mmol), PdCl2(MeCN)2 (3.2 mg, 0.0123 mmol), P(2-Tol)3 (5.6 mg, 
0.0185 mmol), 4-bromoanisole (46.0 mg, 0.246 mmol, 30.8 L) and CuI (24.5 mg, 
0.123 mmol) were employed. Purification by FC (hexane/EtOAc, 97/3) gave styrene 
93f as a (E) : (Z) : (α) = 67 : 13 : 20 mixture of isomers (11.7 mg, 40 %) as a pale 
yellow oil. 1H NMR (400 MHz): 2.53 (E), 2.56 (E) and 2.65-2.73 [(Z)+()] (2 × dt 
and m, J = 14.7, 6.9 Hz; 2H, CH=CHCH2), 2.79-2.84 [(E)+(Z)+()] (m, 2H, CH2Ph), 
3.83 (E), 3.84 (Z) and 3.86 () (3 × s, 3H, OMe), 5.02 () (s, 1H, =CH), 5.27 () (s, 
1H, =CH), 6.15 (E) and 6.28 (Z) (dt, J = 15.8, 6.9 Hz and dt, J = 12.0, 6.7 Hz; 1H, 
CH=CHCH2), 6.40 (E) and 6.44 (Z) (d, J = 15.8 Hz and d, J = 12.0 Hz; 1H, 
CH=CHCH2), 6.84-6.93 [(E)+(Z)+()] (m, 2H, ArH), 7.15-7.31 [(E)+(Z)+()] (m, 
3H, ArH), 7.34-7.45 [(E)+(Z)+()] (m, 4H, ArH); 13C NMR (100.7 MHz; CDCl3):  
[(E)+(Z)+()] 30.5 (t), 34.6 (t), 34.9 (t), 35.7 (t), 37.3 (t), 55.3 (q), 55.5 (q), 113.9 (t), 
122.4 (d), 124.3 (d), 126.0 (d), 126.1 (d), 126.8 (d), 128.2 (d), 128.5 (d), 128.7 (d), 
128.9 (d), 129.1 (d), 129.4 (s), 130.1 (d), 131.1 (s), 134.7 (s), 134.9 (s), 136.6 (s), 
141.9 (d), 142.1 (d), 142.2 (d), 158.7 (s), 159.0 (s); IR max (neat): 3030, 2920, 1605, 
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1510, 1455, 1245, 1030, 965, 855 cm-1; GC/MS analysis for (E)-isomer: retention 
time 12.23 min, m/z (EI+) 238 (M+, 20), 147 (100), 115 (30), 91 (40); (Z)-isomer: 
retention time 11.32 min, m/z (EI+) 238 (M+, 20), 147(10), 115 (40), 91 (100); 
(-isomer: retention time 11.60 min, m/z (EI+) 238 (M+, 60), 147 (20), 115 (30), 104 
(20), 91 (100); HRMS calc’d. for C17H18O 238.1358, found 238.1361 ( 1.4 ppm).  
 
Table 2.6.9, entry 7: 1-Chloro-4-(4-phenylbut-1-enyl)benzene 93g 
 
Using method C, the crude difluoro alkenylgermane (75.8 mg, 0.110 mmol) from the 
photolysis of alkenylgermane 91 for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(104.0 mg, 0.330 mmol), PdCl2(MeCN)2 (2.9 mg, 0.011 mmol), P(2-Tol)3 (5.0 mg, 
0.0165 mmol), 1-bromo-4-chlorobenzene (42.1 mg, 0.220 mmol) and CuI (21.9 mg, 
0.110 mmol) were employed. Purification by FC (hexane/EtOAc, 97/3) gave styrene 
93g as a (E) : (Z) : (α) = 73 : 1 : 26 mixture of isomers (13.8 mg, 52 %) as a pale 
yellow oil. 1H NMR (400 MHz): 2.54 (E), 2.58 (E) and 2.62-2.75 [(Z)+()] (2 × dt 
and m, J = 15.2, 7.1 Hz; 2H, CH=CHCH2), 2.80-2.85 [(E)+(Z)+()] (m, 2H, CH2Ph), 
5.11 () (s, 1H, =CH), 5.31 () (s, 1H, =CH), 5.75 (Z) and 6.26 (E) (2 × dt, J = 11.7, 
7.1 Hz and 15.8, 6.6 Hz; 1H, CH=CHCH2), 6.39 (E) and 6.43 (Z) (2 × d, J = 15.8 Hz 
and J = 11.7 Hz, 1H, CH=CHCH2), 7.08-7.19 [(E)+(Z)+()] (m, 2H, ArH), 7.29-7.38 
(m, 7H, ArH); 13C NMR (100.7 MHz; CDCl3): [(E)+(Z)+()]  34.6 (t), 34.9 (t), 35.8 
(t), 37.2 (t), 113.3 (t), 126.0 (d), 127.1 (d), 127.2 (d), 127.5 (s), 128.4 (d), 128.5 (d), 
128.6 (d), 129.2 (d), 129.7 (s), 130.0 (s), 130.7 (s), 136.2 (s), 137.6 (s), 141.6 (s), 
146.0 (s), 146.1 (s); IR max (neat): 3060, 3025, 2555, 1595, 1490, 1450, 1090, 1015, 
965, 836 cm-1; GC/MS analysis for (E)-isomer: retention time 11.70 min, m/z (EI+) 
244 [M37Cl)+, 10], 242 [M35Cl)+, 30], 151 (100), 115 (80), 91 (100); (Z)-isomer: 
retention time 11.20 min, m/z (EI+) 242 [M35Cl)+, 10], 151 (100), 115 (80), 91 (100); 
(-isomer: retention time 11.05 min, m/z (EI+) 242 [M35Cl)+, 10], 115 (20), 104 (30), 
91 (100); HRMS calc’d. for C16H15Cl 242.0862, found 242.0864 (ppm).  
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Table 2.6.9, entry 8: 1-Fluoro-4-(4-phenylbut-1-enyl)benzene 93h 
 
Using method C, the crude difluoro alkenylgermane (75.8 mg, 0.110 mmol) from the 
photolysis of alkenylgermane 91 for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(104.0 mg, 0.330 mmol), PdCl2(MeCN)2 (2.9 mg, 0.011 mmol), P(2-Tol)3 (5.0 mg, 
0.0165 mmol), 1-chloro-4-fluorobenzene (28.7 mg, 0.220 mmol, 23.4 L) and CuI 
(21.9 mg, 0.110 mmol) were employed. Purification by FC (hexane/EtOAc, 97/3) 
gave styrene 93h as a (E) : (Z) : (α) = 93 : 2 : 5 mixture of isomers (14.4 mg, 58 %) 
as a pale yellow oil. 1H NMR (400 MHz): 2.54 (E), 2.57 (E) and 2.60-2.71 
[(Z)+()] (2 × dt and m, J = 15.0, 7.1 Hz and J = 15.0, 7.1 Hz; 2H, CH=CHCH2), 
2.76-2.84 [(E)+(Z)+()] (m, 2H, CH2Ph), 5.08 () (s, 1H, =CH), 5.27 () (s, 1H, 
=CH), 5.72 (Z) and 6.20 (E) (2 × dt, J = 11.6, 7.1 Hz and J = 15.7, 6.8 Hz; 1H, 
CH=CHCH2), 6.41 (E) and 6.43 (Z) (2 × d, J = 15.7, 6.8 Hz and J = 11.6, 7.1 Hz; 1H, 
CH=CHCH2), 6.98-7.04 [(E)+(Z)+()] (m, 2H, ArH), 7.20-7.36 [(E)+(Z)+()] (m, 
7H, ArH); 13C NMR (100.7 MHz; CDCl3):  31.1 (t) 34.8 (t), 34.9 (t), 35.6 (t), 36.0 
(t), 115.6 (d, 2JC-F = 22.5 Hz), 118.2 (s), 121.4 (d, 3JC-F = 8.3 Hz), 124.3 (d), 126.8 
(d), 128.2 (d), 128.6 (d), 128.7 (d), 129.4 (s), 131.1 (s), 145.3 (d, 1JC-F = 110.2 Hz); 
The 13C NMR signals for the (Z)- and ()-isomer were unable to be identified due to 
the low abundance of these isomers. 19F NMR (376MHz; CDCl3):  -115.5 (s, 1F); 
IR max (neat): 3060, 3025, 2965, 1600, 1510, 1455, 1230, 1155, 965, 850 cm-1; 
GC/MS analysis for (E)-isomer: retention time 10.43 min, m/z (EI+) 226 (M+, 30), 
135 (100), 115 (40), 91 (40); (Z)-isomer: retention time 9.95 min, m/z (EI+) 226 (M+, 
10), 135 (100), 115 (30), 91 (50); ()-isomer: retention time 9.78 min, m/z (EI+) 226 
(M+, 10), 130 (10), 104 (20), 91 (100); HRMS calc’d. for C16H15F 226.1158, found 
226.1157 ( -0.3 ppm).  
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Table 2.6.9, entry 9: 1-(4-(2-Nitrophenyl)but-3-enyl)benzene 93i 
 
Using method C, the crude difluoro alkenylgermane (75.8 mg, 0.110 mmol) from the 
photolysis of alkenylgermane 91 for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(104.0 mg, 0.330 mmol), PdCl2(MeCN)2 (2.9 mg, 0.011 mmol), P(2-Tol)3 (5.0 mg, 
0.0165 mmol), 1-bromo-2-nitrobenzene (44.4 mg, 0.220 mmol, 23.4 L) and CuI 
(21.9 mg, 0.110 mmol) were employed. Purification by FC (hexane/EtOAc, 97/3) 
gave styrene 93i as a (E) : (Z) : (α) = 80 : 20 : 0 mixture of isomers (13.3 mg, 48 %) 
as a pale yellow oil. 1H NMR (400 MHz): 2.41 (E), 2.45 (E) and 2.61-2.70 (Z) (2 × 
dt and m, J = 14.1, 7.5 Hz; 2H, CH=CHCH2), 2.73 (Z) and 2.86 (E) (2 × t, J = 7.0 Hz 
and 7.6 Hz; 2H, CH2Ph), 5.89 (Z) and 6.27 (E) (2 × dt, J = 11.6, 7.4 Hz and J = 15.6, 
6.8 Hz; 1H, CH=CHCH2), 6.76 (Z) and 6.91 (E) (2 × d, J = 11.6 Hz and J = 15.6 Hz, 
1H, CH=CHCH2),  7.23-7.35 [(E)+(Z)] (m, 3H, ArH), 7.40-7.52 [(E)+(Z)] (m, 4H, 
ArH), 7.86 (E) and 7.90 (Z) (2 × d, J = 7.6 Hz and J = 7.9 Hz; 1H, ArH), 8.05 (E) 
and 8.25 (Z) (2 × t, J = 7.6 Hz and J = 7.9 Hz; 1H, ArH); 13C NMR (100.7 MHz; 
CDCl3): [(E)+(Z)]  35.1 (t), 35.9 (t), 36.9 (t), 37.4 (t), 124.3 (d), 128.6 (d), 128.7 (d), 
128.9 (d), 129.5 (d), 131.8 (d), 132.5 (d), 134.4 (s), 135.2 (s), 135.9 (s), 149.1 (s), 
149.2 (s); IR max 3060, 2925, 1604, 1520, 1348, 1099, 963, 835 cm-1; GC/MS 
analysis for (E)-isomer: retention time 12.60 min, m/z (EI+) 253 (M+, 40), 207 (30), 
162 (70), 91 (100); (Z)-isomer: retention time 11.95 min, m/z (EI+) 253 (M+, 20), 
207 (30), 162 (60), 91 (100); HRMS calc’d. for C16H15NO2 253.1103, found 
253.1108 (D 2.0 ppm). 
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Screening for supporting ligands to effect stereoselective formation of (E)-styrene 
93e (Table 2.6.10) 
 
Using a modification of method C in which t-BuXPhos (L1), P(n-Bu)3 (L2), 
PCy3HBF4 (L3) (Hunig’s base (15 mol%) was also employed in this occasion) and 
dppp (L4) were used to replace of P(2-Tol). The crude difluoro alkenylgermane (86.2 
mg, 0.125 mmol) from the photolysis of alkenylgermane 91 for 2 h with 8 
equivalents of Cu(BF4)2·nH2O, TBAF (118.1 mg, 0.375 mmol), PdCl2(MeCN)2 (3.2 
mg, 0.0125 mmol), 4-bromotoluene (42.8 mg, 0.250 mmol, 30.8 L) and CuI (24.9 
mg, 0.125 mmol) were employed. Purification by FC (hexane/EtOAc, 90/10) gave 
(E)-styrene 93e as a major or exclusive isomer. 
 
Using PCy3HBF4 (L3) as supporting ligand (Scheme 2.6.43) 
Using modified method C, the crude difluoro alkenylgermane (86.2 mg, 0.125 mmol) 
from the photolysis of alkenylgermane 91 for 2 h with 8 equivalents of 
Cu(BF4)2·nH2O, TBAF (118.1 mg, 0.375 mmol), PdCl2(MeCN)2 (3.2 mg, 0.0125 
mmol), PCy3-HBF4 (6.9 mg, 0.0188 mmol), Hunig’s base (2.4 mg, 0.0188 mmol, 3.3 
L) 4-bromoacetophenone (49.9 mg, 0.250 mmol) and CuI (24.9 mg, 0.125 mmol) 
were employed. Purification by FC (hexane/EtOAc, 90/10) gave styrene 93c (12.5 
mg, 40 %) as a pale yellow solid. Analytical data as shown above. 
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Cross-coupling of styrenyl germane 92 with aryl bromides (Table 2.6.11) 
h , 2 h
Method C Ph
Ph
H
H
H
H
+
(E)-styrene 96 (Z)-styrene 96
Ph
Ge
C8F17
NpNp
(E)-alkenyl germanes 92
Ph
Ge
FF
C8F17
difluoro germanes
Br
R2
R2 R2
H
Ph
H
-styrene 96
R2
+
 
Table 2.6.11, entry 1: 3,5-Bis(trifluoromethyl)stilbene 96a246 
 
Using method C, the crude difluoro alkenylgermane (65.5 mg, 0.099 mmol) from the 
photolysis of alkenylgermane 92 for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(93.7 mg, 0.297 mmol), PdCl2(MeCN)2 (2.6 mg, 0.0099 mmol), P(2-Tol)3 (4.5 mg, 
0.0149 mmol), 3,5-bis-(trifluoromethyl)bromobenzene (58.0 mg, 0.198 mmol, 34.1 
L) and CuI (19.7 mg, 0.099 mmol) were employed. Purification by FC 
(hexane/EtOAc, 95/5) gave styrene 96a as a (E) : (Z) : (α) = 82 : 17 : 1 mixture of 
isomers (18.2 mg, 58 %) as a white solid. mp. 78-80 oC; 1H NMR (400 MHz): 5.56 
() (s, 1H, =CH), 5.69 () (s, 1H, =CH), 6.63 (Z) and 7.17 (E) (2 × d, J = 12.1 Hz 
and 16.3 Hz; 1H, =CH), 6.87 (Z) and 7.28 (E) (2 × d, J = 12.1 Hz and 16.3 Hz; 1H, 
=CH), 7.30-7.39 [(E)+(Z)+()] (m, 3H, ArH), 7.41-7.45 [(E)+(Z)+()] (m, 2H, ArH), 
7.96 [(Z)+()] and 7.97 (E) (s, 1H, ArH), 8.34 [(Z)+()] and 8.36 (E) (s, 2H, ArH); 
13C NMR (100.7 MHz; CDCl3): [(E)+(Z)+()]  120.8 (d), 123,4 (2s, 1JC-F = 272.9 
Hz, 2 × CF3), 125.5 (d), 126.2 (d), 126.9 (d), 127.4 (d), 128.3 (d), 128.8 (d), 128.9 
(d), 132.0 (2s, 2JC-F = 32.8 Hz), 132.5 (d), 136.0 (s), 139.4 (s), 140.4 (s); 19F NMR 
(376MHz; CDCl3):  -115.2 (s, 6F, 2 × CF3); IR max (neat): 3040, 1790, 1640, 1615, 
1495, 1380, 1280, 1170, 1130, 1110, 960, 895 cm-1; GC/MS analysis for (E)-isomer: 
retention time 9.02 min, m/z (EI+) 316 (M+, 100), 301 (30), 245 (520), 227 (20), 178 
(60); (Z)-isomer: retention time 7.57 min, m/z (EI+) 316 (M+, 100), 301 (30), 245 
(50), 226 (30), 178 (50); ()-isomer: retention time 7.42 min, m/z (EI+) 316 (M+, 
100), 247 (20), 227 (20), 178 (40); HRMS calc’d. for C16H10F6 316.0687, found 
316.0684 ( -0.9 ppm). 
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Table 2.6.11, entry 2: 4-Cyanostilbene 96b247 
 
Using method C, the crude difluoro alkenylgermane (65.5 mg, 0.099 mmol) from the 
photolysis of alkenylgermane 92 for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(93.7 mg, 0.297 mmol), PdCl2(MeCN)2 (2.6 mg, 0.0099 mmol), P(2-Tol)3 (4.5 mg, 
0.0149 mmol), 4-cyanobromobenzene (36.0 mg, 0.198 mmol) and CuI (19.7 mg, 
0.099 mmol) were employed. Purification by FC (hexane/EtOAc, 90/10) gave 
styrene 96b as a (E) : (Z) : (α) = 90 : 10 : 0 mixture of isomers (12.2 mg, 60 %) as a 
pale yellow solid. 1H NMR (400 MHz): 7.02 (Z) and 7.13 (E) (d, J = 11.2 Hz and 
16.4 Hz; 1H, =CH), 7.09 (Z) and 7.25 (E) (d, J = 11.2 Hz and 16.4 Hz; 1H, =CH), 
7.27-7.32 [(E)+(Z)] (m, 1H, ArH), 7.37 (E) and 7.40 (Z) (2 × t, J = 7.4 Hz and 7.4 Hz; 
2H, ArH), 7.43-7.55 [(E)+(Z)] (m, 6H, ArH); GC/MS analysis for (E)-isomer: 
retention time 11.95 min, m/z (EI+) 204 (M+, 100), 190 (50), 101 (30), 89 (30); 
(Z)-isomer: retention time 10.72 min, m/z (EI+) 204 (M+, 100), 190 (30), 100 (40), 
87 (30). 
 
Table 2.6.11, entry 3: 4-Acetylstilbene 96c248 
 
Using method C, the crude difluoro alkenylgermane (65.5 mg, 0.099 mmol) from the 
photolysis of alkenylgermane 92 for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(93.7 mg, 0.297 mmol), PdCl2(MeCN)2 (2.6 mg, 0.0099 mmol), P(2-Tol)3 (4.5 mg, 
0.0149 mmol), 4-bromoacetophenone (39.4 mg, 0.198 mmol) and CuI (19.7 mg, 
0.099 mmol) were employed. Purification by FC (hexane/EtOAc, 90/10) gave 
styrene 96c as a single isomer (12.2 mg, 60 %) as a pale yellow solid. 1H NMR (400 
MHz): 2.64 (s, 3H, CH3), 7.16 (d, J = 16.3 Hz, 1H, =CH), 7.27 (d, J = 16.3 Hz, 1H, 
=CH), 7.30-7.33 (m, 1H, ArH), 7.42 (d, J = 7.6 Hz, 2H, ArH), 7.58 (d, J = 7.6 Hz, 
 190
2H, ArH), 7.62 (d, J = 8.3 Hz, 2H, ArH), 7.99 (d, J = 8.3 Hz, 2H, ArH); m/z (EI+) 222 
(M+, 80), 207 (100), 178 (70), 152 (40), 104 (20); HRMS calc’d. for C16H14O 
222.1045, found 222.1044 ( -0.3 ppm). 
 
Table 2.6.11, entry 4: 4-Methylstilbene 96d247 
 
Using method C, the crude difluoro alkenylgermane (65.5 mg, 0.099 mmol) from the 
photolysis of alkenylgermane 92 for 2 h with 8 equivalents of Cu(BF4)2·nH2O, TBAF 
(93.7 mg, 0.297 mmol), PdCl2(MeCN)2 (2.6 mg, 0.0099 mmol), P(2-Tol)3 (4.5 mg, 
0.0149 mmol), 4-bromotoluene (33.9 mg, 0.198 mmol) and CuI (19.7 mg, 0.099 
mmol) were employed. Purification by FC (hexane/EtOAc, 90/10) gave styrene 96d 
as a (E) : (Z) : (α) = 99 : 1 : 0 mixture of isomers (12.2 mg, 60 %) as a pale yellow oil. 
1H NMR (400 MHz): 2.39 (s, 3H, CH3), 7.08 (d, J = 16.4 Hz, 1H, =CH), 7.13 (d, J 
= 16.4 Hz, 1H, =CH), 7.20 (d, J = 8.0 Hz, 2H, ArH), 7.27-7.30 (m, 1H, ArH), 7.38 (t, 
J = 7.6 Hz, 2H, ArH), 7.45 (t, J = 8.0 Hz, 2H, ArH), 7.53 (t, J = 7.6 Hz, 2H, ArH); 
The (Z)-isomer was not detected by 1H NMR. GC/MS analysis for (E)-isomer: 
retention time 10.48 min, m/z (EI+) 194 (M+, 80), 179 (100), 115 (40), 89 (30); 
(Z)-isomer: retention time 10.25 min, m/z (EI+) 194 (M+, 100), 179 (90), 115 (30), 
89 (20); HRMS calc’d. for C15H14 194.1096, found 194.1096 ( 0 ppm). 
 
4.3 Development of efficient ipso-iododegermylation as a method for 
radio-labelling 
4-Iodopropiophenone249 
 
4-Bromopropiophenone (5.0 g, 23.47 mmol), copper(I) iodide (234.0 mg, 1.17 mmol) 
and sodium iodide (7.04 g, 47.0 mmol) were suspended in 1,4-dioxane (20 mL). 
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N,N-Dimethylethylenediamine (200 mg, 2.35 mmol, 244 µl) was added to the 
reaction vessel and the contents heated to reflux for sixteen hours. After cooling, the 
resultant solution was diluted with saturated aqueous ammonia (50 mL) and 
extracted with CH2Cl2 (3 × 50 mL). The organic layers were dried over sodium 
sulfate and concentrated in vacuo to give 4-iodopropiophenone as white needles 
(5.96 g, 97 %). mp 56-58 °C; 1H NMR (270 MHz, CDCl3): δ 1.21 (t, J = 7.2 Hz, 3H, 
CH2CH3), 2.96 (q, J = 7.2 Hz, 2H, CH2CH3), 7.67 (d, J = 8.4 Hz, 2H, ArH), 7.82 (d, 
J = 8.4 Hz, 2H, ArH); IR (nujol): 1271, 1389, 1576, 1675, 2968 cm-1; m/z (EI+): 
260 (M+). HRMS calc’d. for C9H9IO 259.9698, found 259.9689 (∆ -3.4 ppm).  
 
1-(2,4-Dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3- 
carboxylic acid ethyl ester 106 
 
A solution of lithium hexamethyldisilazide (LHMDS) (16.6 mL, 1.0 M in hexanes, 
16.6 mmol) was placed into a two-necked flask fitted with a pressure-equalised 
dropping funnel and cooled to 0°C. 4-Iodopropiophenone (3.47 g, 13.3 mmol) was 
dissolved in methylcyclohexane (10 mL) and used to charge the dropping funnel, 
before being slowly added to the lithium hexamethyldisilazide over a period of 20 
min. The resultant solution was left to stir for 1 h before dropwise addition of a 
solution of diethyl oxalate (2.43 g, 16.6 mmol, 2.25 mL) in methylcyclohexane (5 
mL). A yellow suspension formed which was allowed to stir for 16 h. The yellow 
solid product deposited after this period was collected by filtration and washed 
extensively with cold ether to give an orange solid (3.6 g). A portion (2.9 g) of this 
solid was added over a period of 2 h to a solution of 2,4-dichlorophenyl hydrazine 
hydrochloride (1.67 g, 7.8 mmol) in 95 % ethanol (40 mL). 500 µL conc. 
hydrochloric was also added to the reaction mixture as a catalyst. The mixture was 
then allowed to stir for 16 h. The reaction broth was subsequently concentrated and 
re-dissolved in 20 mL of glacial acetic acid before heating to reflux for 16 h. After 
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this time the reaction was cooled and excess acetic acid removed under vacuum. The 
resultant crude product was dissolved in EtOAc and washed with water (20 mL) and 
brine (20 mL). The organic layer was dried over sodium sulfate and the solvent 
evaporated to give an orange solid. Purification by FC (hexane/EtOAc, 90/10) to 
yield pyrazole ethyl ester 106 as an orange solid (3.35 g, 85 %). mp. 153-155 °C. 1H 
NMR (270 MHz, CDCl3): δ 1.42 (t, J = 7.1 Hz, 3H, CH2CH3), 2.33(s, 3H, CH3), 4.45 
(q, J = 7.1 Hz, 2H, CH2CH3), 6.86 (d, J = 8.3, 2H, ArH), 7.20-7.46 (m, 3H, ArH), 
7.66 (d, J = 8.3, 2H, ArH). 13C NMR (67.5 MHz, CDCl3): δ 9.6 (q), 14.3 (q), 60.8 (t), 
95.0 (s), 119.0 (s), 123.1 (s), 127.7 (d), 128.0 (s), 130.0 (d), 131.1 (2d), 131.7 (2d), 
132.9 (s), 135.8 (s), 135.9 (s), 137.7 (d), 142.9 (s), 162.7 (s). IR max (neat): 3010, 
2915, 1710, 1490, 1430, 1385, 1360, 1300, 1250, 1190, 1100, 1020, 1000, 965, 870, 
650 cm-1; MS (ESI+): 501 (MH+), 523 (MNa+). HRMS calculated for 
C19H16N2O2Cl2I (MH+) 500.9643, found 500.9612 (∆ 4.2 ppm).  
 
1-(2,4-Dichlorophenyl)-5-(4-bromophenyl)-4-methyl-1H-pyrazole-3- 
carboxylic acid ethyl ester 111250 
 
The bromo pyrazole ethyl ester 111 was prepared by the same procedure described 
for the corresponding iodide above. Thus, 4-bromopropiophenone (4.5 g, 21.1 mmol), 
a solution of LHMDS (26.4 mL, 26.4 mmol, 1 M in hexanes), diethyl oxalate (3.85 g, 
26.4 mmol, 3.58 mL) and 2,4-dichlorophenyl hydrazine hydrochloride (4.96 g, 23.2 
mmol) were used. Purification by FC (hexane/EtOAc, 90/10) gave pyrazole ethyl 
ester 111 (8.44 g, 88 %) as an orange solid. 1H NMR (400 MHz, CDCl3): δ 1.40 (t, J 
= 7.2 Hz, 3H, OCH2CH3), 2.31 (s, 3H, CH3), 4.43 (q, J = 7.2 Hz, 2H, OCH2CH3), 
6.99 (d, J = 8.4 Hz, 2H, ArH), 7.27 (dd, J = 8.5, 2.0 Hz, 1H, ArH), 7.33 (d, J = 8.5 
Hz, 1H, ArH), 7.36 (d, J = 2.0 Hz, 1H, ArH), 7.44 (d, J = 8.4 Hz, 2H, ArH); 13C 
NMR (100.7 MHz, CDCl3): δ 9.6 (q), 14.4 (q), 60.9 (t), 119.1 (s), 123.2 (s), 127.4 (s), 
127.7 (d), 130.0 (d), 130.6 (d), 131.1 (2d), 131.7 (2d), 132.9 (s), 135.8 (s), 136.0 (s), 
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142.8 (s), 142.9 (s), 162.6 (s); IR max (neat): 3025, 2920, 1715, 1490, 1430, 1385, 
1365, 1300, 1240, 1190, 1100, 1020, 980, 965, 880, cm-1; MS (CI+) 455 (MH+, 100); 
HRMS (CI+) calc’d. for C19H16BrCl2N2O2 452.9772 [M(79Br)H+], found 452.9780 ( 
1.7 ppm). 
 
5-(4-Bromophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxylic 
acid 112251 
 
To a solution of pyrazole ethyl ester 111 (1.02 g, 2.246 mmol) in THF (15 mL) was 
added NaOH (2g, 50 mmol) and H2O (4 mL). The reaction mixture was refluxed at 
70 oC for 6 h and extracted with Et2O (3 × 50 mL). The combined organic extracts 
were dried over Na2SO4 and the solvent removed in vacuo. The residue was purified 
by recrystallisation to give pyrazole carboxylic acid 112 as a white solid (0.947 g, 99 
%); 1H NMR (400 MHz, CDCl3): 2.35 (s, 3H, CH3), 7.01 (d, J = 8.4 Hz, 2H, ArH), 
7.30 (dd, J = 8.5, 2.0 Hz, 1H, ArH), 7.34 (d, J = 8.5 Hz, 1H, ArH), 7.41 (d, J = 2.0 
Hz, 1H, ArH), 7.47 (d, J = 8.4 Hz, 2H, ArH); 13C NMR (100.7 MHz, CDCl3): 9.6 
(q), 119.6 (s), 123.5 (s), 127.2 (s), 127.9 (d), 130.2 (d), 130.5 (d), 131.1 (2d), 131.9 
(2d), 132.8 (s), 135.6 (s), 136.3 (s), 142.1 (s), 143.4 (s), 166.0 (s); m/z (CI+) (rel. 
intensity) 452 [M(79Br)H+, 100], 339 (60), 297 (20); HRMS (CI+) calc’d for 
C17H1279Br35Cl2N2O2 (MH)+ 424.9459, found 424.9447 ( -2.9 ppm). 
 
5-(4-Bromophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboylic 
acid tert-butyl ester 113 
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According to the method of Armstrong,252 to a solution of pyrazole carboxylic acid 
112 (0.947 g, 2.223 mmol) in CH2Cl2 (10 mL) was added tert-butyl 
2,2,2-trichloroacetimidate (TBTA, 1.215 g, 5.56 mmol) in cyclohexane (10 mL) and 
BF3-Et2O ( 27.3 L, 0.223 mmol) for 16 h at rt. The resulting mixture was extracted 
with Et2O (3 × 50 mL) and the combined organic extracts were dried over Na2SO4 
and the solvent removed in vacuo. The residue was purified by FC (Hexane/EtOAc, 
10/90) to give pyrazole carboxylic acid tert-butyl ester 113 as a colourless oil (0.911 
g, 85 %). 1H NMR (400 MHz, CDCl3):  1.63 (s, 9H, 3 × CH3), 2.28 (s, 3H, CH3), 
6.98 (d, J = 8.4 Hz, 2H, ArH), 7.29 (dd, J = 8.5, 2.0 Hz, 1H, ArH), 7.35 (d, J = 8.5 
Hz, 1H, ArH), 7.36 (d, J = 2.0 Hz, 1H, ArH), 7.44 (d, J = 8.4 Hz, 2H, ArH); 13C 
(100.7 MHz, CDCl3): 10.0 (q), 20.3 (3q), 81.8 (s), 118.3 (s), 123.1 (s), 127.3 (s), 
127.7 (d), 130.1 (d), 130.7 (d), 131.1 (2d), 131.8 (2d), 132.9 (s), 135.8 (s), 136.0 (s), 
142.7 (s), 144.5 (s), 162.0 (s); IR max (neat): 3010, 2915, 1710, 1490, 1430, 1385, 
1360, 1300, 1250, 1190, 1135, 1100, 1055, 1020, 965, 870 cm-1; m/z (CI+) (rel. 
intensity) 481 [M(79Br)H+, 80], 427 (55), 367 (50), 311 (30); HRMS (CI+) calc’d for 
C21H2079Br35Cl2N2O2 (MH)+ 481.0085, found 481.0089 ( 0.8 ppm). 
 
4-(2-Chloroethyl)phenol252 
 
According to the method of Ehrlich,252
 
4-(2-hydroxyethyl)phenol (8 g, 58 mmol) and 
conc. HCl (60 mL) were heated in a Carius tube at 100 °C for three hours. After 
cooling, the reaction mixture was poured into water (150 mL) and extracted with 
ether (100 mL). The combined extracts were dried over sodium sulfate and 
concentrated in vacuo to give a brown oil. Purification by FC (CH2Cl2) gave 
4-(2-chloroethyl)phenol as a pale brown oil (8.63 g, 98 %). 1H NMR (270 MHz, 
CDCl3): δ 2.98 (t, J = 7.1 Hz, 2H, CH2CH2Cl), 3.67 (t, J = 7.1 Hz, 2H, CH2CH2Cl) 
4.89 (br s, 1H, OH), 6.78 (d, J = 8.4 Hz, 2H, ArH), 7.09 (d, J = 8.4 Hz, 2H, ArH). 
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4-(2-Trichlorogermylethyl)phenol138 
 
According to the method of Turner,138 4-(2-chloroethyl)phenol (7.1 g, 45.3 mmol), 
and dichlorogermylene 1,4-dioxane complex 1 (10.5 g, 45.3 mmol) were heated 
together in a Carius tube at 150 °C for 16 h. After cooling to RT, the mixture was 
diluted with CH2Cl2 (100 mL) and added dropwise to water (100 mL). The resulting 
white precipitate was collected by filtration, washed with water (3 × 100 mL) then 
CH2Cl2 (3 × 100 mL) and dried under suction. The dried precipitate was dissolved in 
conc. hydrochloric acid (100 mL) and extracted with CH2Cl2 (3 × 50 mL). The 
combined organic extracts were dried over sodium sulfate and concentrated in vacuo 
to give 4-(2-trichlorogermylethyl)phenol as a colourless oil (12.50 g, 92 %). 1H 
NMR (400 MHz, CDCl3): δ 2.27-2.33 (m, 2H, ArCH2CH2GeCl3), 2.95-3.00 (m, 2H, 
ArCH2CH2GeCl3), 4.75 (br s, 1H, OH), 6.79 (d, J = 8.5 Hz, 2H, ArH), 7.10 (d, J = 
8.5 Hz, 2H, ArH). 
 
4-{2-[(4-Methoxyphenyl)dichlorogermyl]ethyl}phenol138 
 
To a solution of 4-(2-trichlorogermylethyl)phenol (6.0 g, 20.0 mmol) in THF (50.0 
mL) was added a solution of para-methoxyphenylmagnesiumbromide (200 mL, 
100.0 mmol, 0.5 M in THF).  The resulting reaction mixture was stirred at reflux for 
3 h. The yellow reaction mixture was cooled to 0 C before quenching dropwise with 
methanol until effervescence ceased. The reaction mixture was diluted with Et2O 
(20.0 mL) and washed with water (2 × 20.0 mL). The combined organic extracts 
were dried over sodium sulfate and the solvent was removed in vacuo to give 
tris-para-anisylgermyl phenol as a colourless oil. The tris-para-anisylgermyl phenol 
was then suspended in CH2Cl2 (50 mL) and conc. HCl (50.0 mL) added. The reaction 
mixture was stirred for 16 h and the solvent was then removed in vacuo to give 
4-{2-[(4-methoxyphenyl)dichlorogermyl]ethyl}phenol as a brown oil (7.42 g, 99 %). 
1H NMR (400 MHz, CDCl3): δ 2.03-2.10 (m, 2H, ArCH2CH2Ge), 2.80-2.89 (m, 2H, 
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ArCH2CH2Ge), 3.84 (s, 3H, OCH3), 4.82 (br s, 1H, OH), 6.73 (d, J = 8.4 Hz, 2H, 
ArH), 6.97 (d, J = 8.7 Hz, 2H, ArH), 7.07 (d, J = 8.4 Hz, 2H, ArH), 7.48 (d, J = 8.7 
Hz, 2H, ArH). 13C NMR (100.7 MHz, CDCl3): δ 27.8 (t), 28.6 (t), 55.4 (q), 114.6 
(2d), 115.5 (2d), 126.7 (s), 129.4 (2d), 133.8 (2d+s), 154.1 (s), 162.1 (s). 
 
4-{2-[(4-Methoxyphenyl)dimethylgermyl]ethyl}phenol 107138 
 
To a solution of 4-{2-[(4-methoxyphenyl)dichlorogermyl]ethyl}phenol (5.0 g, 13.45 
mmol) in THF (50 mL) was cooled to -40 oC and added a solution of MeLi (25.2 mL, 
40.34 mmol, 1.6 M in Et2O). The solution was allowed to warm up to RT for 16 h 
before quenching with the cautious addition of sat. NH4Cl solution. The crude 
product was extracted from the resulting biphasic mixture with Et2O (3 × 200 mL), 
dried over sodium sulfate and concentrated in vacuo. Purification by FC 
(hexane/EtOAc, 50/50) gave dimethylgermyl phenol 107 as a yellow oil (3.83 g, 86 
%). 1H NMR (400 MHz, CDCl3): δ 0.34 (s, 6H, 2 × CH3), 1.20-1.27 (m, 2H, 
ArCH2CH2Ge), 2.59-2.67 (m, 2H, ArCH2CH2Ge), 3.82 (s, 3H, OCH3), 4.64 (br s, 1H, 
OH), 6.73 (d, J = 8.5 Hz, 2H, ArH), 6.92 (d, J = 8.5 Hz, 2H, ArH), 7.04 (d, J = 8.5 
Hz, 2H, ArH), 7.38 (d, J = 8.5 Hz, 2H, ArH); 13C NMR (100.7 MHz; CDCl3):  -3.6 
(2q), 18.1 (t), 30.1 (t), 55.1 (q), 113.8 (2d), 115.1 (2d), 128.9 (2d), 132.1 (s), 134.4 
(2d), 136.9 (s), 153.4 (s), 159.8 (s); m/z (EI+) 332 (M+, 5), 317 (20), 224 (50), 211 
(100), 197 (50), 121 (30), 84 (70); HRMS calc’d. for C17H2274GeO2 332.0832, found 
332.0831 ( -0.2 ppm). 
 
4-[2-Dimethyl(4-methoxyphenyl)germylethyl]phenyl ethoxyethyl ether138 
Ge
OMeO
Chemical Formula: C21H30GeO3
Exact Mass: 404.1407
Molecular Weight: 403.1011O  
To a solution of dimethylgermyl phenol 107 (1.52 g, 4.59 mmol) in DMF (10 mL) 
was added K2CO3 (3.17 g, 23.0 mmol), tributylammonium iodide (TBAI) (169.4 mg, 
0.46mmol) and 2-chlorodiethylether (4.98 g, 46.0 mmol, 5.04 mL). The reaction 
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mixture was warmed to 80 oC for 24 h, diluted with Et2O (20.0 mL), and a solution of 
1.0 M NH4Cl was added to the reaction mixture until no effervescence occurred. 
Following extraction with Et2O(2 × 20.0 mL), the combined organic extracts were 
dried over sodium sulfate and evaporated in vacuo to give yellow oily residue which 
was purified by FC (hexane/EtOAc, 90/10) to give pure 
4-[2-Dimethyl(4-methoxyphenyl)germylethyl]phenyl ethoxyethyl ether  as a pale 
yellow oil (1.46 g, 79 %). 1H NMR (400 MHz, CDCl3): δ 0.34 (s, 6H, 2 × CH3), 
1.20-1.28 (m, 5H, ArCH2CH2Ge + OCH2CH3), 2.60-2.66 (m, 2H, ArCH2CH2Ge), 
3.60 (q, J = 7.0 Hz, 2H, OCH2CH3), 3.78 (t, J = 5.0 Hz, OCH2), 3.82 (s, 3H, OCH3), 
4.01 (t, J = 5.0 Hz, OCH2), 6.83 (d, J = 8.6 Hz, 2H, ArH), 6.92 (d, J = 8.4 Hz, 2H, 
ArH), 7.07 (d, J = 8.6 Hz, 2H, ArH), 7.38 (d, J = 8.4 Hz, 2H, ArH), 13C NMR (100.7 
MHz; CDCl3):  -3.5 (q), 15.2 (q), 18.2 (t), 30.2 (t), 55.1 (q), 66.9 (t), 67.5 (t), 69.1 
(t), 113.8 (2d), 114.6 (2d), 128.7 (2d), 132.0 (s), 134.5 (2d), 137.1 (s), 156.9 (s), 
159.9 (s); m/z (EI+) 403 (M+, 20), 388 (30), 211 (100), 193 (40); HRMS calcd for 
C21H3074GeO3 404.1407, found 404.1401 ( -1.5 ppm). 
 
Bromo-{2-[4-(2-ethoxyethoxy)phenyl]ethyl}(4-methoxyphenyl)- 
dimethylgermane 108 
 
To a solution of 4-[2-Dimethyl(4-methoxyphenyl)germylethyl]phenyl ethoxyethyl 
ether (3.87 g, 9.6 mmol) in CH2Cl2 (20 mL) was addd of conc. HBr (3.0 mL, 48% 
wt.). The resulting biphasic reaction mixture was stirred for 16 h at RT, before being 
extracted with CH2Cl2 (3 × 20). The combined organic extracts were dried over 
Na2SO4 and the solvent removed in vacuo to give bromo germane 108 as a yellow oil 
(3.57g, 99 %). 1H NMR (400 MHz, CDCl3): 0.73 (s, 6H, 2 × GeCH3), 1.24 (t, J = 
7.0 Hz, 3H, OCH2CH3), 1.54-1.59 (m, 2H, GeCH2CH2), 2.76-2.85 (m, GeCH2CH2), 
3.60 (q, J = 7.0 Hz, 2H, OCH2CH3), 3.78 (t, J = 5.0 Hz, 2H, OCH2CH2O), 4.10 (t, J 
= 5.0 Hz, 2H, OCH2CH2O), 6.86 (d, J = 8.7 Hz, 2H, ArH), 7.11 (d, J = 8.7 Hz, 2H, 
ArH); 13C (100.7 MHz, CDCl3): 4.1 (2q), 15.2 (q), 23.9 (t), 29.6 (t), 66.8 (t), 67.5 
(t), 69.0 (t), 114.7 (2d), 128.9 (2d), 135.0 (s), 157.2 (s); IR max (neat): 3010, 2875, 
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1600, 1580, 1510, 1500, 1455, 1280, 1250, 1105, 1050, 985, 860 cm-1; MS (EI+) (rel. 
intensity) 376 [M(79Br)+, 40], 348 (20), 224 (10), 193 (100), 179 (25), 121 (60); 
HRMS (EI+) calc’d for C14H2379Br74GeO2 376.0093, found 376.0085 ( -2.2 ppm). 
 
1-(2,4-Dichlorophenyl)-5-[4-({2-[4-(2-ethoxyethoxy)phenyl]ethyl}- 
dimethylgermyl)phenyl]-4-methyl-1H-pyrazole-3-carboxylic acid tert-butyl ester 
114 
 
Method F: to a solution of iPrMgCl (100 L, 0.2 mmol, 2 M in THF) in THF (5.0 
mL) at 0 oC was added a solution of nBuLi (160 L, 0.4 mmol, 2.5 M in hexanes) 
dropwise. After stirring at this temperature for 30 min a bimetallic iPrnBu2MgLi 
complex (0.04 M in THF) was formed as a pale yellow solution.217 In a separate flask, 
a solution of pyrazole carboxylic acid tert-butyl ester 113 (56.3 mg, 0.117 mmol) and 
bromo germane 108 (51.2 mg, 0.136 mmol) in THF (10 mL) was cooled to -78 oC 
and the iPrnBu2MgLi solution (3.5 mL, 0.14 mmol, 0.04 M in THF) added to this 
dropwise. The resulting mixture was stirred at this temperature for 2 h and warmed to 
RT for 14 h. The mixture was diluted with Et2O (50 mL) and a solution of 1.0 M 
NH4Cl was added to the reaction mixture until no effervescence occurred. Following 
extraction with Et2O (3 × 20 mL), the combined the organic extracts were dried over 
Na2SO4 and the solvent removed in vacuo. The residue was purified by FC 
(EtOAc-Hexane, 15/85) to give germyl pyrazole-3-carboxylic acid tert-butyl este 114 
as a pale yellow oil (32.7 mg, 40 %). 1H NMR (400 MHz, CDCl3): 0.33 (s, 6H, 2 × 
GeCH3), 1.20-1.26 (m, 5H, CH3+GeCH2CH2), 1.64 [s, 9H, (CH3)3], 2.30 (s, 3H, 
CH3), 2.57-2.64 (m, 2H, GeCH2CH2), 3.60 (q, J = 7.0 Hz, 2H, OCH2CH3), 3.78 (t, J 
= 5.0 Hz, OCH2CH2O), 4.09 (t, J = 5.0 Hz, 2H, OCH2CH2O), 6.82 (d, J = 8.6 Hz, 2H, 
ArH), 7.03 (d, J = 8.6 Hz, 2H, ArH), 7.07 (d, J = 8.0 Hz, 2H, ArH), 7.27 (dd, J = 8.4, 
2.3 Hz, 1H, ArH), 7.35 (d, J = 8.0 Hz, 2H, ArH), 7.37 (d, J = 8.6 Hz, 2H, ArH); 13C 
(100.7 MHz, CDCl3): -3.8 (2q), 10.1 (q), 15.2 (q), 17.9 (t), 28.3 (3q), 30.1 (t), 66.8 
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(t), 67.5 (t), 69.0 (t), 81.7 (s), 114.5 (2d), 118.1 (s), 127.6 (d), 128.6 (2d), 128.9 (2d), 
130.0 (d), 130.8 (s), 130.9 (d), 133.1 (s), 133.2 (2d), 135.5 (s), 136.4 (s), 136.7 (s), 
142.4 (s), 143.9 (s), 144.4 (s), 156.9 (s), 162.2 (s); IR max (neat): 3010, 2920, 1715, 
1580, 1510, 1430, 1360, 1320, 1300, 1250, 1135, 1100, 1055, 1020, 965, 870; 
HRMS (ESI) calc’d for C35H4235Cl274GeN2O4Na (MNa)+ 721.1631, found 721.1617 
( -1.9 ppm). 
Method G: A solution of pyrazole carboxylic acid tert-butyl ester 113 (523.0 mg, 
1.085 mmol) containing 3 Å MS (200 mg) and bromo germane 108 (611 mg, 1.626 
mmol) in THF (10 mL) was cooled to -78 oC and a solution of t-BuLi (1.74 mL, 
2.436 mmol, 1.4 M in pentane) was added dropwise. The resulting mixture was 
stirred at this temperature for 2 h and warmed up to RT for 4 h. The mixture was 
diluted with Et2O (50 mL) and a solution of 1.0 M NH4Cl was added to the reaction 
mixture until no effervescence occurred. Following extraction with Et2O (3 x 20 mL), 
combined the organic extracts were dried over Na2SO4 and the solvent removed in 
vacuo. The residue was purified by FC (EtOAc-Hexane, 15/85) to give germyl 
pyrazole-3-carboxylic acid tert-butyl ester 114 as a pale yellow oil (393.9 mg, 52 %). 
Analytical data as shown above. 
 
1-(2,4-Dichloro-phenyl)-5-[4-({2-[4-(2-ethoxyethoxy)phenyl]ethyl}dimethylgerm
yl)phenyl]-4-methyl-1H-pyrazole-3-carboxylic acid morpholin-4-ylamide 115 
 
According to the method of Lan,209 to a solution of germyl pyrazole-3-carboxylic 
acid tert-butyl ester 114 (200 mg, 0.286 mmol) and N-aminomorpholine (43.82 mg, 
41.4 L, 0.429 mmol) in THF (5 mL) was added a solution of LHMDS (429 L, 
0.429 mmol, 1.0 M in hexanes) dropwise and stirred for 2 h at RT. The reaction 
mixture was diluted with Et2O (10 mL) and a solution of 1.0 M NH4Cl was added to 
the reaction mixture until no effervescence occurred. Following extraction with Et2O 
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(3 × 10 mL), the combined the organic extracts were dried over Na2SO4 and the 
solvent removed in vacuo. The residue was purified by FC (EtOAc-Hexane, 50/50) 
to give germyl pyrazole-3-carboxylic acid morpholin-4-ylamide 115 as a yellow oil 
(197.3 mg, 95 %). 1H NMR (400 MHz, CDCl3): 0.33 (s, 6H, 2 × GeCH3), 
1.20-1.26 (m, 5H, CH3+GeCH2CH2), 2.38 (s, 3H, CH3), 2.57-2.64 (m, 2H, 
GeCH2CH2), 2.93-2.97 [m, 4H, N(CH2)2], 3.59 (q, J = 7.0 Hz, 2H, OCH2CH3), 3.77 
(t, J = 5.0 Hz, 2H, OCH2CH2O), 3.84-3.87 [m, 4H, O(CH2)2], 4.08 (t, J = 5.0 Hz, 2H, 
OCH2CH2O), 6.81 (d, J = 8.5 Hz, 2H, ArH), 7.02 (d, J = 8.5 Hz, 2H, ArH), 7.07 (d, J 
= 7.9 Hz, 2H, ArH), 7.27-7.30 (m, 2H, ArH), 7.37 (d, J = 7.9 Hz, 2H, ArH), 7.43 (d, 
J = 1.1 Hz, 1H, ArH), 7.72 (s, 1H, NH); 13C (100.7 MHz, CDCl3): -3.8 (2q), 9.4 (q), 
15.1 (q), 17.8 (t), 30.0 (t), 56.0 (2t), 66.5 (2t), 66.8 (t), 67.4 (t), 69.0 (t), 114.5 (2d), 
118.1 (s), 127.7 (d), 128.2 (s), 128.6 (2d), 128.7 (2d), 130.2 (d), 130.6 (d), 133.1 (s), 
133.3 (2d), 135.7 (s), 136.1 (s), 136.6 (s), 142.6 (s), 143.9 (s), 144.2 (s), 156.9 (s), 
160.3 (s); IR (KBr): 3200, 3010, 2920, 2850, 1680, 1525, 1500, 1480, 1385, 1350, 
1240, 1120, 1050, 965, 910, 810, 725 cm-1; HRMS (ESI) calc’d for 
C35H4335Cl274GeN4O4 (MH)+ 727.1873, found 727.1890 ( 2.3 ppm). 
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Screening conditions for ipso-iododegermylation in solution phase (Table 3.4.1) 
 
Entry Conditionsa Yield (%) 
1 NaI, chloramine T, AcOH, 16 h, RT 0c 
2 I2, CCl4, 16 h, RT 0c 
3 NaI, FeCl3, 16 h, RT 0c 
4 ICl, 16 h, RT 0c 
5 NH4I, Oxone, 16 h, RT 0c 
6 NaI, 3-CPBA, 16 h, RTb 0d 
7 NaI, AcO2H, AcOH, 16 h, RTb 0d 
8 I2, 3-CPBA, HOAcb 0d 
9 NIS, TFA (cat.), HOAc, 16 h, RT 0d 
10 I2, HOAc, RT, 16 h 15e 
11 I2, TFA-HOAc, 16 h, RTf 63e 
12 NaI, NCS,TFA-AcOH, 30 min, RTf 85 
aAll reactions were carried out with 2 eq of reagents. bslow addition of peracids in CH2Cl2 (50 L/min 
for 30 min) cNo reaction occurred, recovery of S.M. dDecomposition of S.M. econcomitant with 
by-product 116. f TFA-HOAc (1:3 v/v). 
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Representative procedures for screening ipso-iododegermylation conditions: 
1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic 
acid morpholin-4-ylamide AM281 (105a)209 and  
1-(2,4-dichlorophenyl)-4-methyl-5-phenyl-1H-pyrazole-3-carboxylic acid 
morpholin-4-ylamide 116 
 
Entry 10:  
To a solution of germyl pyrazolyl morpholin-4-ylamide 115 (20 mg, 27.54 mol) in 
HOAc (5mL) was added I2 (14 mg, 55.12 mol). The reaction mixture was stirred at 
RT for the indicated time until complete consumption of starting material 115 as 
monitored by TLC. The resulting mixture was diluted with CH2Cl2 (10 mL) and H2O 
(10 mL), followed by addition of solid NaS2O5 until a colourless solution formed. At 
this point, the pH of the solution was adjusted with solid K2CO3 to pH 8.0. The 
mixture was then extracted with CH2Cl2 (3 × 10 mL) and the combined organic 
extracts were dried over Na2SO4 and the solvent removed in vacuo. The residue was 
purified by FC (EtOAc-Hexane, 50/50) to afford: 
Iodinated pyrazole-3-carboxylic acid morpholin-4-ylamide AM281 (105a) as an 
orange solid ( 2.3 mg, 15 %). 1H NMR (400 MHz, CDCl3): 2.34 (s, 3H, CH3), 
2.90-2.94 [m, 4H, N(CH2)2], 3.80-3.85 [m, 4H, O(CH2)2], 6.83 (d, J = 8.4 Hz, 2H, 
ArH), 7.27-7.29 (m, 2H, ArH), 7.41 (d, J = 1.9 Hz, 1H, ArH), 7.63 (d, J = 8.4 Hz, 2H, 
ArH), 7.69 (s, 1H, NH); 13C (100.7 MHz, CDCl3): 9.2 (q), 55.9 (2t), 66.4 (2t), 95.1 
(s), 118.2 (s), 127.9 (d), 128.0 (s), 130.3 (d), 130.5 (d), 131.0 (2d), 132.8 (s), 135.7 
(s), 136.0 (s), 137.7 (2d), 143.1 (s), 144.0 (s), 160.0 (s); HRMS (ESI) calc’d for 
C21H20Cl2IN4O2 (MH)+ 557.0008, found 557.0022 ( 2.5 ppm).  
Protodegermylation by-product 116  as a pale yellow solid (1.2 mg, 10 %). 1H 
NMR (400 MHz, CDCl3): 2.36 (s, 3H, CH3), 2.93-2.97 [m, 4H, N(CH2)2], 
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3.84-3.86 [m, 4H, O(CH2)2], 7.08-7.14 (m, 2H, ArH), 7.26 (m, 2H, ArH), 7.28-7.32 
(m, 3H, ArH), 7.40(s, 1H, ArH), 7.73 (s, 1H, NH); 13C (100.7 MHz, CDCl3): 9.3 
(q), 56.0 (2t), 66.4 (2t), 118.0 (s), 127.7 (d), 128.3 (s), 128.4 (2d), 128.7 (d), 129.5 
(2d), 130.2 (d), 130.5 (d), 133.0 (s), 135.8 (s), 136.0 (s), 143.8 (s), 144.2 (s), 160.3 
(s); HRMS (ESI) calc’d for C21H21Cl2N4O2 (MH)+ 431.1042, found 431.1044 ( 0.5 
ppm). 
 
Entry 11: 
To a solution of germyl pyrazolyl morpholin-4-ylamide 115 (25.2 mg, 34.7 mol) in 
TFA-HOAc (5 mL, 1:3 v/v) was added I2 (17.6 mg, 69.5 mol). The reaction mixture 
was stirred at RT for the indicated time until complete consumption of starting 
material 115 as monitored by TLC. The resulting mixture was diluted with CH2Cl2 
(10 mL) and H2O (10 mL), followed by addition of solid NaS2O5 until a colourless 
solution formed. At this point, the pH of the solution was adjusted with solid K2CO3 
to pH 8.0. The mixture was then extracted with CH2Cl2 (3 × 10 mL) and the 
combined organic extracts were dried over Na2SO4 and the solvent removed in vacuo. 
The residue was purified by FC (EtOAc-Hexane, 50/50) to afford iodinated pyrazole 
AM281 (105a) as an orange solid (12.2 mg, 63 %) and protodegermylation 
by-product 116 (1.5 mg, 10 %). Analytical data as shown above. 
 
Entry 12: 
To a solution of germyl pyrazolyl morpholin-4-ylamide 115 (23.0 mg, 31.7 mol) 
and NaI (9.5 mg, 63.5 mol) in TFA-HOAc (5 mL, 1:3 v/v) were added NCS (8.5 mg, 
63.5 mol) and stirred for 30 min at RT. The resulting mixture was diluted with 
CH2Cl2 (10 mL) and H2O (10 mL), followed by addition of solid NaS2O5 until a 
colourless solution formed. At this point, the pH of the solution was adjusted with 
solid K2CO3 to pH 8.0. Purification by FC (EtOAc-Hexane, 50/50) gave desired 
iodinated pyrazole-3-carboxylic acid morpholin-4-ylamide AM281 (105a) as an 
orange solid (20.8 mg, 85 %). No protodegermylation by-product 116 was found 
under the conditions. Analytical data as shown above. 
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HypoGel-Br 117138 
 
To a suspension of HypoGel-200-OH (20.0 g, LL = 0.8 mmol g-1, 16.0 mmol) in 
CH2Cl2 at 0 oC was added triphenylphosphine (8.34 g, 32 mmol) and carbon 
tetrabromide (21.22 g, 64 mmol). The resulting yellow suspension was warmed to 
RT and stirred for 24 h. The solvent was then removed by filtration and the resin was 
washed with H2O (3 × 100 mL), MeOH (3 × 100 mL), THF (3 × 100 mL) and 
CH2Cl2 (3 × 100 mL). The resulting resin as dried in vacuo at 50 oC for 16 h to 
furnish bromo resin 117 as yellow grains (21.0 g, LL = 0.8 mmol g-1 was determined 
by the weight increase of the resin); IR max (KBr): 3060, 3020, 2890, 1944, 1875, 
1805, 1750, 1600, 1490, 1455, 1355, 1295, 1105. 980, 890 cm-1. 
 
HypoGel-dimethylgermyl bromide 118 
BrGe
H
O
 
A suspension of HypoGel-Br 117 (5.0 g, LL = 0.8 mmol g-1, 4 mmol), K2CO3 (2.76 
g, 20 mmol), TBAI (1.48 g, 4 mmol) and dimethylgermyl phenol 107 (3.31 g, 10 
mmol) in DMF (15 mL) was heated to 80 oC for 24 h. The solvent was removed by 
filtration and the resin was then washed with H2O (3 × 20 mL), MeOH (3 × 20 mL), 
THF (3 × 20 mL) and CH2Cl2 (3 × 20 mL). The resulting dimethyl-4-anisolyl germyl 
resin was swollen in CH2Cl2 (20 mL) and conc. HBr (2.0 mL, 48% wt.) added. The 
reaction mixture was stirred for 16 h at RT followed by filtration to remove the 
solvent. The resin was successively rinsed with H2O (3 × 20 mL), MeOH (3 × 20 
mL), THF (3 × 20 mL) and CH2Cl2 (3 × 20 mL) and then dried in vacuo at 50 oC for 
16 h to give dimethylgermyl bromide resin 118 as light brown granules (5.84 g, LL = 
0.75 mmol g-1 as determined by the mass of anisole by-product recovered). IR max 
(KBr): 3050, 3010, 2930, 1950, 1840, 1600, 1450, 1110, 960, 850 cm-1. 
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HypoGel-dimethylgermylpyrazole-tert-butyl ester 119 
Ge
N
N
Me
Cl
Cl
O
OtBu
H
O
 
To a suspension of HypoGel-dimethylgermyl bromide 118 (5.0 g, LL = 0.75 mmol 
g-1, 3.75 mmol) and pyrazole carboxylic acid tert-butyl ester 113 (3.62 g, 7.5 mmol) 
in THF (20 mL) was cooled to -78 oC and a solution of t-BuLi (6.03mL, 8.44 mmol, 
1.4 M in pentane) added dropwise. The reaction mixture was stirred at this 
temperature for 2 h, warmed to RT and stirred for further 14 h. A solution of 1.0 M 
NH4Cl was added until no effervescence occurred, and then the solvent was removed 
by filtration and the resin was then washed with H2O (3 × 20 mL), MeOH (3 × 20 
mL), THF (3 × 20 mL) and CH2Cl2 (3 × 20 mL) to afford 
dimethylgermyl-pyrazole-tert-butyl ester resin 119 as brown granules (5.66 g, 55 % 
conversion was determined by the weight increase of the resin and the mass of 
recovered debrominated pyrazole carboxylic acid tert-butyl ester, LL = 0.42 mmol 
g-1); IR max (KBr): 3050, 3010, 2920, 1940, 1830, 1670, 1650, 1600, 1505, 1455, 
1242, 1100, 980, 860 cm-1. 
 
General procedure for the preparation of HypoGel- aryl pyrazolyl germanes 120 
(Scheme 3.4.9) 
HypoGel-dimethylgermyl-pyrazole carboxylic acid morpholin-4-ylamide 120a 
 
To a suspension of HypoGel- dimethylgermyl-pyrazole-tert-butyl ester 119 (0.5 g, 
0.21 mmol, LL = 0.42 mmol g-1) and N-aminomorpholine (107.3 mg, 101 L, 1.05 
mmol) in THF (5 mL) was assed a solution of LHNDS (1.16 L, 1.16 mmol, 1.0 M 
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in THF) dropwise and the resulting suspension stirred for 16 h at RT. The solvent 
was removed by filtration and the resin was then washed with H2O (3 × 20 mL), 
MeOH (3 × 20 mL), THF (3 × 20 mL) and CH2Cl2 (3 × 20 mL) to afford pyrazole 
morpholin-4-ylamide resin 120a as brown grains [0.5 g, LL = 0.42 mmol g-1, as 
determined by swelling a sample of the resin (30.0 mg) in CH2Cl2 and adding of 
conc. HBr (1.0 mL, 48% wt.) for 1 h at RT to achieve the protonolysis of the resin to 
give corresponding protonated pyrazolyl morpholin-4-ylamide 116 (5.4 mg, 12.52 
mmol)]. IR (KBr): 3450 (brs), 3020, 1945, 1800, 1670, 1655, 1600, 1560, 1450, 
1350, 1300, 1245, 1195, 1100, 860, 755 cm-1 
 
HypoGel-dimethylgermyl-pyrazole carboxylic acid piperidin-1-ylamide 120b 
 
Using the general procedure, HypoGel- dimethylgermyl-pyrazole-tert-butyl ester 
119 (0.45 g, 0.189 mmol, LL = 0.42 mmol g-1), N-aminopiperdine (94.7 mg, 102 L, 
0.945 mmol) and a solution of LHMDS (1.04 mL, 1.04 mmol, 1.0 M in hexanes) 
were employed. The solvent was removed by filtration and the resin was washed 
successively with H2O (3 × 20 mL), MeOH (3 × 20 mL), THF (3 × 20 mL) and 
CH2Cl2 (3 × 20 mL) to give pyrazole piperidin-1-ylamide resin 120b as brown grains 
(0.45 g, LL = 0.42 mmol g-1). IR (KBr): 3420 (brs), 3020, 1940, 1875, 1805, 1690, 
1600, 1500, 1490, 1350, 1300, 1245, 1200, 1100, 890, 755 cm-1. 
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HypoGel-dimethylgermyl-pyrazole carboxylic acid N',N'-dimethylhydrazide 
120c 
 
Using the general procedure, HypoGel- dimethylgermyl-pyrazole-tert-butyl ester 
119 (0.5 g, 0.21 mmol, LL = 0.42 mmol g-1), N',N'-dimethylhydrazine (63.1 mg, 80 
L, 1.05 mmol) and a solution of LHMDS (1.16 L, 1.16 mmol, 1.0 M in hexanes) 
were employed. The solvent was removed by filtration and the resin was washed 
successively with H2O (3 × 20 mL), MeOH (3 × 20 mL), THF (3 × 20 mL) and 
CH2Cl2 (3 × 20 mL) to afford pyrazole N',N'-dimethylhydrazide resin 120c as brown 
grains (0.5 g, LL = 0.42 mmol g-1). IR (KBr): 3450 (brs), 3020, 2920, 1940, 1870, 
1800, 1670, 1600, 1500, 1490, 1455, 1350, 1245, 1110, 900, 755 cm-1. 
 
HypoGel-dimethylgermyl-pyrazole carboxylic acid cyclohexylamide 120d 
 
Using the general procedure, HypoGel- dimethylgermyl-pyrazole-tert-butyl ester 
119 (0.5 g, 0.21 mmol, LL = 0.42 mmol g-1), 4-fluoroaniline (104 mg, 120 L, 1.05 
mmol) and a solution of LHMDS (1.16 L, 1.16 mmol, 1.0 M in hexanes) were 
employed. The solvent was removed by filtration and the resin was washed 
successively by H2O (3 × 20 mL), MeOH (3 × 20 mL), THF (3 × 20 mL) and CH2Cl2 
(3 × 20 mL) to give pyrazole cyclohexylamide resin 120d as brown grains (0.45 g, 
LL = 0.38 mmol g-1). IR (KBr): 3420 (brs), 3050, 3010, 2920, 1945, 1875, 1800, 
1650, 1600, 1500, 1455, 1350, 1245, 1195, 1100, 765 cm-1. 
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HypoGel-dimethylgermyl-pyrazole carboxylic acid 4-fluorophenylamide 120e 
 
Using the general procedure, HypoGel-dimethylgermyl-pyrazole-tert-butyl ester 
119 (0.5 g, 0.21 mmol, LL = 0.42 mmol g-1), cyclohexylamine (116.7 mg, 100 L, 
1.05 mmol) and a solution of LHMDS (1.16 L, 1.16 mmol, 1.0 M in hexanes) were 
employed. The solvent was removed by filtration and the resin was washed 
successively with H2O (3 × 20 mL), MeOH (3 × 20 mL), THF (3 × 20 mL) and 
CH2Cl2 (3 × 20 mL) to afford pyrazole 4-fluorophenylamide resin 120e as dark red 
grains (0.43 g, LL = 0.35 mmol g-1). IR (KBr): 3380 (brs), 3045, 3015, 2920, 1945, 
1870, 1805, 1645, 1600, 1500, 1455, 1350, 1300, 1245, 1100, 785 cm-1. 
 
Rapid preparation of iodinated cannabinoid receptor ligands through 
ipso-iododegermylation (Table 3.4.2) 
 
Entry Substrate Time (h) Product Yield (%) Overall yield (%) 
1 120a 1 AM281 (105a) 63 38 
2 120b 1 AM251 (105b) 60 33 
3 120c 1 105c 60 33 
4 120d 1 105d 55 28 
5 120e 6 105e 42 19 
6 120b 5 min AM251 (105b) 8 (1st run) 4.4 
7 120b 5 min AM251 (105b) 5 (2nd run) 2.8 
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Typical procedure for ipso-iododegermylation: 
1-(2,4-Dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic 
acid morpholin-4-ylamide AM281 (105a) 
Entry 1: 
Pyrazole morpholin-4-ylamide resin 120a (52 mg, 0.022 mol, LL = 0.42 mmol g-1) 
and NaI (16.4 mg, 0.11 mmol) were suspended in CH2Cl2 (0.5 mL) in a cartridge and 
a solution of NCS (11.7 mg, 0.087 mmol) in TFA-HOAc (5 mL, 1:3 v/v) were added. 
The reaction mixture was shaken at RT for the indicated time. The solvent was 
removed by filtration and the resin washed with H2O (3 × 10 mL) and CH2Cl2 (3 × 
10 mL). Solid Na2SO5 was then added to the collected organic filtrate until a 
colourless solution formed. The pH of this solution was adjusted to pH 8.0 with 
K2CO3. The mixture was extracted with CH2Cl2 (3 × 10 mL) and combined organic 
extracts were dried over Na2SO4 and the solvent removed in vacuo. The residue was 
purified by FC (hexane/EtOAc, 50/50) to afford iodinated pyrazole-3-carboxylic 
acid morpholin-4-ylamide AM281 (105a) as a white solid (7.7 mg, 63 %). Analytical 
data as shown above. 
 
1-(2,4-Dichloro-phenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic 
acid piperidin-1-ylamide AM251 (105b)221 
Entry 2:  
 
Using the typical procedure described for entry 1, pyrazole piperidin-1-ylamide resin 
120b (55.2 mg, 0.023 mmol, LL = 0.42 mmol g-1), NaI (17.2 mg, 0.115 mmol) and 
NCS (12.3 mg, 0.092 mmol) were employed. The collected organic filtrate was 
analyzed by HPLC prior to purification by FC (hexane/EtOAc, 50/50) to give 
iodinated pyrazole-3-carboxylic acid piperidin-1-ylamide AM251 (105b) (7.7 mg, 
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60 %) as a pale yellow solid. 1H NMR (400 MHz, CDCl3): 1.34-1.47 (m, 2H, CH2), 
1.67-1.77 (m, 4H, 2xCH2), 2.35 (s, 3H, CH3), 2.76-2.92  [m, 4H, N(CH2)2], 6.84 (d, 
J = 8.4 Hz, 2H, ArH), 7.27-7.30 (m, 2H, ArH), 7.42 (d, J = 1.8 Hz, 2H, ArH), 7.64 (d, 
J = 8.4 Hz, 3H, NH+ArH); 13C (100.7 MHz, CDCl3): 9.3 (q), 23.3 (t), 25.4 (2t), 
57.1 (2t), 95.0 (s), 118.2 (s), 127.9 (d), 128.2 (s), 130.3 (d), 130.5 (d), 131.1 (2d), 
132.9 (s), 135.8 (s), 135.9 (s), 137.7 (2d), 143.0 (s), 144.4 (s), 160.0 (s); HRMS (ESI) 
calc’d for C22H22Cl2IN4O (MH)+ 555.0215, found 555.0227 ( 2.2 ppm). 
 
1-(2,4-Dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic 
acid N',N'-dimethylhydrazide 105c 
Entry 3: 
 
Using the typical procedure described for entry 1, N',N'-dimethylhydrazide resin 
120c (43 mg, 0.018 mmol, LL = 0.42 mmol g-1), NaI (13.5 mg, 0.09 mmol) and NCS 
(9.6 mg, 0.072 mmol) were employed. Purification by FC (EtOAc/Hexane, 50/50) 
gave iodinated pyrazole-3-carboxylic acid N',N'-dimethyl-hydrazide 105c as a white 
solid (5.5 mg, 60 %). 1H NMR (400 MHz, CDCl3): 2.33 (s, 3H, CH3), 2.67 [s, 6H, 
N(CH3)2], 6.82 (d, J = 8.3 Hz, 2H, ArH), 7.25-7.28 (m, 2H, ArH), 7.39 (d, J = 1.4 Hz, 
1H, ArH), 7.62 (d, J = 8.3 Hz, 3H, NH+ArH); 13C (100.7 MHz, CDCl3): 9.3 (q), 
47.5 (2q), 95.0 (s), 118.0 (s), 127.8 (d), 128.0 (s), 130.2 (d), 130.4 (d), 131.0 (2d), 
132.8 (s), 135.7 (s), 135.9 (s), 137.6 (2d), 142.9 (s), 144.1 (s), 160.2 (s); HRMS (ESI) 
calc’d for C19H18Cl2IN4O (MH)+ 514.9902, found 514.9905 ( 0.6 ppm). 
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1-(2,4-Dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic 
acid cyclohexylamide 105d 
Entry 4:  
 
Using the typical procedure described in entry 1, pyrazole cyclohexylamide resin 
120d (65 mg, 0.0247 mmol, LL = 0.35 mmol g-1), NaI (18.5 mg, 0.124 mmol) and 
NCS (13.2 mg, 0.099 mmol) were employed. Purification by FC (hexane/EtOAc, 
50/50) gave iodinated pyrazole-3-carboxylic acid cyclohexyl-amide 105d as a white 
solid (7.5 mg, 55 %). 1H NMR (400 MHz, CDCl3): 1.19-1.30 (m, 3H, 3xCH), 
1.35-1.45 (m, 2H, CH2), 1.60-1.66 (m, 1H, CH), 1.72-1.77 (m, 2H, CH2), 1.98-2.01 
(m, 2H, CH2), 2.36 (s, 3H, CH3), 3.89-3.99 (m, 1H, CH), 6.85 (d, J = 8.4 Hz, 3H, 
NH+ArH), 7.29 (s, 2H, ArH), 7.42 (s, 1H, ArH), 7.64 (d, J = 8.4 Hz, 2H, ArH); 13C 
(100.7 MHz, CDCl3): 9.4 (q), 25.0 (2t), 25.6 (t), 33.2 (2t), 47.9 (d), 94.9 (s), 117.7 
(s), 127.9 (d), 128.3 (s), 130.3 (d), 130.6 (d), 131.1 (2d+s), 132.9 (s), 135.9 (s), 137.7 
(2d), 143.1 (s), 145.2 (s), 161.7 (s); HRMS (ESI) calc’d for C23H23Cl2IN3O (MH)+ 
554.0263, found 554.0269 ( 1.1 ppm). 
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1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic 
acid 4-fluorophenylamide 105e  
Entry 5:  
 
Using the typical procedure described for entry 1, pyrazole (4-fluorophenyl)amide 
resin 120e (102 mg, 0.0357 mmol, LL = 0.35 mmol g-1), NaI (26.8 mg, 0.179 mmol) 
and NCS (20.0 mg, 0.15 mmol) were employed. Purification by FC (hexane/EtOAc, 
50/50) gave iodinated pyrazole-3-carboxylic acid (4-fluoro-phenyl)amide 105e as a 
white solid (8.5 mg, 42 %). 1H NMR (400 MHz, CDCl3): 2.42 (s, 3H, CH3), 6.89 
(d, J = 8.3 Hz, 2H, ArH), 7.00-7.07 (m, 2H, ArH), 7.29-7.34 (m, 2H, ArH), 7.45 (d, J 
= 1.8 Hz, 1H, ArH), 7.60-7.65 (m, 2H, ArH), 7.67 (d, J = 8.3 Hz, 2H, ArH), 8.76 (s, 
1H, NH); 13C (100.7 MHz, CDCl3): 9.5 (q), 95.2 (s), 114.9 (s), 115.6 (2d, 2JC-F = 
22.5 Hz), 118.2 (s), 121.4 (2d, 3JC-F = 8.3 Hz), 124.9 (s), 127.9 (d), 130.4 (d), 130.5 
(d), 131.1 (2d), 133.0 (s), 133.8 (s), 135.7 (s), 136.2 (s), 137.8 (2d), 144.2 (d, 1JC-F = 
109.2 Hz), 160.4 (s); 19F NMR (367 MHz, CDCl3): s, 1F); HRMS (ESI) 
calc’d for C23H16Cl2IN3O (MH)+ 565.9699, found 565.9693 ( -1.1 ppm). 
 
1-(2,4-Dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic 
acid piperidin-1-ylamide AM251 (105b) 
Entry 6: 
Using the typical procedure described for entry 1, pyrazole piperidin-1-ylamide resin 
120b (102.1 mg, 0.0429 mmol, LL = 0.42 mmol g-1), NaI (32.1 mg, 0.214 mmol) and 
NCS (22.9 mg, 0.172 mmol) were employed. The reaction mixture was shaken for 5 
min at RT followed by filtration to remove the resin. Purification by PLC 
(hexane/EtOAc, 50/50) gave iodinated pyrazole-3-carboxylic acid 
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piperidin-1-ylamide AM251 (105b) (1.9 mg, 8 %) as a pale yellow solid. Analytical 
data as described previously. 
 
Entry 7: 
The recovered pyrazole piperidin-1-ylamide resin 120b from entry 6 was 
re-subjected to the identical conditions at RT for 5 min. The filtration liquid was 
collected and purified by PLC (EtOAc-Hexane, 50/50) to give iodinated 
pyrazole-3-carboxylic acid piperidin-1-ylamide AM251 (105b) (1.1 mg, 5 %). 
Analytical data as described previously. 
 
HPLC analysis of the crude filtrate obtained from pyrazole piperidin-1-ylamide resin 
120b (Table 3.4.2, entry 2) 
The crude filtrate of iodinated pyrazole 105b was analyzed by HPLC as follows:  
Column: XTerra RP-8, 4.6 mm × 150 mm, 5 μm; Mobile phase: 0.1 % TFA/MeCN : 
H2O = 70 : 30; Flow rate: 1 mL/min; Detection: UV diode array at 250 nm; Injection 
volume: 5 μL.  
The ratio of the peak areas (75 %) was calculated for iodinated product 105b and 
by-product succinimide (Scheme 4.3.1). The three signals for the iodinated product 
105b are attributed to rotameric isomers of this compound (see Section 3.1.3). 
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Scheme 4.3.1. HPLC chromatography of crude filtrate of iodinated 105b. 
 
Si-propyl hydrazine resin 121 
 
To a suspension of Si-propyl bromide resin (0.50 g, LL = 1.43 mmol g-1, 0.715 mmol) 
in DMF (10 mL) was added K2CO3 (0.98 g, 7.1 mmol), NaI (1.07 g, 7.1 mmol) and 
hydrazine hydrate (230 mg, 7.1 mmol, 223 L). The mixture was warmed to 80 oC 
NH
O
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N
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for 24 h. The solvent was then removed by filtration and the resin was washed with 
H2O (3 × 100 mL), EtOH (3 × 100 mL), THF (3 × 100 mL) and CH2Cl2 (3 × 100 
mL). The resulting resin was dried in vacuo at RT for 16 h to furnish Si-hydrazine 
resin 121 as white particles (0.466 g, LL = 1.43 mmol g-1, as determined by the 
weight loss of the resin) ; IR (KBr): 3450 (brs), 3300 (brs), 2950, 1630, 1405, 1110 
cm-1. 
 
Sequential ipso-iododegermylation/succinimide scavenging protocol (Scheme 3.4.10) 
 
Using the typical iodination procedure described above, pyrazole 
piperidin-1-ylamide resin 105b (25.1 mg, 0.0105 mmol, LL = 0.42 mmol g-1), NaI 
(7.9 mg, 0.0527 mmol) and NCS (5.6 mg, 0.042 mmol) were employed. The 
collected organic filtrate was dried in vacuo and re-suspended in EtOH (5 mL) in the 
presence the Si-propyl hydrazine resin 121 (150 mg, 0.215 mmol). The amount of 
succinimide scavenging resin 121 was employed based on the theoretical amount of 
NCS expected to remain. The mixture was then refluxed at 80 oC for 1 h. The resin 
was then filtered off and the filtrate analysed by HPLC. The chromatogram revealed 
a significant improvement in purity (96 %) of the desired product 105b; relative to 
that obtained without the use of the succinimide scavenger resin (Scheme 4.3.2). 
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Scheme 4.3.2. HPLC chromatography of crude filtrate of iodinated 105b after Si-hydrazine resin 121 
treatment. 
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Appendix 1: Solvent purification 
All solvents were distilled before use. Petrol refers to fraction of petroleum-ether 
collected between 40-60 oC. Commercial grade solvents used for flash 
chromatography were used without further purification.  
Anhydrous solvents were obtained as follows: 
 
CH2Cl2          distilled from CaH2 under N2 immediately prior to use. 
1,4-Dioxane            distilled from sodium/benzophenone ketyl under N2 immediately 
prior to use. 
Degassed DMF         N2 gas was purged through DMF for 30 min followed by 
degassed under high vacuum immediately prior to use. 
Et2O            distilled from sodium/benzophenone ketyl under N2 immediately 
prior to use. 
EtOH                 commerically supplied HPLC grade. 
MeCN                commerically supplied HPLC grade. 
MeOH                commerically supplied HPLC grade. 
THF                  distilled from sodium/benzophenone ketyl under N2 immediately 
prior to use. 
Toluene          distilled from sodium under N2 immediately before use. 
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Appendix 2: Reagent purification 
Reagents were used as commercially supplied unless otherwise stated and handled in 
accordance with COSHH regulations. 
 
CBr4                                                                           sublimed immediately under vacuum 0.1 mmHg at 120 oC 
before use 
Cu(BF4)2.nH2O    commercially supplied from Aldrich 
Cu(OTf)2                  commercially supplied from Aldrich 
CuI                           commercially supplied from Aldrich 
C8F17H4I                   commercially supplied from Fluorochem 
C10F21H4I                  commercially supplied from Fluorochem 
Dppp                   commercially supplied from Acros 
GeCl4                        commercially supplied from Aldrich 
Hypogel-OH          commercially supplied from Fluka 
NaI              commercially supplied from Lancaster 
NCS             rapidly re-crystallised from glacial acetic acid and wash with 
cold H2O followed by dried in vacuo. 
Pd(MeCN)2Cl2     commercially supplied from Aldrich 
PPh3                          commercially supplied from Aldrich 
P(2-Tol)3          commercially supplied from Acros 
Si-propyl bromide   commercially supplied from Crawford Scientific 
TBAF.3H2O        commercially supplied from Acros 
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Appendix 3: NMR spectra 
A3.1 1H NMR of Rf-tagged arylgermane 6a (400 MHz, CDCl3) 
 
 
A3.2 13C{1H} and DEPT-135 NMR of 1H NMR of Rf-tagged arylgermane 6a 
(100.7 MHz, CDCl3) 
 
 
6a
C8F17
Ge
OMe
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A3.3 13C{19F} decoupled NMR of Rf-tagged arylgermane 6a (100.7 MHz, CDCl3) 
 
 
A3.4 1H NMR of (E)-styrene 93c (400 MHz, CDCl3) 
 
 
 
 
H
H
Ac
93c (E)- : (Z)- : ()- = 100 : 0 : 0
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A3.5 HSQC of (E)-styrene 93c (500 MHz, CDCl3) 
 
 
A3.6 1H NMR of 1-(4-para-tolylbut-3-enyl)benzene 93e (400 MHz, CDCl3) 
 
 
 
H
H
93e (E)- : (Z)- : ()- = 80 : 8 : 12
Me
(E) 
(Z) 
(α) 
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